National Academies Press: OpenBook
« Previous: Part 1: Assessment Program Profiles and Report Citations
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 311
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 312
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 313
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 314
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 315
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 316
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 317
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 318
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 319
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 320
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 321
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 322
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 323
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 324
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 325
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 326
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 327
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 328
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 329
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 330
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 331
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 332
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 333
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 334
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 335
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 336
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 337
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 338
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 339
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 340
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 341
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 342
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 343
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 344
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 345
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 346
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 347
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 348
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 349
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 350
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 351
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 352
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 353
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 354
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 355
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 356
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 357
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 358
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 359
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 360
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 361
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 362
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 363
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 364
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 365
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 366
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 367
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 368
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 369
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 370
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 371
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 372
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 373
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 374
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 375
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 376
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 377
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 378
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 379
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 380
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 381
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 382
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 383
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 384
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 385
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 386
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 387
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 388
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 389
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 390
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 391
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 392
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 393
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 394
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 395
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 396
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 397
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 398
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 399
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 400
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 401
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 402
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 403
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 404
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 405
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 406
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 407
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 408
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 409
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 410
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 411
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 412
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 413
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 414
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 415
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 416
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 417
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 418
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 419
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 420
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 421
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 422
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 423
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 424
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 425
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 426
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 427
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 428
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 429
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 430
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 431
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 432
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 433
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 434
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 435
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 436
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 437
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 438
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 439
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 440
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 441
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 442
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 443
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 444
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 445
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 446
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 447
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 448
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 449
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 450
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 451
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 452
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 453
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 454
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 455
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 456
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 457
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 458
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 459
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 460
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 461
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 462
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 463
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 464
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 465
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 466
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 467
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 468
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 469
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 470
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 471
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 472
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 473
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 474
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 475
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 476
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 477
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 478
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 479
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 480
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 481
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 482
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 483
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 484
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 485
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 486
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 487
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 488
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 489
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 490
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 491
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 492
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 493
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 494
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 495
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 496
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 497
Suggested Citation:"Part 2: Assessment Report Citations Listed by Technology." Institute of Medicine. 1988. Medical Technology Assessment Directory: A Pilot Reference to Organizations, Assessments, and Information Resources. Washington, DC: The National Academies Press. doi: 10.17226/1090.
×
Page 498

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Part 2 Technoiogy Thesaurus anc! Assessment Report Citations

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Part 2: Assessment Report Citations Listed by Technology This part has two major sections: a 1,200-term technology thesaurus beginning on page 313, and a listing of assessment report citations by technology beginning on page 361. The listing of assessment report citations is arranged according to the terminology set forth in the technology thesaurus. Referring to the technology thesaurus first is the best way to search for assessment report citations by technology. To enhance searching, the thesaurus includes many synonyms, acronyms, and cross- references, and indicates broader and narrower terms to lead users to desired citations. The thesaurus uses the following reference terms: BT NT SEE x _1 . 1 . ~· ~ indicates to the user a broader term under which additional citations may be listed. Most, but not all, BTs have additional citations. Some terms have more than one BT. This is the complementary reference to NT. indicates to the user a narrower term under which additional citations are listed. This is the complementary reference to BT. refers the user to a searchable term, i.e. a synonym or closely related term under which citations are listed, from a non-sear- chable term. This is the complementary reference to x. indicates a non-searchable term, i.e. a synonym or closely related term, from which the user may have been referred to the present searchable term. This is the complementary refer- ence to SEE. SEE ALSO refers the user to a related, though not necessarily synony- mous, searchable term. 312

TECHNOLOGY THESAURUS Abso~pHometry x Radiographic absorptiometry BT Bone mineral studies Dual photon Mingle photon A c e tam i nop hen BT Analgesics An ti pyre tics Acetohydroxamic acid BT Antiurolithics Acidulated phosphate fluoride x APE BT Dental materials Acoustic impedance tests x Tympanometry BT Audiometry tests Activated prothrombin-complex concentrate SEE Anti-inhibitor coagulant complex Acupuncture BT Alternative medicine Pain therapy Acute Physiology and Chronic Health Evaluation SEE APACHE Acyclovir BT Antivirals Adenoidectomy BT Surgery TECHNOLOGY THESAURUS Adhesives NT Bone cements Cyanoacrylates Adjuvant chemotherapy, Breast cancer SEE Chemotherapy Cancer Admission testing, Routine SEE ALSO specific diagnostic tests, procedures, e.g. Radiography Adrenal cortex hormones x Adrenocorticoids Corticosteroids BT Hormones Steroids NT Androgens Estrogens Glucocorticoids Progestins Adrenergic beta receptor blockaders SEE Beta blockers Adrenocorticoids SEE Adrenal cortex hormones Aerosol therapy BT Respiratory therapy SEE ALSO Nebulizers AFP monitoring SEE Alpha fetoprotein assays Maternal serum alpha fetoprotein monitoring AIDS tests SEE HIV detection assays 313

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Albuterol BT Bronchodilators Alclometasone diproprionate Alprostadil BT Anti-inflammatory agents Alternative medicine Glucocorticoids BT Ductus arteriosus patency adjuncts Pro staglan d in s NT Acupuncture Alcohol-abuse deterrents NT Disulfiram Alcoholism screening Allergy-immunology tests BT Diagnostic tests NT Challenge food testing Cytotoxic food testing ELISA Immunoradiometric assays Intracutaneous titration Migration inhibition test Patch tests Amantadine BT Antivirals Ambulances SEE ALSO Intensive care systems, Mobile Ambulatory surgery SEE Surgery- Ambulatory Amcinonide BT Glucocorticoids Amiloride BT Diuretics SEE ALSO Immunoassay systems, Fluorescence Amino acids Allogenic bone marrow transplantation SEE Transplantation-Bone marrow, Aminocaproic acids Allogenic Allopurinol BT Antigout agents Antihyperuricemics Antiurolithics Alpha fetoprotein assays x AFP monitoring Alpha fetoprotein monitoring BT Maternal serum alpha fetoprotein Amox~c~ll~n monitoring BT Antibiotics Oncology tests SEE ALSO Tumor markers Anabollc steroids BT Metabolic and nutrient agents BT Antihemorrhagics Amino glu teth imi de BT Antiadrenals Aminophylline BT Bronchodilators Diuretics SEE ALSO Theophylline Alpha fetoprotein monitoring SEE Alpha fetoprotein assays Maternal serum alpha fetoprotein Analgesla monitoring Alpha receptor blocking agents Analgesics NT Dihydroergotamine Yohimbine Alprazolam BT Antianxiety agents 314 SEE Protein-calorie therapy with anabolic steroids SEE Pain therapy NT Acetaminophen A. . splrln Benoxaprofen Buprenophine Narcotic analgesics

TECHNOLOGY THESAURUS Nonsteroidal anti-inflammatory analgesics Zomepirac sodium SEE ALSO Pain therapy Androgens BT Adrenal cortex hormones Sex hormones Protein-calorie thera~v with anabolic steroids SEE ALSO Anesthesia NT Dental anesthesia Gas scavengers SEE ALSO Anesthetics Epidural Inhalation Anesthetics NT Bupivacaine Etomidate Lidocaine SEE ALSO Anesthesia Angiographic injectors SEE ALSO Angiography Angiography NT Arteriography Digital subtraction angiography Lymphangiography Radionuclide angiography SEE ALSO Angiographic injectors Cardiac catheterization Coronary artery disease diagnosis Angioplasty BT Surgery NT Laser angioplasty Percutaneous transluminal angioplasty SEE ALSO Balloon dilatation catheters Antabuse SEE Disulfiram Anthelmintics BT Antiparasitics NT Niclosamide Praziquantel Antiacne agents NT Isotretinoin Antiadrenals NT Aminoglutethimide Antiallergic agents NT Disodium cromoglycate ~ri ~~~~ Antianxiety agents x Tranquilizers BT NT ~syc~oactlve uru~s Alprazolam Clorazepate Diazepam Halazopam Lactates Lithium Temazepam Triazolam Anti-a'Thythmics NT Digitalis Digoxin Disopyramide Antiarthritics NT Benoxaprofen Esterine Methotrexate Metronidazole Penicillamine Antibacterials BT Antibiotics NT Cephalosporins Chlorhexidine Hexachlorophene Sulfamethoxazole Trimethoprim Andbiotics NT Amoxicillin Antibacterials Antifungal agents Antiparasitics Antiprotozoals Antivirals Azlocillin Bacampicillin Erythromycin Mezlocillin 315

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Metronidazole Nafcillin Piperacillin Silver sulfadiazine ~- · . ~lsomlan Tobramycin Trimethoprim Intravenous -Prophylactic Antibodies SEE Monoclonal antibodies Antibody tests SEE DNA antibody test FIIV detection assays Rubella tests Anticholinergics Anticoagulants NT Heparin Warfarin Anticonvulsants NT Carbamazepine Magnesium sulfate Phenobarbital Phenytoin Primadone Valproate Antidepressants BT Psychoactive drugs NT Trazodone Tryptophan Antidyskinetics NT Levodopa Antifungal agents BT Antibiotics NT Ciclopirox Clotrimazole Econazole Ketoconazole Miconazole nitrate Selenium sulfide Sporicidin Tioconazole 316 Antiglaucoma agents NT Timolol Antigout agents NT Allopurinol Sulfinpyrazone Antihemo'Thagics x FIemostatic drugs NT Aminocaproic acids SEE ALSO Hemostatic materials Antihistamines NT Azatadine Chlorpheniramine Antihyperlipidemic s NT Cholestryamine Gemfibrozil Antihyperprolactinemic s NT Bromocriptine Antihypertensives NT 13ethanidine sulfate Captopril Captopril with hydrochlorothiazide Clonidine Enalapril Guanabenz Guanadrel sulfate Hydralazine Methyldopa Metolazone Nitroprusside Prazosin Reserpine Reserpine with chlorthalidone Saralasin Antihyperuricemics NT Allopurinol Sulfinpyrazone Anti-inflammatory agents NT Alclometasone dipropionate Aspirin Benoxaprofen Dimethyl sulfoxide

TECHNOLOGY THESAURUS And-inhibitor coagulant complex x Activated prothrombin-complex concentrate lProthrombin-complex concentrate Andlymphocyte serum BT Immunosuppressants Antiman~cs NT Lithium Antineoplastics NT Carmustine Cyclophosphamide Dacarbazine Estramustine Interferons Methotrexate Streptozocin Tamoxiphen SEE ALSO Antineoplastics handling Chemotherapy Cancer Antineoplastics handling SEE ALSO Antineoplastics Andparasidcs BT Antibiotics NT Anthelmintics Insecticides Andplatelet therapy Andprotozoal agents BT Antibiotics NT Pyrimethamine Sulfadoxine Antiprur~tics NT Camphor Andpsor~adcs NT Methotrexate Me thoxs al e n SEE ALSO PUVA therapy Antipsychotics BT Psychoactive drugs NT Rubidium Andpyresis SEE ALSO Antipyretics Antipyretics NT Acetaminophen · . . Asp~r~n Benoxaprofen Ibuprofen SEE ALSO Antipyresis Antiseborrheic agents NT Selenium sulfide Andspasmodics NT Oxybutynin chloride with metoclopramide Andthymocyte serum BT Immunosuppressants Antitussives NT Dextromethorphan Antiulcer agents NT Gastric acid secretion inhibitors Sucralfate Antiurolithics NT Acetohydroxamic acid Allopurinol Penicillamine Antivirals BT NT Antibiotics Acyclovir Amantadine Interferons Vidarabine Aortocoronary bypass SEE Coronary artery bypass grafting APACHE x Acute Physiology and Chronic Health Evaluation APF SEE Acidulated phosphate fluoride 317

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Apheresis NT Plasma exchange Plasma perfusion Plas map heres is SEE ALSO Plasma separation systems Apnea monitoring SEE ALSO Apnea monitors Apnea monitors SEE ALSO Apnea monitoring Aspartame Artificial procreation NT In vitro fertilization Artificial sweeteners BT Metabolic and nutrient agents NT Aspartame Saccharin Sorbitol Xylitol Physiologic monitoring BT Artificial sweeteners systems Appetite suppressants NT Diethylpropion Phenylpropranolamine Appointment reminders SEE Reminder systems A· e spleen Assertiveness training Assessment methods Appropriateness Evaluation Protocol NT Clinical trials Arrhythmia monitoring BT Electrocardiography SEE ALSO Arrhythmia monitors Arrhythmia monitors SEE ALSO Arrhythmia monitoring Arteriography BT Angiography NT Ultrasound Arteries Arthritis tests BT Analgesics Antlpyretlcs Anti-inflammatory agents Cost benefit/effectiveness analysis Double blinding Postmarketing surveillance Asthma prophylactics NT Disodium cromoglycate Atenolol BT Beta blockers Attention deficit disorder therapy SEE Methylphenidate SEE Rheumatology tests Audiometry tests Arthroscopy BT Endoscopy Artificial heart BT Circulatory assistance Artificial hip SEE Hip joint replacement Hip prothesis Artificial intelligence SEE Expert systems Artificial pancreas 318 BT Diagnostic tests NT Acoustic impedance test Autologous blood transfusion SEE Blood transfusion Autologous Autologous bone marrow transplantation SEE Transplantation Bone marrow, Autologous Automated microbiology systems Automobile passenger restraints x Car seats Seat belts (Automobile)

TECHNOLOGY THESAURUS Autopsy Autotransfusion units BCNU BT Blood transfusion systems BEAM Aversion therapy Azatadine BT Antihistamines Azathioprine BT Immunosuppressants Azlocillin BT Antibiotics B-mode scanning SEE Ultrasonography Bacampicillin BT Antibiotics Bacterial antigens Balance training devices Balloon angioplasty SEE Percutaneous transluminal angioplasty Balloon dilatation catheters x Dilatation catheters SEE ALSO Angioplasty Percutaneous balloon valvuloplasty Bar codes Barbiturates BT Sedatives SEE Carmustine SEE Brain electrical activity mapping Beclomethasone BT Glucocorticoids Beds, Electric Behavioral disorders screening Behavioral therapy Bendien's test BT Oncology tests Benoxaprofen BT Analgesics Antiarthritics Anti-inflammatory agents Antipyretics Bentonite flocculation test x DNA-bentonite flocculation test BT Rheumatology tests Benzyl alcohol Beta blockers x Adrenergic beta receptor blockaders NT Atenolol Labetalol Metoprolol Nadolol Oxprenolol Pindolol Propranolol Beta-carotene Barium enema with sigmoidoscopy SEE ALSO Vitamin A SEE ALSO Cancer screening, Colorectal Sigmoidoscopy Betamethasone Batteries, Electric BCG immunotherapy BT Immunotherapy Cancer BCG vaccine BT Vaccines BT Glucocorticoids Bethanidine sulfate BT Antihypertensives 319

MEDICAL ~C~OL~Y ASSESSMENT DI~CTORY Bibliographic information bases Blood cultures x Computer databases Databases BT Infectious disease tests BT Information systems Blood gas monitoring NT CHEMLINE HISTLINE MEDLINE TOXLINE SEE ALSO Computer-assisted instruction Computer-assisted patient care Data banks Te e rammg Bicap probe treatment SEE Endoscopy and electrocoagulation Bilio-pancreatic bypass BT Surgery Morbid obesity Bilirubinometers Biochemical analyzers SEE ALSO Biochemical profiles Biochemical profiles BT Diagnostic tests SEE ALSO Biochemical analyzers Biofeedback x Electromyographic biofeedback Biopsy BT Diagnostic tests Surgery Endometrial -Fetal blood Renal Blood banks SEE ALSO Blood transfusion Blood cell count BT Cell counts Hematology tests Blood chemistry analyzers SEE ALSO Blood gas monitors Blood glucose monitors 32O BT Cardiopulmonary tests SEE ALSO Blood gas monitors Blood gas monitors x Carbon dioxide monitors NT Oximeters SEE ALSO Blood chemistry analyzers Blood gas monitoring Oxygen analyzers Blood glucose control devices SEE ALSO Blood glucose monitors Blood glucose monitoring BT Endocrinology-metabolism tests SEE ALSO Blood glucose monitors Blood glucose monitors SEE ALSO Blood chemistry analyzers Blood glucose control devices Blood glucose monitoring Blood pressure monitoring x Sphygmomanometry SEE ALSO Blood pressure monitors Blood pressure monitors x Sphygmomanometers SEE ALSO Blood pressure monitoring Physiologic monitoring systems Blood substitutes Blood transfusion BT Transfusion SEE ALSO Blood banks Autologous Blood transfusion systems Blood transfusion systems Infectious disease tests NT Autotransfusion units SEE ALSO Blood transfusion Granulocyte transfusion

TECHNOLOGY THESAURUS Blood urea concentration BT Kidney function tests Blood warners Bolen's test BT Oncology tests Bone cements BT Adhesives SEE ALSO Bone prosthesis {oint prosthesis Bone densitometry SEE Bone mineral studies Bone growth stimulation x Electrical stimulation-Bone growth SEE ALSO Bone growth stimulators Bone growth stimulators SEE ALSO Bone growth stimulation Bone marrow transplantation Bronchodilators Breast cancer screening SEE Cancer screening Breast Breast feeding Breast imaging NT Mammography Thermography Breast Transillumination- Breast Ultrasonography-B reast SEE ALSO Breast physical examination Cancer screening-Breast Breast physical examination SEE ALSO Breast imaging Cancer screening-Breast Breath tests BT Gastroenterology tests Bromocriptine BT Antihyperprolactinemics SEE Transplantation Bone marrow NT Albuterol Bone mineral studies x Bone densitometry Densitometry Photode nsito me try Radiogrammetry Aminophylline Ephedrine Iodide therapy Theophylline Bumetanide BT Diuretics BT Endocrinology-metabolism tests NT Absorptiometry Computed tomography Bone Bupivacaine mineral BT Anesthetics Bone prosthesis SEE ALSO Bone cements Joint prosthesis Boston elbow SEE Elbow prosthesis Botulinum toxin BT Neurotoxins Brain electrical activity mapping x BEAM SEE ALSO Electroencephalography Evoked potentials Buprenorphine BT Analgesics Burn units SEE ALSO Supportive care Bypass graft materials CABG CAD SEE Coronary artery bypass grafting SEE Computer-aided design 321

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Caerulein CAI Capsule method x Ceruletide BT Diagnostic agents Captopril BT Antihypertensives SEE Computer-assisted instruction Calcium channel blockers NT Diltiazem Nifedipine Verapamil Calcium chloride BT Metabolic and nutrient agents Camphor BT Antipruritics Cancer screening SEE ALSO Oncology tests Breast SEE ALSO Breast imaging Breast physical examination Cervical SEE ALSO Pap smear olorectal SEE ALSO Barium enema with sigmoidoscopy Colonoscopy Sigmoidoscopy Stool guaiac Lung Cannabis x Marijuana CAPD Capitation payment x Prepayment SEE ALSO Competition Card~o~nte~ram Health maintenance ~ . . . organizations Incentive payment Prospective payment systems 322 Captopril with hydrochlorthiazide BT Antihypertensives SEE ALSO Hydrochlorthiazide Car seats SEE Automobile passenger restraints Carbamazepine BT Anticonvulsants Carbon dioxide laser surgery SEE Laser surgery-Carbon dioxide Carbon dioxide lasers SEE Lasers-Carbon dioxide Carbon dioxide monitors SEE Blood gas monitors Carcinoembryonic antigen assays x CEA BT Oncology tests SEE ALSO Tumor markers Cardiac catheterization x Heart catheterization BT Surgery-Heart SEE ALSO Angiography Catheters Cardiac enzyme assays BT Cardiopulmonary tests Cardiac monitors x Heart monitors NT Electrocardiographs SEE Continuous ambulatory peritoneal Cardiac pacemakers · SEE ALSO Circulatory assistance dialysis Cardiac rehabilitation BT Rehabilitation BT Coronary artery disease dignosis SEE ALSO Electrocardiography

TECHNOLOGY THESAURUS Cardiokymography x Electrokymography SEE ALSO Coronary artery disease diagnosis Cardiopulmonary tests BT Diagnostic tests NT Blood gas monitoring Cardiac enzyme assays Cephradine . . . ~ rgonov~ne provocative testing Lipoprotein evaluation Carmusdne x BCNU BT Antineoplastics Carotid body resection BT Surgery Carotid endarterectomy BT Surgery Case management CAT scanners SEE Computed tomography scanners CAT scans SEE Computed tomography Cataract extraction BT Surgery Eye SEE ALSO Corneal endothelial cell microscopy Catheters CEA NT Dilatation catheters SEE ALSO Cardiac catheterization Chelation therapy SEE Carcinoembryonic antigen assays Cefotaxime BT Cephalasporins Cell counters NT Leukocyte differential counters SEE ALSO Cell counts Cell counts BT Diagnostic tests NT Blood cell count SEE ALSO Cell counters Centrifuges Cephalosporins BT Antibacterials NT Cefotaxime Cephradine Moxalactam BT Cephalasporins Cerebral artery anastomosis BT Surgery SEE ALSO Extracranial-intracranial arterial bypass Cerebrospinal fluid shunt valves Ceruletide SEE Caerulein Cervical cancer screening SEE Cancer screening-Cervical Cervical cap BT Contraception Cervical dilators Cesarean section BT Surgery Challenge food testing x Provocation tests BT Allergy-immunology tests SEE ALSO Cytotoxic food testing Deferoxamine x FIemoperfusion with deferoxamine EDTA Penicillamine SEE ALSO Penicillamine Chemical Dictionary Online SEE CHEMLINE 323

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY CHEMLINE x Chemical Dictionary Online BT Bibliographic information bases Chymopapain MEDLARS Chemonucleolysis x Enzyme therapy SEE ALSO Chymopapain Chemonucleolytics NT Chymopapain Chemotherapy~ancer ~1. . ~ Ciclopirox Cimetidine Cine-CT x ^aguvant cnemotherapy, ~reast cancer SEE ALSO Antineoplastics In vitro chemosensitivity Cingulotomy testing BT Surgery Chlorhexidine BT Antibacterials C hl orpheni ram in e BT Antihistamines Chlorthalidone BT Diuretics SEE ALSO Reserpine with chlorthalidone BT Surgery Cholangiography Chromatogenesis assist devices BT Chemonucleolytics SEE ALSO Chemonucleolysis BT Antifungal agents BT Histamine Hz-receptor antagonists BT Computed tomography Circulatory assistance NT Artificial heart External counterpulsation Intra-aortic balloon pumps Ventricular assist devices SEE ALSO Cardiac pacemakers C. · - 1rcumclslon Citrates SEE ALSO Cholangiopancreatography SEE Potassium citrate Cholecystography Cholan~iopancreatoaraphy Clinical ecology _ ~ . , x Endoscopic retrograde Clinical trials cholangiopancreatography ERCP BT Gastroenterology tests SEE ALSO Cholangiography Cholecystography Cholecystectomy BT Surgery Cholecystography SEE ALSO Cholangiography Clotrimazole BT Assessment methods -Randomized Clonidine BT Antihypertensives Clorazepate BT Antianxiety agent Cholangiopancreatography BT Antifungal agents Cholestryamine BT Antihyperlipidemics Chorionic villi sampling BT Genetic screening 324 Coaguladon assays BT Hematology tests NT Partial thromboplastin time Prothrombin time

TECHNOLOGY THESAURUS Cochlear implantation BT Surgery SEE ALSO Cochlear implants Cochlear implants SEE ALSO Cochlear implantation Hearing aids Cochleostomy BT Surgery Codeine NT Narcotic analgesics Cognitive therapy Collagen implants BT Surgery Colonoscopy BT Gastrointestinal endoscopy SEE ALSO Cancer screening Colorectal Colorectal cancer screening SEE Cancer screening-Colorectal Computer-aided design Communication aids for the handicapped x CAD Communication systems NT Emergency communications systems Satellite communication Telemetry SEE ALSO Information systems Community health centers Competition NT Competitive bidding SEE ALSO Capitation payment Prospective payment systems Competitive bidding BT Competition Computed tomography x CAT scans CT scans Tomography, X-ray computed BT Radiography NT Cine-CT Dual-energy scanned projection radiography SEE ALSO Computed tomography scanners SPECT imaging Stereotactic neurosurgery, Computed tomography- ass~sted Bone mineral assessments BT Bone mineral studies Head -Liver and spleen -Pancreas Opine Computed tomography scanners x CAT scanners CT scanners Tomographic scanners BT Radiographic equipment SEE ALSO Computed tomography Computer-assisted instruction x CAI BT Information systems SEE ALSO Bibliographic information bases Computer-assisted patient care Computer equipment Computer software Computer-assisted padent care NT Decision support systems Expert systems SEE ALSO Bibliographic information bases Computer-assisted education Computer equipment Data banks Medical record systems Computer databases SEE Bibliographic information bases Data banks 325

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Computer equipment x Decision support systems SEE ALSO Computer-assisted education Computer-assisted patient care Computer software Expert systems MEDLINE-Optical disks Computer software SEE ALSO Computer equipment Contact lens cleaners SEE ALSO Contact lenses Contact lens lubricants SEE ALSO Contact lenses Contact lens markers SEE ALSO Contact lenses Contact lenses NT Contact lenses, Hydrophilic SEE ALSO Contact lens cleaners Contact lens lubricants Contact lens markers Contact lenses, Hydrophilic BT Contact lenses Continuing medical education SEE Physician education Continuous ambulatory peritoneal dialysis x CAPD BT Peritoneal dialysis Continuous arteriovenous hemofiltration SEE Hemofiltration Continuous passive motion devices SEE ALSO Continuous passive motion therapy Continuous passive modon therapy Coronary care units BT Exercise therapy SEE ALSO Continuous passive motion devices Continuous positive airway pressure Corticosteroids - x CPAP BT Respiratory therapy 326 Contraception NT Cervical cap Oral contraceptives Tubal ligation SEE ALSO Estrogens Contralateral breast surgery BT Surgery Breast Contrast media SEE Radiographic contrast dyes Cornea transplantation SEE Transplantation-Cornea Corneal endothelial cell microscopy SEE ALSO Cataract extraction Corneal grafts BT Surgery Eye Coronary artery bypass grafting x Aortocoronary bypass CABG Coronary artery surgery BT Surgery Heart Coronary artery disease diagnosis SEE ALSO Angiography Cardiointegram Cardiokymography Echocardiography Electrocardiography ~ . Erase tests Photokymography Ultrasound-Cardiac output Coronary artery jeopardy score Coronary artery surgery SEE Coronary artery bypass grafting Percutaneous transluminal coronary angioplasty Coronary care units, Mobile SEE Intensive care systems, Mobile SEE Adrenal cortex hormones

TECHNOLOGY THESAURUS Cost benefit/effectiveness analysis BT Assessment methods Counseling CPAP NT Genetic counseling Nutritional counseling Peer group counseling Cytotoxic tests SEE Continuous positive airway pressure CPT~ codes x Current Procedural Terminology Cytoxan Creatinine concentration, Serum x Serum creatinine concentration Dacarbazine BT Kidney function tests x DTIC BT Antineoplastics Cromolyn sodium SEE Disodium cromoglycate DAY Cryometers SEE ALSO Cryopreservation Darkrooms Cryonreservation Cryosurgery Cytotoxic food testing BT Allergy-immunology tests Cytotoxic tests SEE ALSO Challenge food testing BT Diagnostic tests NT Cytotoxic food testing Hair analysis Micronucleus test SEE Cyclophosphamide SEE Discretionary adjustment factor SEE Radiographic darkrooms SEE ALSO Cryometers Databanks x Computer databases Databases BT Surgery Arrhythmias CT scanners SEE Computed tomography scanners CT scans SEE Computed tomography Current Procedural Terminology SEE CPT-4 codes Cushions Cyanoacrylates BT Adhesives Cyclophosph~nide x Cytoxan BT Antineoplastics Cyclothiazide BT Diuretics SEE ALSO Bibliographic information bases Computer-assisted patient care Information systems Registries Databases Day care SEE Bibliographic information bases Data banks Debridement BT Surgery n oeaslon support systems SEE Computer-assisted patient care Computer equipment Information systems Decubitus surgery BT Surgery 327

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Deferoxamine SEE Chelation therapy-Deferoxamine Defibrillation SEE ALSO Defibrillators Defibrillators SEE ALSO Defibrillation Densitometry SEE Bone mineral studies Dental resins Dental alloys BT Dental materials Dental amalgam BT Dental materials SEE ALSO Dental amalgamators Dental sealants Dental amalgamators x Dental equipment SEE ALSO Dental amalgam Dental anesthesia BT Anesthesia Dental bonding SEE ALSO Dental resins Dental bridges Dental caries removal systems Dental ceramics BT Dental materials Dental crowns Dental equipment SEE Dental amalgamators Dental scaling and stain-removal devices Dental sterilization devices Dental visible light-curing units Dental implants x Osseointegrated implants Dental materials NT Acidulated phosphate fluoride Dental alloys Dental amalgam Dental ceramics 328 Dental resins Dental sealants Fluoride varnishes Toothpaste Dental radiography x Radiography, Dental X-rays, Dental NT Radiopaque plastics BT Dental materials SEE ALSO Dental bonding Dental scaling and stain-removal devices x Dental equipment BT Dental materials Dental sterilization devices x Dental equipment Dental visible light-curing units x Dental equipment Denture cleansers Dentures Depo-Provera SEE Medroxyprogesterone Desoximetasone BT Glucocorticoids Detoxification NT Hubbard method Developmental disabilities screening Dexamethasone BT Glucocorticoids SEE ALSO Dexamethasone suppression test Dexamethasone suppression test BT Endocrinology-metabolism tests SEE ALSO Dexamethasone Dextromethorphan BT Antitussives

TECHNOLOGY THESAURUS Dextrose Diaphanography BT Metabolic and nutrient agents SEE Transillumination Dextrose with saline solution Diathermy BT Metabolic and nutrient agents Diagnosis related groups SEE DRGs Diagnostic agents NT Caerulein Isosulfan blue Secretin SEE ALSO Radiographic contrast dyes Radiopharmaceu ticals Diagnostic imaging NT Magnetic resonance imaging Positron emission tomography Radionuclide imaging Radiography Thermography Transillumination Ultrasonography Diazepam BT Antianxiety agents Diet therapy NT Sodium restriction Protein-calorie therapy with anabolic steroids SEE ALSO Food diaries Heal bypass with diet therapy Infant foods Nutritional counseling Diethylpropion BT Appetite suppressants Dillunisal SEE ALSO specific anatomical sites, e.g. Digital imaging Angiography; Breast imaging Diagnostic tests NT Allergy-immunology tests Audiometry tests Biochemical profiles Biopsy Cardiopulmonary tests Digital radiography Cell counts Cytotoxic tests Endocrinology-metabolism tests Fertility tests Gastroenterology tests Genetic tests Hematology tests Infectious disease tests Kidney function tests Microbiological testing systems Oncology tests Rheumatology tests Seromucoid assays Dialysis NT Hemodialysis Peritoneal dialysis BT Nonsteroidal anti-inflammatory analgesics x Digital radiography NT Digital subtraction angiography Dual-energy scanned projection radiography SEE ALSO Picture archiving and communication systems Radiography SEE Digital imaging Digital subtraction angiography x DSA BT Angiography Digital imaging Digitalis BT Anti-arrhythmics Digoxin BT Anti-arrhythmics Dihydroergotamine BT Alpha receptor blocking agents Vascular headache suppressants 329

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Dilatation and curettage BT Surgery Dilatation catheters SEE Balloon dilatation catheters Diltiazem BT Calcium channel blockers Dimethyl sulfoxide x DMSO BT Anti-inflammatory agents Dipyridamole x Persantine BT Vasodilators Discography BT Radiography Discretionary adjustment factor x DAF BT Prospective payment systems Double blinding SEE ALSO DRGs Dosimetry Disodium cromoglycate x Cromolyn sodium BT Antiallergic agents Asthma prophylactics Disopyramide DRGs BT Anti-arrhythmics Drug costs Disposables reuse SEE Reuse of disposables Disulfiram x Antabuse BT Alcohol-abuse deterrents Drug ordering Diuretics NT Amiloride Aminophylline Bumetanide Chlorthalidone Cyclothiazide Furosemide Hydrochlorthiazide Metolazone Triamterene 33O DMSO SEE Dimethyl sulfoxide DNA antibody test x Antibody tests BT Rheumatology tests DNA-bentonite flocculation test SEE Bentonite flocculation test Doman-Delacato treatment BT Physical therapy Dopamine BT Vasopressors Doppler ultrasound SEE Ultrasound SEE Radiation measurement BT Assessment methods x Diagnosis related groups SEE ALSO Discretionary adjustment factor Prospective payment systems Drug labeling Drug monitoring SEE Therapeutic drug monitoring x Drug prescribing Prescribing Drug preparation NT Ethanol Drug prescribing SEE Drug ordering Drug regulation DSA SEE Digital subtraction angiography

TECHNOLOGY THESAURUS DTIC SEE Dacarbazine Dual-energy scanned projection radiography BT Computed tomography Digital imaging Ductus arteriosus patency adjuncts NT Alprostadil ECG SEE Electrocardiography Echocardiography BT Ultrasonography SEE ALSO Coronary artery disease diagnosis SEE Bone growth stimulation Cardiac ~erebellar Cerebral palsy Cranial Facial nerve palsy Muscular -Neural Neuromuscular coliosis Echocine SEE Ultrasonography Spinal ECMO SEE Extracorporeal membrane Electrical shmulators oxygenation SEE ALSO Bone growth stimulators Electrical stimulation Econazole BT Antifungal agents ECT SEE Electroconvulsive therapy Edinburgh masker EDTA SEE Chelation therapy EDTA Electrocardiographs NT Cardiac monitors SEE ALSO Electrocardiography Physiologic monitoring systems Electrocardiography x ECG EKG NT Arrhythmia monitoring EEG FIolter monitoring SEE Electroencephalography Minnesota Q-Q codes Ventricular mapping, Intraoperative EKG SEE ALSO Coronary artery disease SEE Electrocardiography diagnosis Cardiointegram Elbow prosthesis Electrocardiographs x Boston elbow BT Joint prosthesis Electrocoaguladon Electrical shmulation NT Transcutaneous electrical nerve stimulation SEE ALSO Electrical stimulators Bone growth BT Surgery SEE ALSO Laser photocoagulation Electroconvulsive therapy x ECT 331

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Electroencephalographs SEE ALSO Electroencephalography BT NT Electroencephalography x EEG SEE ALSO Brain electrical activity mapping Electroencephalographs Evoked potentials Stereotaxic depth electrode . . imp antat~on Topographic brain mapping Electrokymography SEE Cardiokymography Electrolyte ~njechon BT Metabolic and nutrient agents E 1 e c t r o m y o g r a p h i c b i o f e e d b a c k E n d o s c o p y SEE Biofeedback BT NT Electronystagmography Electrosurgery BT Surgery SEE ALSO Electrosurgical devices Electrosurg~cal devices SEE ALSO Electrosurgery Electroversion therapy ELISA Endocr~nology-metabolism tests Diagnostic tests Blood glucose monitoring Bone mineral studies Dexamethasone suppression test Hydroxycholecalciferol level Thyroxine assays Vitamin B12 assay ~- SEE ALSO Endoscopy Endoscopic retrograde cholangiopancreatography SEE Cholangiopancreatography Endoscopic retrograde sphincterotomy SEE Sphincterotomy Surgery Arthroscopy Esophagoscopy Fetoscopy Gastrointestinal endoscopy Hysteroscopy Ureteroscopy Endoscopy and electrocoagulation x Bicap probe treatment Endothelial cell photography x Specular microscopy x Enzyme-linked immunosorbent assay Enteral nutrition BT Allergy-immunolgy tests Embolotherapy SEE Therapeutic embolization Emergency commun~cation systems BT Communication systems Emergency kits SEE ALSO Emergency services First aid Emergency services SEE ALSO Enteral nutrition pumps Enteral nutrition pumps SEE ALSO Enteral nutrition Metabolic and nutrient agents Enzyme-albumin polymers x Enzyme therapy Enzyme-linked immunosorbent assay SEE ELISA Enzyme therapy SEE ALSO Emergency kits SEE Chemonucleolysis Enalapr'1 BT Antihypertensives 332 Enzyme-albumin polymers Hyaluronidase

TECHNOLOGY THESAURUS Ephedrine BT Bronchodilators Epikeratophakia BT Keratoplasty EACH Ethanol BT Drug preparation Ethynodiol diacetate with ethinyl estradiol BT Oral contraceptives Etomidate SEE Cholangiopancreatography BT Anesthetics Ergonovine provocative testing Evoked potentials BT Cardiopulmonary tests x Visual evoked potentials SEE ALSO Brain electrical activity mapping Electroencephalography Ericsson sex selection method x Sex selection ERS SEE Sphincterotomy Erythrocyte sedimentation rate BT Hematology tests Erythromycin BT Antibiotics Esophageal pH monitoring BT Gastroenterology tests Esophageal reflux surgery SEE Surgery Esophageal reflux Esophagoscopy BT Endoscopy Esterine x Antiarthritics Estramustine BT Antineoplastics Estrogen replacement therapy BT Hormone therapy SEE ALSO Estrogens Estrogens BT Adrenal cortex hormones Sex hormones SEE ALSO Estrogen replacement therapy Oral contraceptives ESWL SEE Lithotripsy Extracorporeal shock wave Exercise tests x Stress tests SEE ALSO Coronary artery disease diagnosis Exercise therapy BT Physical therapy NT Continuous passive motion SEE ALSO Physical therapy with home exercise Expert system evaluation SEE ALSO Expert systems Expert systems x Artificial intelligence BT Computer-assisted patient care SEE ALSO Computer equipment Expert system evaluation Information systems Medical record systems External counterpulsation BT Circulatory assistance Extracorporeal membrane oxygenation x ECMO Extracorporeal shock wave lithotripsy SEE Lithotripsy Extracorporeal shock wave Extracranial-intracranial arterial bypass BT Surgery SEE ALSO Cerebral artery anastomosis 333

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Eye surgery Eyeglasses SEE Surgery-Eye BT Vision aids Fat emulsions SEE Intravenous fat emulsions Fertility tests BT Diagnostic tests NT Sperm penetration assay Food irradiation F·1- . . . ertlllzatlon In vitro SEE In vitro fertilization Fetal monitoring SEE ALSO Fetal monitors Fetal monitors SEE ALSO Fetal monitoring Fetal shunts Fluoroscopy BT Radiography SEE ALSO Fluoroscopy units Fluoroscopy units BT Radiographic equipment SEE ALSO Fluoroscopy Food diaries SEE ALSO Diet therapy Fructose BT Metabolic and nutrient agents Functional tests Furosemide BT Diuretics Gait assessment SEE ALSO Surgery-Fetal Gamma cameras Fetal surgery SEE Surgery Fetal Fetoscopy BT Radionuclide imaging Gammaglobulin, Total serum SEE Kunkel test BT Endoscopy SEE ALSO Genetic screening SEE Gastric bubble F.. . . 'armogen scanning First aid Fish oils x Omega-3 fatty acids Flagyl SEE Metronidazole Flexible sigmoidoscopy SEE Sigmoidoscopy Fluid therapy SEE Oral rehydration therapy Fluoride varnishes BT Dental materials 334 Garren gastric bubble Gas scavengers BT Anesthesia SEE ALSO Emergency kits Gastric acid secretion inhibitors Heimlich maneuver BT Antiulcer agents NT Histamine Hz-receptor antagonists Secretin Gastric balloon dilatation Gastric bubble x Garren gastric bubble Gastric freezing Gastric restrictive surgery BT Surgery-Morbid obesity

TECHNOLOGY THESAURUS Gastroenterology tests BT Diagnostic tests NT Breath tests Genetic toxicology tests BT Genetic tests Cholangiopancreatography Glaucoma screening Esophageal pH monitoring BT Vision screening Rehfuss test SEE ALSO Perimetry Tonometry Gastroesophageal antireflux prosthesis BT Prostheses Gastro-ileal bypass BT Surgery-Morbid obesity Gastrointestinal endoscopy BT Endoscopy NT Colonoscopy Sigmoidoscopy Gemfibrozil BT Antihyperlipidemics Generators, Electric Genetic complementation test BT Genetic tests Genetic counseling Glucocorticoids BT Adrenal cortex hormones NT Alclometasone dipropionate Amcinonide Beclomethasone Betamethasone Desoximetasone Dexamethasone Hydrocortisone Glutathione disulfides BT Metabolic and nutrient agents Glyceryl trinitrate x Nitroglycerin BT Vasodilators Gonadorelin hydrochloride BT Pituitary and hypothalmic hormones BT Counseling SEE ALSO Genetic screening Granulocyte transfusion BT Transfusion ~ · · - wenet~c eng~neer~ng SEE ALSO Interferons Growth hormone Monoclonal antibodies SEE Human growth hormone Genetic screening BT Genetic tests NT Chorionic villi sampling Hemoglobinopathies screening Maternal serum alpha fetoprotein . . mon~tor~ng Hypothyroidism screening, Neonatal Hair analysis Phenylketonuria screening BT Cytotoxic tests SEE ALSO Fetoscopy Guanabenz BT Antihypertensives Guanadrel sulfate BT Antihypertensives Genetic tests Genetic counseling Halazepam BT Diagnostic tests NT Genetic complementation tests Genetic screening Genetic toxicology tests Somatic cell mutation tests Health insurance BT Antianxiety agents Health examination x Medical evaluation Physical examination NT Unbundling 335

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Health maintenance organizations Hemofiltration x HMOs SEE ALSO Capitation payment Health promotion x Disease prevention Hearing aids SEE ALSO Cochlear implants - Use Heart catheterization SEE Cardiac catheterization Heart-lung transplantation SEE Transplantation Heart-lung Heart monitors SEE Cardiac monitors Heart surgery SEE Surgery Heart Heart transplantation SEE Transplantation Heart Heart valve implantation SEE ALSO Heart valve prosthesis Heart valve prosthesis SEE ALSO Heart valve implantation Heavy-ion irradiation SEE Radiation therapy Heimlich maneuver SEE ALSO First aid Hematology tests BT Diagnostic tests NT Blood cell count Coagulation assays Erythrocyte sedimentation rate Hemoglobin A1C measurements Hemoglobinopathies screening Hemodialysis BT Dialysis SEE ALSO Chelation therapy- Deferoxamine Hemofiltration 336 x Continuous arteriovenous hemofiltration SEE ALSO Hemodialysis Hemoglobin A1C measurements BT Hematology tests Hemoglobinopathies screening x Sickle cell screening BT Genetic screening Hematology tests Hemoperfusion with deferoxamine SEE Chelation therapy Deferoxamine Hemophilus influenza type B vaccine x HiB vaccine BT Vaccines Hemostatic drugs SEE Antihemorrhagics Hemostatic materials SEE ALSO Antihemorrhagics Heparin BT Anticoagulants Hepatitis B tests BT Infectious disease tests Hepatitis B vaccine SEE Viral hepatitis vaccine Herpes simplex infection screening, Neonatal Hexachlorophene BT Antibacterials HGH SEE Human growth hormone HiB vaccine SEE Hemophilus influenza type B vaccine Hip joint replacement x Artificial hip Total hip joint replacement BT Surgery SEE ALSO Hip prosthesis

TECHNOLOGY THESAURUS Hip prosthesis x Artificial hip BT Joint prosthesis SEE ALSO Hip joint replacement Histamine Hz-receptor antagonists BT Gastric acid secretion inhibitors NT Cimetidine Ranitidine Histamine therapy HISTLINE History of Medicine Online SEE HISTLINE HIV detection assays x AIDS tests Antibody tests HTLV III antigen detection assays BT Infectious disease tests HMOs SEE Health maintenance organizations Hydrocortisone Holter monitoring BT Glucocorticoids BT Electrocardiography Hydromorphone Home care Hormone therapy NT Estrogen replacement therapy SEE ALSO Hormones Hormones Hospice Hostel NT Adrenal cortex hormones Pituitary and hypothalmic hormones Secretin Sex hormones SEE ALSO Hormone therapy HTLV III antigen detection assays Hypnosis SEE HIV detection assays Hubbard method BT Detoxification Human growth hormone x Growth hormone HGH Somatotropin BT Pituitary and hypothalmic hormones Human milk banking Humidifiers x History of Medicine Online Hyaluronidase BT Bibliographic information bases BT Enzyme therapy MEDLARS H ybri doma s ~ Aft SEE ALSO Monoclonal antibodies Hydralazine BT Antihypertensives Hydrochlorothiazide BT Diuretics SEE ALSO Captopril with hydrochlorothiazide BT Narcotic analgesics Hydrotherapy x Whirlpool baths Hydroxycholecalciferol level x 25 hydroxyvitamin D level BT Endocrinology-metabolism tests Hyperbaric oxygen therapy BT Oxygen therapy Hyperthermia systems SEE ALSO Hyperthermia therapy Hyperthermia therapy SEE ALSO Hyperthermia systems SEE ALSO Hypnotic drugs 337

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Hypnotic drugs BT Psychoactive drugs NT Methaqualone Phenobarbital SEE ALSO Hypnosis Hypothyroidism screening, Neonatal Hysterectomy BT Surgery Hysteroscopy BT Endoscopy ll~uprofen Ileal bypass BT Antipyretics Nonsteroidal anti-inflammatory analgesics BT Surgery- Morbid obesity SEE ALSO Ileal bypass and diet therapy Ileal bypass and diet therapy In vitro fertilization SEE ALSO Diet therapy Ileal bypass I. magma centers SEE ALSO Radiography Immunotherapy Cancer NT BCG immunotherapy Impedance plethysmography SEE Plethysmography Impotence diagnosis NT Papaverine SEE ALSO Plethysmography Impotence surgery SEE Surgery Impotence Impotence treatment NT Papaverine Yohimbine In vitro chemosensitivity testing SEE ALSO Chemotherapy Oncology testing F.~. . . . x ert~zat~on In vitro BT Artificial procreation Incentive payment SEE ALSO Capitation payment Immunoassay systems, Fluorescence Incentive spirometry SEE ALSO Allergy-immunology tests Immunologic diagnostic tests Incontinent pads SEE Allergy-immunology tests Incubator therapy BT Respiratory therapy Immunoradiometric assay with monoclonal SEE ALSO Incubators antibodies BT Immunoradiometric assays Incubators SEE ALSO Monoclonal antibodies Immunoradiometric assays x Radioimmunoassays BT Allergy-immunology tests NT Immunoradiometric assay with monoclonal antibodies ~Induction of labor Ract~oallergosorbent test Immunosuppressants NT Antilymphocyte serum Antithymocyte serum Azathioprine 338 SEE ALSO Incubator therapy Radiant warmers Indomethacin BT Nonsteroidal anti-inflammatory analgesics Infant foods BT Metabolic and nutrient agents SEE ALSO Diet therapy Infectious disease tests BT Diagnostic tests NT Blood cultures Hepatitis B tests

TEC~OLOGY THESAURUS HIT detection assays Rubella tests Syphilis tests Throat cultures Urinalysis Influenza vaccine BT Vaccines Information systems x Decision support systems Online information systems NT Bibliographic information bases Computer-assisted instruction Medical record systems MEDLARS Reminder systems SEE ALSO Communication systems Data banks Expert systems Infusion controllers SEE Infusion pumps Infusion pumps x Infusion controllers Insulin delivery devices Insulin pumps External Implantable Injury severity scales Insecticides BT Antiparasitics NT Malathion Insulin Insulin delivery devices SEE Infusion pumps Insulin injection Insulin pumps SEE Infusion pumps Intensive care NT Neonatal intensive care SEE ALSO Intensive care systems, Mobile Physiologic monitoring systems Intensive care systems, Mobile x Coronary care units, Mobile Mobile intensive care systems SEE ALSO Ambulances Intensive care Interferons BT Antineoplastics Antivirals SEE ALSO Genetic engineering Intermittent positive pressure breathing x IPPB BT Respiratory therapy Intra-aortic balloon pumps BT Circulatory assistance Intracranial pressure monitoring SEE ALSO Intracranial pressure monitors Intracranial pressure monitors SEE ALSO Intracranial pressure monitoring Intracutaneous titration x Rinkel serial intracutaneous titration BT Allergy-immunology tests Intraocular lens implantation BT Surgery Eye SEE ALSO Intraocular lenses Intraocular lenses SEE ALSO Intraocular lens implantation Intraosseous pressure measurement Intravenous fat emulsions x Fat emulsions Iodide therapy 13T Bronchodilators Iodoxamate meglumine BT Radiographic contrast dyes 339

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Iontophoresis IPPB Iridology SEE Intermittent positive pressure breathing Iron-dextran complex Kidney transplantation SEE Transplantation Kidney Kinetic therapy BT Physical therapy Knee prosthesis x New Jersey integrated knee replacement system BT Metabolic and nutrient agents BT Joint prosthesis Isosulfan blue BT Diagnostic agents Isotretinoin 13T Antiacne agents Joint prosthesis x Orthopedic joint implants BT Prostheses NT Elbow prosthesis Hip prosthesis Knee prosthesis SEE ALSO Bone cements Bone prosthesis Joint scanning using Technetium Tc-99m SEE Scintiphotography Joint Keratomileusis BT Keratoplasty Keratophakia BT Keratoplasty Keratoplasty NT Epikeratophakia Keratomileusis Keratophakia Radial keratotomy Ketoconazole BT Antifungal agents Keyes technique Kidney function tests BT Diagnostic tests NT Blood urea concentration Creatinine concentration, Serum 34O Kunkel test x Gammaglobulin, Total serum BT Rheumatology tests Kyphoscoliosis surgery SEE Surgery Scoliosis L-Dopa SEE Levodopa Labetalol BT Beta blockers Lactates BT Anti-anxiety agents Laparotomy BT Surgery Laser angioplasty BT Angioplasty Laser surgery Laser iridotomy BT Laser surgery Surgery Eye Laser photocoagulation x Photocoagulation BT Laser surgery SEE ALSO Electrocoagulation Laser radiation therapy x Photoradiation therapy Laser surgery BT Surgery NT Laser angioplasty Laser iridotomy Laser photocoagulation Laser trabeculoplasty SEE ALSO Lasers

TECHNOLOGY THESAURUS Carbon dioxide Nd:YAG Laser trabeculoplasty x Trabeculoplasty BT Laser surgery Lasers SEE ALSO Laser surgery Carbon dioxide Nd:YAG x Neodymium:Yttrium-aluminum garnet lasers Lithotripsy Extracorporeal shock wave x ESWL Extracorporeal shock wave lithotripsy SEE ALSO Lithotripters, Extracorporeal shock wave - Percutaneous Transurethral SEE ALSO Nephrolithotomy Lithotripters, Extracorporeal shock wave BT Ultrasound equipment Therapeutic SEE ALSO Lithotripsy Laxadves NT Sodium cellulose phosphate Liver transplantation Sodium phosphate Extracorporeal shock wave SEE Transplantation-Liver Lead screening Leisure skills training Leukocyte differential counters BT Cell counters Levodopa Lidocaine x L-Dopa BT Antidyskinetics BT Anesthetics Ligament prosthesis BT Prostheses Limb perfusion Linear pumps Lipectomy SEE Suction lipectomy Lipoprotein evaluation BT Cardiopulmonary tests Lithium L· e xlscope BT Radiographic equipment Long term care x Nursing homes Lung cancer screening SEE Cancer screening Lung Lymphangiography BT Angiography Magnesium chloride BT Metabolic and nutrient agents Magnesium sulfate BT Anticonvulsants Magnetic resonance imaging x MRI NMR Nuclear magnetic resonance BT Diagnostic imaging SEE ALSO Magnetic resonance imaging systems BT Anti-anxiety agents Antimanics 341

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY -Brain and spine L· ~ ung 1nJury Multiple sclerosis Neoplasms Magnetic resonance imaging systems SEE ALSO Magnetic resonance imaging Magnetic resonance spectroscopy MEDLARS Magnetoencephalography x MEG Malathion BT Insecticides Mammographic devices SEE ALSO Mammography MEDLEYS Online Mammography BT Breast imaging SEE ALSO Mammographic devices Maple syrup urine disease screening Marijuana SEE Cannabis Mass spectroscopy Mastectomy BT Surgery Breast Maternal serum alpha fetoprotein monitoring x AFP monitoring Alpha fetoprotein monitoring BT Genetic screening NT Alpha fetoprotein assays Measles-mumps-rubella vaccine x MMR vaccine BT Vaccines Medical evaluation SEE Health examination Medical Literature Analysis and Retrieval System SEE MEDLARS 342 Medical record systems BT Information systems NT Registries SEE ALSO Computer-assisted patient care Expert systems Reminder systems Medicare Prospective Payment System SEE Prospective payment systems x Medical Literature Analysis and Retrieval System BT Information systems NT CHEMLINE HISTLINE MEDLINE TOXLINE SEE MEDLINE MEDLINE x MEDLARS Online BT Bibliographic information bases MEDLARS Optical disks SEE ALSO Computer equipment Medroxyprogesterone x Depo-Provera BT Progestins MEG SEE Magnetoencephalography Melodic intonation therapy Metabolic and nutrient agents x Minerals NT Amino acids Artificial sweeteners Calcium chloride Dextrose Dextrose with saline solution Electrolyte injection Fructose Glutathione disulfides Infant foods Magnesium chloride

TECHNOLOGY THESAURUS Polydextrose Potassium chloride Potassium citrate Potassium phosphate Vitamins SEE ALSO Enteral nutrition Miconazole BT Antifungal agents Microbiological testing systems BT Diagnostic tests NT Automated microbiology systems Oral rehydration therapy Parenteral nutrition Microbiology equipment Protein-calorie therapy with anabolic steroids Micronucleus test Methaqualone BT Hypnotic drugs Sedatives Methotrexate BT Antiarthritics Antineoplastics Antipsoriatics Methexsalen BT Antipsoriatics Repigmenting agents Methyldopa BT Antihypertensives Methylethylketone BT Solvents Methylphenidate BT Cytotoxic tests Microsurgery BT Surgery Migration inhibition test BT Allergy-immunology tests Minerals BT Metabolic and nutrient agents Minnesota Q-Qs codes BT Electrocardiography MMR vaccine SEE Measles-mumps-rubella vaccine Mobile intensive care systems SEE Intensive care systems, Mobile Mobility aids x Attention deficit disorder therapy Moire topography Metoclopramide SEE Oxybutynin chloride with metoclopramide Metolazone BT Antihypertensives Diuretics Metoprolol BT Beta-blockers Metronidazole BT Antiarthritics Antibiotics Mezlocillin BT Antibiotics x Photogrammetry Shadow moire contourography Monoclonal antibodies x Antibodies SEE ALSO Genetic engineering Hybridomas Immunoradiometric assay with monoclonal antibodies Mouth protectors Moxalactam BT Cephalosporins MRI SEE Magnetic resonance imaging 343

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Mycoplasma complement fixation test Nephrolithotomy BT Rheumatology tests BT Surgery SEE ALSO Lithotripsy Transurethral Myoelectric prostheses BT Prostheses Nadolol BT Beta blockers Nafcillin BT Antibiotics Nail bed transplantation Nephrostomy BT Surgery Neurosonology SEE Ultrasound Neurotoxins NT Botulinum toxin SEE Transplantation-Nail bed Neutralization therapy Naloxone BT Narcotic antagonists Narcotic analgesics BT Analgesics NT Codeine Narcotic antagonists NT Naloxone Nd:YAG laser surgery SEE Laser surgery Nd:YAG Nd:YAG lasers SEE Lasers Nd:YAG Nebulizers SEE ALSO Aerosol therapy Needle aspiration cytology Negative pressure respirators NMR BT Respirators Neodymium:Yttrium-aluminum garnet lasers SEE Nd:YAG lasers Neonatal intensive care BT Intensive care SEE ALSO Neonatal monitors Neonatal monitors SEE ALSO Neonatal intensive care 344 Food allergies SEE ALSO Challenge food testing New Jersey integrated knee replacement system SEE Knee prosthesis Hydromorphone Niclosamide Pentazocine BT Anthelm~nt~cs Nicotine gum Nifedipine BT Calcium channel blockers Nissen fundoplication BT Surgery-Morbid obesity Nitroglycerin SEE Glyceryl trinitrate Nitroprusside BT Antihypertensives SEE Magnetic resonance imaging Noncardiac pain diagnosis Nonio'iizing radiation measurement devices BT Radiation measurement devices Nonsteroidal anti-inflammatory analgesics NT Diflunisal Ibuprofen Indomethacin Piroxicam

TEC~OLOGY THESAURUS Norethindrone with ethinyl estradiol Organ preservation BT Oral contraceptives Normaline kit Nuclear magnetic resonance imaging SEE Magnetic resonance imaging Nursing homes SEE Long term care Nutritional counseling BT Counseling SEE ALSO Diet therapy ORT Obesity surgery SEE ALSO Organ procurement Transplantation Organ procurement SEE ALSO Organ preservation Transplantation Organ transplantation SEE Transplantation Orphan devices SEE Oral rehydration therapy SEE Surgery-Morbid obesity Orthodontic appliances Omega-3 fatty acids SEE Fish oils Oncology tests BT Diagnostic tests NT Alpha fetoprotein assays Bendien's test Bolen's test Carcinoembryonic antigen assays In vitro chemosensitivity testing Pap smear Prostatic acid phosphatase kits Stool guaiac Tumor stem cell assays SEE ALSO Cancer screening Osteoporosis screening x Orthodontic wires Orthodontic wires SEE Orthodontic appliances Orthopedic joint implants SEE Joint prosthesis Orthotic devices NT Posture control devices Shoe insoles Osseointegrated implants SEE Dental implants Online information bases SEE Information systems Optical disk SEE MEDLINE Optical disks Oral contraceptives Osteotomy SEE Tibial osteotomy Outpatient surgery SEE Surgery, Ambulatory Oximeters BT Contraception BT Blood gas monitors - NT Ethynodiol diacetate with ethinyl SEE ALSO Oximetry estradiol Norethindrone with ethinyl estradiol Oximetry SEE ALSO Estrogens Progestins Oral rehydration therapy x Fluid therapy ORT Rehydration therapy SEE ALSO Metabolic and nutrient agents SEE ALSO Oximeters Oxprenolol BT Beta blockers Oxybutynin chloride with metoclopramide x Antispasmodics Metoclopramide 345

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Oxygen-air proportioners Oxygen analyzers Peer group counseling BT Counseling SEE ALSO Blood gas monitors Penicillamine Oxygen therapy NT Hyperbaric oxygen therapy Inhalation -Topical PACS Pain assessment Pain therapy x Analgesia NT Acupuncture Transcutaneous electrical nerve stimulation SEE ALSO Analgesics Palatopharyngoplasty BT Surgery Pancreas transplantation SEE Transplantation Pancreas Pap smear Papaver~ne Parenteral nutrition 13T Oncology tests SEE ALSO Cancer screening Cervical BT Impotence diagnosis Impotence treatment Vasodilators Perimetry x Total parenteral nutrition TEN SEE ALSO Metabolic and nutrient agents BT Antiarthritics Antiurolithics SEE ALSO Chelation therapy Pencillamine Penile artery bypass BT Surgery Impotence Penile prosthesis SEE Picture archiving and communication BT Prostheses systems Pentazocine BT Narcotic analgesics Pentetate indium disodium BT Radiopharmaccuticals Percutaneous balloon valvuloplasty BT Surgery SEE ALSO Balloon dilatation catheters Percutaneous transluminal angioplasty x Balloon angioplasty PTA BT Angioplasty NT Percutaneous transluminal coronary angioplasty Percutaneous transluminal coronary angioplasty x Coronary artery surgery PTCA BT Percutaneous transluminal angioplasty Surgery Heart BT Vision screening Periodontal ligament injection Partial thromboplastin time Perltoneal d~alys~s BT Coagulat~on assays Patch tests BT Allergy-immunology tests PEEP valves x Positive end expiratory pressures valves 346 BT Dialysis NT Continuous ambulatory peritoneal dialysis SEE ALSO Peritoneal dialysis cyclers Peritoneal dialysis solutions

TEC~OLOGY THESAURUS Peritoneal dialysis cyclers Photoplethysmography SEE ALSO Peritoneal dialysis SEE Plethysmography Peritoneal dialysis solutions Peritoneal dialysis solutions SEE ALSO Peritoneal dialysis Peritoneal dialysis cyclers Phototherapy Permanent eyeliner BT Surgery Persantine SEE Dipyridamole Pertussis vaccine BT Vaccines PET scan SEE Positron emission tomography Phenobarbital BT Anticonvulsants Hypnotic drugs Sedatives Phenylketonuria screening BT Genetic screening Phenylpropanolamine BT Appetite suppressants Phenytoin BT Anticonvulsants Phlebography x Venography Phonocardiography Photocoagulation SEE Laser photocoagulation Photodensitometry Photoradiation therapy SEE Laser radiation therapy NT Ultraviolet therapy SEE ALSO Laser radiation therapy Phyllocontin SEE Aminophylline Physical examination SEE Health examination Physical therapy x Physiotherapy NT Doman-Delacato treatment Exercise therapy Kinetic therapy Physical therapy with home exercise SEE ALSO Exercise therapy Physician education x Continuing medical education SEE ALSO Computer-assisted instruction Physiologic monitoring systems SEE ALSO Apnea monitors Blood pressure monitors Electrocardiographs Intensive care Physiotherapy SEE Physical therapy Picture archiving and communication systems x PACS SEE ALSO Digital imaging Pindolol SEE Bone mineral studiesBT Beta blockers Photogrammetry SEE Moire topography PhotokymogTaphy SEE ALSO Coronary artery disease diagnosis Piperac ill in BT Antibiotics Piroxicam BT Nonsteroidal anti-inflammatory analgesics 347

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Pituitary and hypothalmic hormones BT Hormones NT Gonadorelin hydrochloride Human growth hormone Plasma exchange Plethysmography x Impedance plethysmography Photoplethysmography SEE ALSO Impotence diagnosis Pneumococcal vaccine x Therapeutic plasma exchange BT Vaccines TPE BT Apheresis SEE ALSO Plasma exchange devices Plasma, Frozen Plasma infusion Plasmapheresis Plasma exchange devices SEE ALSO Plasma exchange Plasma filters SEE ALSO Plasma perfusion Plasma, Frozen SEE ALSO Plasma exchange Plasma infusion Plasma infusion SEE ALSO Plasma exchange Plasma, Frozen Plasma perfusion BT Apheresis SEE ALSO Plasma filters Posture control devices BT Orthotics Polydextrose BT Metabolic and nutrient agents Polypectomy BT Surgery Polyurethane tubing Positive end expiratory pressure valves SEE PEEP valves Plasma separation systems Positron emission tomography x PET scan Tomography, Emission computed Tomography, Positron emission SEE ALSO SPECT imaging Postmarketing surveillance BT Assessment methods Postural drainage BT Respiratory therapy Plasma separation systems SEE ALSO Apheresis Plasma filters Plasmapheresis BT Apheresis SEE ALSO Plasma exchange Plasminogen activators SEE Tissue plasminogen activators Plasticizers Platelet transfusion PPS x Thrombocyte transfusion Praziquantel BT Transfusion 348 Potassium chloride BT Metabolic and nutrient agents Potassium citrate x Citrates BT Metabolic and nutrient agents Potassium phosphate BT Metabolic and nutrient agents SEE Prospective payment systems BT Anthelmintics Prazasin BT Antihypertensives

TEC~OLOGY THESAURUS Prenatal care Prenatal education Prepayment SEE Capitation payment Prescribing SEE Drug ordering Pressure transducers Primadone BT Anticonvulsants Progestin receptor assays Progestins Prolotherapy SEE ALSO Sclerotherapy Propranolol BT Beta blockers Prospective payment systems x Medicare Prospective Payment System PPS NT Discretionary adjustment factor SEE ALSO Capitation payment Competition DRGs Prostaglandins NT Alprostadil Prostate surgery Ligament prosthesis Myoelectric prostheses Penile prosthesis Socket prosthesis Protein-calor~e therapy with anabolic steroids x Anabolic steroids BT Diet therapy SEE ALSO Metabolic and nutrient agents Prothrombin-complex concentrate SEE Anti-inhibitor coagulant complex BT Adrenal cortex hormones Sex hormones NT Medroxyprogesterone SEE ALSO Oral contraceptives Prothrombin time BT Coagulation assays Provocation tests Food allergies SEE Challenge food testing Psoralens and ultraviolet A therapy SEE PUVA therapy Progestin receptor assays Psychoactive drugs BT Psychotherapy NT Antianxiety agents Antidepressants Anti psychotics Hypnotic drugs Sedatives Psychosurgery BT Psychotherapy Surgery Psychotherapy NT Psychoactive drugs Psychosurgery PTA SEE Surgery Prostate PICA Prostatic acid phosphatase kits BT Oncology tests SEE ALSO Tumor markers Pulmonary function tests Prostheses 1.~. SEE Percutaneous transluminal angioplasty SEE Percutaneous transluminal coronary angioplasty SEE ALSO Respiratory therapy NT Gastroesophageal antireflux Punctal occlusion prosthesis Joint prosthesis BT Surgery-Eye 349

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY PUVA therapy x Psoralens and ultraviolet A therapy BT Ultraviolet therapy Pyelography BT Radiography Pyr~methamine Radiographic equipment x X-ray equipment NT Computed tomography scanners Fluoroscopy units Lixiscope Radiographic film processors SEE ALSO Radiography BT Antiprotozoal agents Radiographic film x X-ray film Quality assurance programs Radial keratotomy BT Keratoplasty Radiant warmers BT Radiographic materials Radiographic film processors x X-ray film processors BT Radiographic equipment SEE ALSO Incubators Radiographic materials Radiation measurement x Dosimetry NT Nonionizing radiation measurement Radiography devices NT Radiographic contrast dyes Radiographic film x Roentgenography SEE ALSO Radiation protection X-rays BT Diagnostic imaging NT Cholangiography Cholangiopancreatography Cholecystography Computed tomography Discography Fluoroscopy Pyelography Urography SEE ALSO Digital imaging Imaging centers Radiation protection Radiographic equipment Radiographic materials Radiation protection SEE ALSO Radiation measurement Radiation therapy x Heavy-ion irradiation Radioactive materials NT Radiopharmaceuticals Radioallergosorbent test x RAST BT Immunoradiometric assays Radiogrammetry SEE Bone mineral studies Radiographic absorptiometry SEE Absorptiometry Radiographic contrast dyes x Contrast media BT Radiographic materials NT Iodoxemate meglumine SEE ALSO Radiopharmaceuticals Radiographic darkrooms x Darkrooms 35O Radiography, Dental SEE Dental radiography Radioimmunoassays SEE Immunoradiometric assays Radionuclide angiography BT Angiography Radionuclide imaging Radionuclide imaging BT Diagnostic imaging NT Gamma cameras Radio nu clide an gio graphy

TECHNOLOGY THESAURUS Scin tip ho to graphy SPECT Thallium imaging Ventilation-perfusion lung scans SEE ALSO Radionuclide laboratories Reminder systems Radio pharmaceu ticals Radionuclide laboratories SEE ALSO Radionuclide imaging Radiopaque plastics BT Dental radiography Radiopharmaceutical s Relative value scales Relaxation therapy x Appointment reminders BT Information systems SEE ALSO Medical record systems Repigmenting agents NT Methoxsalen Reserpine BT Radioactive materials NT Pentetate indium sodium Technetium Tc-99m kits Xenon SEE ALSO Radiographic contrast dyes Radionuclide imaging Respirators Randomized clinical trials SEE Clinical trials Randomized Ranitidine RAST BT Histamine Hz-receptor antagonists SEE Radioallergosorbent test Rectal mucosal replacement Registries BT Medical record systems SEE ALSO Data banks Rehabilitation NT Cardiac rehabilitation Pain rehabilitation SEE ALSO Rehabilitation programs Resuscitators Rehabilitation programs SEE ALSO Rehabilitation Spinal cord injury Stroke Rehfuss test BT Gastroenterology tests Rehydration therapy SEE Oral rehydration therapy BT Antihypertensives Reserpine with chlorthalidone BT Antihypertensives SEE ALSO Chlorthalidone NT Negative pressure repirators SEE ALSO Respiratory therapy Ventilators Respiratory therapy NT Aerosol therapy Continuous positive airway pressure Incentive spirometry Intermittent positive pressure breathing Postural drainage SEE ALSO Pulmonary function tests Respirators Resuscitation SEE ALSO Resuscitators Mouth-to-mouth SEE ALSO Resuscitation Reuse of disposables x Disposables reuse Rheumatology tests x Arthritis tests BT Diagnostic tests NT Bentonite flocculation test DNA-antibody test Kunkel test Mycoplasma complement fixation test 35]

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Rhinoplasty BT Surgery Ringer's irrigation Rinkel serial intracutaneous titration SEE Intracutaneous titration Roentgenography SEE Radiography Routine admission testing SEE Admission testing, Routine Rubella tests x Antibody tests BT Infectious disease tests Rubidium BT Antipsychotics Saccharin BT Artificial sweeteners Saralasin BT Antihypertensives Sex hormones Scales, Patient BT Hormones Satellite communication Steroids BT Communication systems NT Androgens Estrogens Progestins Schizophrenia screening Scintiphotography Second opinions Secretin BT Diagnostic agents Gastric acid secretion inhibitors Hormones Sedatives BT Psychoactive drugs NT Barbiturates Methaqualone Phenobarbital Selenium sulfide 13T Antifungal agents Antiseborrheic agents Sensory integrative therapy Seromucoid assay BT Diagnostic tests Serum creatinine concentration SEE Creatinine concentration, Serum Sex selection SEE Ericsson sex selection method BT Radionuclide imaging SEE ALSO Technetium Tc-99m kits SEE Moire topography Heart Joint S cl erothe rap y SEE ALSO Prolotherapy SI units Scoliosometry Screening SEE specific diseases or disorders, e.g. Cancer screening Seat belts (Automobile) SEE Automobile passenger restraints 352 Shadow moire contourography Shape sensor Shoe insoles BT Orthotic devices SEE Systeme International units Sickle cell screening SEE Hemoglobinopathies screening Sigmoidoscopy x Flexible sigmoidoscopy BT Gastrointestinal endoscopy

TEC~OLOGY THESAURUS SEE ALSO Barium enema with Specular microscopy . . slgmolc .oscopy Cancer screening Colorectal Silver sulfadiazine BT Antibiotics Singer-Blom valve operation BT Surgery Single photon emission computed tomography SEE SPECT imaging Ssomlcm BT Antibiotics Smoke detectors Socket prosthesis BT Prostheses Sodium cellulose phosphate BT Laxatives Sodium chloride SEE Endothelial cell photography Sperm penetration assay BT Fertility tests Sphincterotomy x Endoscopic retrograde sphincterotomy ERS BT Surgery Sphygmomanometers SEE Blood pressure monitors Sphygmomanometry SEE Blood pressure monitoring S. ~ . . penal Injury programs SEE Rehabilitation programs- Spinal cord injury Spinal puncture BT Surgery Sporicidin BT Metabolic and nutrient agentsBT Antifungal agents Sodium phosphate BT Laxatives Sodium restriction BT Diet therapy Solvents NT MethylethylketoneStapling Somatic cell mutation tests BT Genetic tests Somatotropin SEE Human growth hormone Sorbitol BT Artificial sweeteners SPECT imaging x Single photon emission computed tomography Tomography, Single photon emission computed BT Radionuclide imaging Sterilizers SEE ALSO Computed tomography Positron emission tomography Sprinklers Standardized Medreview Instrument Stapedectomy BT Surgery SEE Surgical stapling Stereotaxic depth electrode implantation BT Surgery SEE ALSO Electroencephalography Stereotaxic neurosurgery, Computed tomography-assisted BT Surgery Sterile water for injection Sterilization equipment SEE ALSO Sterilizers SEE ALSO Sterilization equipment 353

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Steroids NT Adrenal cortex hormones Sex hormones SEE ALSO Hydroxycholecalciferol level Protein-calorie therapy with anabolic steroids Stool guaiac BT Oncology tests SEE ALSO Cancer screening-Colorectal Streptokinase x Thrombolytic therapy Streptozocin BT Antineoplastics Stress tests SEE Stroke programs Exercise tests SEE Rehabilitation programs Stroke Sucralfate BT Suction equipment Antiulcer agents Suction lipectomy x Lipectomy BT Surgery Morbid obesity Sulfadoxine BT Antiprotozoal agents Sulfamethoxazole x Sulfonamides BT Antibacterials Sulfinpyrazone BT Antigout agents Antihyperuricemics Sulfonamides SEE Sulfamethoxazole Sulocddil BT Vasodilators Sunlamps SEE ALSO 354 Phototherapy Supportive care SEE ALSO Burn units Surgery NT Ad e no id ecto my Angioplasty Biopsy Carotid body resection Carotid endarterectomy Cerebral artery anastomosis Cesarean section Cholecystectomy Cingulotomy r~ ~ . . ~lrcumaslon Cochlear implantation Cochleostomy Collagen implants Cryosurgery Debridement Decubitus surgery Dilatation and curettage Electrocoagulation Electrosurgery Endoscopy Extracranial-intracranial arterial bypass Hip joint replacement Hysterectomy Laparotomy Laser surgery Mastectomy Microsurgery Nephrolithotomy Nephrostorny Palatopharyngoplasty Percutaneous balloon valvuloplasty Permanent eyeliner Polypectomy Psychosurgery Rhinoplasty Singer-Blom valve operation Sphincterotomy Spinal puncture Stapedectomy Stereotaxic depth electrode . . 1mp antatlon Stereotaxic neurosurgery, Computed tomography-assisted Surgical stapling Temporomandibularjoint procedure Thoracentesis

TEC~OLOGY THESAURUS Tibial osteotomy Tibial tubercle elevation Tonsillectomy Tooth extraction Transplantation Transsexual surgery Tubal ligation Vertebral artery surgery Ambulatory x Outpatient surgery Breast NT Contralateral breast surgery Mastectomy Esophageal reflux Eye NT Cataract extraction Corneal grafts Intraocular lens implantation Keratoplasty Laser iridotomy Punctal occlusion SEE ALSO Surgical aids Ophthalmic Fetal SEE ALSO Fetal shunts Heart NT Cardiac catheterization Coronary artery bypass grafting Team care Percutaneous translum~nal coronary angioplasty SEE ALSO Cryosurgery Arrhythmias Percutaneous transluminal valvuloplasty Impotence NT Penile artery bypass Morbid obesity NT Bilio-pancreatic bypass Gastric restrictive surgery Gastro-ileal bypass Ilea! bypass Nissen fundoplication Suction lipectomy -Prostate ~coliosis Surgical aids ~p}ithalmic Surgical case carts Surgical drapes Surgical gloves Surgical shunt Surgical stapling x Stapling BT Surgery Sutures Syphylis tests BT Infectious disease tests S. yrmge pumps Systeme International units x SI units Tamoxifen BT Antineoplastics Technetium Tc 99m kits BT Radiopharmaceuticals SEE ALSO Scintiphotography Telemetry BT Communication systems r_~ emazepam BT Antianxiety agents Temporomandibular joint procedure x TMJ procedure BT Surgery TENS SEE Transcutaneous electrical nerve . , . stlmulatlon 355

MEDICAE TECHNOLOGY ASSESSMENT DIRECTORY Thallium imaging Tibial tubercle elevation BT Radionuclide imaging BT Surgery Theo-Dur SEE Theophylline Theophylline x Theo-Dur BT Bronchodilators SEE ALSO Aminophylline Therapeutic drug monitoring Tissue banks x Drug monitoring Therapeutic embolization x Embolotherapy Therapeutic plasma exchange SEE Plasma exchange Thermography BT Diagnostic imaging Breast BT Breast imaging Thermometers T. . . nlamlne SEE Vitamin B1 Thoracentesis BT Surgery Throat cultures BT Infectious disease tests Thrombocyte transfusion SEE Platelet transfusion Thrombolytic therapy NT Streptokinase Tissue plasminogen activators Thymoxamine BT Vasodilators Thyroxine assays BT Endocrinology-metabolism tests Tonometry Tibial osteotomy x Osteotomy BT Surgery 356 Timolol BT Antiglaucoma agents Tinnitus maskers .. Tioconazole BT Antifungal agents SEE ALSO Tissue preservation technics Tissue plasminogen activators x Plasminogen activators TPA BT Thrombolytic therapy Tissue preservation technics SEE ALSO Tissue banks TMJ procedure SEE Temporomandibular joint procedure Tobramycin BT Antibiotics Tocodynamometry x Uterine monitorin~ Tomographic scanners SEE Computed tomographic scanners Tomography, Emission computed SEE Positron emission tomography Tomography, Positron emission SEE Positron emission tomography Tomography, Single photon emission computed SEE SPECT imaging Tomography, Standard Tomography, X-ray computed SEE Computed tomography BT Vision screening Tonsillectomy BT Surgery

TEC~OLOGY THESAURUS Tooth extraction BT Surgery Toothpaste BT Dental materials Topical oxygen therapy SEE Oxygen therapy Topical Topographic brain mapping SEE ALSO Electroencephalography Total hip joint replacement SEE Hip joint replacement Total parenteral nutrition SEE Parenteral nutrition Tourniquets Toxicology Information Online SEE TOXLINE TOXLINE x Toxicology Information Online BT Bibliographic information bases MEDLARS TPA TPE TPN SEE Tissue plasminogen activators SEE Plasma exchange SEE Parenteral nutrition Trabeculoplasty SEE Laser trabeculoplasty T. . ranqu1 1zers SEE Antianxiety agents T~ - ransruslon NT Blood transfusion Granulocyte transfusion [Platelet transfusion Transillumination Breast x Diaphanography BT Breast imaging Diagnostic imaging Transplantation BT Surgery SEE ALSO Organ preservation Organ procurement -Bone marrow Bone marrow, Allogenic Bone marrow, Autologous {:ornea Heart Heart-lung Kidney Liver - Nail bed Pancreas Transsexual surgery BT Surgery Trazadone Transcutaneous electrical nerve stimulation Triamterene x TENS BT Electrical stimulation Pain therapy Transfer factor therapy BT Antidepressants BT Diuretics Triazolam BT Antianxiety agents Trimethoprim BT Antibiotics 357

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Tryptophan BT Antidepressants Tubal ligation BT Contraception Surgery Tuberculosis screening Tumor markers SEE ALSO Alpha fetoprotein assays Carcinoembryonic antigen assays Prostatic acid phosphatase kits Tumor stem cell assay BT Oncology tests Tym pan o me try SEE Acoustic impedance test Type A score Ultrasonography x B-mode scanning Echocine BT Diagnostic imaging Ultrasound NT Echocardiography Ultrasound x Doppler ultrasound Neurosonology NT Ultrasonography SEE ALSO Lithotripsy, Extracorporeal shock wave Lithotripsy, Percutaneous Ultrasound equipment- Therapeutic Cardiac output SEE ALSO Coronary artery disease . . . ct~agnos~s -Intracperative Obstetrics and gynecology SEE ALSO Ultrasonography- Follicular growth Pelvimetry Ultrasound equipment SEE ALSO Ultrasound Diagnostic Therapeutic NT Lithotripters, Extracorporeal shockwave - Arteries BT Arteriography Ultraviolet therapy SEE ALSO Echocardiography BT Phototherapy NT PUVA therapy -Breast Follicular growth SEE ALSO Ultrasound Obstetrics and gynecology Ureteroscopy Head Pancreas Pregnancy SEE ALSO Ultrasound Obstetrics and gynecology -Prostate Minuses 358 Unbundling BT Health insurance BT Endoscopy Urinalysis x Urine culture BT Infectious disease tests SEE ALSO Urologic disease screening Urinary sphincter, Artificial Urine autoinjection Urine culture SEE Urinalysis

TEC~OLOGY THESAURUS Urography BT Radiography Urologic disease screening SEE ALSO Urinalysis Uterine monitoring SEE Tocodynamometry Vaccination policy Vaccines NT Valproate BCG vaccine Hemophilus influenza type B vaccine Influenza vaccine Measles-mumps-rubella vaccine Pertussis vaccine Pneumococcal vaccine Viral hepatitis vaccine x Valproic acid BT Anticonvulsants Valproic acid SEE Valproate Vascular access ports Vascular headache suppressants NT Dihydroergotamine Vasodilators NT Dipyridamole Glyceryl trinitrate Papaverine Suloctidil Thymoxamine Vasopressors NT Dopamine Venography SEE Phlebography Ventilation-perfusion lung scans BT Radionuclide imaging Ventilators SEE ALSO Respirators Ventricular assist devices BT Circulatory assistance Ventricular mapping, Intraoperative BT Electrocardiography Verapamil BT Calcium channel blockers Vertebral artery surgery BT Surgery Vidarabine BT Antivirals Viral hepatitis vaccine x Hepatitis B vaccine BT Vaccines Vision aids NT Eyeglasses Vision screening NT Glaucoma screening Perimetry Tonometry Visual evoked potentials SEE Evoked potentials Vitamin A SEE ALSO Beta-carotene Vitamin B1 x Thiamine Vitamin B12 assay BT Endocrinology-metabolism tests . . v ~tam~ns Vitamin E BT Vitamins Vitamins BT NT Metabolic and nutrient agents Vitamin A Vitamin B 1 Vitamin B12 assay Vitamin E SEE ALSO Hydroxycholecalciferol level Warfarin BT Anticoagulants Wheelchair tray systems 359

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Wheelchairs Whirlpool baths SEE Hydrotherapy X-ray equipment X-ray film SEE X-ray film processors Radiographic equipment Radiographic film SEE Radiographic film processors X-rays SEE Radiography X-rays, Dental SEE Radiography, Dental 360 Xenon Xylitol BT BT Radiopharmaceuticals Artificial sweeteners Yohimbine BT Alpha receptor blocking agents Impotency treatment Zomepirac sodium BT Analgesics 25 hydroxyvitamin D level SEE Hydroxycholecalciferol level

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Absorptiometry National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bone mineral densi ty studies: radiographic absorptiometry. Ongoing. Absorptiometry Dual photon Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Absorptiometry, dual photon for osteoporosis monitoring. 1986. tIn formation syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Absorptiometry, single and dual photon. 1986. "Information synthe ses] ECRI Technology Assessment Program. Bone mineral assessment, noninvasive (dual photon absorptiometry and quantitative computed tomography). J Health Care Technol 1986;2: 183-200. [Information synthe ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Dual photon absorp tiometry for measuring bone mineral density. 1986. ECRI Technology Assessment Program. Dual-photon absorptiometry for bone mineral content. Issues Health Care Technol 1984;sec.5.A.3. "Information syntheses] Absorptiometry- Single photon Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Absorptiometry, single and dual photon. 1986. "Information synthe ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Acyclovir Health Technology Assessment. Single photon ab sorptiometry for measuring bone mineral density. 1986. Acetaminophen Racz WJ. "Department Pharmacology, Queens Univer sity] "Medical Research Council - Canada] Acetamino phen induced hepatotoxicity. (Grant period 1983-1985~. Food and Drug Administration, Center for Drugs and Biologics. Pentazocine hydrochloride and acetamino- phen. 1982. (NTIS order no. PB82-9159041. tInfor- mation syntheses, Expert opinion, epidemiological and other observational methods, Clinical trials, Bench testing] Acetohydroxamic acid Food and Drug Administration, Center for Drugs and Biologics. Acetohydroxamic acid. 1987. (Summary basis of approval, NDA # 18-749~. [Information syn- theses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Acidulated phosphate fluoride Clark DC, Hanley JA, Stamm JEW, Weinstein PL. tMcGill University, Department of Epidemiology and Biostatistics] An empirically based system to estimate the effectiveness of caries-preventive agents: a com- parison of the effectiveness estimates of APE gels and solutions and fluoride varnishes. . Caries Res 1985;19:83-95. Acoustic impedance tests California Medical Association, Medical Practice Opin- ion Program. Acoustic impedance testing in school screening. 1985 Sep. (Medical Practice Opinion #325) tGroup judgment] Acupuncture American Academy of Neurology, Practice Committee. Acupuncture. 1981 Jul. fExpert opinion, Group judgment] American Medical Association, Council on Scientific Af- fairs. Acupuncture. 1981. tGroup judgment] Food and Drug Administration, Center for Drugs and Biologics. Acyclovir. 1982. (NTIS order no. PB82-9159021. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 361

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Adenoidectomy National Institutes of Health, Consensus Development Program. Indications for tonsillectomy and adenoi- dectomy: phase I. (Consensus Development Confer- ence Statement, Jul 20 1978~. [Group judgment] Adhesives American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Council update on "adhesion" and "adhesive" materials. ~ Am Dent As- soc 1981;103:252-253. Admission testing, Routine U.S. Administrators, Professional Policy Committee. Admission screening - hospital. [7/86] tGroup judg- ment] U.S. Administrators, Professional Policy Committee. Preadmission/presurgical screening. t7/86] [Group judgment] Kaplan ED, et al. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The usefulness of preoperative laboratory screening. [AMA 1985 Jun;253~24~:3576-3589. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Routine admission testing - medical ad- missions. 1983. "Information syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Routine admission testing - surgical ad- missions. 1983. "Information syntheses] Adrenal cortex hormones Veterans Administration, Cooperative Studies Pro- gram. Evaluations of corticosteroid therapy in gram negative sepsis. Pending. (Clinical trials] Keogh BA, Bernardo }, Hunninghake GW, et al. [Na- tional Heart, Lung, and Blood Institute] Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 1983; 127: 18-27. Veterans Administration, Cooperative Studies Pro- gram. Evaluations of corticosteroid therapy in severe sepsis. Ongoing. "Clinical trials] Aerosol therapy Blue Cross and Blue Shield Association, Medical Neces- sity Program. Respiratory therapy: aerosol therapy. 1982. [Information syntheses] 362 Albuterol Food and Drug Administration, Center for Drugs and Biologics. Albuterol sulfate. 1982. (NTIS order no. PB82-915903~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Alclometasone dipropionate Food and Drug Administration, Center for Drugs and Biologics. Alclometasone dipropionate. 1983. (NTIS order no. PB83-915901). [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing Alcoholism screening Hirst M. "National Health Research and Development Program - Canada] Toward a non-invasive screen for susceptibility to alcoholism. 1986. (Grant No. 6606-2676-521. Allergy-immunology tests American College of Physicians, Clinical Efficacy As- sessment Project. Allergy testing, expected comple- tion 1988. "Information syntheses] Allopurinol Food and Drug Administration, Center for Drugs and Biologics. Allopurinol 100 ma. 1987. (Summary basis of approval, NDA # 18-832~. [Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Allopurinol 300 mg.1987. (Summary basis of approval, NDA # 18-8321. "Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Alpha fetoprotein assays Travenol Labs, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Gamma dab (1251) AFP RIA kit: summary of safety and effec- tiveness. 1986 Jun 17. (PMA no. P790032-000). Centers for Disease Control. (Food and Drug Adminis- tration, Center for Devices and Radiological Health] AFP mid-pregnancy reference preparation: summa- ry of safety and effectiveness. 1985 ~an 3 (PMA no. P820077-0001.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Hybritech, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Tandem (R)-E AFP: summary of safety and effectiveness. 1985 May 23. (PMA no. P840035-000). Kallestad Labs, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Quanti- tope 1251 AFP kit and control serum: summary of Amantadine National Institutes of Health, Consensus Development Program. Amantadine: does it have a role in the pre- vention and treatment of influenza? (Consensus De- velopment Conference Statement, Oct 15-16 1979~. (Group judgment] safety and effectiveness. 1985 Feb 17. (PMA no. PB00025-000~. Ambulances Abbott. tFood and Drug Administration, Center for Devices and Radiological Health] Abbott AFP: sum- mary of safety and effectiveness. 1984 Jul 25. (PMA no. P780005-000). Amersham Corporation. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Amersham AFP: summary of safety and effective- ness. 1984 Soul 6 (PMA no. P78006-000~. Wampole Labs. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] AFP RIA kit: summary of safety and effectiveness. 1984 Feb 17. (PMA no.P76001-000). Abbott Labs. tFood and Drug Administration, Center for Devices and Radiological Health] Abbott AF- P-EIA diagnostic kit for cancer: summary of safety and effectiveness. 1983 Jul 19. (PMA no. P820060~. Alprazolam Food and Drug Administration, Center for Drugs and Biologics. Alprazolam. 1982. (NTIS order no. PB82-915901). [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Alprostadil Food and Drug Administration, Center for Drugs and Biologics. Alprostadil (PGE1~.1982. (NTIS order no. PB82-915901). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Alternative medicine Office of Technology Assessment, U.S. Congress. Non- traditional methods of cancer management. Wash- ington, D.C.: U.S. Government Printing Office (to be completed in Summer 19881. Health Council of the Netherlands. Alternative medi- cine. Ongoing assessment. American Academy of Pediatrics, Committee on Hospi- tal Care. Guidelines for air and ground transporta- tion. Pediatrics (To be published). Amcinonide Food and Drug Administration, Center for Drugs and Biologics. Amcinonide. 1982. (NTIS order no. PB82-915901). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Amiloride Food and Drug Administration, Center for Drugs and Biologics. Amiloride HC1. 1982. (NTIS order no. PB82-915901). f Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Amiloride HCl/hydrochlorothiazide. 1982. (NTIS order no. PB82-9159011. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Amino acids Food and Drug Administration, Center for Drugs and Biologics. 8% amion tsic] acid injection. 1982. (NTIS order no. PB82-915904~. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Aminocaproic acids Food and Drug Administration, Center for Drugs and Biologics. 8% amino acid injection. 1982. (NTIS or- der no.PB82-915904~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] 363

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Aminoglutethimide Food and Drug Administration, Center for Drugs and Biologics. Aminoglutethimide. 1981. (NTIS order no. PB81-915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Aminophylline Food and Drug Administration, Center for Drugs and Biologics. Aminophylline, USP. 1982/ (NTIS order no. PB82-915903J. [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Amoxicillin Food and Drug Administration, Center for Drugs and Biologics. Amoxicillin. 1981. (NTIS order no. PB81-915901~. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Analgesics National Institutes of Health, Consensus Development Program. Analgesic-associated kidney disease. (Con- sensus Development Conference Statement, Feb 27-29, 1984). Androgens Sherwin BB tSir Mortimer B. Davis-tewish General Hospital, Montreal] "Medical Research Council- Can- ada] Long-term effects of androgen and/or estrogen on psychosexual functioning, hormone levels, and lipid metabolism in surgically menopausal women. (Grant period 1984-1985) Anesthesia Cohen C. [The Hastings Center] Ethical problems in the clinical practice of anesthesia. In: Dekornfeld T. ed. Textbook of anesthesia. 1986. Duncan PG. iNational Health Research and Develop- ment Program - Canada] The influence of anesthesia and surgery on the outcome of pregnancy - pilot analysis. 1986. (Grant No. 6607-1289-531. American Academy of Pediatrics, Committee on Drugs. Guidelines for the elective use or conscious use of sedation, deep sedation, and general anesthesia in pediatric patients. Pediatrics 1985 Aug. 364 ECRI Technology Assessment Program. Deaths during general anesthesia. ~ Health Care Technol 1985; 1: 155-75. "Information syntheses] ECRI Technology Assessment Program. Monitoring of exhaled C02 levels during anesthesia. Issues Health Care Technol 1985 ;sec.5.M.4. "Information synthe- ses] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Anesthesia for ce- sarean section. 1982 May. (Technical bulletin no. 65~. (Expert opinion] Health Council of the Netherlands. Recent develop- ments in anesthesiology. 1978. Anesthesia Epidural Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Epidural analge- sia therapy. 1986. "Information syntheses] Anesthesia-Inhalation Health Council of the Netherlands. Inhalation sedation in dentistry. 1986. "English summary only]. Angiographic injectors Food and Drug Administration, Center for Devices and Radiological Health. Safety and performance of an- giographic and lymphographic injectors. 1984. (NTIS Order No. PB84- 195544~. Angiography United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of IGE L/U arm angiograph unit. 1986 Feb. (Report no. STB/86/7) tEpidemiological and other observational methods, Bench testing] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Coronary angiography and cardiac catheterization. 1985. [Information syntheses] American College of Cardiology/American Heart Asso- ciation Task Force on Assessment of Cardiovascular Procedures. Guidelines for coronary angiography. Ongoing. [Group judgment] Angi op l as t y U.S. Administrators, Professional Policy Committee. Coronary artery angioplasty. t7/86] EGroup judg- ment1

ASSESSMENT [LEPORT CITATIONS BY ~ CHONOLOGY Anthelmintics American Academy of Pediatrics, Committee on Drugs. Commentary on anthelmintics. Pediatrics 1978 Aug. Antianxiety agents American Medical Association, Council on Scientific Af- fairs. Prescription of tranquilizers and antidepres- sants for women (Board of Trustees report X, I-80. 1981. Group judgment] And-arrhythmics Nattel S. [Department Pharmacology and Therapeutics, McGill University] "Medical Research Council - Cana- da] Effects of antiarrhythmic drugs on arrhythmias related myocardial infarction. (Grant period 1981-1985). Andbiodcs American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Antimicrobial therapy for gynecologic infections. 1986 Oct. (Tech- nical bulletin no. 97~. tExpert opinion] Health Council of the Netherlands. Use of antibiotics. 1977. Andbiodcs Intravenous Lewin and Associates, Inc.] The safety, efficacy, and cost effectiveness of home intravenous antibiotics. 1986 Feb. [Information syntheses, Modeling, Cost an- alyses] Antibiotics Prophylactic American College of Obstetricians and Gynecologists, Committee Opinion. Prophylactic use of antibiotics with abdominal hysterectomy. "Information synthe- ses] American Academy of Pediatrics, Committee on Drugs. Antimicrobial prophylaxis in pediatric surgical pa- tients. Pediatrics 1984 Sep. American Academy of Pediatrics, Committee on Infec- tious Diseases. Antimicrobial prophylaxis in pediatric surgical patients. Pediatrics 1984 Sep. Anticholinerg~cs California Medical Association, Medical Practice Opin- ion Program. Anticholinergic drugs for nicotine ad- diction. 1985 May. (Medical Practice Opinion #322) tGroup judgment] Blazer DO, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The risk of anticho- linergic toxicity in the elderly: a study of prescribing practices in two populations. ~ Cardiol 1983 Jan;38~ 1):31-35. Anticoagulants Veterans Administration, Cooperative Studies Pro- gram. Anticoagulants in the Rx of CA (RA-233i. Pending. "Clinical trials] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Anticoagulant therapy in the myocardi- al infarction patient. 1985. "Information syntheses] Anticonvulsants American Academy of Pediatrics, Committee on Drugs. Behavioral and cognitive effects of anticonvulsant therapy. Pediatrics 1985 Oct. American College of Obstetricians and Gynecologists, Committee Opinion. Anticonvulsants and pregnancy. Revised 1984 Soul. "Information syntheses] American Academy of Pediatrics, Committee on Drugs. Anticonvulsants and pregnancy. Pediatrics 1980 Feb. Antidepressants American Medical Association, Council on Scientific Af- fairs. Prescription of tranquilizers and antidepres- sants for women (Board of Trustees report X, I-80. 1981. (Group judgment] Antihypertensives Curb ~D, Borhani NO, Blaszkowski TP, et al. "National Heart, Lung, and Blood Institute] Patient perceived side effects to antihypertensive drugs. J Community Health, accepted for publication. Curb D J. Borhani NO, et al. (National Heart, Lung, and Blood Institute] Long-term surveillance for adverse effects of antihypertensive drugs. tAMA 1985;253:3263-3268. Hypertension Detection and Follow-up Program Coop- erative Group. "National Heart, Lung, and Blood In- stitute] Five-year findings of the Hypertension Detec- tion and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension 1985; 7: 105- 112. 365

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Multiple Risk Factor Intervention Trial Research Group. "National Heart, Lung, and Blood Institute] Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Mul- tiple Risk Factor Intervention Trial. Am ~ Cardiol 1985;55: 1-15. Hypertension Detection and Follow-up Program Coop- erative Research Group. "National Heart, Lung, and Blood Institute] The effect of antihypertensive drug treatment on mortality in the presence of testing elec- trocardiographic abnormalities at baseline: the HDFP experience. Circulation 1984;70:996-1003. Lasser N. Grandits G. Caggiula A, et al. "National Heart, Lung, and Blood Institute] Effects of antihyperten- sive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am ~ Med 1984;76:52-66. Hardy R}, Hawkins CM. "National Heart, Lung, and Blood Institute] The impact of selected indices of anti-hypertensive treatment on all-cause mortality. Am ~ Epidemiol 1983;117:566-574. Wassertheil-Smoller S. Langford HG, Blaufox MD et al. "National Heart, Lung, and Blood Institute] Rate of hypertension return after withdrawal of prolonged antihypertensive therapy. Clin Sci 1982;63(Suppl 81:4235-4255. Anti-inhibitor coagulant complex National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. The use of anti-inhi- bitor coagulant complex (activated prothrombin- -complex concentrate) in the treatment of patients with hemophilia A and antibodies to factor VIII. 1981. Antilymphocyte serum American College of Physicians, Clinical Efficacy As- sessment Project. Antilymphocyte (ALG) and antithy- mocyte (ATG) globulin in renal transplantation. 1982. [Information syntheses] Antineoplastics handling American Medical Association, Council on Scientific Af- fairs. Guidelines for handling parenteral antineoplas- tics. MAMA 1985 Mar 15;253: 1590-1592. (Group judgment] 366 Antiplatelet therapy Veterans Administration, Cooperative Studies Pro- gram. Antiplatelet therapy after coronary artery by- -pass graft (CABG) surgery-I. Ongoing. "Clinical tri- als] Veterans Administration, Cooperative Studies Pro- gram. Antiplatelet therapy after coronary artery by- pass graft (CABG) surgery-II. Ongoing. (Clinical tri- als] Antipyresis Kramer MS, Naimark LE, Leduc DO. [McGill Univer- sity, Department of Epidemiology and Biostatistics] Is antipyresis harmful? Proceedings of the Ambulatory Pediatric Association 1984 annual meeting, San Fran- cisco. 1984:88. APACHE Wagner DP, Draper EA. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research1 Acute Physiology and Chronic Health Examination (APACHE II) and Medicare reimbursement. Health Care Finance Rev 1984 Nov;annual suppl:91-105. Apheresis Health Council of the Netherlands. Therapeutic hema- pheresis. 1986. LEnglish summary only]. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Apheresis in the treatment of systemic lupus erythematosus (SLE). 1986. U.S. Administrators, Professional Policy Committee. Therapeutic apheresis (plasmapheresis) [7/86] tGroup judgment] American Academy of Neurology, Practice Committee. Apheresis (therapeutic) in the treatment of Guillain- Barre syndrome. 1985 Jun. tExpert opinion, Group judgment] American Academy of Neurology, Practice Committee. Apheresis in treatment of systemic lupus erythemato- sus. 1985 Jun. fExpert opinion, Group judgments American College of Physicians, Clinical Efficacy As- sessment Project. Apheresis in chronic inflammatory demyelinating polyneuropathy and in renal trans- plantation. Ann Inter Med 1985;103:630-3. fInfor- mation syntheses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY ECRI Technology Assessment Program. Therapeutic apheresis. ~ Health Care Technol 1985; 1 :279-98. fIn- formation syntheses] National Center for Health Services Research and Health Care Technology Assessment. Apheresis in the treatment of Guillain-Barre syndrome.1985. American Academy of Neurology, Practice Committee. Apheresis in treatment of chronic relapsing polyn- europathy. 1984 Feb. tExpert opinion, Group judg- ment] American College of Physicians, Clinical Efficacy As- sessment Project. Apheresis in chronic severe rheu- matoid arthritis. 1984. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Apheresis in the treatment of chronic relapsing polyneuropathy. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Apheresis used in preparation for kidney transplant. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Apheresis for the treatment of Goodpasture's syndrome and membra- nous proliferative glomerulonephritides. 1983. Office of Technology Assessment, U.S. Congress. The safety, efficacy, and cost effectiveness of therapeutic apheresis. Washington, D.C.: U.S. Government Print- ing Office, July 1983. (Health technology case study series #23~. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Apheresis for multi- ple sclerosis. 1982. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Rheumatoid vasculi- tis therapeutic apheresis. 1982. American Academy of Neurology, Practice Committee. Apheresis for multiple sclerosis. 1981 Soul. tExpert opinion, Group judgment] National Center for Health Services Research and A'Thy~nia monitors Health Care Technology Assessment, Office of Health Technology Assessment. Therapeutic aphere sis for rheumatoid arthritis. 1981. Apnea monitoring National Institute of Child Health and Human Devel- opment. Infantile apnea and home monitoring. Be- thesda, MD: National Institute of Child Health and Human Development, 1987 (in press). (Group judg- ment, Expert opinion] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. SIDS (home ap- nea monitoring of siblings). 1986. "Information syn- thesesl National Institutes of Health, Consensus Development Program. Infantile apnea and home monitoring. (Consensus Development Conference Statement, Sep 29-Oct 1 1986~. tGroup judgment] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Apnea monitoring for 24-hour surveillance of newborns at risk for sud- den infant death syndrome. JAMA 1984 fan 27. tEx- pert opinion, Information syntheses] Apnea monitors Teledyne, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Sleep sentry (TM): summary of safety and effectiveness.1982 Sep 17. (PMA no. P81004-000). Appropriateness Evaluation Protocol Appropriateness of hospitalization: a comparative anal- ysis of reliability and validity of the Appropriateness Evaluation Protocol and the Standardized Medreview Instrument. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Reducing inappropriate use of inpatient medical, surgi- cal, and pediatric services extension of the Appro- priateness Evaluation Protocol. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219~. ECRI Health Devices Program. Arrhythmia monitoring systems, computerized. Health Devices 1985;14:287-319. 367

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY American Hospital Association, Hospital Technology Series Program. Computerized arrhythmia monitor- ing systems. 1982. (Guideline report) "Information syntheses, Expert opinion, Cost analyses] ECRI Health Devices Program. Arrhythmia monitoring systems, computerized. Health Devices 1982; 11:211-247. Arteriography U.S. Administrators, Professional Policy Committee. Coronary arteriography. t7/86] (Group judgment] Gersh B T. Kronmal RA, Frye RL, et al. "National Heart, Lung, and Blood Institute] Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older: a report from the Coronary Artery Surgery Study. Circulation 1983;67:483-490. Arthroscopy U.S. Administrators, Professional Policy Committee. Arthroscopy of joints other than the knee. [7/86] [Group judgments U.S. Administrators, Professional Policy Committee. Arthroscopy of knee. t7/86] tGroup judgment] California Medical Association, Medical Practice Opin- ion Program. Assistant surgeon for arthroscopic pro- cedures. 1984 Apr. (Medical Practice Opinion #239) tGroup judgment] ECRI Technology Assessment Program. Diagnostic and operative arthroscopy. Issues Health Care Technol 1982;sec.5.A.1. [Information syntheses] Artificial heart Office of Technology Assessment, U.S. Congress. The artificial heart: cost, risks, and benefits. Washington, D.C.: U.S. Government Printing Office, May 1982. (Health technology case study series #9~. Artificial pancreas Albisser AM. "Hospital for Sick Children, Toronto] [Medical Research Council - Canada] Clinical applica- tions of an artificial pancreas. (Grant period 1975-1985). Artificial procreation Health Council of the Netherlands. Artificial procre- ation. 1986. (English summary only). 368 Artificial sweeteners American Diabetes Association, Task Force of the Council on Nutrition Sciences and Metabolism. Posi- tion statment on use of noncaloric sweeteners. 1987. tExpert opinion, Group judgment] Aspartame American Medical Association, Council on Scientific Af- fairs. Aspartame: review of safety issues. JAMA 1985 Tul 18;254:400-402. [Group judgment] A· e splrm Hennekens C, Eberlein K. [National Heart, Lung, and Blood Institute] A randomized trial of aspirin and beta-carotene among U.S. physicians. Prev Med 1985:Appendix VI. American Academy of Pediatrics, Committee on Infec- tious Diseases. Aspirin and Reye syndrome. Pediatrics 1982 Jun. Aspirin Myocardial Infarction Research Group. jNa- tional Heart, Lung, and Blood Institute] Aspirin Myocardial Infarction Study: design, methods and baseline results. DHEW Pub. No. (NIH) 80-2106, 1980. Aspirin Myocardial Infarction Research Group. tNa- tional Heart, Lung, and Blood Institute] A random- ized controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980;243:661-669. Aspirin Myocardial Infarction Study Research Group. [National Heart, Lung, and Blood Institute] The As- pirin Myocardial Infarction Study: final results. Cir- culation 1980;60(Suppl V)V79-V84. Coronary Drug Research Group. (National Heart, Lung, and Blood Institute] Aspirin in coronary heart disease. Circulation 1980;62(Suppl V):V59-V62. Gent M, Barnett H}M, Sackett DL, Taylor DW. [McMaster University, Department of Clinical Epide- miology and Biostatistics] A randomized trial of aspi- rin and sulfinpyrazone in patients with threatened stroke: results and methodologic issues. Circulation 1980;62(Suppl V):V-97. Assertiveness training Glueckauf RL. "National Health Research and Develop- ment Program - Canada] Assertion training for disa- bled persons in wheelchairs. 1986. (Grant No. 6606-2255-011.

ASSESSMENT REPORT CITATIONS BY TEC~OLOGY Assessment methods Griffith BD, White HD, Drott MC, Saye ~D. "National Library of Medicine] Tests of methods for evaluating bibliographic databases an analysis of the National Library of Medicine's handling of literatures in the medical behavioral sciences. ~ Am Soc Info Sci 1986;37:261-70. Atenolol Food and Drug Administration, Center for Drugs and Biologics. Atenolol. 1981. (NTIS order no. PB81 -915911). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Audiometry tests Smith A, MacMurray SB, Goodman IT. iNational Health Research and Development Program - Cana- da] A comparison of crib-o-gram and brainstem elec- tric response audiometry in the screening of hearing loss in high risk neonates. 1986. (Grant No. 6606- 1924-43). Automated microbiology systems Roche Diagnostic Systems. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Co- bas bact: summary of safety and effectiveness. 1986 Jul 7. (PMA no. P840065-000~. ECRI Technology Assessment Program. Automated microbiology systems. Issues Health Care Technol 1985;sec.5.M.5. "Information syntheses] ECRI Technology Assessment Program. Automated microbiology systems. I Health Care Technol 1985; 1:213-30. [Information syntheses] Automobile passenger restraints American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Automobile pas- senger restraints for children and pregnant women. 1983 Dec. (Technical bulletin no. 74~. j expert opin- ion] Office of Technology Assessment, U.S. Congress. Man- datory passive restraint systems in automobiles. Washington, D.C.: U.S. Government Printing Office, September 1982. (Health technology case study series #20). Autopsy American Medical Association, Council on Scientific Af- fairs. Autopsies: interim report (Substitute Resolution 11, A-841. 1985. tGroup judgment] American Academy of Neurology, Practice Committee. Autopsies on patients with slow virus diseases. 1984 Nov. [Expert opinion, Group judgments Autotransfusion units American Hospital Association, Hospital Technology Series Program. Autotransfusion units. 1982. (Guide- line report) "Information syntheses, Expert opinion, Cost analyses] Aversion therapy American College of Physicians, Clinical Efficacy As- sessment Project. Chemical aversion therapy in the treatment of alcoholism, expected completion 1988. [Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Aversion therapy for alcoholism. 1984 Feb. (Medical Practice Opinion #311) tGroup judg- ment1 National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Alcohol aversion therapy. 1981. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Chemical aversion therapy for treatment of alcoholism. Ongoing. Azatadine Food and Drug Administration, Center for Drugs and Biologics. Azatadine maleate & pseud. sulfate. 1982. (NTIS order no. PB82-915902~. LInformation synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testings Azathioprine Parfrey PS, Hutchinson TA, Lowry RP, Knaack J. Gutt- man RD. iMcGill University, Department of Epidemi- ology and Biostatistics] Causes of late allograft failure and the role of azathioprine reduction. Transplant Proc 1984; 16:1100-1102. 369

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Food and Drug Administration, Center for Drugs and Biologics. Azathioprine. 1981. (NTIS order no. PB81 -915907~. fInformation syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Azlocillin Food and Drug Administration, Center for Drugs and Biologics. Azlocillin sodium. 1982. (NTIS order no. PB82-915904~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Bacampicillin Food and Drug Administration, Center for Drugs and Biologics. Bacampicillin hydrochloride. 1982. (NTIS order no. PB82-915902~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Bacterial antigens California Medical Association, Medical Practice Opin- ion Program. Injections of universal bacterial antigen. 1980 Jan. (Medical Practice Opinion #210) tGroup judgment] Balance training devices Fernie GR. "National Health Research and Develop-' ment Program - Canada] Balance training device for stroke rehabilitation. 1986. (Grant No. 6606-3023-451. Balloon dilatation catheters Scimed Life Systems, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Scimed PTCA dilatation catheter: summary of safety and effectiveness. 1987 Jan 16. (PMA no. P860019-000~. Medi-tech. [Food and Drug Administration, Center for Devices and Radiological HealthJ Med-tech coronary balloon dilatation catheter system: summary of safety and effectiveness. 1986 Feb 10. (PMA no. P840040-000~. Advanced Catheter Systems. iFood and Drug Adminis- tration, Center for Devices and Radiological Health] Simpson-Robert coronary balloon dilatation catheter: summary of safety and effectiveness. 1982 Mar 26. (PMA no. P810046-000~. 37O American Hospital Association, Hospital Technology Series Program. Bar coding technology - applications in health care. 1984. (Guideline report) Barbiturates California Medical Association, Medical Practice Opin- ion Program. Barbiturate coma. 1983 Feb. (Medical Practice Opinion #280) tGroup judgment] Barium enema with sigmoidoscopy Irvine EJ. [National Health Research and Development Program - Canada] A prospective study to compare diagnostic agreement and cost-effectiveness of air contrast barium enema plus flexible sigmoidoscopy with colonoscopy in rectal bleeding. l 986. (Grant No. 6606-2974-42). Batter~es, Electric ECRI Health Devices Program. Batteries, zinc air. Health Devices 1985; 14:209-211. BCG immunotherapy American Medical Association, Diagnostic and Thera- peutic Technology Assessment. BCG immunothera- py in bladder cancer. Mar 31, 1986. tExpert opinion, Information syntheses] BCG vaccine Pabst HF. (National Health Research and Development Program - Canada] BCG vaccine take in babies with and without maternal PPD sensitization.1986. (Grant No. 6609- 1205-54~. Beclomethasone Food and Drug Administration, Center for Drugs and Biologics. Beclomethasone dipropionate. 1981. (NTIS order no. PB81-915912). "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing Beds, Electric ECRI Health Devices Program. Electric beds. Health Devices 1986;15-299-316.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Behavioral disorders screening Benzyl alcohol Bytes TA. "National Health Research and Development Program - Canada] An assessment of a survey instru- ment designed to diagnose children's behavioural dis- orders. 1986. (Grant No. 6606-2245-04~. Behavioral therapy Cunningham A{. [National Health Research and Devel- opment Program - Canada] A randomized control trial of a brief behavioural training group pro- gramme for alleviating psychological distress in can- cer patients. 1986. (Grant No. 6606-2884-44~. D'Arcy C. [National Health Research and Development Program - Canada] Phobia, anxiety and alcoholism: evaluating a behavioural treatment program. 1986. (Grant No. 6608- 1182-43~. White DR. (National Health Research and Develop- ment Program - Canada] Evaluation of a behavioral- -development treatment for childhood obesity. 1986. (Grant No. 6605- 1876-42~. Bendien's test National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bendien's test for cancer and tuberculosis. 1982. Benoxaprofen Food and Drug Administration, Center for Drugs and Biologics. Benoxaprofen. 1982. (NTIS order no. PB82-915903~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Bentonite flocculation test American College of Physicians, Clinical Efficacy As- sessment Project. Bentonite flocculation test. 1982. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Desoxyribonucleic acid-bentonite flocculation for the diagnosis of rheu- matoid arthritis. 1981. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. The use of the ben- tonite flocculation test in the diagnosis of rheumatoid arthritis. 1981. American Academy of Pediatrics, Committee on Drugs. Benzyl alcohol: toxic agent in neonatal units. Pediat- rics 1983 Sep. American Academy of Pediatrics, Committee on Fetus and Newborn. Benzyl alcohol: toxic agent in neonatal units. Pediatrics 1983 Sep. Beta blockers Beta-Blocker Heart Attack Study Group. iNational Heart, Lung, and Blood Institute] The Beta-Blocker Heart Attack Trial: cooperative trial-preliminary re- port. {AMA 1986;246:2073-2074. Byington RP for the Beta-Blocker Heart Attack Trial Research Group. "National Heart, Lung, and Blood Institutel Beta-Blocker Heart Attack Trial - design, methods and baseline results. Controlled Clin Trials 1984;4:382-437. Korenbrot CC, Aalto LH, Laros RK. [University of Cali- fornia, San Francisco, Institute for Health Policy Studies] The cost effectiveness of stopping preterm labor with beta-adrenergic treatment. N Engl J Med 1984;310:691-696. Furberg CD, Byington RP for the BHAT Research Group. "National Heart, Lung, and Blood Institute] What do subgroup analyses reveal about differential response to beta-blocker therapy? The Beta-Blocker Heart Attack Trial experience. Proceedings of the Workshop on Implications of Recent Beta-Blocker Trials for Post-Myocardial Infarction Patients. Circu- lation 1983;67(Supplement b:I-98. Beta-Blocker Heart Attack Trial Research Group. [Na- tional Heart, Lung, and Blood Institute] Beta-Blocker heart attack trial - design features. Controlled Clin Trials 1981 ;2:275-285. Beta-carotene Hennekens C, Eberlein K. liNational Heart, Lung, and Blood Institute] A randomized trial of aspirin and beta-carotene among U.S. physicians. Prev Med 1985 :Appendix VI. Willett WC, Polk BF, Underwood BA, et al. iNational Heart, Lung, and Blood Institute] Relation of serum vitamins A and E and carotenoids to the risk of can- cer. N Engl J Med 1984;310:410-434. 371 ? -

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Betamethasone Food and Drug Administration, Center for Drugs and Biologics. Betamethasone dipropionate. 1987. (Sum- mary basis of approval, NDA # 19- 136~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Betamethasone dipropionate. 1987. (Sum- mary basis of approval, NDA # 19-1371. [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Betamethasone dipropionate. 1987. (Sum- mary basis of approval, NDA # 19- 138~. f Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Betamethasone valerate. 1983. (NTIS or- der no. PB83-915902~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Bethanidine sulfate Food and Drug Administration, Center for Drugs and Biologics. Bethanidine sulfate. l 981. (NTIS order no. PB81-915908~. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Bibliographic information bases "National Library of Medicine] An analysis of the Na- tional Library of Medicine's (NLMJ handling of the medical behavioral sciences' (MBS) literatures. Final report. (Five volumes plus executive summary). Be- thesda, MD: National Library of Medicine, 1984. Epidemiological and other observational methods] Siegel ER, Kameen K, Sinn SK, Weise FO. "National Library of Medicine] A comparative evaluation of the technical performance and user acceptance of two prototype online catalog systems. Info Technol Libr 1984;3:35-46. Epidemiological and other observa- tional methods] Bibliographic info~madon bases-Training [National Library of Medicines Evaluation of PC-orient- ed training packages for the NLM chemical and toxi- cological online files. Bethesda, MD: National Library of Medicine. Ongoing. Epidemiological and other observational methods] 372 Bilio-pancreadc bypass California Medical Association, Medical Practice Opin- ion Program. Bilio-pancreatic bypass surgery for obe- sity. 1983 Mar. (Medical Practice Opinion #284) tGroup judgment] Bilirubinometers ECRI Technology Assessment Program. Noninvasive bilirubinometers. Issues Health Care Technol 1983;sec.5.B.4. "Information syntheses] Biochemical analyzers United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. An evaluation of the Beckman Astra 8 with enzymes. 1985 Jul. (Report no. STB3A/85/32) Epidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of Analogue LM3 analyser. l 985 May. (Report no. STB3/85/25) Epidemiological and other observa- tional methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of the IQ Bio Microlite Floteskan system. 1985 Oct. (Report No. STB3A/85/43) Epidemiological and other observational methods, Bench testing] Biochemical profiles Blue Cross and Blue Shield Association, Medical Neces- sity Program. Biochemical profiles in ambulatory screening and preadmission testing of adults. 1987. fInformation syntheses! Biofeedback Milner M, Levison H. "National Health Research and Development Program - Canada] Evaluation of re- laxed breathing and its augmentation with biofeed- back upon bronchospasm induced by methacholine in paediatric patients with chronic asthma. 1986. (Grant No. 6606-2113-53~. Sullivan SJ. "National Health Research and Develop- ment Program - CanadaJ Electromyographic biofeed- back and the learning process in the treatment of hemiplegia. 1986. (Grant No. 6605-2415-45). U.S. Administrators, Professional Policy Committee. Biofeedback. t7/86] [Group judgments

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American College of Physicians, Clinical Efficacy As sessment Project. Biofeedback for gastrointestinal dis orders. Ann Intern Med 1 985; 1 03:29 1 -3,240-44. [In formation syntheses] American College of Physicians, Clinical Efficacy As sessment Project. Biofeedback for headaches. Ann Intern Med 1985; 102: 128-31. "Information synthe ses] American College of Physicians, Clinical Efficacy As sessment Project. Biofeedback for hypertension. Ann Intern Med 1985; 102:709-15. [Information synthe ses] American College of Physicians, Clinical Efficacy As sessment Project. Biofeedback for neuromuscular disorders. Ann Intern Med 1985;102:854-8. LInfor mation syntheses] American Academy of Neurology, Practice Committee. Electromyographic biofeedback in treatment of hy peractivity. 1984 Feb. tExpert opinion, Group judg mentJ American Medical Association, Diagnostic and Thera peutic Technology Assessment. Biofeedback for managing vascular and tension headaches. tAMA 1983 Nov 14. tExpert opinion, Information synthe ses] California Medical Association, Medical Practice Opin ion Program. Biofeedback. 1983 Aug. (Medical Prac tice Opinion #240) [Group judgment] American Academy of Neurology, Practice Committee. Biofeedback for headaches. 1982 Jun. tExpert opin ion, Group judgment] American Academy of Neurology, Practice Committee. Biofeedback treatment for migraine headache. 1980 Apr. tExpert opinion, Group judgment] Biopsy Endometrial American College of Obstetricians and Gynecologists, Committee Opinion. Endometrial sampling. 1985 Jun. "Information syntheses] Biopsy Fetal blood American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Fetal blood sam- Blood cultures pling. 1976 Oct. (Technical bulletin no. 421. tExpert . . . opinions Biopsy Renal Parfrey PS, et al. McGill University, Department of Epidemiology and Biostatistics] The diagnostic and prognostic value of renal allograft biopsy. Transplan- tation 1984;38~6~:586-590. Blood banks Office of Technology Assessment, U.S. Congress. Blood policy and technology. Washington, D.C.: U.S. Gov- ernment Printing Office, January 1985. Blood cell count Blue Cross and Blue Shield Association, Medical Neces- sity Program. Complete blood count and leukocyte differential count. 1987. fInformation syntheses] Koepke JA, ed. Differential leukocyte counting. CAP Conference/Aspen 1977. Skokie, IL: College of American Pathologists, 1978. [Expert opinion, Bench testing] Blood chemistry analyzers United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. An evaluation of the Kone Process selective chemistry analyser.1985 Soul. (Report no. STB3A/85/31) tEpide- miological and other observational methods, Bench testings Office of Technology Assessment, U.S. Congress. Cos- t-effectiveness of automated multichannel chemistry analyzers. Washington, D.C.: U.S. Government Print- ing Office, April 1981. (Health technology case study series #41. Weinstein MC, Pearlman LA. "Harvard School of Public Health, Institute for Health Research] Case study on cost-effectiveness of automated multichannel chemis- try analyzers. The implications of cost-effectiveness analysis of medical technology background paper #2: case studies of medical technologies. Office of Tech- nology Assessment, U.S. Congress. Washington, D.C.: U.S. Government Printing Office, 198 1. tEpide- miological methods] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Blood cultures.1987. "Information syn- theses] 373

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Blood gas monitoring Blue Cross and Blue Shield Association, Medical Neces- sity Program. Arterial blood gas analysis. 1987. tIn- formation syntheses] Medical Technology and Practice Patterns Institute. End tidal carbon dioxide monitoring. 1987. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Diagnostic studies for respiratory pa- tients: arterial blood gas analysis. 1982. "Information syntheses] Blood gas monitors ECRI Health Devices Program. Carbon dioxide moni- tors. Health Devices 1986; 15: 255-85. Litton Datamedix. [Food and Drug Administration, Center for Devices and Radiological Health] Litton transcutaneous C02 system: summary of safety and effectiveness. 1986 Sep 26. (PMA no. P850087-000~. Radiometer! America. tFood and Drug Administration, Center for Devices and Radiological Health] Radiom- eter TCM-10 transcutaneous carbon dioxide moni- tor: summary of safety and effectiveness. 1984 Apr 13. (PMA no. P800043-002). ECRI Health Devices Program. Blood gas/pH analyzers. Health Devices 1983;12:59-78. ECRI Health Devices Program. Oxygen monitors, transcutaneous. Health Devices 1983; 12:213-51. ECRI Technology Assessment Program. Transcutan- eous C02 monitors. Issues Health Care Technol 1983;sec.5.M.3. "Information syntheses] Narco Scientific. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Monitoring system TCPC02: summary of safety and effective- ness. 1983 Feb 15. (PMA no. P820025-000J. Sensormedics. [Food and Drug Administration, Center for Devices and Radiological Health] Cutaneous gas monitor: summary of safety and effectiveness. 1983 Sep 16. (PMA no. P830008-0001. Biochem International Inc. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Lifespan (TM) 100 TCPC02 monitor: summary of safety and effectiveness. 1982 Oct 1. (PMA no. P820019-000). Hewlett-Packard Co. [Food and Drug Administration, Center for Devices and Radiological Health] H-P cap- nometer model 47210A, option A10 cutaneous: sum- mary of safety and effectiveness. 1982 Apr 13. (PMA no. P810043-000). 374 Kontron Cardiovascular Inc. [Food and Drug Adminis- tration, Center for Devices and Radiological Health] Kontron cutaneous PC02 monitor: summary of safety and effectiveness. 1982 Jun 18. (PMA no. P810037 000). Orange Medical Instruments. (Food and Drug Admin- istration, Center for Devices and Radiological Health] Transconjunctival oxygen monitor: summary of safe- ty and effectiveness. 1982 Nov 19. (PMA no. P820011-000). ECRI Technology Assessment Program. Noninvasive blood gas oxygen monitors. Issues Health Care Tech- nol 1981 ;sec.5.M.1. "Information syntheses] Blood glucose control devices National Center for Health Services Research and Health Care Technology Assessment, Off~ce of Health Technology Assessment. Closed-loop blood glucose control device. 1983. Blood glucose monitoring American Diabetes Association, Consensus Develop- ment Panel. Consensus statement on self-monitoring of blood glucose. Diabetes Care 1987; 10:95-99. [Ex- pert opinion, Group judgment] American Diabetes Association. Bedside blood glucose monitoring in hospitals. Diabetes Care 1986;9:89. [Expert opinion, Group judgment] American College of Physicians, Clinical Efficacy As- sessment Project. Home blood glucose monitoring. Ann Intern Med 1983;99:272-4. "Information syn- theses] Blood glucose monitors National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Home blood glucose monitors. 1982. California Medical Association, Medical Practice Opin- ion Program. Stat-tek glucose analyzer for diabetes. 1981 Aug. (Medical Practice Opinion #260) tGroup judgment] Blood pressure monitoring Medical Technology and Practice Patterns Institute. Ambulatory blood pressure monitoring. 1987.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American College of Physicians, Clinical Efficacy As- sessment Project. Automated ambulatory blood pres- sure monitoring. Ann Intern Med 1986;104:275-8. [Information syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Automated and semi-automated ambulatory blood pressure monitor- ing. 1986. "Information syntheses] Georgetown University Medical Center, Institute for Health Policy Analysis. National Health Services and Practice Patterns Survey. Report on fully automated blood pressure monitoring: current and future appli- cations. Washington, DC: Institute for Health Policy Analysis, 1986. "Information syntheses, Expert opin- ion, Group judgment, Cost analyses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Fully automated blood pressure monitoring of hypertension. 1986. Barnett GO, et al. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] A computer-based monitoring system for follow-up of elevated blood pressure. Med Care 1983 Apr;21 (4) :400-409. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Fully automated am- bulatory blood pressure monitoring of hypertension. 1983. California Medical Association, Medical Practice Opin- ion Program. Constant blood pressure monitoring. 1982 Aug. (Medical Practice Opinion #275) [Group judgments National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Ambulatory blood pressure monitoring in hypertensives using semiauto- matic, patient-activated portable devices. 1982. American College of Physicians, Clinical Efficacy As- sessment Project. 24-hour sphygmomanometry. 1981. fInformation syntheses] National Institutes of Health, Consensus Development Program. Improving clinical and consumer use of blood pressure measuring devices. (Consensus Devel- opment Conference Statement, Apr 26-27 1979~. (Group judgments {ohns Hopkins Program for Medical Technology and Practice Assessment. An assessment of automatic blood pressure monitoring. Planned. ECRI Health Devices Program. Sphygmomanometers, automatic. Health Devices 1986; 15: 187-208. American Hospital Association, Hospital Technology Series Program. Automated indirect blood pressure measurement devices. 1982. (Guideline report) fIn- formation syntheses, Expert opinion, Cost analyses] ECRI Technology Assessment Program. Automatic in- direct blood pressure monitors. Issues Health Care Technol 1982 ;sec.5.B.2. "Information syntheses] Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Sphygmo- manometers. 1978. Blood substitutes ECRI Technology Assessment Program. Blood substi- tute. Issues Health Care Technol 1982;sec.5.B.3. tIn- formation syntheses] Blood transfusion U.S. Administrators, Professional Policy Committee. Transfusion - preparation of blood. t7/86] tGroup judgment] CBO (Centraal Begeleidingsorgaan voor de Intercolle- giale Toetsing) Consensus Development Program. Blood transfusion therapy. 1982. tDutch language only] tGroup judgment, Expert opinion] Polesky HE, Walker RH, eds. Safety in transfusion prac- tices. CAP Conference/Aspen 1980. Skokie, IL: Col- lege of American Pathologists, 1981. tExpert opinion, Bench testing] National Institutes of Health, Consensus Development Program. Transfusion therapy in pregnant sickle cell disease patients. (Consensus Development Confer- ence Statement, Apr 23-24 19791. tGroup judgment] Blood transfusion-Autologous U.S. Administrators, Professional Policy Committee. Autologous blood transfusions. Ongoing. tGroup judgment! Blood urea concentration Blue Cross and Blue Shield Association, Medical Neces- sity Program. Blood urea nitrogen concentration and serum creatinine concentration. 1987. "Information syntheses] 375

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Blood warmers ECRI Health Devices Program. Blood warmers. Health Devices 1984; 13: 191-219. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Blood- warmers for use during transfusion. 1981. Bolen's test National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bolen's test for can- cer. 1982. Bone cements Food and Drug Administration, Center for Devices and Radiological Health. To cement or not to cement? or has the FDA approved the use of this device? 1986. (FDA Pub No. FDA86-4202). Miller {E. [Montreal General Hospital Research Insti- tute] "Medical Research Council- Canada] Optimiza- tion of fixation of artificial joint components to bone - the prevention of loosening in total joint arthroplasty. (Grant period 1974-1985~. Dow Corning Wright fFood and Drug Administration, Center for Devices and Radiological Health] CMW bone cement: summary of safety and effectiveness. 1984 Apr 24. (PMA no. N18466-000). EM Labs. fFood and Drug Administration, Center for Devices and Radiological Health] Palacos R bone ce- ment: summary of safety and effectiveness. 1984 Feb 28. (PMA no. P810020-000). Bone growth stimulation Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Electrical bone growth stimulation. 1986. fInformation syntheses] U.S. Administrators, Professional Policy Committee. Bone healing/electromagnetic stimulation. Ongoing. tGroup judgment] Bone growth stimulators Advanced Biosearch Assn. tFood and Drug Administra- tion, Center for Devices and Radiological HealthJ Orthopak (R) bone growth stimulator: summary of safety and effectiveness. 1986 Apr 9. (PMA no. P850022-000). 376 American Medical Electronics, Inc. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Physio-stim (TM) I & II Model 6000 & 7000: summary of safety and effectiveness. 1986 Apr 18. (PMA no. P850007-000). ECRI Technology Assessment Program. Bone growth stimulators. Issues Health Care Technol 1981 ;sec.5.B.1. "Information syntheses] Bone mineral studies American College of Physicians,Clinical Efficacy Assess- ment Project. Bone mineral densitometry, 1987. tIn- formation syntheses] American College of Physicians, Clinical Eff~cacy As- sessment Project. Radiologic methods to evaluate bone mineral content. Ann Intern Med 1 984; 1 00: 1 08- 1 1. [I nformation syntheses] California Medical Association, Medical Practice Opin- ion Program. Bone densitometry.1982 Nov. (Medical Practice Opinion #254) tGroup judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bone mineral stud- ies. 1982. Bone prosthesis Unilab, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Kiel Surgibone: summary of safety and effectiveness. 1982 Jun 18. (PMA no. P800044-000). Botulinum toxin American Academy of Ophthalmology. Botulinum tox- in therapy of eye muscle disorders: safety and effec- tiveness. San Francisco, CA: American Academy of Ophthalmology, 1984. "Information syntheses, Ex- pert opinion1 Brain electrical activity mapping U.S. Administrators, Professional Policy Committee. B.E.A.M. t7/86] tGroup judgment Breast feeding American Academy of Pediatrics, Committee on Nutri- tion. Promotion of breast feeding. 1982. American Academy of Pediatrics, Committee on Nutri- tion. Breast feeding and contraception. 1981.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American College of Obstetricians and Gynecologists, Committee Opinion. Breast-feeding and contracep- tion. 1981 May. "Information syntheses] American Academy of Pediatrics, Committee on Nutri- tion. Encouraging breast-feeding. Pediatrics 1980 Mar. American Academy of Pediatrics, Committee on Nutri- tion. Breast-feeding. Pediatrics 1978 Oct. American Academy of Pediatrics, Committee on Nutri- tion. Commentary on breast-feeding and infant for- mulas, including proposed standards for formulas. Pediatrics 1976 Feb. Health Council of the Netherlands. Breast feeding (con- tamination of milk'. Ongoing assessment. Breast imaging U.S. Administrators, Professional Policy Committee. Breast imaging. [7/861 tGroup judgment] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Diagnostic imaging in the evaluation of breast disease. 1984. [Information syntheses] Breast physical examination Eddy DM. [Duke University, Center for Health Policy Research and Education] The effectiveness, cost, & cost-effectiveness of breast cancer screening with an- nual mammography & breast physical exam. for women over 65. Report prepared for Committee on Ways & Means, Subcommittee on Health, U.S. House of Representatives. 1986 Jan 7. "Information synthe- ses] Breath tests National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. 13CO2 breath test for diagnosing bile acid malabsorption. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. 13CO2 breath test for diagnosing fat malabsorption. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. 13C and 14C glycocholate tests. 1983. [Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. 13C and 14C glycocholate, H2 breath, 13C trioctanoin, and 14C triolein breath tests. 1983.tInformation syntheses] American College of Physicians, Clinical Efficacy As- sessment Project.14C xylose breath test. 1983. [Infor- mation syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Lactulose H2 breath test. 1983. iIn- formation syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. The H2 breath test. 1983. tInfor- mation syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Lactose breath hy- drogen test for the diagnosis of lactose malabsorption. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Lactulose breath hy- drogen test for small bowel bacterial overgrowth and small bowel transit time. 1983. Bromocriptine American College of Obstetricians and Gynecologists, Committee Opinion. Clinical use of bromocriptine. Pending. "Information syntheses] Food and Drug Administration, Center for Drugs and Biologics. Bromocriptine mesylate. 1981. (NTIS or- der no. PB81-915912~. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Bumetz~ide Food and Drug Administration, Center for Drugs and Biologics. Bumetanide injectable. 1987. (Summary basis of approval, NDA #18-226~. [Information syn- theses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Bumetanide tablets. 1987. (Summary basis of approval, NDA # 18-2251. Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Bupivacaine Food and Drug Administration, Center for Drugs and Biologics. Bupivacaine hydrochloride. 1982. (NTIS order no. PB82-9159011. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing 377

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Buprenorphine Food and Drug Administration, Center for Drugs and Biologics. Buprenorphine HC1. 1982. (NTIS order no. PB82-915901~. [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Burn units Subcommittee on Institutional Program Guidelines. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Division] Burn unit guidelines. Revised 1985. "Information syntheses, Expert opinion, Groupjudg- ment] Payne BC. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Burn care facility study. 1984. (NTIS order no. PB84-240688) Bypass graft materials Veterans Administration, Cooperative Studies Pro- gram. Comparative efficacy of vascular by-pass graft materials in lower extremity revascularization. Ongo- ing. [Clinical trials] Caerulein Food and Drug Administration, Center for Drugs and Biologics. Ceruletide diethylamine. 1982. (NTIS or- der no. PB82-915901). "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Calcium channel blockers American Medical Association, Council on Scientific Af- fairs. Calcium channel blocking agents. JAMA 1983 Nov 11 ;250:2522-2524. tGroup judgment] Calcium chloride Food and Drug Administration, Center for Drugs and Biologics. CaC12, MgCl, Kcl, & NaCl. 1982. (NTIS order no. PB82-915902~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Camphor American Academy of Pediatrics, Committee on Drugs. Camphor: who needs it? Pediatrics 1978 Sep. 378 Cancer screening American College of Obstetricians and Gynecologists, Committee Opinion. ACOG statement on periodic cancer screening for women. l 980 Jun. "Information syntheses] Cancer screening-Breast Eddy DM. (Duke University, Center for Health Policy Research and Education] Screening for breast cancer, reassessment. (Expected publication 1988) [Informa- tion syntheses]. Miller AB. "National Health Research and Development Program - Canada] National study of screening for breast cancer. 1986. (Grant No. 6613- 1149-X). American College of Physicians, Clinical Efficacy As- sessment Project. Screening for breast cancer. Ann Intern Med 1985; 103: 143-6,79-85. "Information syn- theses] American College of Radiology, Task Force on Breast Cancer. Policy statement: breast cancer screening centers. 1985. tGroup judgment] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Epidemiology and diagnosis of breast disease. 1983 Sep. (Technical bul- letin no. 71). fExpert opinion] National Institutes of Health, Consensus Development Program. Breast cancer screening. (Consensus Devel- opment Conference Statement, Sep 14-16 19771. tGroup judgment] Health Council of the Netherlands. Screening for breast cancer. Ongoing assessment. Cancer screening Cervical Eddy DM. fDuke University, Center for Health Policy Research and Education] Screening for cervical can- cer, reassessment. (Expected publication 19881. tIn- formation syntheses] Cohen MM. "National Health Research and Develop- ment Program - Canada] A population-based study of cervical screening in Manitoba. 1986. (Grant No. 6607- 1401 -53). American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Cervical cytology: evaluation and management of abnormalities. 1984 Oct. (Technical bulletin no. 811. fExpert opinion] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Diagnosis and management of invasive cervical carcinomas. 1983 May. (Technical bulletin no. 691. tExpert opinion]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Eddy DM. tDuke University, Center for Health Policy Research and Educations Appropriateness of cervical cancer screening. Gynecol Oncol 1981; 12: S 168- 187. [Information syntheses] Office of Technology Assessment, U.S. Congress. Allo- cating costs and benefits in disease prevention: an application to cervical cancer screening. Washington, D.C.: U.S. Government Printing Office, May 1981. (Health technology case study series ;~7) Cancer screening- Colorectal Eddy DM. tDuke University, Center for Health Policy Research and Education] Screening for colorectal cancer, reassessment. (Expected publication 19881. [Information syntheses] Brandeau ML, Eddy DM. (Duke University, Center for Health Policy Research and Education] The workup of the asymptomatic patient with a positive fecal oc- cult blood test. Med Decis Making 1987;7:32-46. ~In- formation syntheses] Eddy DM, Nugent FW, Eddy IF, et al. (Duke University, Center for Health Policy Research and Education] Screening for colorectal cancer in a high-risk popula- tion: results of a mathematical model. Gastroenterol- ogy 1987;92 :682-692. (Information syntheses] Wiens E, Kumpula VW, Hill GB. (National Health Re- search and Development Program -Canada] Early de- tection of colorectal cancer in Northern Alberta. 1986. (Grant No. 6609-1243-531. Eddy DM. (Duke University, Center for Health Policy Research and Education] Screening for colon cancer: a technology assessment.1981. (Office of Technology Assessment background paper #2: case studies of medical technologies) fInformation syntheses] Office of Technology Assessment, U.S. Congress. Screening for colon cancer. Washington, D.C.: U.S. Government Printing Of rice, April 1981. (Health technology case study series #3~. National Institutes of Health, Consensus Development Program. Mass screening for colo-rectal cancer. (Con- sensus Development Conference Statement, tune 26-28 1978~. tGroup judgment] Cancer screening-Lung Eddy DM. [Duke University, Center for Health Policy Research and Education] Screening for lung cancer, reassessment. (Expected publication, 1988) tInforma- tion syntheses! Chretien M, M'Bikay M. iNational Health Research and Development Program - Canada] Screening of bron- chogenic adenocarcinoma: development of a model to use tumour markers. 1986. (Grant No. 6605-2299-52~. California Medical Association, Medical Practice Opin- ion Program. Early detection of lung cancer. 1985 Dec. (Medical Practice Opinion #337) (Group judg- ment] National Institutes of Health, Consensus Development Program. Mass screening for lung cancer. (Consensus Development Conference Statement, Sep 18-20 19781. Group judgment] Cannabis American Medical Association, Council on Scientific Af- fairs. Marijuana, its health hazards and therapeutic potentials. JAMA 1981 Oct 16;246: 1823. tGroup judgment] American Medical Association, Council on Scientific Af- fairs. Marijuana in the 80's. 1980. tGroup judgment] Capitation payment Alternate models for prepaid capitation of health care services for Medicare beneficiaries Oregon. In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. fan 1986. (HCFA Pub. No. 032191. Analysis of long-term care payment systems. In: Office of Research and Demonstrations, Health Care Fi- nancing Administration. Health care financing status report: research and demonstrations in-health care financing. fan 1986. (HCFA Pub. No. 03219~. Capitation payment system for all end-stage renal dis- ease services. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219). Determination of health maintenance organization cap- itation rates for Medicare beneficiaries. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Jan 1986. (HCFA Pub. No. 032191. 379

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Evaluation of health maintenance organization (HMO) Capsule method capitation demonstrations. In: Office of Research and Demonstrations, Health Care Financing Administra tion. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Evaluation of prepaid managed health care demonstra tion. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Evaluation of prepaid risk-bearing care organization. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ ing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Health Care Plus: the Lutheran Medical Center pro gram for prepaid managed health care. In: Office of Research and Demonstrations, Health Care Financ ing Administration. Health care financing status re port: research and demonstrations in health care fi nancing. Jan 1986. (HCFA Pub. No. 03219). Medicare Prospective Capitation Demonstration Pro ject. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Missouri Medicaid Prepaid Health Demonstration Pro ject. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Program for prepaid managed health care. In: Office of Research and Demonstrations, Health Care Financ ing Administration. Health care financing status re port: research and demonstrations in health care fi nancing. Ian 1986. (HCFA Pub. No. 03219). Project HOPE, Center for Health Affairs. Access to technology and quality of care in capitated plans. On go~ng. University of Pennsylvania, Leonard Davis Institute of Health Economics. Full Medicare capitation for ESRD beneficiaries: design, implementation, and evaluation of a controlled nationwide demonstration. Planned. (Submitted to the Health Care Financing Administration). 380 American College of Physicians, Clinical Efficacy As- sessment Project. Gastric analysis by the capsule meth- od (Heidelberg). 1981. fInformation syntheses] Captopril Food and Drug Administration, Center for Drugs and Biologics. Captopril. 1981. (NTIS order no. PB81-9159071. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Veterans Administration, Cooperative Studies Pro- gram. Clinical studies on captopril: evaluation of low doses, twice daily doses and addition of hydrochloro- thiazide. [1980] [Clinical trials] Captopril with hydrochlorothiazide Veterans Administration, Cooperative Studies Pro- gram. Clinical studies on captopril: evaluation of low doses, twice daily doses and addition of hydrochloro- thiazide. t1980] "Clinical trials] Carbamazepine Garfinkel PK. FDepartment Psychiatry, University To- ronto] "Medical Research Council - Canada] Bulimia: neuroendocrine evaluation, relationship to effective disorder and treatment with carbamazepine. (Grant period 1983- 19851. Food and Drug Administration, Center for Drugs and Biologics. Carbamazepine. 1982. (NTIS order no. PB82-915901). [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Veterans Administration, Cooperative Studies Pro- gram. Evaluation of anti-epileptic drugs (phenobarb vs. phenytoin vs. primidone vs. carbamazepine). t1980] "Clinical trials] Veterans Administration, Cooperative Studies Pro- gram. Efficacy and toxicity of carbamazepine vs. val- proic acid for partial seizures. Ongoing. "Clinical tri- als1 Carcinoembryonic antigen assays Blue Cross and Blue Shield Association, Medical Neces- sity Program. Carcinoembryonic antigen. 1987. tIn- formation syntheses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Hybritech Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Tandem (R)-R carcinoembryonic antigen assay: summary of safety and effectiveness. 1986 Jul 1. (PMA no. P840019-000). Hoffman-LaRoche Inc. fFood and Drug Administra- tion, Center for Devices and Radiological Health] CEA-Roche (R) EIA: summary of safety and effec- tiveness. 1985 fun 12. (PMA no. P840027-000~. Abbott Laboratories. iFood and Drug Administration, Center for Devices and Radiological Health] Abbott CEA-EIA kit: summary of safety and effectiveness. 1984 Aug 21. (PMA no. P830066-000~. National Institutes of Health, Consensus Development Program. CEA as a cancer marker. (Consensus Devel- opment Conference Statement, Sep 29-Oct 1 1980~. [Group judgment] U.S. Administrators, Professional Policy Committee. CEA testing. Ongoing. tGroup judgment] Cardiac catheterization Miller RS. "National Health Research and Development Program - Canada] Psychological preparation for stressful medical procedures: heart catheterization. 1986. (Grant No. 6606-2640-44~. American College of Physicians, Clinical Efficacy As- sessment Project. The safety and efficacy of ambula- tory cardiac catheterization in the hospital and free standing setting. Ann Intern Med 1985:103;294-8. "Information syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Coronary angiography and cardiac catheterization. 1985. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cardiac catheteriza- tion in a freestanding setting. Ongoing. Cardiac enzyme assays Blue Cross and Blue Shield Association, Medical Neces- sity Program. Cardiac enzyme assays in the diagnosis of myocardial infarction. 1987. "Information synthe- ses] Cardiac monitors Food and Drug Administration, Center for Devices and Radiological Health. Development of test methods and draft standard for cardiac monitors.1984. (NTIS Order No. PB84-187756~. Food and Drug Administration, Center for Devices and Radiological Health. Standard for cardiac monitors, heart rate meters, and alarms. 1984. (NTIS Order No. PB84- 188812). Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Heart mon- itors. 1981. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Real time cardiac monitors. Ongoing. Cardiac pacemakers Cardiac pacemakers. In: Prospective Payment Assess- ment Commission. Technical appendixes to the re- port and recommendations to the Secretary, U.S. De- partment of Health and Human Services, April 1, 1986. Washington, DC: Government Printing Office, 1986:99-101. "Information syntheses, Cost analysesJ Cardiac Pacemakers, Inc. iFood and Drug Administra- tion, Center for Devices and Radiological Health] Models 925,2040,2041,6564: summary of safety and effectiveness. 1986 Jan 24. (PMA no. P840068-000). ECRI Technology Assessment Program. Temporary external noninvasive pacemakers. Issues Health Care Technol 1986;sec.5.P.ll. fInformation syntheses] Georgetown University Medical Center, Institute for Health Policy Analysis. New medical technologies in a cost containment environment: implantable antita- chyarrhythmia devices. Washington, DC: Institute for Health Policy Analysis, 1986. fInformation syn- theses, Expert opinion, Group judgment, Cost ana- lyses1 Medtronic, Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Activitrax models 8400, 8402, 8403: summary of safety and effectiveness. 1986 Jul 11. (PMA no. P850051-0001. Medtronic, Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Steroid tip (TM) model 4503 & 4003 transvenous pacing: sum- mary of safety and effectiveness. 1986 Aug 22. (PMA no. P830061-0001. Medtronic. [Food and Drug Administration, Center for Devices and Radiological Health] Model 5525 trans- venous atrial & Model 5025 ventrical: summary of safety and effectiveness. 1986 Aug 22. (PMA no. P850089-000). 381

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Pacemaker Systems, Inc. a Siemens Co. Good and Drug Administration, Center for Devices and Radiological Health] DDD pulse generator 674: summary of safety and effectiveness. 1986 Sep 8. (PMA no. P840014-000). Seecor, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Stat-Pace II: sum- mary of safety and effectiveness. 1986 Soul 1. (PMA no.P840002-000). Telectronics LTD. tFood and Drug Administration, Center for Devices and Radiological Health] Telec- tronics pasar model 4171 PG: summary of safety and effectiveness. 1986 Nov 10. (PMA no. P850027-000). American Medical Association, Council on Scientific Af- fairs. The use of cardiac pacemakers in medical prac- tice. JAMA 1985 Oct 11;254 (14) 1952-1954. tGroup judgment; Blue Cross and Blue Shield Association, Medical Neces- sity Program. Permanent cardiac pacemakers. 1985. "Information syntheses] Biotronik Sales, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Diplos model 03: summary of safety and effectiveness. 1984 Apr 6. (PMA no. P820076-000). California Medical Association, Medical Practice Opin- ion Program. Cardiac pacemakers. 1984 Mar. (Medi- cal Practice Opinion #291) Group judgment] Frye RL, Collins }i, DeSanctis RW, et al. LAmerican College of Cardiology/American Heart Association Task Force on Assessment of Cardiovascular Proce- dures] Guidelines for permanent cardiac pacemaker implantation. J Am Coll Cardiology 1984;4:434-42. (Group judgment] Intermedics Inc. fFood and Drug Administration, Cen- ter for Devices and Radiological Health] Cosmos (TM) system: summary of safety and effectiveness. 1984 Apr 25. (PMA no. P830026-0001. Intermedics, Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Cybertach (TM) 60 pulse generator & programmer: summary of safety and effectiveness. 1984 Dec 12. (PMA no. P820022-000). Pacesetter Systems Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Model 283 pulse generator & model 370/375 sup- ports: summary of safety and effectiveness. l 984 Apr 20. (PMA no. P830045-000). Cordis Corp. iFood and Drug Administration, Center for Devices and Radiological Health] Gemini (R) theta model 415A cardiac pacer: summary of safety and effectiveness. 1983 Dec 7. (PMA no. P830007-000). 382 ECRI Health Devices Program. External transcutan- aeous pacemakers, Pace*Aid Model 50C. Health De- vices 1983;13:3-13. Medtronic, Inc. fFood and Drug Administration, Cen- ter for Devices and Radiological Health] Versatrax model 7000 universal A-V pulse generator: summary of safety and effectiveness. 1983 ~an 7. (PMA no. P820003-0001. Pacesetter Systems, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Programalith (TM) model 223 pulse generator 398 P: summary of safety and effectiveness. 1983 Feb 25. (PMA no. P820023-000~. Telectronics, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Autima (TM) model 2251 & model 2600: summary of safety and effectiveness. 1983 Mar 11. (PMA no. P820018-000~. Cordis Corp. tFood and Drug Administration, Center for Devices and Radiological Health] Cordis sequicor theta models 233D & 233E: summary of safety and effectiveness. 1982 Dec 10. (PMA no. P820014-000~. ECRI Technology Assessment Program. Multipro- grammable pacemakers. Issues Health Care Technol 1982;sec.5.P.3. "Information syntheses] ECRI Technology Assessment Program. Multipro- grammable pacemakers. Issues Health Care Technol 1982;sec.5.P.3. fInformation syntheses] Siemens-Elema Pacmaker Div. fFood and Drug Admin- istration, Center for Devices and Radiological Health] Endocardial pacemaker lead w/carbon tip: summary of safety and effectiveness. 1982 Sep 24. (PMA no. P800041 -0001. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). External pacemakers. 1978. Cardiac rehabilitation American College of Physicians, Clinical Eff~cacy As- sessment Project. Rehabilitation of the myocardial in- farction patient, expected completion 1988. fInfor- mation syntheses] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Cardiac rehabilita- tion services. Jul 16,1986. [Expert opinion, Informa- tion syntheses] Oldridge NB. [National Health Research and Develop- ment Program - Canada] Comprehensive early reha- bilitation after myocardial infarction (MI). 1986. (Grant No. 6606-2724-44).

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY U.S. Administrators, Professional Policy Committee. Cardiac rehabilitation programs. t7/86] (Group judg- ment] Blue Cross and Blue Shield Association, Medical Neces- sity Program.-Outpatient cardiac rehabilitation. 1985. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Intraarterial BCNU chemotherapy. 1982 Oct. (Medical Practice Opinion #276) Group judgment] Carotid body resection National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cardiac rehabilita tion program services. Ongoing. body resection. 1985. Cardiointegram National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cardiointegram as an alternative to stress test or thallium stress test. On- going. Cardiokymography American College of Physicians, Clinical Efficacy As- sessment Project. Cardiokymography. ACP Observer 1986 Ian :8,10. tI nformation syntheses] ECRI Technology Assessment Program. Cardiokymo- graphy. Issues Health Care Technol 1986;sec.5.C.8. fInformation syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Cardiokymography. 1985. fInforma- tion syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Reassessment of car- diokymography. 1985. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Cardiokymography for (non-invasive) cardiological diagnosis. tAMA 1984 Feb 24. tExpert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cardiokymography. 1983. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cardiokymography. Ongoing. Carmusdne American Academy of Neurology, Practice Committee. Carotid infusion of BCNU for glioblastoma multi- forme. 1982 fun. tExpert opinion, Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bilateral carotid Carotid endarterectomy National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Carotid endarterec- tomy. Ongoing. U.S. Administrators, Professional Policy Committee. Carotid endarterectomy. Ongoing. (Group judg- ment] Case management Case-managed medical care for nursing home patients. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care f~nanc- ing status report: research and demonstrations in health care financing. fan 1986. (HCFA Pub. No. 032191. Evaluation of Massachusetts case-managed medical care for nursing home patients. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Cataract extraction American Academy of Ophthalmology. Cataract sur- gery in the 1980's. San Francisco, CA: American Academy of Ophthalmology, 1987. "Information syn- theses, Expert opinion! California Medical Association, Medical Practice Opin- ion Program. Assistant surgeon at cataract surgery. 1985 May. (Medical Practice Opinion #324) tGroup judgment] Project HOPE, Center for Health Affairs. Background paper on cataract surgery and physician payment un- der the Medicare program. (for U.S. Congress, Office of Technology Assessment). 1985 Oct. [Information syntheses. Cost analyses! 383

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Catheters U.S. Administrators, Professional Policy Committee. Swan Ganz. [7/861 tGroup judgment] Food and Drug Administration, Center for Devices and Radiological Health. Vascular catheter devices: a study of safety and performance - volume 1. 1983. (NTIS Order No. PB83-144659~. Food and Drug Administration, Center for Devices and Radiological Health. Vascular catheter devices: a study of safety and performance - volume 2. 1983. (NTIS Order No. 83- 144667~. Storz Instrument Co. iFood and Drug Administration, Center for Devices and Radiological Health] Lincoff- -design scleral buckling balloon catheter: summary of safety and effectiveness. 1983 Nov 21. (PMA no. P820009-000~. Cefotaxime Food and Drug Administration, Center for Drugs and Biologics. Sterile cefotaxime sodium.1981. (NTIS or- der no. PB81-915906~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Cell counters Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of automated differ- ential cell counting devices - Volume I: review of literature and labeling. 1984. (NTIS Order No. PB84- 189356). Cell counts California Medical Association, Medical Practice Opin- ion Program. Endothelial cell counts. 1983 Sep. (Medical Practice Opinion #303) [Group judgments Centrifuges United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Sur- vey of bench top centrifuges. 1985 May. (Report no. STB3A/85/20) tEpidemiological and other observa- tional methods, Bench testing] Cephradine Food and Drug Administration, Center for Drugs and Biologics. Cephradine. 1982. (NTIS order no. PB82-915901~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 384 Cerebral artery anastomosis U.S. Administrators, Professional Policy Committee. Cerebral artery anastomosis, superficial temporal- -middle. tGroup judgment] U.S. Administrators, Professional Policy Committee. Cerebral artery anastomosis, superficial temporal- -middle. t7/86] tGroup judgment] Cerebrospinal {luid shunt valves Food and Drug Administration, Center for Devices and Radiological Health. An investigation of cerebrospi- nal fluid shunt valves - test results for twenty-five valves: final report- Phase III. Cervical cap Love E, Cruickshank B. [National Health Research and Development Program - Canada] A study in Canadi- an women of the clinical efficacy and acceptability of the cervical cap as a method of reversible contracep- tion. 1986. (Grant No. 6613-1232-X). Cervical dilators Gynotech, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Dilapan (TM): summary of safety and effectiveness. 1986 Jun 11. (PMA no. P840045-000). Cabot Medical Corp. [Food and Drug Administration, Center for Devices and Radiological Health] Lamicel (TM): summary of safety and effectiveness. 1983 Jul 19. (PMA no. P820075-000). Cesarean sechon American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Anesthesia for ce- sarean section.1982 May. (Technical bulletin no.65). [Expert opinion] National Institute of Child Health and Human Devel- opment. Cesarean childbirth. Bethesda, MD: Nation- al Institute of Child Health and Human Develop- ment, 1981. (NIH publication no. 82-2067) tGroup judgment, Expert opinion] National Institutes of Health, Consensus Development Program. Cesarean childbirth. (Consensus Develop- ment Conference Statement, Sep 22-24 1980). (Group judgment]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Challenge food testing California Medical Association, Medical Practice Opin- ion Program. Intradermal provocative titration/diag- nosis of food allergy. 1984 Feb. (Medical Practice Opinion #293) [Group judgment] California Medical Association, Medical Practice Opin- ion Program. Sublingual challenge technique/diagno- sis of food allergy. 1984 Feb. (Medical Practice Opin- ion #294) [Group judgment] California Medical Association, Medical Practice Opin- ion Program. Challenge food testing for depression. 1982 Feb. (Medical Practice Opinion #257b) tGroup judgment] California Medical Association, Medical Practice Opin- ion Program. Challenge food testing for respiratory disorders. 1982 Feb. (Medical Practice Opinion #257c) [Group judgment] California Medical Association, Medical Practice Opin- ion Program. Challenge food testing for rheumatoid arthritis. 1982 Feb. (Medical Practice Opinion #257a) Group judgment! National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Intracutaneous (in- tradermal) and subcutaneous provocative and neu- tralization testing and neutralization therapy for food allergies. 1981. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Sublingual provoca- tive testing and neutralization therapy for food aller- gies. 1981 Chelation therapy McLachlan DR, Dalton A}. "National Health Research and Development Program - Canada] Aluminum chelation in Alzheimer's disease: a therapeutic pro- posal. 1986. (Grant No. 6606-2330-081. American Medical Association, Council on Scientific Af- fairs. Chelation therapy. 1984. tGroup judgment] Chelation therapy- Deferoxamine National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hemoperfusion in conjunction with deferoxamine for the treatment of aluminum toxicity or iron overload in ESRD patients. 1986. Chelation therapy-EDTA American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Chelation therapy (with EDTA) for atherosclerosis. iAMA 1983 Aug 5. [Expert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Ethylenediamine-te- tra-acetic acid (EDTA) chelation therapy for athero- sclerosis. 1981. Chelation therapy Penicillamine Crawhall, J. "National Health Research and Develop- ment Program - Canada] Effect of D-penicillamine on circulating immune complexes and rheumatoid fac- tor. What is the mechanism of its therapeutic action? 1986. (Grant No. 6605-1758-521. CHEMLINE Siegel ER, Spann M, Collins KA, Hazard G. Woodsmall RM. [National Library of Medicine] Report on the CHEMLINE evaluation study. Bethesda, MD: Na- tional Library of Medicine, 1985. tEpidemiological and other observational methods] Woelfel JC, Tesorero J. [National Library of Medicines An evaluation of CHEMLINE: the results of a survey of users by the National Library of Medicine. Vienna, VA: Market Dynamics, Inc. 1985. tEpidemiological and other observational methods] Chemonucleolysis ECRI Technology Assessment Program. Chemonucleo- lysis of herniated lumbar disks. Issues Health Care Technol 1983;sec.5.C.3. "Information syntheses] Chemotherapy Cancer Lymphomas, leukemia, and chemotherapy. In: Pro- spective Payment Assessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Hu- man Services, April 1, 1986. Washington, DC: Gov- ernment Printing Of lice, 1986: 121- 123. [Informa- tion syntheses, Cost analyses] U.S. Administrators, Professional Policy Committee. Adjuvant chemotherapy for breast cancer. t7/863. [Group judgments U.S. Administrators, Professional Policy Committee. Chemotherapy. t7/861. tGroupjudgment] 385

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY National Institutes of Health, Consensus Development Cholangiography Program. Adjuvant chemotherapy for breast cancer. (Consensus Development Conference Statement, Sep 9- 11 19851. tGroup judgment] Pritchard KI. "Department Medicine, University of To ronto] iMedical Research Council - Canada] A trial of adjuvant therapy in post menopausal women with axillary node positive breast cancer. (Grant period 1984-1985). National Institutes of Health, Consensus Development Program. Adjuvant chemotherapy of breast cancer. (Consensus Development Conference Statement, {ul 14- 16 1980~. EGroup judgment] Chlorhexidine Food and Drug Administration, Center for Drugs and Biologics. Chlorhexidine gluconate. 1981. (NTIS or der no. PB81-915911). "Information syntheses, Ex pert opinion, Epidemiological and other observation al methods, Clinical trials, Bench testing] Chlorpheniramine Food and Drug Administration, Center for Drugs and Biologics. Chlorpheniramine maleate pseudoophe drine sulfate. 1981. (NTIS order no.PB81-9159061. "Information syntheses, Expert opinion, Epidemio logical and other observational methods, Clinical tri als, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Phenylpropanolamine hydrochloride chlorpheniramine maleate. 1981. (NTIS order no. PB 81 -915910~. "Information syntheses, expert opin ion, Epidemiological and other observational meth ods, Clinical trials, Bench testing] Chlorthalidone Grimm RH, Neaton ID, McDonald M, et al for the Multiple Risk Factor Intervention Trial Research Group. "National Heart, Lung, and Blood Institute] Beneficial effects from systematic dosage reduction of the diuretic chlorthalidone: a randomized study with in a clinical trial. Am Heart ~ 1985;109:858-864. Hulley SB, Furberg CD, Gurland B}, et al for the SHEP Research Group. "National Heart, Lung, and Blood Institute] The Systolic Hypertension in the Elderly Program (SHEP': antihypertensive efficacy of chlorthalidone. Am ~ Cardiol 1985 ;56: 913-920. 386 U.S. Administrators, Professional Policy Committee. Cholangiography, routine operative. t7/86] tGroup judgment] Kreek MJ, Balint JA. "American Gastroenterological Association, Patient Care Committee] "Skinny nee- dle" cholangiography: results of a pilot study of a voluntary prospective method for gathering risk data on new procedures. Gastroenterology 1980;78:598-604. "Information syntheses] Cholangiopancreatography American College of Physicians, Clinical Efficacy As- sessment Project. Efficacy of endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic retrograde sphincterotomy (ERS). 1984. tInforma- tion syntheses] Cholecystectomy U.S. Administrators, Professional Policy Committee. Cholecystectomy. t7/86] tGroup judgment] Cholecystography Food and Drug Administration, Center for Devices and Radiological Health. Assessment and modification of clinical utility in diagnostic radiology: the oral chole- cystogram and the upper gastrointestinal examina- tions. 1985. (NTIS Order No. PB85-246916/AS) Cholestryamine Oster G. Epstein AM. bPolicy Analysis, Inc.] The cost-ef- fectiveness of cholestyramine in the prevention of coronary heart disease: whom should we treat? JAMA (submitted for publication) Brensike ~F, Levy RI, Kelsey SF, et al. "National Heart, Lung, and Blood Institute1 Effects of therapy with cholestyramine on progression of coronary arterio- sclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulationl984:69;313-324. Levy RI, Brensike JF, Epstein SF, et al. (National Heart, Lung, and Blood Institute1 The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of the NHLBI Type II Coronary Intervention Study. Circu- lation 1984;69:325-337.

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Chorionic villi sampling Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Chorionic villi sampling. 1986. [Information syntheses] ECRI Technology Assessment Program. Chorionic vil- lus sampling (CVS). Issues Health Care Technol 1986;sec.5.C.6. [Information syntheses] Hunter A. "National Health Research and Development Program - Canada] The use of Chorionic villi biopsy for the first trimester diagnosis of genetic diseases. 1986. (Grant No. 6606-2681-52~. California Medical Association, Medical Practice Opin- ion Program. Chorionic villus biopsy. 1985 Sep. (Medical Practice Opinion #328) tGroup judgment] fUniversity of Lausanne, Institute of Social and Preven- tive Medicine] Evaluation of efficacy and safety of Chorionic villi sampling (CVS). Ongoing. [Clinical tri- als] Chromatogenesis assist devices Repro-Med System, Inc. Wood and Drug Administra- tion, Center for Devices and Radiological Health] Re- pro-Med-THD: summary of safety and effectiveness. 1985 {an 25. (PMA no. P820034-000~. Chymopapain Food and Drug Administration, Center for Drugs and Biologics. Chymopapain. 1983. (NTIS order no. PB83-9159011. f Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Health Council of the Netherlands. Chymopapain. On- go~ng. Ciclopirox Food and Drug Administration, Center for Drugs and Biologics. Ciclopirox olamine.1983. (NTIS order no. PB83-915901). [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Cimetidine Carlsson P. Jonsson. [Linkoping University, Center for Medical Technology Assessment] Medical technology assessment in a macroeconomic perspective a study of the introduction of cimetidine for treatment of ulcers. 1986. (Discussion series paper #1) "Swedish language only] tCost analyses, Epidemiological meth- ods] University of Pennsylvania, Leonard Davis Institute of Health Economics. Cost-benefit and cost-effective- ness analysis in policymaking: cimetidine as an exam- ple. 1982. (Proceedings of an International Sympo- sium. November 22-24,1981, funded by Smith Kline and French Laboratories). Fineberg HV, Pearlman LA. "Harvard School of Public Health, Institute for Health Research] Benefit-and- -cost analysis of medical interventions: the case of cimetidine and peptic ulcer disease. In: The implica- tions of cost-effectiveness analysis of medical techno- logy/background paper #2: case studies of medical technologies. Office of Technology Assessment, U.S. Congress. Washington, D.C.: U.S. Government Print- ing Of rice, 1981. "Information syntheses] Office of Technology Assessment, U.S. Congress. Bene- fit and cost analysis of medical interventions: the case of cimetidine and peptic ulcer disease. Washington, D.C.: U.S. Government Printing Office, September 1981. (Health technology case study series #11). Cine-CT American Hospital Association, Hospital Technology Series Program. Cine-CT: progress and opportuni- ties.1986. (Guideline report) fInformation syntheses, Expert opinion, Cost analyses] Cingulotomy American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Sterotactic cingulo- tomy treatment for psychiatric disorders. JAMA 1985 Nov 15. tExpert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Stereotactic cingulo- tomy as a means of psychosurgery. 1985. American Academy of Neurology, Practice Committee. Sterotactic cingulotomy. 1984 Nov. tExpert opinion, Group judgment] C· . . ~rcumc~s~on American Academy of Pediatrics, Committee on Fetus and Newborn. Report of the Ad Hoc Task Force on Circumcision. Pediatrics 1975 Oct. Clinical ecology American College of Physicians, Clinical Efficacy As- sessment Project. Clinical ecology, expected comple- tion 1988. [Information syntheses] 387 1:

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Clinical trials Mattson M, Curb ~D, McArdle R and the AMIS and BHAT Research Group. "National Heart, Lung, and Blood Institute] Participation in a clinical trial: the patient's point of view. Controlled Clin Trial 1985;6: 156-167. Thomson ME, Kramer MS. tMcGill University, Depart- ment of Epidemiology and Biostatistics] Methodolog- ical standards for controlled clinical trials of perinatal contact: studies of early contact and maternal-infant behavior. Pediatrics 1983;73:294-300. Lipid Research Clinics Program. [National Heart, Lung, and Blood Institute] Recruitment for clinical trials: the Lipid Research Clinics Coronary Primary Preven- tion Trial experience. Its implications for future tri- als. (AHA Monograph No. 93) Circulation 1982 ;66: IV 1 -IV78. Mosteller F. iNational Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Improving the preci- sion of clinical trials. Am ~ Public Health 1982 May;72~5) :430. Howard ~M, DeMets D, and the BHAT Research Group. "National Heart, Lung, and Blood Institute] How informed is informed consent? The BHAT ex- perience. Controlled Clin Trials 1981;2:287-303. Clinical trials-Randomized Antczak AA, Tang I, Chalmers TC. "National Center for Health Services Research and Health Care Tech- nolog,v Assessment, Division of Extramural Research] Quality assessment of randomized control trials in dental research. I. Methods. T Periodont Dis 1986;21 :305-314. Antczak AA, Tang I, Chalmers TC. "National Center for Health Services Research and Health Care Tech- nology Assessment, Division of Extramural Research1 Quality assessment of randomized control trials in dental research. II Results. I Periodent Res 1986;21:315-321. Office of Technology Assessment, U.S. Congress. The impact of randomized clinical trials on health policy and medical practice. Washington, D.C.: U.S. Gov- ernment Printing Office, August 1983. 388 Clonidine Food and Drug Administration, Center for Drugs and Biologics. Clonidine. 1987. (Summary basis of ap- proval, NDA ~ 18-891~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clincial trials, Bench testing] Clorazopate Food and Drug Administration, Center for Drugs and Biologics. Clorazopate dipotassium. 1981. (NTIS or- der no. PB81-9159041. fInformation syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Clotrimazole Food and Drug Administration, Center for Drugs and Biologics. Clotrimazole. 1987. (Summary basis of ap- proval, NDA #18-827). "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Coagulation assays Triplett DA, ed. Advances in coagulation testing: inter- pretation and application. Skokie, IL: College of American Pathologists. (expected 1987) tExpert opin- ion, Bench testing] Triplett DA, ed. Standardization of coagulation assays: an overview. CAP Conference/Aspen 1980. Skokie, IL: College of American Pathologists, 1981. tExpert opinion, Bench testing] Cochlear implant;ation Medical Technology and Practice Patterns Institute. Cochlear implantation. 1987. Cochlear implants Medical Technology and Practice Patterns Institute. Cochlear implants outpatient training. 1987. ECRI Technology Assessment Program. Multichannel cochlear implants for profound deafness. Issues Health Care Technol 1986;sec.5.C.7. fInformation synthesesJ National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cochlear implants. 1986. U.S. Administrators, Professional Policy Committee. Cochlear implants. f7/86] tGroup judgment]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY 3M. (Food and Drug Administration, Center for De- vices and Radiological Health] 3M brand cochlear implant system/house design: summary of safety and effectiveness. 1984 Dec 24. (PMA no. P830069-000~. American Medical Association, Council on Scientific Af- fairs. Cochlear implants. TAMA 1983 Tut 15;250:391-392. [Group judgment] ECRI Technology Assessment Program. Single-channel cochlear implants for profound deafness. Issues Health Care Technol 1983;sec.5.C.1. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Cochlear implant for deafness. 1981 Aug. (Medical Practice Opinion Program # 178) [Group judgments Veterans Administration, Cooperative Studies Pro- gram. A prospective randomized cooperative study of cochlear implants. Ongoing. "Clinical trials] Cochleostomy American Academy of Neurology, Practice Committee. Cochleostomy with neurovascular transplant in treat- ment of Meniere's Disease. 1982 Oct. tExpert opin- ion, Group judgment] Codeine American Academy of Pediatrics, Committee on Drugs. Use of codeine- and dextromethorphan-containing cough syrups in pediatrics. Pediatrics 1978 Jul. Cognitive therapy Cott A. "National Health Research and Development Program - Canada] Intervention in disability and chest pain associated with iaj mitral valve prolapse and (b) no known cardiac disease: a cognitive-beha- vioral approach. (Grant No. 6606-2250-05~. Garner DM. "National Health Research and Develop- ment Program - Canada] Cognitive therapy for an- orexia nervosa and bulimia. 1986. (Grant No. 6606-2666-46). Collagen implants Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Collagen im- plants. 1986. fInformation syntheses] California Medical Association, Medical Practice Opin- ion Program. Collagen implant. 1983 Apr. (Medical Practice Opinion #283) tGroup judgment] ECRI Technology Assessment Program. Collagen im- plants for smoothing skin. Issues Health Care Tech- nol 1983;sec.5.C.2. "Information syntheses] Colonoscopy Mellow MH. Endoscopic laser treatment of colon can- cer. In: American Society for Gastrointestinal Endos- copy, Committee on Technology Assessment. Thera- peutic gastrointestinal endoscopy: an information re- source manual.1987. [Information syntheses, Expert opinion, Group judgment, Cost analyses] American Society for Gastrointestinal Endoscopy. The role of colonoscopy in the management of patients with colonic polyps. Revised 1986 May. American Society for Gastrointestinal Endoscopy. The role of colonoscopy in the patients with inflammatory bowel diseases. Revised 1986 May. Irvine EJ. [National Health Research and Development Program - Canada] A prospective study to compare diagnostic agreement and cost-effectiveness of air contrast barium enema plus flexible sigmoidoscopy with colonoscopy in rectal bleeding.1986. (Grant No. 6606-2974-42). American College of Physicians, Clinical Efficacy As- sessment Project. Colonoscopy: management of co- lorectal neoplasia. 1985. [Information syntheses] Commu'iication aids for the handicapped Parnes PH. [National Health Research and Develop- ment Program - Canada] Towards development of a modular universal wheelchair tray system for com- munication control and ADL. 1986. (Grant No. 6605-3006-51). Office of Technology Assessment, U.S. Congress. Assis- tive devices for severe speech impairments. Washing- ton, D.C.: U.S. Government Printing Off~ce, Decem- ber 1983. (Health technology case study series #26) Office of Technology Assessment, U.S. Congress. Se- lected telecommunications devices for hearing-im- paired persons. Washington, D.C.: U.S. Government Printing Office, December 1982. (Health technology case study series #21) Communication systems Darnell TC, et al. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] After hours tele- phone access to physicians with access to computer- ized medical records. Med Care 1985 Jarl;23~1):20-26. 389

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Simborg DW, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] A hospital local area communication network: the first year's experi- ence. IEEE 1982:479-481. Community health centers Grossman M, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research; An economic analy- sis of community health centers. 1984. (NTIS order no. PB84-159185) Competition Competitive managed health plans for AFDC Medicaid recipients. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Tan 1986. (HCFA Pub. No. 03219). Costs, outcomes, and competition in the End-Stage Re- nal Disease Program. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. tan 1986. (HCFA Pub. No. 03219). Enrollment of Medicare beneficiaries under a unique intra-health maintenance organization competition model. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Evaluation of Medicaid competition demonstrations. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ- ing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Evaluation of the Medicare competition demonstra- tions. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Independent broker: coordinating open enrollment for Medicare health maintenance organizations and com- petitive medical plans. In: Office of Research and Demonstrations, Health Care Financing Admimistra- tion. Health care financing status report: reseaarch and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). 39O Medicaid voucher demonstration. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Medicare competition demonstrations. In: Office of Re- search and Demonstrations, Health Care Finanicng Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Research on competitive forces driving Medicare utiliza- tion. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219) Senior Group Health Plan Waiver-Only Medicare Com- petition Demonstration Program. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Statewide Medicaid competition demonstration. In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Waiver-Only Competition Project for Southern Califor- nia, Illinois, Indiana, and Texas. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). American Medical Association, Council on Scientific Af- fairs. Effects of competition in medicine. TAMA 1983 Apr 8; 249: 1 864- 1 868. tGroup judgment] Office of Technology Assessment, U.S. Congress. Medi- cal technology under proposals to increase competi- tion in health care. Washington, D.C.: U.S. Govern- ment Printing Office, October 1982. Competitive bidding Demonstration and evaluation of competitive bidding as a method of purchasing durable medical equipment. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ- ing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219).

ASSESSMENT [DEPORT CITATIONS BY ~ CEUNOLOGY Demonstration and evaluation of competitive bidding as a method to purchase clinical laboratory services. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. End-stage renal disease competitive bidding demonstra- tion. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Computed tomography Hussain S. Belidegrun A, Seltzer SE, Feldstein ML, et al. Harvard School of Public Health, Institute for Health Research] CT differentiation of malignant from benign adrenal masses. Am I Roentgenol, in press fEpidemiological methods] American College of Physicians, Clinical Efficacy As- sessment Project. A comparative assessment of stan- dard and computed tomography in the evaluation of neoplasms of the chest.1986. "Information syntheses] ECRI Technology Assessment Program. Three-dimen- sional computed tomography. Issues Health Care Technol 1986;sec.5.T.6. [Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Computed tomography- multiplanar reconstruction. 1984 Nov. (Medical Practice Opinion #310) tGroup judgment] Fineberg HV, Wittenberg i, Ferrucci l, Meuller P. Si- meone I, Goldman i. "Harvard School of Public Health, Institute for Health Research] The clinical value of body computed tomography over time and technologic change. Am I Roentgenol 1983; 141: 1067-1072. fEpidemiological methods] Office of Technology Assessment, U.S. Congress. The feasibility of economic evaluation of diagnostic proce- dures: the case of CT scanning. Washington, D.C.: U.S. Government Printing Office, April 1981. (Health technology case study series #2) Swedish Planning and Rationalization Institute of the Health Services. Spri technology report 2: CT scan- ning in Sweden - costs and effectiveness. 1981. (Spri report 73) Cost analyses, Epidemiological and other observational methods] American Medical Association, Council on Scientific Af- fairs. Importance of diagnostic computerized tomo- graphic scanning. 1980. [Group judgmentJ Subcommittee on Institutional Program Guidelines. [Health and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Division] Computed tomography guidelines. 1980. "Information syntheses, Expert opinion, Group judgment] Wittenberg J. Fineberg HV, Ferrucci JT Jr, Simeone IF, Mueller PR, van Sonnenberg E, Kirkpatrick RH. "Harvard School of Public Health, Institute for Health Research] The clinical efficacy of computed body tomography. II. Am J Roentgenol 1980; 134: 1111-1120. tEpidemiological methods] Fineberg HV, Wittenberg I, Ferruci IT, tr. "Harvard School of Public Health, Institute for Health Re- search] The clinical value of diagnostic tests: CT as a prototype. IN: Margulis A, Burhenne HJ, eds. Ali- mentary tract radiology: abdominal imaging, v. 3. St. Louis, Missouri: C.V. Mosby, 1979. tEpidemiological methods] Fineberg HV. "Harvard School of Public Health, Insti- tute for Health Research] Medical technology policies and computed tomography. Ann Intern Med 1979;90:114-115. "Information syntheses] ~ : Wittenberg J. Fineberg HV, Black EB, Kirkpatrick RH, Schaffer DL, Ikeda MK, Ferrucci JT Jr. "Harvard Medical School, Institute for Health ResearchJ The clinical efficacy of computerized body tomography. Am J Roentgenol 1978;131:5-14. fEpidemiological methods] Computed tomography Bone mineral assess- ments ECRI Technology Assessment Program. Bone mineral assessment, noninvasive (dual photon absorptiometry and quantitative computed tomography). J Health Care Technol 1986;2:183-200. iInformation synthe- ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Bone mineral densi- ty studies: computed tomography. Ongoing. Computed tomography Head U.S. Administrators, Professional Policy Committee. CT scans - head. t7/86] tGroup judgment] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Enhanced computed tomography in head trauma. JAMA 1985 Dec 20. tExpert opinion, Information syntheses] 391

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Blue Cross and Blue Shield Association, Medical Neces- sity Program. CT scan in the evaluation of headaches, cerebrovascular disease and dementia. 1984. tInfor- mation syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Head CT scan and ultrasound in the pediatric patient. 1984. "Information syntheses] McNeil BJ, Hanley JA. tMcGill University, Department of Epidemiology and Biostatistics] Critical questions regarding a new diagnostic technology: a case study using computed tomography (CT) of the head. In: Culyer AJ, Horisberger, eds. Economic and medical evaluation of health care technologies, proceedings of Wolfsberg Conference. 1983. National Institutes of Health, Consensus Development Program. Computed tomographic scanning of the brain. (Consensus Development Conference State- ment, Nov 4-6 1981). Group judgment] Fineberg HV, Bauman K, Sossman M. "Harvard School of Public Health, Institute for Health Research] Com- puterized cranial tomography: effect on diagnostic and therapeutic plans. tAMA 1977;238:224-227. tEpidemiological methods] Computed tomography Liver and spleen U.S. Administrators, Professional Policy Committee. Li- ver/spleen scans. Ongoing. [Group judgment] Computed tomography Pancreas Fineberg HV, Wittenberg I. "Harvard School of Public Health, Institute for Health Research] Evaluation of computed tomography in pancreatic cancer. Bull Cancer (Paris) 1980;67:390-394. fEpidemiological methods] Fineberg HV. "Harvard School of Public Health, Insti- tute for Health Research] Assessing the diagnostic contribution of imaging tests: computed tomography and ultrasound of the pancreas. In: Alperovitch A, de Dombal FT, Gremy F. eds. Evaluation of efficacy of medical action. New York: Elsevier-North Holland, 1979. [Epidemiological methods] Computed tomography Spine U.S. Administrators, Professional Policy Committee. CT scans cervical and lumbar spine. [7/86] tGroup judgment] California Medical Association, Medical Practice Opin- ion Program. Computerized tomography for lumbar spine. Feb 1983. (Medical Practice Opinion #282) tGroup judgment] 392 Computed tomography scanners United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Com- parison of imaging performance of CT scanners (Is- sue four). 1986 Mar. (Report no. STB/86/10) tEpide- miological and other observational methods, Bench testing] ECRI Technology Assessment Program. Imatron high- -speed CT scanner. Issues Health Care Technol 1985 ;sec.5.C.5. fInformation synthesis] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Picker Modulex T for radiography, to- mography and occasional peripheral angiography. 1985 Dec. (Report no. STB6E/85/45) tEpidemiologi- cal and other observational methods, Bench testing] American Hospital Association, Hospital Technology Series Program. Computerized tomographic scan- ners. 1984. (Guideline report) [Information synthe- ses, Expert opinion, Cost analyses] Office of Technology Assessment, U.S. Congress. Policy implications of computed tomography (CT) scanners: an update. Washington, D.C.: U.S. Government Printing Office, January 1981. Office of Technology Assessment, U.S. Congress. Policy implications of computed tomography (CT) scanners. Washington, D.C.: U.S. Government Printing Office, August 1978. Fineberg HV, Parker GS, Pearlman LA. "Harvard School of Public Health, Institute for Health Re- search1 CT scanners: distribution and planning status in the United States. N Eng J Med 1977;297:216-218. [Epidemiological methods] Johns Hopkins Program for Medical Technology and Practice Assessment. An evaluation of patterns of uti- lization of CT scanners, with particular attention to variations in practice patterns. Planned. Computer-aided design Fernie GR. [National Health Research and Develop- ment Program - Canada] An evaluation of computer- -aided design of trans-tibial prosthetic sockets. 1986. (Grant No. 6606-3024-511. Computer-assisted instruction Office of Technology Assessment, U.S. Congress. Com- puter technology in medical education and assess- meet. Washington, D.C.: U.S. Government Printing Office, September 1979.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY [National Library of Medicine] Evaluation of the Tech- nological Innovations in Medical Education (TIME) Project. Bethesda, MD: Lister Hill Center, National Library of Medicine. Ongoing. [Epidemiological and other observational methods] Computer-assisted patient care McDonald C}, Tierney WM. "National Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] The medical gopher: a microcomputer system to help find, organize, and decide about patient data. West Med (in press) Self-care home computer program to reduce health care costs. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219). ECRI Health Devices Program. Patient care manage- ment system, SpaceLabs. Health Devices 1986; 15:286-94. American Academy of Pediatrics, Committee on Prac- tice and Ambulatory Medicine. Computers in your practice. Pediatrics 1985 Jul. Bleich HC. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Clinical computing in a teaching hospital. N Engl ~ Med 1985 Mar 31(12):756-764. Computer equipment American Hospital Association, Hospital Technology Series Program. Microcomputers in hospitals. 1984. (Guideline report) fInformation syntheses, Expert opinion, Cost analyses] Computer software Self-care home computer program to reduce health care costs. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Contact lens cleaners Stericon Laboratories. (Food and Drug Administration, Center for Devices and Radiological Health] Stericon saline solution: summary of safety and effectiveness. 1987 Janl6. (PMA no. P850070-0001. Allergan Pharmaceuticals, Inc. [Food and Drug Admin- istration, Center for Devices and Radiological Health] Oxysept system: summary of safety and effectiveness. 1986 Nov 20. (PMA no. P850088-000~. Barnes-Hind Inc. [Food and Drug Administration, Center for Devices and Radiological HealthJ Softmate (R) hydrogen peroxide disinfection system: summary of safety and effectiveness. 1986 Oct 6. (PMA no. P840066-000). Bausch & Lomb (R). (Food and Drug Administration, Center for Devices and Radiological Health] B & L sterile all purpose solution & contact cleaner: summa- ry of safety and effectiveness. 1986 Dec 16. (PMA no. P830002-000). Bausch & Lomb. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] B & L Sensi- tive Eyes (TM) saline/cleaning solution: summary of safety and effectiveness. 1986 Jul 7. (PMA no. 850036-000). Bausch & Lomb. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] B & L Ther- ma-zyne, Fizziclean: summary of safety and effective- ness. 1986 Nov 5. (PMA no. P850093-0001. Bausch & Lomb. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Sensitive eyes chemical disinfectant: summary of safety and effectiveness. 1986 Jan 2. (PMA no. P840020-000~. Blairex Laboratories, Inc. fFood and Drug Administra- tion, Center for Devices and Radiological Health] Blairex sterile saline solution: summary of safety and effectiveness. 1986 Mar 6. (PMA no. P850045-000~. Coopervision, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Coo- pervision peroxide system: summary of safety and effectiveness. 1986 Mar 12. (PMA no. P830023-0001. Coopervision, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Mira- soak (TM) rinsing, disinfecting & storage solution: summary of safety and effectiveness. 1986 Aug 18. (PMA no. P810038-000~. Coopervision. [Food and Drug Administration, Center for Devices and Radiological Health] Miraflow extra strength cleaner: summary of safety and effective- ness. 1986 Nov 5. (PMA no. P850055-0001. Dey Laboratories, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Dey-vial (R): summary of safety and effectiveness.1986 Apr 1. (PMA no.P840061-000~. 393

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Ocumed Inc. (Food and Drug Administration, Center for Devices and Radiological Health] Sodium chloride tablets 250 MG: summary of safety and effectiveness. 1986 Mar 12. (PMA no. P850016-000). Paco Pharmaceutical Services, Inc. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Non-preserved saline solution: summary of safety and effectiveness. 1986 Sep 23. (PMA no. P850025-000). Paco Pharmaceutical Services, Inc. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Sorbic acid preserved daily cleaner: summary of safety and effectiveness. 1986 Nov 10. (PMA no. P850076-000). Paco Research Corp. tFood and Drug Administration, Center for Devices and Radiological Health] Charter Labs saline solution: summary of safety and effective- ness. 1986 Dec 17. (PMA no. P840069-000). Stericon Laboratories. tFood and Drug Administration, Center for Devices and Radiological Health] Crysta- lens saline spray: summary of safety and effective- ness. 1986 Mar 24. (PMA no. P850065-000). Alcon Labs., Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Polquat dis- infection system: summary of safety and effective- ness. 1985 Sep 18. (PMA no. P830034-000). Allergan. [Food and Drug Administration, Center for Devices and Radiological Health] Model no. ALS-IV heat disinfection unit: summary of safety and effec- tiveness. 1985 May 20. (PMA no. P840054-000). Bausch & Lomb. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] B & L Sensi- tive Eyes (TM) daily cleaner: summary of safety and effectiveness. 1985 Jul 9. (PMA no. P830013-000). Pharmafair, Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Saltair tablets (250MG): summary of safety and effectiveness. 1985 ~un 5. (PMA no. P840034-000). Allergan Optical. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] The soft lens thermal disinfecting unit: summary of safety and ef- fectiveness. 1984 Jan 4. (PMA no. P820082-000). Alcon Laboratories, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Mi- cro-therm disinfectant unit: summary of safety and effectiveness. 1983 Jan 25. (PMA no. P820041-000). Alcon Laboratories, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Op- ti-clean (TM) LC 1323: summary of safety and effec- tiveness. 1983 May 13. (PMA no. P820036-000). 394 Alcon Labs, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Alcon en- zyme cleaner: summary of safety and effectiveness. 1983 Jan 25.(PMA no. P820001-000). Allergan Pharmaccuticals, Inc. (Food and Drug Admin- istration, Center for Devices and Radiological Health] Lens Plus (TM): summary of safety and effectiveness. 1983 Jul 19. (PMA no. P820050-000). Amcon Inc. [Food and Drug Administration, Center for Devices and Radiological Health] The Amcon Way Plus: summary of safety and effectiveness. 1983 Feb 22. (PMA no. P800069-002). Barnes-Hind/Hydrocurve, Inc. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Soft lens salt tablets: summary of safety and effectiveness. 1983 Jul 29. (PMA no. P800067-000). Bausch & Lomb Optics Center. [Food and Drug Admin- istration, Center for Devices and Radiological Health] Sensitive Eyes (TM) saline & cleaning solution: sum- mary of safety and effectiveness. 1983 Sep 16. (PMA no. P820031-000). Blairex Laboratories, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological HealthJ The Blairex system: summary of safety and effective- ness. 1983 Feb 18. (PMA no. PB00028-003). C.C. Kelly Enterprises. tFood and Drug Administration, Center for Devices and Radiological Health] Eyerisol (R): summary of safety and effectiveness. 1983 May 31. (PMA no. P810034-000). CIBA Vision Care [Food and Drug Administration, Center for Devices and Radiological Health] Salt tab- lets: summary of safety and effectiveness. 1983 Feb 18. (PMA no. P810015-001). CIBA Vision Care Corporation. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Septicon (TM) disinfection regimen for use with . . . : summary of safety and effectiveness. 1983 Apr 8. (PMA no. P820040-000). Coopervision, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Heatcase (TM): summary of safety and effectiveness. 1983 Jul 19. (PMA no. P830001-000). Eaton Medical Corporation. [Food and Drug Adminis- tration, Center for Devices and Radiological Health] Easy Eyes (TM): summary of safety and effectiveness. 1983 Jul 19. (PMA no. P830009-000). Horizon Pharmacal, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] The Horizon system: summary of safety and effec- tiveness. 1983 Feb 18. (PMA no. P810009-002).

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Kestrel. fFood and Drug Administration, Center for Devices and Radiological Health] Kestrel no. 695 heater: summary of safety and effectiveness. 1983 Jun 10. (PMA no. P820087-000). Marlin Industries. tFood and Drug Administration, Center for Devices and Radiological Health] Marlin squeeze bottle & Marlin salt tablets: summary of safe- ty and effectiveness. 1983 Feb 18. (PMA no. P800038-001). National Patent Development Corporation. tFood and Drug Administration, Center for Devices and Radio- logical Health] Hydron (TM) saline system (135 & 250 mg): summary of safety and effectiveness. 1983 Feb 25. (PMA no. P810047-002). Professional Supplies. tFood and Drug Administration, Center for Devices and Radiological Health] The soft rinse system: summary of safety and effectiveness. 1983 Feb 18. (PMA no. P800060-003). Amcon Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Nor-Sa-Tab: sum- mary of safety and effectiveness. 1982 Feb 19. (PMA no. P800069-000). Barnes-Hind Pharmaceuticals, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Softmate weekly cleaning solution: summary of safety and effectiveness. 1982 Mar 26. (PMA no. P810017-000). Bausch & Lomb. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Sensitive eyes (TM) saline solution: summary of safety and effectiveness. 1982 Nov 11. (PMA no. P810039-000). Central Pharmaceuticals, Inc. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Central's pharm. salt tablets for disinfection: summa- ry of safety and effectiveness. 1982 Jan 15. (PMA no. P810030-000). Coopervision, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Mirasol (TM): summary of safety and effectiveness. 1982 Jan 12. (PMA no. P810008-000). Horizon Pharmacal, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] The Horizon system: summary of safety and effec- tiveness. 1982 ~an 12. (PMA no. P810009-000). International Hydron Corporation. [Food and Drug Administration, Center for Devices and Radiological Health Hydron (TM) saline system (135 & 250 mg): summary of safety and effectiveness. 1982 Apr 9. (PMA no. P810047-000). International Hydron Corporation. tFood and Drug Administration, Center for Devices and Radiological Health] Hydron (R) lens care unit: summary of safety and effectiveness. 1982 Oct 9. (PMA no. P820007-000). Professional Pharmaceal Co. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Salt tablets: summary of safety and effectiveness. 1982 Jan 5. (PMA no.P810003-000). Professional Supplies. tFood and Drug Administration, Center for Devices and Radiological Health] The soft rinse system: summary of safety and effectiveness. 1982 Tan 1. (PMA no. P800060-000). Sherman Labs, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Sof! Pro- -clean contact lens cleaner: summary of safety and effectivness. 1982 Tul 23. (PMA no. P810041-000). Standard Pharmacal Corp. tFood and Drug Adminis- tration, Center for Devices and Radiological HealthJ Lens-sol: summary of safety and effectiveness. 1982 Mar 26. (PMA no. P810012-000). Contact lens lubr~cants Paco Pharmaceutical Services, Inc. fFood and Drug Ad- ministration, Center for Devices and Radiological Health] Sorbic acid preserved lens lubricant: summa- ry of safety and effectiveness. 1986 Oct 9. (PMA no. P850075-000). Allergan Pharmaccuticals. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Lens-wet (TM): summary of safety and effectiveness. 1982 May 14. (PMA no. P800065-000). Cooper Labs, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Clerz lubricating & rewetting eye drops: summary of safety and effectiveness. 1982 {ul 13. (PMA no. PB00034-000). Contact lens markers Frigitronics, Inc. fFood and Drug Administration, Cen- ter for Devices and Radiological Health1 Softmark: summary of safety and effectiveness. 1983 Jul 19. (PMA no. P820027-000). Contact lenses Alcon Laboratories, Inc. fFood and Drug Administra- tion, Center for Devices and Radiological Health1 Scanlens (Scafilcon A contact lens): summary of safety and effectiveness. 1987 Jan 16. (PMA no. P850033-000). 395

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Paragon Optical Inc. (Food and Drug Administration, Center for Devices and Radiological Health] Para- perm E.W. blue rigid gas permeable contact lens: summary of safety and effectiveness. 1987 Feb 18. (PMA no. P850038-000). CTL, Inc. (Food and Drug Administration, Center for Devices and Radiological Health] Customeyes (TM) 45L & 55L (Bufilcon A): summary of safety and effec- tiveness. 1986 Jul 1. (PMA no. P850057-0004. CTL, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Customeyes 70L & 79L (Lidofilcon A & B): summary of safety and efecti- veness. 1986 foul 1. (PMA no. P850058-000~. Custom Tint Lab., Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Perma- tint (R): summary of safety and effectiveness. 1986 Mar 14. (PMA no. P820059-000J. Custom Tint Lab., Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Perma- tint (R): summary of safety and effectiveness. 1986 Mar 26. (PMA no. P820059-000~. Oculus Contact Lens Company. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Ocusil (TM' contact lens: summary of safety and effectiveness. 1986 Jan 2. (PMA no. P840050- 0001. Syntex Opthalmics Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Po- lycon contact lens: summary of safety and effective- ness. 1986 Feb 10. (PMA no. N 18120-015~. University Optical Products Co. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] The Boston lens II Alges (R) bifocal contact lens: summary of safety and effectiveness. 1986 {an 24. (PMA no. P850008-000~. University Optical Products Company. tFood and Drug Administration, Center for Devices and Radiological Health] Alges (TM) (Hefilcon A) contact lens: sum- mary of safety and effectiveness. 1986 Apr 28. (PMA no. P850002-000~. Bausch & Lomb. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] B & L 58 (TM) (Etafilcona) contact lens: summary of safety and effectiveness. 1985 Sep 23. (PMA no. P850039-000~. Frigitronics, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Saturn II (TM) (Synergicon A) contact lens: summary of safety and effectiveness. 1985 Mar 22 (PMA no. P840004-000~. 396 Heyer Schulte Corp. [Food and Drug Administration, Center for Devices and Radiological Health] Sauflon (R) PW (Lidofilcon B): summary of safety and effec- tiveness. 1985 May 10. (PMA no. P790020-0084. Heyer Schulte Corp. tFood and Drug Administration, Center for Devices and Radiological Health] Sauflon (r) 70 (Lidofilcon A): summary of safety and effective- ness. 1985 May 10 (PMA no. P790020-002~. Hydracon. tFood and Drug Administration, Center for Devices and Radiological Health] Hydracon (R) con- tact lenses: summary of safety and effectiveness.1985 Nov 19. (PMA no. P820017-001~. University Optical Products Company. [Food and Drug Administration, Center for Devices and Radiological Health] Alges (TM) (Hef~lcon A) contact lens: sum- mary of safety and effectiveness. 1985 Dec 4. (PMA no. 850002-000~. Visiontech, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Sauflon PW-70 A & B: summary of safety and effectiveness. 1985 Jun 19. (PMA no. P840031-000~. Wesley ~essen. [Food and Drug Administration, Center for Devices and Radiological Health] Airlens (R) (Air- focon A) lens blue & clear: summary of safety and effectiveness. 1985 Jan 18. (PMA no. P830070-000~. Advanced Optical Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Softics (TM) (polymacon): summary of safety and effective- ness. 1984 Ju13. (PMA no. P830012-000~. Barnes-Hind Pharmaceuticals. tFood and Drug Admin- istration, Center for Devices and Radiological Health] Gas permeable regimen: summary of safety and ef- fectiveness. 1984 Apr 25. (PMA no. P820053-000~. CIBA Vision Care Corporation. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Cibatint (TM) tinting process: summary of safety and effectiveness. 1984 Apr 10. (PMA no. P820086-000~. Committee on Ophthalmic Procedures Assessment. [American Academy of Ophthalmology] Therapeutic contact lenses for recurrent corneal erosion. San Francisco, CA: American Academy of Ophthalmolo- gy, 1984. [Information syntheses, Expert opinion] Hydracon. [Food and Drug Administration, Center for Devices and Radiological Health] Hydracon (R) con- tact lenses: summary of safety and effectiveness.1984 Aug 7. (PMA no. P820017-002~. Office of Technology Assessment, U.S. Congress. The contact lens industry. Washington, D.C.: U.S. Gov- ernment Printing Office, December 1984 (Health technology case study series #31)

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Polymer Technology Corporation. Hood and Drug Ad- ministration, Center for Devices and Radiological Health] Boston lens (R) lens-clear: summary of safety and effectiveness. 1984 {an 27. (PMA no. P820065-000). Salvatori Ophthalmics, Inc. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Paraperm 02 clear & blue lens: summary of safety and effectiveness. 1984 Apr 25. (PMA no. 820062-000~. Bausch and Lomb. [Food and Drug Administration, Center for Devices and Radiological Health] 03/04 (TM) lens series: summary of safety and effectiveness. 1983 Aug 16. (PMA no. N16895-025~. Con-cise. tFood and Drug Administration, Center for Devices and Radiological Health] Paraperm OF con- tact lens clear & blue: summary of safety and effec- tiveness. 1983 Dec 8. (PMA no. P820061-000~. Custom Tint Lab., Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Perma- tint (R): summary of safety and effectiveness. 1983 Nov 9. (PMA no. P820059-000~. Frigitronics, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Opus-III contact lenses: summary of safety and effectiveness. 1983 Sep 2. (PMA no. P820074-000~. Hydracon. tFood and Drug Administration, Center for Devices and Radiological Health] Hydracon (R) con- tact lenses: summary of safety and effectiveness.1983 Mar 25. (PMA no. P820017-000~. Optacryl Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Optacryl 60-clear: summary of safety and effectiveness. 1983 Dec 8. (PMA no. P820056-000~. Paragon Optical Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Para- perm 02 contact lens: summary of safety and effec- tiveness. 1983 Dec 8. (PMA no. P820063-000~. Tohnson and {ohnson Co. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Chamber lens models 101, 101 B. 101 T: summary of safety and effectiveness. 1982 Mar 26. (PMA no. P790027-000~. Salvatori Ophthalmics, Inc. iFood and Drug Adminis- tration, Center for Devices and Radiological Health] (Polymacon) contact lenses: summary of safety and effectiveness. 1982 Sep 17. (PMA no. P820005-000~. Syntex Ophthalmics Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Po- lycon contact lens: summary of safety and effective- ness. 1982 Sep 21 (PMA no. N 18120-0081. Georgetown University Medical Center, Institute for Health Policy Analysis. Extended wear contact lenses. (Planned). Contact lenses, Hydrophilic Bausch & Lomb (R). iFood and Drug Administration, Center for Devices and Radiological Health] B & L (R) (Amefocon A) oxygen permeable lens: summary of safety and effectiveness. 1986 Aug 7. (PMA no. P830050-000~. Bausch & Lomb. fFood and Drug Administration, Cen- ter for Devices and Radiological Health] Silsoft (Elas- tofilcon A) contact lenses: summary of safety and effectiveness. 1986 Feb 2. (PMA no. P850068-000~. Briggs Ophthalmics Corp. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Sunsoft (Methafilcon A) hydrophilic contact lens: summary of safety and effectiveness. 1986 Aug 7. (PMA no. P850077-001~. Briggs Ophthalmics Corporation. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Sunsoft (Methafilcon A) hydrophilic contact lens: summary of safety and effectiveness. 1986 Mar 28. (PMA no. P850077-000~. Coast Contact Lens, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Hy- dra (Methafilcon A) contact lens: summary of safety and effectiveness. 1986 Aug 7. (PMA no. P850079-0011. Coast Contact Lens, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Hy- drasoft (Methafilcon A) contact lens: summary of safety and effectiveness. 1986 Mar 28. (PMA no. P850079-000~. Kontur Kontact Lens Co. Inc. fFood and Drug Admin- istration, Center for Devices and Radiological Health] Kontur soft (Methafilcon A) contact lens: summary of safety and effectiveness. 1986 Aug 7. (PMA no. P850078-0001. Kontur Kontact Lens Co. Inc. tFood and Drug Admin- istration, Center for Devices and Radiological Health] Kontur soft (Methafilcon A) contact lens: summary of safety and effectiveness. 1986 Mar 28. (PMA no. P850078-000~. N & N Menicon Inc. fFood and Drug Administration, Center for Devices and Radiological Health] (Mafil- con) soft contact lenses: summary of safety and effec- tiveness. 1986 Dec 17. (PMA no. PB00031-000~. 397

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Permeable Contact Lenses, Inc. (Food and Drug Ad- ministration, Center for Devices and Radiological Health] SOP lens (TM): summary of safety and effec- tiveness. 1986 {an 21. (PMA no. P840055-0001. Toray Industries Inc. iFood and Drug Administration, Center for Devices and Radiological Health] Toray soft contact lenses: summary of safety and effective- ness. 1986 Mar 5. (PMA no. P840044-000~. UCO Optics, Inc. [Food and Drug Administration, Cen- ter for Devices and Radiological Health] Aquasept II: summary of safety and effectiveness. 1986 Feb 14. (PMA no. N 17679-008~. Wesley-tessen. [Food and Drug Administration, Center for Devices and Radiological Health] Durasoft 4 (ofil- con A) spherical hydrophilic lens: summary of safety and effectiveness. 1986 Aug 14. (PMA no. Pod. International Hydron Corp. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] X-70 soft contact lens: summary of safety and effec- tiveness. 1985 May 10. (PMA no. P830047-0004. National Patent Development Corporation. [Food and Drug Administration, Center for Devices and Radio- logical Health] Hydron hydrophilic contact lens: sum- mary of safety and effectiveness. 1985 Nov 18. (PMA no. P78007-016). Optical Plastic Research. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Softview spherical & toric contact lens: summary of safety and effectiveness. 1985 Feb 20. (PMA no. P830003-000). Paris Contact Lens Lab. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Softsite (Hefilcon A) contact lens: summary of safety and effectiveness. 1985 Nov 21. (PMA no. N 17793-006). Product Development Corp. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Soft hydrophilic contact lens: summary of safety and effectiveness. 1985 Nov 21. (PMA no. P850041-000). Salvatori Ophthalmics, Inc. EFood and Drug Adminis- tration, Center for Devices and Radiological Health] Synsoft (TM) (polymacon) bifocal contact lens: sum- mary of safety and effectiveness. 1985 Mar 22. (PMA no. P840006-000). Soft Lense Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Hydrocurve II bifocal lens: summary of safety and effectiveness. 1985 Mar 22. (PMA no. N17752-016). 398 Wesley-Jessen. [Food and Drug Administration, Center for Devices and Radiological HealthJ Durasoft (R) 3 for extended wear: summary of safety and effective- ness. 1985 Sep 11. (PMA no. P830039-000). Alden Optical Labs., Inc. (Food and Drug Administra- tion, Center for Devices and Radiological Health] AL-47 soft contact lens: summary of safety and effec- tiveness. 1984 Mar 9. (PMA no. P820078-000). Comfort Flex Hydrophilics Inc. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] TRI POL 43 contact lens: summary of safety and effectiveness. 1984 Apr 17. (PMA no. P780013-004). Frontier Contact Lense. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Hy- dro mare lenses (hydrophilic): summary of safety and effectiveness. 1984 Sep 17. (PMA no. N 18033-006). Metrosoft, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Metro 55 (Meth- afilcon A): summary of safety and effectiveness.1984 TU1 3 (PMA no. P830077-000). Ocu-Ease Optical Products, Inc. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Ocu-flex: summary of safety and effective- ness. 1984 Apr 25. (PMA no. P820051-000). Syntex Ophthalmics Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Soft contact lens: summary of safety and effectiveness. 1984 Jan 17. (PMA no. N17987-007). Vision Ease Contact Lens Co. fFood and Drug Adminis- tration, Center for Devices and Radiological Health] VE soft hydrophilic contact lens: summary of safety and effectiveness. 1984 Mar 9. (PMA no. P830049-000). CIBA Vision Care Corporation. fFood and Drug Ad- ministration, Center for Devices and Radiological Health] Softcon (Vifilcon A) soft contact extended wear lens: summary of safety and effectiveness. 1983 Apr 29. (PMA no. P820021-000). Contact Lens Corporation of America. fFood and Drug Administration, Center for Devices and Radiological Health] Softact II (polymacon): summary of safety and effectiveness. 1983 Aug 5. (PMA no. P830006-000). Dow Corning Corporation. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Silicon(R) (silafilcon A) contact lens daily wear: sum- mary of safety and effectiveness. 1983 Dec 12. (PMA no. P800054-004).

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Optech, Inc. (Food and Drug Administration, Center for Devices and Radiological Health] Optech fre-flex soft contact lens: summary of safety and effective- ness.l983 Feb 15. (PMA no. P810050-000~. Wesley Jesson Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Durasoft (R) Trutocal (TM): summary of safety and effective- ness. 1983 Jun 3. (PMA no. N17852-008~. Bausch and Lomb. tFood and Drug Administration, Center for Devices and Radiological Health] Softens (r) polymacon P.A.1 series: summary of safety and effectiveness. 1982 Dec 17. (PMA no. N 16895 019~. CIBA Vision Care. tFood and Drug Administration, Center for Devices and Radiological Health] Weicon (R) (Tefilicon) hydrophilic contact lens: summary of safety and effectiveness. 1982 {ul 27. (PMA no. P810005-002~. Coopervision, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Cooper (TM) 38 (polymacon) hydrophilic contact lens: sum- mary of safety and effectiveness. 1982 May 21. (PMA no. P810057-000~. Danker and Wohlk, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Danker silicone lens (Dimefocon-A': summary of safety and effectiveness. 1982 tun 13. (PMA no. P790010-000~. Metrosoft, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Metrosoft (TM) II (polymacon) hydrophilic contact: summary of safe- ty and effectiveness. 1982 Sep 24. (PMA no. P820026-000~. Soft Lense Inc. tFood and Drug Administration, Center for Devices and Radiolog~cal Health] Hydrocurve: summary of safety and effectiveness. 1980 Jan 11. (PMA no.N17752-000~. Soft Lense Inc. iFood and Drug Administration, Center for Devices and Radiological Health] Hydrocurve: summary of safety and effectiveness. 1980 Mar 14. (PMA no. N 17752-001). Condnuous ambulatory per~toneal dialysis Office of Technology Assessment, U.S. Congress. The effectiveness and costs of continuous ambulatory peritoneal dialysis. Washington, D.C.: U.S. Govern- ment Printing Of fice, September 1985. (Health tech- nology case study series #35) Stason WB, Barnes BA. "Harvard School of Public Health, Institute for Health Research] Effectiveness and costs of continuous ambulatory peritoneal dialy- sis (CAPD). Washington, D.C.: U.S. Congress, Office of Technology Assessment, July 1985. (Health Tech- nology Case Study 35, OTA-HCS-35) "Information syntheses] American Medical Association, Council on Scientif~c Af- fairs. Continuous ambulatory peritoneal dialysis. {AMA 1982 Nov 12;248:2340. tGroup judgment] Hutchinson TA, Cole CH, Kaye M. fMcGill University, Department of Epidemiology and Biostatistics] Chronic ambulatory peritoneal dialysis versus other dialysis therapy - a matched cohort study. Clin Res 1982;30:431A. Continuous passive motion devices Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Continuous pas- sive motion device. 1986. ECRI Health Devices Program. Continuous passive mo- tion (CPM' leg exercisers. Health Devices 1986; 15:3-22. ECRI Technology Assessment Program. Continuous passive motion (CPM) devices. Issues Health Care Technol 1985;sec.5.C.4. fInformation syntheses] Continuous passive motion therapy California Medical Association, Medical Practice Opin- ion Program. Continuous passive motion for stiffen- ing conditions. 1983 Mar. (Medical Practice Opinion #306) tGroup judgment] Continuous positive airway pressure Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Nasal continuous positive airway pressure. 1986. "Information synthe- ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Continuous positive airway pressure (CPAP) for the treatment of obstruc- tive sleep apnea. 1986. Contraception American College of Obstetricians and Gynecologists, Committee Opinion. Contraception for women in their later reproductive years. 1985 Dec. tInforma- tion syntheses] 399

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY American Academy of Pediatrics, Committee on Nutri- tion. Breast feeding and contraception. 1981 American Academy of Pediatrics, Committee on Ado- lescence. Contraception for the adolescent. Pediatrics 1980 Mar. Contralateral breast surgery California Medical Association, Medical Practice Opin- ion Program. Contralateral breast surgery following mastectomy. 1986 Feb. (Medical Practice Opinion #338) tGroup judgment! Colneal endothelial cell microscopy Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Corneal endothe- lial cell microscopy. 1986. I Information syntheses] Eddy IF, Eddy, DM. [Duke University, Center for Health Policy Research and Education] The value of corneal endothelial cell microscopy for cataract sur- gery. Report prepared for the Blue Cross and Blue Shield Association. 1986. "Information syntheses] Corneal grafts Chipman ML. "National Health Research and Develop- ment Program - Canada] Population-based studies of corneal graft outcome. 1986. (Grant No. 6606-2671-46). Coronary artery bypass grafting American College of Physicians, Clinical Efficacy As- sessment Project. A comparative assessment of coro- nary artery bypass surgery and percutaneous translu- minal coronary angioplasty, expected completion 1988. [Information syntheses] Frasure-Smith N. [National Health Research and Devel- opment Program - Canadal The psychosocial out- comes of coronary bypass surgery: a study of patient and spouse adjustment during the first post-surgical year. 1986. (Grant No. 6605-2021-44~. Gersh B}, Kronmal RA, Schaff HV, et al. "National Heart, Lung, and Blood Institute] Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from the Coronary Artery Surgery Study (CASS) registry. N Engl J Med 1985;313:217-224. Passamani E, David B. Gillespie M}, et al. [National Heart, Lung, and Blood Institute] A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med 1985;312: 1655-1671. 4OO Wortman PM, Yeaton WH. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Cumulat- ing quality of life results in controlled clinical trials of coronary artery bypass graft surgery. Controlled Clin Trials 1985 Dec;6~4~:289-305. Yeaton WH and Wortman PM. (National Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] Medical technology assessment: the evaluation of cor- onary artery bypass graft surgery using data synthesis techniques. Int J Technol Assessment Health Care 1985 Jan; 1~1~:125-1416. CASS Principal Investigators and Their Associates. tNa- tional Heart, Lung, and Blood Institute] Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: myocardial infarction and mortality in the randomized trial. N Engl J Med 1984;310:750-758. King's Fund. [King's Fund Centre for Service Develop- ment. King's Fund Forum Consensus and Controver- sies in Medicine] Coronary artery bypass surgery: the First UK Consensus Development Conference.1984. CASS Principal Investigators and Their Associates. tNa- tional Heart, Lung, and Blood Institute] Coronary Artery Surgery Study iCASS): a randomized trial of coronary artery bypass surgery: quality of life in pa- tients randomly assigned to treatment groups. Circu- lation 1983;68:951-960. CASS Principal Investigators and Their Associates. tNa- tional Heart, Lung, and Blood Institute] Coronary Artery Surgery Study (CASS): randomized trial of coronary artery bypass surgery: survival data. Circu- lation 1983;68:939-950. CASS Principal Investigators and Their Associates. [Na- tional Heart, Lung, and Blood Institute] Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: comparability of en- try characteristics and survival in randomized patients and nonrandomized patients meeting randomization criteria. J Am Coll Card 1983;3:114-128. Davis KB, Chatman BR, Killip T. et al. "National Heart, Lung, and Blood Institute] Effect of coronary bypass surgery on operative mortality and survival patterns in subsets of patients with left main coronary artery disease. In: Hammermeister KE, ed. Coronary bypass surgery. New York: Praeger Scientific, 1983 :99- 127. Davis KB, Kennedy JW, Berger RL, et al. "National Heart, Lung, and Blood Institute] Operative mortal- ity in the CASS registry. In: Hammermeister KE ed. Coronary bypass surgery. New York: Praeger Scien- tific, 1983:99-127.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Frommer PL, Fisher LD, Mock MB, et al. "National Heart, Lung, and Blood Institute] The Coronary Ar- tery Surgery Study: a randomized trial in the context of the registry. In: Hammermeister KE, ed. Coronary bypass surgery. New York: Praeger Scientific, 1983:57-82. Gersh By, Kronmal RA, Frye RL, et al. National Heart, Lung, and Blood InstituteJ Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older: a report from the Coronary Artery Surgery Study. Circulation 1983 ;67 :483-490. Ryan T}, Bailey KR, McCabe CH, et al. iNational Heart, Lung, and Blood Institute] The effects of digitalis on survival in high-risk patients with coronary artery dis- ease: the Coronary Artery Surgery Study (CASS). Circulation 1983;67:735-742. Mock MB, Ringvist I, Fisher LD, et al. "National Heart, Lung, and Blood Institute] Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1982;66:562-568. Weinstein MC, Stason WB. "Harvard School of Public Health, Institute for Health Research] Cost-effective- ness of coronary artery bypass surgery. Circulation 1 982 ;66(Suppl III ): III56-III66. [Information syn- theses] Berger RL, Davis KB, Kaiser GC, et al. "National Heart, Lung, and Blood Institute] Preservation of the myo- cardium during coronary artery bypass grafting. Cir- culation 1981;64 (Supplement II):II61-II66. Chaitman BR, Fisher LD, Bourassa MG, et al. "National Heart, Lung, and Blood Institute] Effect of coronary bypass surgery on survival patterns in subsets of pa- tients with left main coronary artery disease. Report of the collaborative study in Coronary Artery Surgery (CASS). Am J Cardiol 1981;48:765-777. Kennedy TW, Kaiser GC, Fisher LD, et al. "National Heart, Lung, and Blood Institute] Clinical and angio- graphic predictors of operative mortality from the collaborative study in Coronary Artery Surgery (CASS). Circulation 198 1;63;793-802. Principal Investigators of CASS and Their Associates. "National Heart, Lung, and Blood Institute] National Heart, Lung, and Blood Institute Coronary Artery Surgery Study. Circulation 1981;63 (AHA Mono- graph No. 79~: I 1-181. Kennedy tW, Kaiser GC, Fisher LD, et al. [National Heart, Lung, and Blood Institute] Multivariate dis- criminant analysis of the clinical and angiographic predictors of operative mortality from the Collabora- tive Study in Coronary Artery Surgery (CASS). J Thorac Cardiovasc Surg 1980;80:876. National Institutes of Health, Consensus Development Program. Coronary artery bypass surgery: scientific arid clinical aspects. (Consensus Development Con- ference Statement, Dec 3-5 19801. tGroup judgment] Russell RO, Wayne iB, Kronenfeld l, et al. iNational Heart, Lung, and Blood Institute] Surgical versus medical therapy for treatment of unstable angina: changes in work status and family income. Am T Car- diology 1980;45:134-140. Unstable Angina Pectoris Study Group. "National Heart, Lung, and Blood Institute] Unstable Angina Pectoris Study National Cooperative Study Group to compare medical and surgical therapy. III. Results in patients with S-T segment elevation during pain. Am T Cardiology 1980;45:819-824. Unstable Angina Pectoris Study Group. "National Heart, Lung, and Blood Institute] Unstable Angina Pectoris National Cooperative Study Group to com- pare medical and surgical therapy. II. In-hospital ex- perience and initial follow-up results in patients with one, two and three vessel disease. Am I Cardiol 1978;42:839-848. Neuhauser D, Jonsson E. "Harvard School of Public Health, Institute for Health Research] Managerial re- sponse to new health care technology: coronary ar- tery bypass surgery. In: Abernathy WJ, Sheldon A, Prahalad CK, eds. The management of health care. Cambridge: Ballinger Press, 1975. "Information syn- theses] Veterans Administration, Cooperative Studies Pro- gram. Coronary artery surgery I: stable angina (vein by-pass). Ongoing. [Clinical trialsJ Veterans Administration, Cooperative Studies Pro- gram. Coronary artery surgery II: unstable angina (vein by-pass). Ongoing. "Clinical trialsJ Coronary artery disease diagnosis Fineberg HV, Stason WB. "Harvard School of Public Health, Institute for Health Research] Cost-effective- ness of alternative diagnostic strategies for coronary artery disease. Circulation 1982;66(III):80-86. tInfor- mation syntheses] Coronary artery jeopardy score Califf RM, et al. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol May 1985;5~51: 1055-1063. 4O!

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Coronary care units U.S. Administrators, Professional Policy Committee. Coronary care units, admission to. ; 7/86] (Group judgment] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Intensive cardiac care unit. 1985. tIn- formation syntheses] Cost benefit/effectiveness analysis Health Industry Manufacturers Association. tBattelle Medical Technology Assessment Program] A guide to cost-effectiveness analysis for medical device and di- agnostic manufacturers. Washington, D.C.: Health Industry Manufacturers Association, 1985. (HIMA Report Number B5-2, HIMA Research Reports Se- ries Number 3) [Cost analyses] Avorn ~L. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Benefit and cost anal- ysis in geriatric care: turning age discrimination into health policy. N Engl ~ Med 1984 May;310~201:1294- 1301. University of Pennsylvania, Leonard Davis Institute of Health Economics. Cost benefit, cost effectiveness, and other decision making techniques in health care resource allocation. 1983. (Proceedings of a Regional Symposium, November 4-6, 1982, funded by Smith Kline and French Laboratories). Lubeck D. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Cost-benefit analysis of heart disease research. 1982. (NTIS order no; PB82- 194556) Swedish Planning and Rationalization Institute of the Health Services. Spri technology report 3: cost effec- tiveness analysis in health care. 1981. tCost analyses, Epidemiological and other observational methods] Office of Technology Assessment, U.S. Congress. The implications of cost-effectiveness analysis of medical technology. Washington, D.C.: U.S. Government Printing Office, August 1980. Linkoping University, Center for Medical Technology Assessment . Development of simulation models for use in cost-effectiveness studies. Planned. Counseling Pless IB. [National Health Research and Development Program - Canada] Social support & counselling in the prevention of psychosocial maladjustment in chil- dren with chronic illness. 1986. (Grant No. 6605- 2060-431. 402 American Academy of Pediatrics, Committee on Ado- lescence. Pregnancy and abortion counseling. Pediat- rics 1979 Jun. CPI-4 codes Feasibility of incorporating CPT-4 codes for physician billing into the diagnosis-related groups system for in- hospital Medicare surgical patients. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Tan 1986. (HCFA Pub. No. 03219). Creatinine concentration, Serum Blue Cross and Blue Shield Association, Medical Neces- sity Program. Blood urea nitrogen concentration and serum creatinine concentration. 1987. [Information syntheses] Cryometers Food and Drug Administration, Center for Devices and Radiological Health. Hypodermic thermocouple tis- sue cryometers. 1984. (NTIS Order No. PB84- 190776~. Cryopreservation Martin RH. "National Health Research and Develop- ment Program - Canada] The effect of cryopreserva- tion on the frequency of chromosome abnormalities in human sperm. 1986. (Grant No. 6609- 1319-52~. Schachar NS. [Department Surgery, University Calga- ry] "Medical Research Council - Canada] Investiga- tion of optimal methods of cryopreservation of os- teoarticular allografts for transplantation. (Grant pe- riod 1984-1985~. Cryosurgery American College of Obstetricians and Gynecologists, Committee Opinion. The use of cryosurgery in the treatment of CIN. Revised 1986 Nov. "Information syntheses] Cryosurgery Arrhythmias American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Ablation of accessory pathways in Wolff-Parkinson-White Syndrome. Mar 31, 1986. iExpert opinion, Information synthesesJ

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Cushions Conine TA. (National Health Research and Develop- ment Program - Canada] A controlled randomized trial of two seat cushions in the prevention of decubi- tus ulcers in institutionalized elderly persons. 1986. (Grant No. 6610- 1493-55~. Cyanoacrylates Committee on Ophthalmic Procedures Assessment. fAmerican Academy of Ophthalmology] Cyanoacry- late tissue adhesive. San Francisco, CA: American Academy of Ophthalmology, 1984. fInformation syn- theses, Expert opinion] Cyclophosphamide California Medical Association, Medical Practice Opin- ion Program. Cytoxan therapy for multiple sclerosis. 1985 Oct. (Medical Practice Opinion #329' Group judgment] Cyclothiazide Food and Drug Administration, Center for Drugs and Biologics. Cyclothiazide. 1981. (NTIS order no. PB81 -915905~. (Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Cytotoxic food testing California Medical Association, Medical Practice Opin- ion Program. Cytotoxic testing for food allergy. 1984 Feb. (Medical Practice Opinion #265) (Group judg- ment] American College of Physicians, Clinical Efficacy As- sessmentProlect. CYtotoxicfoodtestin~.1981. FInfor- mation syntheses] _ _J _ _ _ ~ ~_ ~; L National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Cytotoxic leukocyte test for the diagnois of food allergy. 1981. Dacarbazine Food and Drug Administration, Center for Drugs and Biologics. DTIC (Dome). 1981. (NTIS order no. PB81 - 15907~. fInformation syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Data banks Medicare automated data retrieval system. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Jan 1986 (HCFA Pub. No. 032191. Seshia SS, Shwedyk E. "National Health Research and Development Program - Canada] Computerized EEG data base from prolonged ambulatory 4 channel (cas- sette) recordings in children. 1986. (Grant No. 6607- 1257-42). Pryor DB, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Clinical data- bases accomplishments and unrealized potential. Med Care 1985 May 23~51:648-662. Tugwell P. "Department Medicine, McMaster Universi- ty] "Medical Research Council - Canada] Clinical trials computer network. (Grant period 1984-1985~. Fries ~F. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The chronic disease data bank: first principles to future directions. ~ Med and Philos 1984 May;9~21:161-180. Li Tem, Sherman H. Cook EF, et al. "Harvard School of Public Health, Institute for Health Research] The selective impact of a cardiology data bank on physi- cian's therapeutic recommendations. Medical Deci- sion Making 1984;4~21: 165-177. tEpidemiological methods] Stead EA. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] A medical database approach to evaluate technology. 1984. (NTIS order no. PB84-200559) Brian EW. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Evaluation of auto- mated hospital data management systems in 100-300 bed hospitals. 1983. (NTIS order no. PB 83- 153437~. Loeser J. Zvagulis I, Hercz L, Pless IB. tMcGill Universi- ty, Department of Epidemiology and Biostatistics] The organization and evaluation of a computer-assist- ed centralized immunization registry. Am T Public Health 1983;73~111:1298-1301. 403

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Lundberg ED, McBride R. Rawson TE, et al. "National Heart, Lung, and Blood Institute] A data base man- agement system developed for the Coronary Artery Surgery Study (CASS) and other clinical studies. In: Riddle K, Thurber P. Keen P. et al. eds. Proc of the 15th Hawaii Internat Confon Systems Sciences, 1982, Vol II, Software, Hardware, Decision Support Sys- tems, Special Topics, North Hollywood, CA: Western Periodicals Co, 1982 :484-500. Wiederhold GC, Blum RL. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Integrat- ing medical knowledge and clinical data banks. 1981. (NTIS order no. PB81-227233) Day care Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Hospital day medicine unit guidelines. 1984. "Information syntheses, Expert opinion, Groupjudg- ment1 Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Geriatric units in hospitals, geriatric day hospital guidelines. 1979. I Information syntheses, Expert opinion, Group judgment] Subcommittee on Special Services in Hospitals. Health and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Diabetic day care unit guidelines. 1978. tInfor- mation syntheses, Expert opinion, Group judgment] Debr~dement National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Debridement and other treatment of mycotic toenails. 1985. Decubitus surgery U.S. Administrators, Professional Policy Committee. Decubitus surgery. t7/86] tGroup judgment] Defibrillation Eisenberg MS, Hallstrom A, Bergner LG. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Re- search] Defibrillation by emergency medical techni- cians. 1983 May. (NTIS order no. PB85-163632/AS). 404 Eisenberg MS, et al. "National Center for Health Serv- ices Research and Health Care Technology Assess- ment, Division of Extramural Research] Treatment of ventricular fibrillation: emergency medical techni- cian defibrillation and paramedic services. JAMA 1984 Apr;251(13): 1723-26. Def~br~llators Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Automatic im- plantable cardioverter defibrillator. 1986. [Informa- tion syntheses] ECRI Technology Assessment Program. Automatic im- plantable cardioverter/def brillator. Issues Health Care Technol 1986;sec.5.D.3. fInformation synthe- ses] Implantable defibrillator. In: Prospective Payment As- sessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Human Services, April 1, 1986. Washington, DC: Government Printing Office, 1986: 103. [Information syntheses, Cost analyses] U.S. Administrators, Professional Policy Committee. Cardioverter defibrillator, implantable. f7/86] tGroup judgment] Cardiac Pacemakers, Inc. (Food and Drug Administra- tion, Center for Devices and Radiological Health] AID-B automatic implantable cardiovertor defibrilla- tor: summary of safety and effectiveness. 1985 Nov 15. (PMA no. P830060-000). National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Implantable auto- matic cardioverter-defibrillators. 1985. Food and Drug Administration, Center for Devices and Radiological Health. A study of DC defibrillator safe- ty and performance - performance and safety stan- dard - volume II. 1984. (NTIS Order No. PB84- 188838). ECRI Health Devices Program. Defibrillators, line- powered. Health Devices 1983; 12:291 -314. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Defibrilla- tors. 1983. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Portable defibrillatory. 1983. Battelle Medical Technology Assessment Program. Cost- effectiveness of the implantable cardiac defibrillator. Ongoing. Johns Hopkins Program for Medical Technology and Practice Assessment. An analysis of automatic implan- table cardiac defibrillators (AICDs). Planned.

ASSESSMENT ILEPORT CITATIONS BY ~ CHENOLOGY Dental alloys American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Report on base metal alloys for crown and bridge applications: bene- fits and risks. ~ Am Dent Assoc 1985; 111 :479-483. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Classification sys- tem for cast alloys. ~ Am Dent Assoc 1984;109:766. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Biological effects of nickel-containing dental alloys. ~ Am Dent Assoc 1982; 104:501-505. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Classification and definition of alloys used for casting substrates for porcelain veneering. ~ Am Dent Assoc 1981; 103:755- 757. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Porcelain-metal alloy compatibility: criteria and test methods. ~ Am Dent Assoc 1981; 102:71 -72. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on low-gold-content alloys for fixed prostheses. ~ Am Dent Assoc 1980; 100:237-240. Veterans Administration, Cooperative Studies Pro- gram. Clinical comparison of base metal alloys vs. a gold alloy used in the fabrication of fixed (crown and bridge) restorations. Ongoing. "Clinical trials] Dental amalgam American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Safety of dental amalgam. ~ Am Dent Assoc 1983;106:519-520. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. High copper-con- tent amalgam alloys. ~ Am Dent Assoc 1982; 105: 1077-1080. Dental amalgamators American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on amalgamators. ~ Am Dent Assoc 1983; 107:639-640. Dental anesthesia National Institutes of Health, Consensus Development Program. Anesthesia and sedation in the dental of- fice. (Consensus Development Conference State- ment, Apr 22-24 1985~. tGroup judgment! Dental bonding American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Dentin bonding systems: an update. ~ Am Dent Assoc 1987;114:91- 95. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Resin dental bonding systems. ~ Am Dent Assoc 1984;108:240- 241. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on enamel bonding of composites, preformed laminate, and laboratory fabricated resin veneers. ~ Am Dent Assoc 1984;109:762-764. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. State of the art and science of bonding in orthodontic treatment. I Am Dent Assoc 1982; 105:844-850. Dental bridges Veterans Administration, Cooperative Studies Pro- gram. A five year clinical evaluation of alternative crown and bridge systems (NIDR). Ongoing. (Clinical trials] Dental caries removal systems National Patent Development Corp. (Food and Drug Administration, Center for Devices and Radiological Health] GE-lOlE caries removal agent/system: sum- mary of safety and effectiveness. 1986 May 2. (PMA no. P830035-0001. Dental ceramics Veterans Administration, Cooperative Studies Pro- gram. Clinical studies of biphasic calcium phosphate ceramic in peridontal osseous defects. (Clinical trials Dental crowns American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Recent develop- ments in materials and process for ceramic crowns. Am Dent Assoc 1985;110:548-549. Veterans Administration, Cooperative Studies Pro- gram. A five year clinical evaluation of alternative crown and bridge systems (NIDR). Ongoing. "Clinical trials] 4°5

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Dental implants American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Dental endosseous implants. ~ Am Dent Assoc 1986; 113:949-950. Karlsson CT. [Linkoping University, Center for Medi- cal Technology Assessment] Economics of osseointe- grated implants a prestudy.1986. (Discussion series paper #8) [Swedish language only] tCost analyses, Epidemiological methods] American Dental Association, Council on Dental Mate- rials, Instruments and Equipment, Council on Dental Research, and Council on Dental Therapeutics. FIy- droxylapatite, beta tricalcium phosphate, and autoge- nous and allogenic bone for filling periodontal de- fects, alveolar ridge augmentation, and pulp capping. ~ Am Dent Assoc 1984; 108 :822-831. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Council reevalu- ates position on dental endosseous implants. ~ Am Dent Assoc 1980;100:247. National Institutes of Health, Consensus Development Program. Dental implants: benefit and risk. (Consen- sus Development Conference Statement, fun 13-14 1978~. tGroup judgment] Linkoping University, Center for Medical Technology Assessment. Economics of ossointegrated implants. Ongoing. Veterans Administration, Cooperative Studies Pro- gram. Dental implants (removable vs. permanent dentures). Ongoing. "Clinical trials] Dental materials American Dental Association, Council on Dental Thera- peutics, Council on Dental Materials, Instruments, and Equipment. The use of root canal filling materi- als containing paraformaldehyde: a status report. J Am Dent Assoc 1987 ~an; 114:95. Helitrex, Inc. [Food and Drug Administration, Center for Devices and Radiological Health] Collacote (TM): summary of safety and effectiveness. 1986 tan 2. (PMA no. P840062-000). American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Recommenda- tions in dental mercury hygiene, 1984. J Am Dent Assoc 1984;109:617-619. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Reported sensitiv- ity to glass ionomer luting cements. ~ Am Dent Assoc 1984; 109:617-619. 406 Osmed, Inc. [Food and Drug Administration, Center for Devices and Radiological Healths Drilac cubes (TM): summary of safety and effectiveness. 1983 Feb 25. (PMA no. P800012-000). American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on precious metal scrap. ~ Am Dent Assoc 1982; 105: 1080-1081. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. A status report on resilient denture base materials. ~ Am Dent Assoc 1981; 103:450-451. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. ADA Council is- sues updated mercury hygiene measures recom- mended. ADA News 1981 Sep 7. Dental radiography Food and Drug Administration, Center for Devices and Radiological Health. Basic concepts in the selection of patients for dental x-ray examinations. 1986. (GPO Stock No. 017-015-00230-6, NTIS Order No. PB86- 126067/AS). American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Recommenda- tions in radiographic practices, 1984. T Am Dent As- soc 1984; 109:764-765. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Biological effects of radiation from dental radiography. ~ Am Dent Assoc 1982; 105:275-281. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Recommenda- tions in radiographic practices. J Am Dent Assoc 1981; 103: 103-104 Dental resins American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Posterior compos- ite resins. J Am Dent Assoc 1986;112:717-709. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Posterior compos- ite resins: an update. J Am Dent Assoc 1986; 113:950- 952. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on enamel bonding of composites, preformed laminate, and laboratory fabricated resin veneers. J Am Dent Assoc 1984;109:762-764.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on posterior composites. ~ Am Dent Asso 1983;107:71- 75. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on microfilled composite restorative resins. ~ Am Dent Assoc 1982-105:488-492. Dental scaling and stain-removal devices American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report on professional scaling and stain-removal devices. I Am Dent Assoc 1985; 111:801-802. Dental sealants American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Pit and fissure sealants. ~ Am Dent Assoc 1983; 107:465. National Institutes of Health, Consensus Development Program. Dental sealants in the prevention of tooth decay. (Consensus Development Conference State- ment, Dec 5-7 19831. tGroup judgment] Dental sterilization devices American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Current status of sterilization instruments, devices, and methods for the dental office. ~ Am Dent Assoc 1981; 102:683-689. Dental visible light-cur~ng units American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Visible light-cured composites and activating units. ~ Am Dent Assoc 1985; 110: 100-103 American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report: dental visible light-curing units. ~ Am Dent Assoc 1982; 104:505. Denture cleansers American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Denture cleansers. ~ Am Dent Assoc 1983;106:77-79. Dentures Veterans Administration, Cooperative Studies Pro- gram. Dental implants (removable vs. permanent dentures). Ongoing. Clinical trials] Desoximetasone Food and Drug Administration, Center for Drugs and Biologics. Desoximetasone. 1982. (NTIS order no. Pb82-9159021. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Developmental disabilities screening American Academy of Pediatrics, Committee on Dis- abilities. Screening for developmental disabilities. Pe- diatrics 1986 Sep. Mowat DL. "National Health Research and Develop- ment Program - Canada] An outreach program to promote utilization of health and developmental screening for three-year-old children (Demonstra- tion). 1985. (Grant No. 6601 - 1041 -441. Dexamethasone Collaborative Group on Antenatal Steroid Therapy. "National Heart, Lung, and Blood Institute] Preven- tion of respiratory distress syndrome: effect of ante- natal dexamethasone administration. Hospital and follow-up studies. 1985 iNIH Publication No. 85- 2695] Collaborative Group on Antenatal Steroid Therapy. "National Heart, Lung, and Blood Institute] Effects of antenatal dexamethasone administration in the in- fant: long-term follow-up. J Pediatr 1984;104:259- 267. Collaborative Group on Antenatal Steroid Therapy. "National Heart, Lung, and Blood Institute] Effect of antenatal dexamethasone administration on the pre- vention of respiratory distress syndrome. Am ~ Obstet Gynecol 1981;141:276-287. Dexamethasone suppression test American College of Physicians, Clinical Efficacy As- sessment Project. The dexamethasone suppression test. Ann Intern Med 1983;100:307-8. "Information syntheses] Dextrometho~phan Food and Drug Administration, Center for Drugs and Biologics. Dextromethorphan resin complex. 1983. (NTIS order no. PB83-915901). fInformation synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testings 407

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY American Academy of Pediatrics, Committee on Drugs. Use of codeine- and dextromethorphan-containing cough syrups in pediatrics. Pediatrics 1978 Jul. Dextrose Food and Drug Administration, Center for Drugs and Biologics. Salts solution plus dextrose and glutathione disulfides. l 982. (NTIS order no. PB82-915901). fIn- formation syntheses, Expert opinion, Epidemiologi- cal and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. 10~o Dextrose injection, USP. 1981. (NTIS order no. PB81-9159091. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. JO Dextrose in lactated Ringer's injection in polyolefin bottle.1981. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Dextrose with saline solution Food and Drug Administration, Center for Drugs and Biologics.5% Dextrose & 0.3~o NaC1 Inj., USP.1981. (NTIS order no. PB81 -915909~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics.5% Dextrose & 0.9% NaC1 Inj., USP.1981. (NTIS order no. PB81 -915909~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Dialysis Medical Technology and Practice Patterns Institute. Di- alysis treatment for end stage renal disease (inpa- tient). 1987. Medical Technology and Practice Patterns Institute. Di- alysis treatment for end stage renal disease (outpa- tient). 1987. National Kidney Dialysis and Kidney Transplantation Study. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. 408 Burton Hl. "National Health Research and Develop- ment Program - Canada] Factors influencing out- come of home and satellite care dialysis.1986. (Grant No. 6606-2304-05~. Health Council of the Netherlands. Dialysis and kidney transplantation. 1986. "English summary only]. Hutchinson TA, Harvey CE. tMcGill University, De- partment of Epidemiology and Biostatistics] Survival with different forms of dialysis treatment a prog- nostically controlled comparison. J Am Soc Artif Inter Organs 1985;8:13-17. Hutchinson TA, Michaud L, Thomas DC. tMcGill Uni- versity, Department of Epidemiology and Biostatis- tics] Comparison of survival with dialysis and renal transplantation - the effect of the method of statistical analysis on results. T Am Soc Artif Intern Organs 1985;8: 18-21. Parfrey PS, Hutchinson TA, Harvey C, Guttman RD. fMcGill University, Department of Epidemiology and Biostatistics] Transplantation versus dialysis in diabet- ic patients with renal failure. Am J Kidney Dis 1985;5: 112-116. Hutchinson TA, Thomas DC, Lemieux iC, Harvey CF. tMcGill University, Department of Epidemiology and Biostatistics] A prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 1984;26:44-51. Food and Drug Administration, Center for Devices and Radiological Health. Investigation of the risks & haz- ards with devices associated with peritoneal dialysis (including intermittent dialysis & continuous ambula- tory peritoneal dialysis) & sorbent regenerated dialy- sate delivery systems. 1983. (NTIS Order No. PB83- 175984~. Health Council of the Netherlands. Dialysis. Ongoing assessment. Diathelmy Food and Drug Administration, Center for Devices and Radiological Health. Therapeutic microwave and shortwave diathermy: a review of thermal effective- ness, safe use, and state of the art: 1984. 1985. (GPO Stock No. 017-015-00226-8, NTIS Order No. PB85- 170165/AS). American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Diathermy for treat- ing musculoskeletal conditions. JAMA 1983 {ul 22- 29. fExpert opinion, Information syntheses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Diathermy as a phys- ical therapy modality. 1983. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Shortwave diather- my. 1981. Diazepam Ray WA, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Reducing long- term diazopam prescribing in office practice: a con- trolled trial of educational visits. MAMA 1986 Nov; 256( 1 8~: 2536-2539. Food and Drug Administration, Center for Drugs and Biologics. Diazepam. 1981. (NTIS order no. PB81- 915906~. fInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials. Bench testing] Diet therapy American Diabetes Association. Nutritional recommen- dations and principles for individuals with diabetes mellitus. Diabetes Care 1987; 10: 126-132. tExpert opinion, Group judgment] American Academy of Pediatrics, Committee on Nutri- tion. Prudent life-style for children: dietary fat and cholesterol. Pediatrics 1986 Sep. Cameron R. Horlick L, Shepel L. "National Health Re- search and Development Program - Canada] Toward an economical, broadly accessible weight control pro- gram: the refinement and evaluation of a correspon- dence approach. 1986. (Grant No. 6606-2588-42~. End-Stage Renal Disease Nutritional Therapy Study. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ- ing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Haynes RB. [McMaster, Department of Clinical Epide- miology and Biostatistics] Is weight loss an effective treatment for hypertension? The evidence against. Can T Physiol Pharmacol 1986;64:825-830. Health Council of the Netherlands. Very low energy diets. 1986. "English summary only]. Kramer MS. "National Health Research and Develop- ment Program - Canada] Infant determinants of childhood adiposity: the effectiveness of prophylactic nutrition. 1986. (Grant No. 6605- 1693-43~. National Institutes of Health, Consensus Development Program. Diet and exercise in noninsulin-dependent diabetes mellitus. (Consensus Development Confer- ence Statement, Dec 8- 10 1986~. tGroup judgment] Patrick I. "National Health Research and Development Program - Canada] The nutritional requirements for energy, potassium and zinc for rapid "catch-up" growth in children with cystic fibrosis. 1986. (Grant No. 6606-2303-07). Langford HG, Blaufox MD, Oberman A, et al. tNation- al Heart, Lung, and Blood Institute] Dietary therapy slows the return of hypertension after stopping pro- longed medication. JAMA 1985;5:657-664. Williams CN. "National Health Research and Develop- ment Program - CanadaJ Prevalence and pathogene- sis of cholesterol gallstones in Halifax: prevention of recurrence by diet changes after medical dissolution therapy. 1985. (Grant No. 6603- 1125-44~. Langford HG, Blaufox MD, Oberman A, et al. tNation- al Heart, Lung, and Blood Institute] Effect of weight loss on the return of hypertension after withdrawal of prolonged antihypertensive therapy. In: Nutritional Prevention of Cardiovascular Disease.1984:311-315. Wing R. Caggiula A, Nowalk M, et al. "National Heart, Lung, and Blood Institute] Dietary approaches to the reduction of blood pressure: the independence of weight and sodium/potassium interventions. Prev Med 1984;13:233- 234. American Academy of Pediatrics, Committee on Nutri- tion. Toward a prudent diet for children. Pediatrics 1983 Jan. American Medical Association, Council on Scientific Af- fairs. Dietary and pharmacologic therapy for the lipid risk factors. JAMA 1983 Oct 14;250: 1873-1879. [Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Obesity and protein supplemented fasting. 1982. National Institutes of Health, Consensus Development Program. Defined diets and childhood hyperactivity. (Consensus Development Conference Statement, Jan 13-15 1982~. tGroup judgment] 409

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Remmell PS, Gorder DD, Hall Y. et al (for the MRFIT Group). [National Heart, Lung, and Blood Institute] Assessing dietary adherence in the Multiple Risk Fac- tor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool. ~ Am Dietetic Assn 1980;76:351-356. Diethylpropion Food and Drug Administration, Center for Drugs and Biologics. Diethylpropion hydrochloride. 1983. (NTIS order no. PB83-915901). "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Diflunisal Food and Drug Administration, Center for Drugs and Biologics. Diflunisal. 1982. (NTIS order no. PB82-915904J. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Digital imaging Steering Committee on Future Health Scenarios, Com- mission on Future Health Care Technology (Nether- lands). Prospective assessment of future health care technology: digital imagery. 1987. ECRI Technology Assessment Program. X-ray image digitizing systems. Issues Health Care Technol 1984;sec.5.D.4. Information syntheses] ECRI Technology Assessment Program. Digital radiog- raphy and fluoroscope. Issues Health Care Technol 1983;sec.5.D.2. "Information syntheses] Digital subtraction angiography U.S. Administrators, Professional Policy Committee. Digital subtraction angiography - intravenous. t7/86] [Group judgment] ECRI Technology Assessment Program. Digital sub . . traction ang~ography (DSA). J Health Care Technol 1 985; 1: 1 77-2 1 2. [Information syntheses] Office of Technology Assessment, U.S. Congress. The cost effectiveness of digital subtraction angiography in the detection of cerebrovascular disease. Washing- ton, D.C.: U.S. Government Printing Office, May 1985. (Health technology case study series #34) Swedish Planning and Rationalization Institute of the Health Services. Spri technology report 6: digital sub- traction angiography economical, medical, techni- cal and planning aspects. 1985. "Swedish language only] (Cost analyses, Epidemiological and other ob- servational methods] 4IO American Hospital Association, Hospital Technology Series Program. Digital subtraction angiography. 1982. (Guideline report) "Information syntheses, Ex- pert opinion, Cost analyses] Digitalis Byington R. Goldstein S. for the BHAT Research Group. "National Heart, Lung, and Blood Institute] Association of digitalis therapy with mortality in survi- vors of acute myocardial infarction: observation in the Beta-Blocker Heart Attack Trial. ~ Am Coll Cardiol 1985;6:976-982. Digoxin Muller JE, Turi ZG, Store PH, et al and the MILIS Study Group. [National Heart, Lung, and Blood In- stitute] Digoxin therapy and mortality after myocar- dial infarction. Experience in the MILIS Study. N Eng J Med 1986;314:265-271. Food and Drug Administration, Center for Drugs and Biologics. Digoxin. 1982. (NTIS order no. PB82-915904~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Dihydroergotamine Food and Drug Administration, Center for Drugs and Biologics. Ergoloid mesylates. 1981. (NTIS order no. PB81-9159041. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Dilatadon and curettage U.S. Administrators, Professional Policy Committee. Di- latation and curettage. t7/861 tGroup judgment] Diltiazem Food and Drug Administration, Center for Drugs and Biologics. Diltiazem hydrochloride. 1983. (NTIS or- der no. PB83-915901~. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Dimethyl sulfoxide American Academy of Pediatrics, Committee on Drugs. Dimethyl sulfoxide (DMSO). Pediatrics 1983 Jan. American Medical Association, Council on Scientific Af- fairs. Dimethyl sulfoxide. JAMA 1982 Sep 17;248: 1369. tGroup judgment]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY California Medical Association, Medical Practice Opin- ion Program. DMSO. 1981 Jan. (Medical Practice Opinion #248) tGroup judgment] Dipyridamole Veterans Administration, Cooperative Studies Pro- gram. Platelet aggregation in diabetes (use of ASA & persantine). t1980~. [Clinical trials] Discography California Medical Association, Medical Practice Opin- ion Program. Discography for cervical and lumbar disorders. l 985 Feb. (Medical Practice Opinion #317) tGroup judgment] Discretionary adjustment factor Project HOPE, Center for Health Affairs. A technology- specific approach to estimating the scientific and tech- nological component of the discretionary adjustment factor for excluded hospitals: options and issues.(for Prospective Payment Assessment Commissions).1987 Feb. [Cost analyses] Project HOPE, Center for Health Affairs. A technology- specific approach to estimating the scientific and tech- nological component of the discretionary adjustment factor: options and issues. (for the Prospective Pay- ment Assessment Commission). 1987 Feb. tCost ana- lyses] Disodium cromoglycate Food and Drug Administration, Center for Drugs and Biologics. Cromolyn sodium. 1982. (NTIS order no. PB82-915903~. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Disopyramide Food and Drug Administration, Center for Drugs and Biologics. Disopyramide phosphate. 1982. (NTIS or- der no. PB82-915904~. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Disulfiram Critchfield GC, Eddy DM. fDuke University, Center for Health Policy Research and Education] A confidence profile analysis of the effectiveness of disulfiram in the treatment of chronic alcoholism. Med Care (Sub- mitted for publication) fInformation syntheses] Veterans Administration, Cooperative Studies Pro- gram. Antabuse in the treatment of alcoholics on methadone maintenance. t1980] "Clinical trials] Veterans Administration, Cooperative Studies Pro- gram. Disulf~ram (antabuse) in the treatment of alco- holism. ~ 1980] [Clinical trialsJ Diuretics Kuller L, Farrier N. Borhani N. et al. "National Heart, Lung, and Blood Institute] Relationship of diuretic therapy and serum magnesium levels among partici- pants in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1985; 122: 1045-1059. Shekelle R. "National Heart, Lung, and Blood Institute] Diuretic treatment of hypertension and changes in plasma lipids over six years in the Multiple Risk Factor Intervention Trial. In: Paolette R et al. (eds). End- points for cardiovascular drug studies. New York: Raven, 1984:216. Wassertheil-Smoller S. Langford HG, Blaaufox MD, et al. "National Heart, Lung, and Blood Institute] Diure- tics and salt-restriction in blood pressure control. In: Winick M ed. Nutrition and drugs. New York: John Wiley and Sons Inc. 1983: 175- 189. DNA antibody test American College of Physicians, Clinical Efficacy As- sessment Project. DNA antibody test.1982. tInforma- tion syntheses] Doman-Delacato treatment American Academy of Pediatrics, Committee on Dis- abilities. The Doman-Delacato treatment of neuro- logically handicapped children. Pediatrics 1982 Nov. Dopamine Food and Drug Administration, Center for Drugs and Biologics. Dopamine HC1. 1987. (Summary basis of approval substitute, NDA # 19-099) "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing1 Food and Drug Administration, Center for Drugs and Biologics. Dopamine HC1. 1987. (Summary basis of approval substitute, NDA # 19-0991. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing1 411

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Food and Drug Administration, Center for Drugs and Biologics. Dopamine hydrochloride injection. 1981. (NTIS order no. PB81 -915908~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Double blinding Byington RP, Curb D i, Mattson ME for the Beta Blocker Heart Attack Trial Research Group. tNation- al Heart, Lung, and Blood Institute] Assessment of double-blindness at the conclusion of the Beta-B- locker Heart Attack Trial. JAMA 1985;253(12): 1733-1766. DRGS Burn DRGs. In: Prospective Payment Assessment Com- mission. Technical appendixes to the report and rec- ommendations to the Secretary, U.S. Department of Health and Human Services, April 1,1986. Washing- ton, DC: Government Printing Office, 1986: 124-126. "Information syntheses, Cost analyses] Creating diagnosis-related-group-based physician reim- bursement schemes: a conceptual and empirical anal- ysis. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Development of staging for six rehabilitation conditions and a cross-reference system with their respective diagnois-related groups. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. tan 1986. (HCFA Pub. No. 03219). Diagnosis-related groups and nursing resources. In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Diagnosis-related groups refinement for nursing care. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ- ing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Diagnosis-related groups refinement using measures of disease severity. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). 412 Disease-specific severity adjustments to diagnosis-relat- ed groups. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health ~ . care tenoning status report: research and demonstra- tions in health care financing. Tan 1986. (HCFA Pub. No. 03219). Economics of diagnosis-related-group-based physician reimbursement. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986 (HCFA Pub. No. 03219). Feasibility of incorporating CPT-4 codes for physician billing into the diagnosis-related groups system for in-hospital Medicare surgical patients. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Jan 1986. (HCFA Pub. No. 03219). Further analysis of the medical doctor diagnosis-related groups algorithms. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. fan 1986. (HCFA Pub. No. 03219). Learning from and improving diagnosis-related groups for end-stage renal disease patients. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Lymphomas, leukemia, and chemotherapy. In: Pro- spective Payment Assessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Hu- man Services, April 1, 1986. Washington, DC: Gov- ernment Printing Of rice, 1986: 121 - 123. tInforma- tion syntheses, Cost analyses] Medical doctor diagnosis-related groups algorithms. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). PPS payments for expensive prosthetic and implantable devices and other medical supplies. In: Prospective Payment Assessment Commission. Technical appen- dixes to the report and recommendations to the Sec- retary, U.S. Department of Health and Human Serv- ices, April 1, 1986. Washington, DC: Government Printing Office, 1986:87-96 fInformation syntheses, Cost analyses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Project HOPE, Center for Health Affairs. Evaluating the heterogeneity of DRGs involving lymphomas, leu- kemias, and chemotherapy and developing alterna- tive classifications of discharges. (for Prospective Pay- ment Assessment Commission). 1986 Aug.; Informa- tion syntheses, Cost analyses] Severity of illness and diagnosis-related groups in select- ed cancers. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. {an 1986. (HCFA Pub. No. 03219). Upper extremity procedures. In: Prospective Payment Assessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Human Services, April 1, 1986. Washington, DC: Government Print- ing Office, 1986:115-117. "Information syntheses, Cost analyses] University of Pennsylvania, Leonard Davis Institute of Health Economics. Adjustment artifacts in DRG- based Medicare reimbursement. 1985 Aug. (Final re- port to the National Center for Health Services Re- search, DHHS) University of Pennsylvania, Leonard Davis Institute of Health Economics. DRG's disease staging, and vari- ance reduction. 1985 tul. (Final Report to the Nation- al Center for Health Services Research, DHHS) Office of Technology Assessment, U.S. Congress. Diag- nosis-related groups (DRGs) and the Medicare pro- gram: implications for medical technology, Washing- ton, D.C.: U.S. Government Printing Office, July 1983. Project HOPE, Center for Health Affairs, Evaluating the clinical and resource heterogeneity in DRG 468. (for Prospective Payment Assessment Commission). Ongoing; expected 1987. (Information syntheses] D'ug costs Leonard Davis Institute of Health Economics. Cost of generic vs. branded ethical drugs. 1986 fun. (Final report to Ayerst Laboratories) Drug labeling Office of Technology Assessment, U.S. Congress. Drug labeling in developing countries. Washington, D.C.: U.S. Government Printing Office (to be completed in Winter 1988/891. American Academy of Pediatrics, Committee on Drugs. Unapproved uses of approved drugs: the physician? the package insert, and the FDA. Pediatrics 1978 Aug. Drug ordering Ray WA, Schaffner \V, Federspiel CF. "National Center for Health Services Research and Health Care Tech- nology Assessment, Division of Extramural Research] Persistence of improvement in antibiotic prescribing practice. tAMA 1 985 Mar;253( 1 2): 1 774- 1 776. Ray WA, et al. (National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Improving antibi- otic prescribing in outpatient practice: nonassociation of outcome with prescriber characteristics and meas- ures of receptivity. Med Care 1985 Nov;23~11~: 1307-1313. Schaffner W. Ray WA, Federspiel CF. [National Center for Health Services Research and Health Care Tech- nology Assessment, Division of Extramural Research] Improving prescribing in outpatient practice. 1985 Oct. (NTIS order no. PB86-218997/AS) American Medical Association, Council on Scientific Af- fairs. Prescription Abuse Data Synthesis (PADS) Pro- ject and the AMA prescription drug abuse activity. 1984. tGroup judgment] Gehlbach SH, et al. (National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Improving drug prescribing in a primary care practice. Med Care 1984 Mar;22~31: 193-201. Seigel. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The effects of a computerized drug order review system. 1984. (NTIS order no. PB84- 156199) Soumerai SB, Avorn JL. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Efficacy and cost-containment in hospital pharmacotherapy: state-of-the-art and future directions. Milbank Mem Fund Q 1984;63~31. Blazer DO, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The risk of anticho- linergic toxicity in the elderly: a study of prescribing practices in two populations. I Cardiol 1983 Jan;38(1) :31 -35. Koespell TD, et al. (National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The Seattle evalua- tion of computerized drug profiles: effect on provid- er activities. Med Care 1983 May 21 (5) :498-507. 413

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Schaffner W. et al. iNational Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Improving antibi- otic prescribing in office practice. JAMA 1983 Oct;250(13): 1728-1732. Brand DA. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] A computer audit to improve ER drug prescribing. l 982. (NTIS order no. PB82-253188). Tompkins RK, Koopsell TO. "National Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] Experimental evaluation of computerized drug pro- files. 1982. (NTIS no. PB82-265257) American Academy of Pediatrics, Committee on Drugs. Generic prescribing. Pediatrics 1976 Feb. Georgetown University Medical Center, Institute for Health Policy Analysis. Therapeutic drug substitu- tion: legal liability. Ongoing. Dlug preparation American Academy of Pediatrics, Committee on Drugs. "Inactive" ingredients in pharmaceutical products. Pediatrics 1985 Oct. American Academy of Pediatrics, Committee on Drugs. "Look-alikes." Pediatrics 1983 Aug. D'ug regulation Poisson, B. iLinkoping University, Center for Medical Technology Assessment] The economics of drug reg- ulation. 1986. (Discussion series paper #5) tInforma- tion syntheses] Dual-energy scanned projection radiography ECRI Technology Assessment Program. Dual-energy scanned projection radiography. Issues Health Care Technol 1982;sec.5.D.1. "Information syntheses] Echocardiography ECRI Technology Assessment Program. Two-dimen- sional Doppler echocardiography. Issues Health Care Technol 1986;sec.5.E.5. "Information syntheses] U.S. Administrators, Professional Policy Committee. Echocardiography in artherosclerotic coronary artery disease. 7/86. tGroupjudgment] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Echocardiogram. 1985. "Information syntheses] 414 Blue Cross and Blue Shield Association, Medical Pro- gram. Doppler flow velocity study. 1985. fInforma- tion syntheses] ECRI Technology Assessment Program. Two-dimen- sional Doppler echocardiography. J Health Care Technol 1 985 ;2: 1 29-50. fInformation syntheses] American Hospital Association, Hospital Technology Series Program. Echocardiography. 1984. (Guideline report) "Information syntheses, Expert opinion, Cost analyses! U.S. Administrators, Professional Policy Committee. Echocardiography/re-evaluation. Ongoing. tGroup judgment] Econazole Food and Drug Administration, Center for Drugs and Biologics. Econazole nitrate. 1983. (NTIS order no. PB83-915901~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Edinburgh Masker American Academy of Neurology, Practice Committee. Edinburgh Masker for stuttering. 1983 fun. tExpert opinion, Group judgment] Elbow prosthesis Office of Technology Assessment, U.S. Congress. The Boston elbow. Washington, D.C.: U.S. Government Printing Office, November 1984. (Health technology case study series #29) Electrical stimulation Cardiac Medical Technology and Practice Patterns Institute. En- docardial electrical stimulation. 1987. American College of Physicians, Clinical Efficacy As- sessment Project. Endocardial electrical stimulation. AnnInternMedl984;100:452-4.tInformationsyn- theses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Diagnostic endocar- dial electrical stimulation. 1984. U.S. Administrators, Professional Policy Committee. Programmed electronic stimulation - post-myocardial infarct. Ongoing. tGroup judgment]

ASSESSMENT I0EPORT CITATIONS BY ~ CHNOLOGY Electrical stimulation Cerebellar American Academy of Neurology, Practice Committee. Cerebellar stimulator implantation for cerebral palsy. 1982 Oct. [Expert opinion, Group judgment] American Academy of Neurology, Practice Committee. Cerebellar stimulator implantation. 1982 Jun. tEx- pert opinion, Group judgment] Electrical stimulation Cerebral palsy Milner M. (Department Biomedical Engineering, Uni- versity Toronto] (Medical Research Council - Canada] Therapeutic and orthotic aspects of electro-stimula- tion in paediatric cerebral palsy. (Grant period 1981-1985). Electrical shmulation Cranial California Medical Association, Medical Practice Opin- ion Program. Cranial electrotherapy stimulation. 1984 Nov. (Medical Practice Opinion #315) tGroup judgment] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Cranial electrostimu- lation for treatment of anxiety and/or depression. JAMA 1984 Feb 24. tExpert opinion, Information syntheses] Electrical shmulation Facial nerve palsy National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Electrotherapy for treatment of facial nerve paralysis. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Electrotherapy for treatment of facial nerve paralysis (Bell's Palsy). 1982. American Academy of Neurology, Practice Committee. Electrical stimulation for treatment of Bell's Palsy. 1981 Apr. [Expert opinion, Group judgments American Academy of Neurology, Practice Committee. Electrical stimulation for treatment of facial nerve palsy. 198 1 May. [Expert opinion, Group judgment] Electrical stimulation Muscular California Medical Association, Medical Practice Opin- ion Program. Noninvasive muscle stimulators for pre- vention of muscle atrophy. 1983 JU1. (Medical Practice Opinion #292) tGroup judgment] Electrical stimulation Neural Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Electrical nerve stimulation of the ear. 1986. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Neurostimulation for urethral sphinc- ter spasticity. 1985 Dec. (Medical Practice Opinion #336) (Group judgment] American Academy of Neurology, Practice Committee. Electrical nerve stimulation of post-surgical pain. 1981 Apr. tExpert opinion, Group judgment] Electrical stimulation Neuromuscular National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Neuromuscular electrical stimulation in the treatment of disuse atro- phy in the absence of nervous system involvement. 1984. Electrical stimulation Scoliosis American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Implanted electro- spinal stimulator for scoliosis. JAMA 1984 May 25. tExpert opinion, Information syntheses] Electrical stimulation Spinal Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Electrical nerve stimulation (implantable spinal cord stimulator). 1986. [Information syntheses] American Academy of Neurology, Practice Committee. Spinal cord stimulation for treatment of cerebral pal- sy. 1982 Jun. fExpert opinion, Group judgment] American Academy of Neurology, Practice Committee. Spinal stimulation for multiple sclerosis. 1980 May. tExpert opinion, Group judgment] Electrical stimulators Medtronic, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Medtronic (R) scoliosis system, model 3100-2: summery of safety and effectiveness. 1986 Jan 2. (PMA no. P840022-0001. Medtronic, Inc. fFood and Drug Administration, Cen- ter for Devices and Radiological Health] Itrel (R) to- tally implantable spinal cord stimulation system: sum- mary of safety and effectiveness. 1985 Jan 2. (PMA no. P840001-000~. 415 ...... Act.

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Medtronic, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Isomed (R) electro-spinal orthosis single channel S: summary of safety and effectiveness. 1984 Ian 25. (PMA no. P810062-000). Electro-Biology, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Scolitron (TM) stimulator: summary of safety and effective- ness. 1983 Feb 25. (PMA no .P820008-000~. Avery Labs, Inc. (Food and Drug Administration, Cen- ter for Devices and Radiological Health] Spinal epidu- ral electrode for P.E.N.S. models E-355: summary of safety and effectiveness. 1982 Mar 2. (PMA no. P810033-OOo). Electrocardiographs Blue Cross and Blue Shield Association, Medical Neces- sity Program. Electrocardiogram.1985. "Information syntheses] ECRI Health Devices Program. Electrocardiographs, three-channel. Health Devices 1984; 13: 235-59. Food and Drug Administration, Center for Devices and Radiological Health. Development of test methods for disposable ECG electrodes - Volume I. 1984. (NTIS Order No. PB84-193960~. ECRI Health Devices Program. Operating room ECG monitors. Health Devices 1982;11:155-74. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Three channel (phone) electrocardiographs. 1977. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). One chan- nel electrocardiographs. 1975. Electrocardiography Blue Cross and Blue Shield Association, Medical Neces- sity Program. Routine preoperative and general hos- pital admission electrocardiograms. 1987. tInforma- tion syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Signal averaged ECG. 1986. "Information syntheses] Fancott T. [National Health Research and Development Program - Canada] A prototype ambulatory ECG tape analysis system.1986. (Grant No.6605-2052-511. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Vectorcardiogram. 1985. fInformation syntheses] 4~6 Multiple Risk Factor Intervention Trial Research Group. [National Heart, Lung, and Blood Institute] Exercise electrocardiogram and coronary heart dis- ease mortality in the Multiple Risk Factor Interven- tion Trial. Am ~ Cardiol 1985;55:16-24. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Mandatory EKG pri- or to elective surgery. JAMA 1983 Jul 29. [Expert opinion, Information syntheses] ECRI Technology Assessment Program. Mobile com- puterized ECG interpretive systems. Issues Health Care Technol 1983;sec.5.E.2. "Information synthe- ses] American College of Cardiology/American Heart Asso- ciation Task Force on Assessment of Cardiovascular Procedures. Guidelines for ambulatory electrocardio- graphic monitoring. Ongoing. tGroup judgment] U.S. Administrators, Professional Policy Committee. Protocol for use of multiple EKG's and chest X-rays in CCUs and ICUs. Ongoing. (Group judgment] Electrocoagulation Johnston ~H. Ulcer hemorrhage - heater probe treat- ment. In: American Society for Gastrointestinal En- doscopy, Committee on Technology Assessment. Therapeutic gastrointestinal endoscopy: an informa- tion resource manual. 1987. "Information syntheses, Expert opinion, Group judgment, Cost analyses1 Papp JP. Control of upper gastrointestinal bleeding by monopolar electrocoagulation. In: American Society for Gastrointestinal Endoscopy, Committee on Tech- nology Assessment. Therapeutic gastrointestinal en- doscopy: an information resource manual. 1987. tIn- formation syntheses, Expert opinion, Group judg- ment, Cost analyses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Endoscopic electro- coagulation of upper gastrointestinal bleeding. 1986. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Endoscopic electro- coagulation for gastrointestinal hemorrhage. JAMA 1985 May 11. tExpert opinion, information synthe- ses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Electroconvulsive therapy Martin BA, Kedwood HB, Kramer PM. "National Health Research and Development Program - Cana- da] Electroconvulsive therapy for psychogeriatric pa- tients: evaluation of new stimulus waveform technol- ogy. 1986. (Grant No. 6606-2460-44). National Institutes of Health, Consensus Development Program. Electroconvulsive therapy. (Consensus De- velopment Conference Statement, Jun 10-12 1985). tGroup judgments Electroencephalographs ECRI Health Devices Program. EEG monitors. Health Devices 1986; 15 :71 -95. Shwedyk E, Sesha S. (National Health Research and Development Program - Canada] Pattern recognition system for ambulatory electroencephalograms: de- sign and evaluation.1986. (Grant No.6607- 1352-51). Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Electro-en- cephalographs. 1981. Electroencephalography ECRI Technology Assessment Program. Computer- -processed EEG monitoring during surgery. Issues Health Care Technol 1986;sec.5.E.4. "Information syntheses] Seshia SS, Shwedyk E. "National Health Research and Development Program - Canada] Computerized EEG data base from prolonged ambulatory 4 channel (cas- sette) recordings in children. 1986. (Grant No. 6607- 1257-42). American Academy of Neurology, Practice Committee. EEG guidelines for epileptic mentally retarded. 1984 Nov. iExpert opinion, Group judgments California Medical Association, Medical Practice Opin- ion Program. Video electroencephalographic moni- toring. 1984 Nov. (Medical Practice Opinion #314) [Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Ambulatory electro- encephalographic (EEG) monitoring. 1984. American Academy of Neurology, Practice Committee. Twenty-four hour EEG ambulatory monitoring. 1983 Jun. tExpert opinion, Group judgment] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. 24-hour ambulatory EEG monitoring for diagnosing seizure disorders. tAMA 1983 Dec 23. [Expert opinion, Information syntheses] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Quantitative EEG (fast Fourier transform analysis) operative monitor- ing of cerebrovascular status. MAMA 1983 Ju115.tEx- pert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. EEG monitoring during open heart surgery. 1983. American Academy of Neurology, Practice Committee. EEG monitoring- ambulatory. 1982 Apr. tExpert opinion, Group judgment] American Academy of Neurology, Practice Committee. EEG monitoring during open-heart surgery and im- mediate post-operative period. 1982 Oct. LExpert opinion, Group judgments American Academy of Neurology, Practice Committee. EEG interpretation and brain stem evoked response. 1981 Jul. fExpert opinion, Group judgment! American Academy of Neurology, Practice Committee. Continuous EEG monitoring during surgery. 1980 Apr. [Expert opinion, Group judgment] Electrolyte injection Food and Drug Administration, Center for Drugs and Biologics. Multiple electrolyte injection. 1981. (NTIS order no. PB81 -915901). "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Electronystagmography American Academy of Neurology, Practice Committee. Electronystagmography. 1984 Jun. tExpert opinion, Group judgment] Electrosurgery Food and Drug Administration, Center for Devices and Radiological Health. Investigation and studies in elec- trosurgery. 1984. (NTIS Order No. PB84- 1916341. Electrosurgical devices ECRI Health Devices Program. Electrosurgical active electrode pencils, hand controlled. Health Devices 1986; 15: 151-77. 417

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY ECRI Health Devices Program. Electrode monitoring systems, electrosurgical. Health Devices 1985; 14:115-31. Electroversion therapy National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Electroversion ther apy for the treatment of alcoholism. 1983. ELISA Spence L, Bishai FR, Sekla LH. "National Health Re search and Development Program - Canada1 Applica tion of ELISA to monitoring for activity of western equine encephalitis.1986. (Grant No.6606-2368-541. Emergency communication systems ECRI Technology Assessment Program. Personal emergency response system (PERS). Issues Health Care Technol 1986;sec. 5.P.10. "Information synthe ses] Fine EG [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] An evaluation of the 911 sys tem. 1983 (NTIS order no. PB83-137968~. Dibner AS, Lowry L, Morris TN. "National Center for Health Services Research and Health Care Technol ogy Assessment, Division of Extramural Research] Usage and acceptance of an emergency alarm system by the elderly. Gerontologist 1982;22~6~:538-539. Enalapril Ruchlin HS, Morris TN. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Cost-ben- efit analysis of an emergency alarm and response system: a case study of a long term care program. Health Serv Res 1981 Spring;16~1~:65-80. Sherwood S. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Effects of an emer- gency alarm and response for the aged. 1981. (NTIS order no. PB81-137259) Emergency kits American Dental Association, Council on Dental Thera- peutics. Office emergencies and emergency kits. ~ Am Dent Assoc 1980; 101. 418 Emergency services American Academy of Pediatrics, Committee on Hospi- tal Care. Emergency services. Pediatrics (To be pub- lished). U.S. Administrators, Professional Policy Committee. Emergency rooms. t7/86] tGroup judgment] Subcommittee on Institutional Program Guidelines. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Division] Prehospital emergency care serv- ices. 1985. [Information syntheses, Expert opinon, Group judgment1 Hallstrom A, Eisenberg MS, Bergner L. "National Cen- ter for Health Services Research and Health Care Technology Assessment, Division of Extramural Re- search] Modeling the effectiveness and cost-effective ness ot an emergency service system. Soc Sci Med 1981 Mar; 15c(1): 13-17. Strauss ], et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Evaluation of emer- gency room referral system. 1981. (NTIS order no. PB81-231755) Eisenberg MS, Bergner L, Hallstrom A. [National Cen- ter for Health Services Research and Health Care Technology Assessment, Division of Extramural Re- search] Out-of-hospital cardiac arrest: improved sur- vival with paramedic services. Lancet 1980 Apr 12:812-814. Food and Drug Administration, Center for Drugs and Biologics. Enalapril maleate/hydro-chlorothiazide. 1987. (Summary basis of approval substitute, NDA # 19-221~. [Information syntheses, Expert opinion, Epi- demiological and other observational methods, Clini- cal trials, Bench testing] Endoscopes Food and Drug Administration, Center for Devices and Radiological Health. A study of the common charac- teristics, hazards, and performance problems of en- doscopes and endoscopic accessories. 1984. (NTIS Order No. PB84-187202).

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Endoscopy Ponsky JL. Percutaneous endoscopic gastrostomy and jejunostomy. In: American Society for Gastrointesti- nal Endoscopy, Committee on Technology Assess- ment. Therapeutic gastrointestinal endoscopy: an in- formation resource manual. 1987. [Information syn- thesis, Expert opinion, Group judgment, Cost analyses] Health Council of the Netherlands. Endoscopy. Ongo- ing assessment. U.S. Administrators, Professional Policy Committee. Guidelines of appropriate indications for "oscopies". Ongoing. tGroup judgment] Endoscopy and electrocoagulation Protell RL. Ulcer hemorrhage - bicap probe treatment. In: American Society for Gastrointestinal Endoscopy, Committee on Technology Assessment. Therapeutic gastrointestinal endoscopy: an information resource manual. l 987. [Information sytheses, Expert opinion, Group judgment, Cost analyses] Endotllelial cell photography National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Endothelial cell pho- tography. 1982. Enteral nutrition Patrick }. "National Health Research and Development Program - Canadal Nutritional resuscitation of chil- dren with cerebral palsy: does the amount and type of dietary lipid in enteral feeds influence membrane function? 1986. (Grant No. 6606-2684-52~. Enteral nutrition pumps ECRI Health Devices Program. Enteral feeding pumps. Health Devices 1984;14:9-30. Enzyme-albumin polymers Poznansky M}. "Department Physiology, University A1- berta] [Medical Research Council - Canada] Soluble enzyme-albumin polymers: new approaches to en- zyme therapy. (Grant period 1976-1985~. Ephedrine Food and Drug Administration, Center for Drugs and Biologics. Chlorpheniramine maleate pseudoophe- drine sulfate. 1981. (NTIS order no.PB81-915906~. "Information syntheses, Expert opinion, Epidemio- logical and other observational methods, Clinical tri- als, Bench testing] Epikeratophakia American Academy of Ophthalmology. Epikeratopha- kia procedures for the correction of severe hyperopia, myopia, and keratoconus, San Francisco, CA: Ameri- can Academy of Ophthalmology, expected comple- tion October 1987.tInformation syntheses, Expert . . Oplnlon Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Epikeratophakia. 1986. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Epikeratophakia in children. 1986 Dec. (Medical Practice Opinion #344) [Group judgment! Ergonovine provocative testing American College of Physicians, Clinical Efficacy As- sessment Project. Ergonovine provocative testing. Ann Intern Med 1984;100:152-2. "Information syn- thesesl Ericsson sex selection method California Medical Association, Medical Practice Opin- ion Program. Ericsson sex selection method. 1983 Sep. (Medical Practice Opinion #298) tGroup judg- ment] Erythrocyte sedimination rate Blue Cross and Blue Shield Association, Medical Neces- sity Program. Erythrocyte sedimentation rate. 1987. [Information syntheses] Erythromycin Food and Drug Administration, Center for Drugs and Biologics. Erythromycin base (enteric-coated pellets). 1981. (NTIS order no. PB81-915904~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing; 419

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Esophageal pH monitoring National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. 24-hour ambulatory esophageal pH monitoring. 1985. Esophagoscopy California Medical Association, Medical Practice Opin- ion Program. Hospital admission following rigid eso- phagoscopy. 1986 Jul. (Medical Practice Opinion #339) tGroup judgment] Ester~ne California Medical Association, Medical Practice Opin- ion Program. Esterine for treatment of rheumatoid arthritis. 1981 Dec. (Medical Practice Opinion #253) liGroup judgment] Estramustine Food and Drug Administration, Center for Drugs and Biologics. Estramustine phosphate sodium. 1982. (NTIS order no.PB82-915901). "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Estrogen replacement therapy American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Estrogen replace- ment therapy. 1986 Jun. (Technical bulletin no. 93~. [Expert opinion] American Medical Association, Council on Scientific Af- fairs. Estrogen replacement in the menopause. JAMA 1983 Jan 21;249:359. tGroup judgment] Ethanol American Academy of Pediatrics, Committee on Drugs. Ethanol in liquid preparations intended for children. 1984. Ethynodiol diacetate with ethinyl estradiol Food and Drug Administration, Center for Drugs and Biologics. Ethynodiol diacetate with ethinyl estradiol. 1982. (NTIS order no. PB82-915901). "Information syntheses, Expert opinion, Epidemiological, and oth- er observational methods, Clinical trials, Bench test- ing1 Etomidate Food and Drug Administration, Center for Drugs and Biologics. Etomidate. 1983. (NTIS order no. PB83-915901. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Etomidate. 1982. (NTIS order no. PB82-9159041. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Evoked potentials American Academy of Neurology, Practice Committee. Somatosensory evoked response. 1983 Nov. tExpert opinion, Group judgment] American Academy of Neurology, Practice Committee. Visual evoked potentials. 1981 Jul. tExpert opinion, Group judgment] ECRI Technology Assessment Program. Evoked poten National Institutes of Health, Consensus Development tial (EP) response measurement. Issues Health Care Program. Estrogen use and postmenopausal women. Technol 1981;sec.5.E.1. fInformation syntheses] (Consensus Development Conference Statement, Sep U.S. Administrators, Professional Policy Committee. 13- 14 19794. tGroup judgment] Evoked potential monitoring. Ongoing. (Group judg ment| Estrogens Sherwin BB iSir Mortimer B. Davis-}ewish General Hospital, Montreal] "Medical Research Council- Can ada] Long-term effects of androgen and/or estrogen on psychosexual functioning, hormone levels, and lipid metabolism in surgically menopausal women. (Grant period 1984- 1985) 420 Exercise tests Schlant RC, Blomqvist CG, Brandenburg RO, et al. fAmerican College of Cardiology/American Heart Association Task Force on Assessment of Cardiovas- cular Procedures1 Guidelines for exercise testing. J Am Coll Cardiol 1986;8:725-738. tGroup judgment] U.S. Administrators, Professional Policy Committee. Stress tests. t7/86] tGroup judgment!

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Blue Cross and Blue Shield Association, Medical Neces- sity Program. Cardiac exercise stress test. 1985. tIn- formation syntheses] American Medical Association, Council on Scientific Af- fairs. Indications and contraindications for exercise testing. JAMA 1981 Aug 28;246: 1015. (Group judg- ment] Fisher LD, Kennedy tW, Chaitman BR, et al. [National Heart, Lung, and Blood Institute] Diagnostic quanti- fication of CASS (Coronary Artery Surgery Study) clinical and exercise test results in determining pres- ence and extent of coronary artery disease: a multi- variate approach. Circulation 1981 ;63:987- 1000. Exercise therapy National Institutes of Health, Consensus Development Program. Diet and exercise in noninsulin-dependent diabetes mellitus. (Consensus Development Confer- ence Statement, Dec 8-10 1986~. tGroup judgment] U.S. Administrators, Professional Policy Committee. Exercise training for chronic obstructive lung disease. t7/86] (Group judgment] American Medical Association, Council on Scientific Af- fairs. Exercise programs for the elderly.1983. (Group judgment] American Medical Association, Council on Scientific Af- fairs. Physician-supervised exercise programs in reha- bilitation of patients with coronary heart disease. JAMA 1981 Apr 10;245:1463. [Group judgment] Expert system evaluation [National Library of Medicine] Testing of a general methodology for the evaluation of expert systems in medicine. Bethesda, MD: Lister Hill Center, National Library of Medicine. Ongoing. [Epidemiological and other observational methods] Expert systems Shwedyk E, Sesha S. [National Health Research and Development Program - Canada] Pattern recognition system for ambulatory electroencephalograms: de- sign and evaluation.1986. (Grant No. 6607- 1352-51). Smith CC. (National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Microchip medicine. Ambassador 1986 Apr;19~4~:20-22. Chang E}H. Department Computer Science, Universi- ty Victoria] Medical Research Council - Canada] Computer assisted medical reasoning. (Grant period 1984-1985). Food and Drug Administration, Center for Devices and Radiological Health. Computerized treatment plan- ning systems - proceedings of a symposium held at Henry Ford Hospital, Detroit, Michigan. 1984. (NTIS Order No. 84- 155118~. Blum RL. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Discovery, confirma- tion, and incorporation of causal relationships from a large time-oriented clinical data base: the RX Project. Comput Biomed Res 1982; 15~2~: 164- 187. Wagner D, Knaws W. Draper E. iNational Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] In: Blum B. ed. Proceedings: Sixth Annual Symposium on Computer Applications in Medical Care, October 30-November 2, 1982, IEEE Computer Society, 727-731. Roderer NK, King DW, McDonald DD, Bush CG. tNa- tional Library of Medicine] Evaluation of the Hepati- tis Knowledge Base System. Rockville, MD: King Re- search, Inc., 1981. tEpidemiological and other obser- vational methodsJ National Institutes of Health, Consensus Development Program. The use of microprocessor-based "intelli- gent" machines in patient care. (Consensus Develop- ment Conference Statement, Oct 17-19 19791. [Group judgment] External counterpulsation National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. External counter- pulsation. 1984. Extraco~poreal membrane oxygenation ECRI Technology Assessment Program. Extracorpore- al membrane oxygenation (ECMO) for newborn res- piratory failure. Issues FIealth Care Technol 1986;5.E.6. "Information synthesesJ Extracra'iial-intracranial arterial bypass American Academy of Neurology, Practice Committee. Extracranial-intracranial bypass surgery for treat- ment or prevention of stroke. l 986 Feb. tExpert opin- ion, Group judgment] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Extracranial-in- tracranial artery bypass surgery. 1986. "Information syntheses] 421

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY EC/IC Bypass Study Group. tMcMaster University, De partment of Clinical Epidemiology and Biostatistics] Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. New Eng ~ Med 1985;313: 1191-1200. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Extra-intracranial artery bypass surgery in the treatment of strokes. On go~ng. Eyeglasses American Dental Association, Council on Dental Mate rials, Instruments and Equipment. The effects of blue light on the retina and the use of protective filtering glasses. ~ Am Dent Assoc 1986; 112:533-535. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Ultraviolet absorb ing or reflecting spectacle lenses for aphakic and pseudophakic patients. 1981. Fetal monitoring Thompson M, Cohen A, Palmer H. "Harvard School of Public Health, Institute for Health Research] Deci sion making on clinical use of electronic fetal moni tors. Semin Fam Med. in press. [Epidemiological methods] Medical Technology and Practice Patterns Institute. Fe tal heart monitoring. 1987. U.S. Administrators, Professional Policy Committee. Fe tal monitoring- non-stress training. t7/86] tGroup judgment] American College of Obstetricians and Gynecologists, Committee Opinion. Current role of electronic heart rate monitoring in labor. Revised 1985 Jul. [Informa tion syntheses] American Medical Association, Council on Scientific Af fairs. Electronic fetal monitoring. MAMA 1981 Nov 20;246:2370. [Group judgment] Fish oils Thompson MS, Cohen AB. "Harvard School of Public Health, Institute of Health Research] Decision analy- sis: electronic fetal monitoring. In: Wortman PM, ed. Methods for evaluating health services. Beverly Hills: Sage, 1981. [Epidemiological methods] Neutra RR, Fienberg SE, Greenland S. Friedman EA. "Harvard School of Public Health, Institute for Health Research] Effect of fetal monitoring on neo- natal death rates. N Eng ~ Med 1978;299:324-326. tEpidemiological methods] 422 American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Intrapartum fetal monitoring. 1977 Jan. (Technical bulletin no. 441. [Expert opinions American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Fetal heart rate monitoring. 1975 Jun. (Technical bulletin no. 321. [Expert opinion] U.S. Administrators, Professional Policy Committee. In- trapartum fetal monitoring. Ongoing. tGroup judg- ment] Fetal monitors ECRI Health Devices Program. Fetal monitors. Health Devices 1982; 11: 123-44. Fetal shunts U.S. Administrators, Professional Policy Committee. In- trauterine fetal shunts. Ongoing. Group judgment] Fetoscopy American College of Obstetricians and Gynecologists, Committee Opinion. Fetoscopy. Revised 1984 Soul. fInformation syntheses] Fibrinogen scanning Hull R. Hirsch I, Sackett DL, et al. tMcMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Replacement of venography in suspected ve- nous thrombosis by impedance plethysmography and I-fibrinogen leg scanning. Ann Intern Med 1981 ;94: 12-15. First aid American Academy of Pediatrics, Committee on Acci- dent and Poison Prevention. Revised first aid for the choking child. Pediatrics 1986 Jun. Office of Technology Assessment, U.S. Congress. The health effects of fish oil. Washington, D.C.: Office of Technology Assessment, February 1984.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Fluoride varnishes Clark DC, Hanley JA, Stamm JEW, Weinstein PL. McGill University, Department of Epidemiology and Biostatistics] An empirically based system to estimate the effectiveness of caries-preventive agents: a com- parison of the effectiveness estimates of APE gels and solutions and fluoride varnishes. Caries Res 1985; 19:83-95. Clark DC. "Department Dentistry, McGill University] "Medical Research Council - Canada] The preventive effect of fluoride varnishes on dental caries: three year community trial. (Grant period 1981- 19851. [luoroscopy Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Videofluorosco- pic evaluation in speech pathology. 1986. tInforma- tion syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Upper gastrointestinal fluoroscopic study. 1984. [Information syntheses] ECRI Technology Assessment Program. Digital radiog- raphy and fluoroscope. Issues Health Care Technol 1983;sec.5.D.2. [Information syntheses] Fluoroscopy units ECRI Technology Assessment Program. Remote con- trol fluoroscope units. Issues Health Care Technol 1981 ;sec.5.F.1. "Information syntheses] Food diaries Dubois S. [National Health Research and Development Program - Canada] Validity of food records and di- etary recalls in elderly subjects. 1986. (Grant No. 6605-2284-42). Remmell PS, Benfari RC (for the MRFIT Group). (Na- tional Heart, Lung, and Blood Institute] Assessing dietary adherence in the Multiple Risk Factor Inter- vention Trial (MRFIT). II. Food record rating as an indicator of compliance. ~ Am Dietetic Assn, 1980;76:357-360. Food irradiation Health Council of the Netherlands. Food irradiation. Ongoing assessment. Fructose Olefsky TM, Crapo P. American Diabetes Association] Fructose, xylitol, and sorbitol. Diabetes Care 1980;3:390-393. tExpert opinion, Group judgment] Functional tests Scott RN. "National Health Research and Development Program - Canada] Functional tests for upper ex- tremity amputees. 1986. (Grant No. 6604-1048-514. Furosemide Food and Drug Administration, Center for Drugs and Biologics. Furosemide injection. 1981. (NTIS order no. PB81-915908~. fInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testingj Food and Drug Administration, Center for Drugs and Biologics. Furosemide tablets. 1981. (NTIS order no. PB81 -915911). f Information syntheses, expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Gait assessment Rang MC, Milner M. "National Health Research and Development Program - Canada] Preoperative and . postoperative gait assessments as a guide in planning tendon transfers about the anklejoint in children with cerebral palsy. 1986. (Grant No. 6606-2110-51). Winter DA. "National Health Research and Develop- ment Program - Canada] Ambulation profiles: corre- lation with biomechanical variables as a quantifier of gait dysfunction. 1985. (Grant No. 6606-2313-01~. Gamma cameras United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Per- formance assessment of gamma cameras, part four. 1986 Mar. (Report no. STB/86/9) tEpidemiological and other observational methods, Bench testing] Gas scavengers ECRI Health Devices Program. Anesthesia unit gas scavengers. Health Devices 1983; 12: 267-286. American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Council position on nitrous oxide scavenging and monitoring clevice.s T Am Dent Assoc 1980;101:62. . ,~ 423

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Gastric balloon dilatation Kozarek RA. Balloon dilation. In: American Society for Gastrointestinal Endoscopy, Committee on Technol- ogy Assessment. Therapeutic gastrointestinal endos- copy: an information resource manual. 1987. tInfor- mation synthesis, Expert opinion, Group judgment, Cost analyses] Gastric bubble Medical Technology and Practice Patterns Institute. Gastric bubble for treatment of morbid obesity. l 987. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Garren gastric bubble for morbid obesity. TAMA 1986 Dec 19. tExpert opin- ion, Information syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Gastric bubble. 1986. [Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Gastric bubble for treatment of obesity. 1986 Aug. (Medical Practice Opinion #343) tGroup judgment] ECRI Technology Assessment Program. Gastric bubble. Issues Health Care Technol 1986;sec.5.G.1. tInfor- mation syntheses] U.S. Administrators, Professional Policy Committee. Gastric bubble, Garren-Edwards. [7/86] tGroupjudg- ment] Garren L, Garren M. [Food and Drug Administration, Center for Devices and Radiological Health] Garren gastric bubble: summary of safety and effectiveness. 1985 Oct 29.(PMA no. P840025-000). Gastric freezing National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Gastric freezing for peptic ulcer disease. 1982. Fineberg HV. "Harvard School of Public Health, Insti- tute for Health Research] Gastric freezing: a study of diffusion of a medical innovation. In: Medical techon- ology and the health care system: a study of the diffu- sion of equipment-embodied technology. Washing- ton, D.C.: National Academy of Sciences, 1979. (Epi- demiological methods] 424 Gastroesophageal antireflux prosthesis American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Angelchik antireflux prosthesis treatment of gastroesophageal reflux. JAMA 1986 Sep 12. tExpert opinion, Information syntheses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Angelchik antire- flux prosthesis. 1986. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Angelchik anti-re- flux prosthesis. 1986. ECRI Technology Assessment Program. Angelchik gas- troesophageal antireflux prosthesis. Issues Health Care Technol 1985;sec.5.A.4. [Information synthe- ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Anti-gastroesopha- geal reflux implantation. 1983. Gastro-ileal bypass California Medical Association, Medical Practice Opin- ion Program. High gastric bypass for morbid obesity. 1981 Feb. (Medical Practice Opinion #246) [Group judgment] Gastrointestinal endoscopy Silvis SE. Endoscopic retrograde sphincterotomy (ERS). In: American Society for Gastrointestinal Endoscopy, Committee on Technology Assessment. Therapeutic gastrointestinal endoscopy: an information resource manual. 1987. [Information syntheses;Expert opin- ion, Group judgment, Cost analyses] Webb WA. Esophageal and gastric foreign bodies: en- doscopic removal. In: American Society for Gastroin- testinal Endoscopy, Committee on Technology As- sessment. Therapeutic gastrointestinal endoscopy: an information resource manual. 1987. LInformation syntheses, Expert opinion, Group judgment, Cost an- alyses| American Society for Gastrointestinal Endoscopy. Ap- propriate use of gastrointestinal endoscopy. 1986 Jun. American Society for Gastrointestinal Endoscopy. Stan- dards of practice for gastrointestinal endoscopy. Re- vised 1986 Mar.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of esophagitis. Revised 1986 Mar. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of the patient with peptic ulcer disease. Revised 1986 Mar. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the management of upper gas- trointestinal hemorrhage. Revised 1986 Mar. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the patient with lower gastroin- testinal bleeding. 1986 May. American Society for Gastrointestinal Endoscopy. The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. Revised 1986 Mar. U.S. Administrators, Professional Policy Committee. Upper G-I endoscopy. t7/86] tGroup judgment] American College of Physicians, Clinical Efficacy As- sessment Project. Esophagogastroduodenoscopy (EGD). "Information syntheses] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Endoscopic topical therapy for gastrointestinal hemorrhage. MAMA 1985 May 11. tExpert opinion, Information syntheses] Office of Technology Assessment, U.S. Congress. The cost-effectiveness of upper gastrointestinal endosco- py. Washington, D.C.: U.S. Government Printing Of- fice, May 1981. (Health technology case study series #8) Showstack JA, Schroeder SA, Steinberg HR. "University of California, San Francisco, Institute for Health Poli- cy Studies] Evaluating the costs and benefits of a diag- nostic technology: the case of upper gastrointestinal endoscopy. Med Care 1981; 19:498-508. National Institutes of Health, Consensus Development Program. Endoscopy in upper GI bleeding. (Consen- sus Development Conference Statement, Aug 20-22 19801. [Group judgments Gemfibrozil Food and Drug Administration, Center for Drugs and Biologics. Gemf~brozil. 1982. (NTIS order no. PB82 915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Generators, Electric United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Philips Medical Systems Saturn 500 and Saturn 850 generators. 1985 Aug. (Report no. STB6E/85/28) [Epidemiological and other observa- tional methods, Bench testing] Genetic complementation test Gravel RA. "National Health Research and Develop- ment Program - Canada] Genetic complementation analysis in clinical diagnosis. 1986. (Grant No. 6606-1932-52~. Genetic counseling U.S. Administrators, Professional Policy Committee. Genetic counselling and screening. t7/86] tGroup judgment] American Medical Association, Council on Scientific Af- fairs. Genetic counseling and prevention of birth de- fects. JAMA 1982 Jul 9;248:221. tGroup judgment] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Prevention of Tay-Sachs disease: carrier identification and genetic counseling.1976 Jan. (Technical bulletin no.341. [Ex . . pert opinion Genetic engineering American Academy of Pediatrics, Committee on Bioethics. Proposed guidelines on genetic engineer- ing. Pediatrics 1985 Jun. Genetic screening Steering Committee on Future Health Scenarios, Com- mission on Future Health Care Technology (Nether- lands). Prospective assessment of future health care technology: genetic screening.1987. Office of Technology Assessment, U.S. Congress. Tech- nologies for detecting heritable mutations in human beings. Washington, D.C.: U.S. Government Printing Office, September 1986. U.S. Administrators, Professional Policy Committee. Genetic counselling and screening. t7/861 tGroup judgment] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Prenatal detection of neural tube defects. 1982 Oct. (Technical bulletin no. 671. tExpert opinion] 425

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY National Institute of Child Health and Human Devel- opment. Antenatal diagnosis. Bethesda MD: National Institute of Child Health and Human Development, 1979. (NIH publication no. 80-1973) iGroup judg- ment, Expert opinion] National Institutes of Health, Consensus Development Program. Antenatal diagnosis. (Consensus Develop- ment Conference Statement, Mar 5-7 1979J. [Group judgment] Thompson M. "Harvard School of Public Health, Insti- tute for Health Research] Prenatal diagnosis and pub- lic policy. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention and treatment. New York: Plenum Press, 1979. [Information syntheses] Health Council of the Netherlands. Screening for neu- ral tube defects. Ongoing. National Institute of Child Health and Human Devel- opment. Antenatal diagnosis of hereditary disease (an update of the 1979 Conference on Antenatal Diagno- sis). Planned. (Group judgment, Expert opinion] Genetic toxicology tests Gilman {P. [National Health Research and Develop- ment Program - Canada] Methods survey - genetic toxicology tests using cultured mammalian cells. 1986. (Grant No. 6606-3145-55~. Glaucoma screening Eddy DM. tDuke University, Center for Health Policy Research and Education] Screening for glaucoma, reassessment. (Expected publication 1988) tInforma- tion syntheses] Price M. [Department Ophthalmology, University Brit- ish Columbia] "Medical Research Council - Canada] The development of electrodiagnostic tests to detect early chronic open angle glaucoma. (Grant period 1983-1985~. Eddy DM, Sanders L, Eddy I. (Duke University, Center for Health Policy Research and Education] The value of screening for glaucoma with tonometry. Surv Ophthalmol 1983;28:194-205. "Information synthe- sesJ Glucocorticoids American Medical Association, Council on Scientific Af- fairs. Glucocorticoid-induced osteonecrosis. 1986. tGroup judgment] 426 Glutathione disulfides Food and Drug Administration, Center for Drugs and Biologics. Salts solution plus dextrose and glutathione disulfides.1982. (NTIS order no. PB82-915901~. tIn- formation syntheses, Expert opinion, Epidemiologi- cal and other observational methods, Clinical trials, Bench testing] Glyceryl tri~iitrate ECRI Technology Assessment Program. Transdermal delivery of nitroglycerin. Issues Health Care Technol 1983;sec.5.T.2. "Information syntheses] Food and Drug Administration, Center for Drugs and Biologics. Nitroglycerin for injection. 1981. (NTIS order no. PB81 -9159121. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Gonadorelin hydrochloride Food and Drug Administration, Center for Drugs and Biologics. Gonadorelin HC1. 1982. (NTIS order no. PB82-9159041. fInformation syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Granulocyte transfusion Strauss RG, Connett ~E, Gale RP, et al. iNational Heart, Lung, and Blood Institute] A controlled trial of pro- phylactic granulocyte transfusions during initial in- duction chemotherapy for acute myelogenous leuke- mia. N Eng J Med 1981;305:597-603. Winston DJ, Ho WG, Gale RP. (National Heart, Lung and Blood Institute] Prophylactic granulocyte trans- fusions during chemotherapy of acute nonlymphocy- tic leukemia. Ann Intern Med 1981;94:616-622. Guanabenz Food and Drug Administration, Center for Drugs and Biologics. Guanabenz acetate. 1983. (NTIS order no. PB83-9159031. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Guanadrel sulfate Food and Drug Administration, Center for Drugs and Biologics. Guanadrel sulfate. 1983. (NTIS order no. PB 83-915901). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Hair analysis Health Council of the Netherlands. Hair analysis. On- going assessment. Halazepam Food and Drug Administration, Center for Drugs and Biologics. Halazepam. 1981. ~ NTIS order no. PB81 -915912~. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Health examination American Academy of Pediatrics, Committee on School Health. School health examinations. AAP News 1986 Feb. U.S. Administrators, Professional Policy Committee. Pe- riodic health screening. t7/86] tGroup judgmentJ Strom BL, Melmon KL, Miettinen, OS. tMcGill Univer- sity, Department of Epidemiology and Biostatistics] Post-marketing studies of drug efficacy: a perspec- tive. Arch Intern Med 1985;145:1791-1793. Spitzer WO. [McGill University, Department of Epide- miology and Biostatistics] The periodic health exami- nation: 1. Introduction. Can Med Assoc 1984; 130: 1276-1278. The Task Force on the Periodic Health Examination. W.O. Spitzer, Chairman. tMcGill University, Depart- ment of Epidemiology and Biostatistics] The periodic health examination: 2.1984 update. Can Med Assoc 1984;130: 1278-1285. American Medical Association, Council on Scientific Af- fairs. Medical evaluations of healthy persons. MAMA 1983 Mar 25;249: 1626-1633. tGroup judgment] Eddy DM. EDuke University, Center for Health Policy Research and Education] Guidelines for the cancer- -related checkup: recommendations and rationale. CA-A Cancer J Clin 1980;30: 193-240. "Information syntheses] Health ~nsurance Analysis of physician pricing behavior, third-party ad- ministrative practices. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Health care alternatives within Title XIX: evaluation of alternative reimbursement methods to providers of primary care medical services. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Test of the out-of-pocket cost savings as an incentive for changing beneficiary choice behavior. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Tan 1986. (HCFA Pub. No. 03219~. Conrad D, Milgrom P. Kiyak A. [National Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] Insurance plan effects on dental provider treatment of elderly patients. Med Care 1984;22~5~:430-445. University of Pennsylvania, Leonard Davis Institute of Health Economics. Adverse selection in multiple-op- tion group insurance. Ongoing. (Study for National Center for Health Services Research, DHHS) Health ma~ntenance organ~zations A demonstration of cost control and patient satisfaction resulting from the relaxation of the maximum public enrollment rule for HMO's. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Evaluation of Medicare health maintenance organiza- tion demonstration projects. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Evaluation of health maintenance organization (HMO) capitation demonstrations. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care f~nancing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Evaluation of social health maintenance organization demonstrations. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. 427

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Independent broker: coordinating open enrollment for Medicare health maintenance organizations and com- petitive medical plans. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219~. Medicare health maintenance organization additional benefits. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Social Health Maintenance Organization Project for long-term care. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Health promotion Project HOPE, Center for Health Affairs. Work site health promotion program evaluation. Ongoing, ex- pected 1987. (Information syntheses] Jonsson B. ~Linkoping University, Center for Medical Technology Assessments Economic aspects of pre- vention as a health technology. 1986. (Discussion se- ries paper #3) [Swedish language only] "Information syntheses] University of Pennsylvania, Leonard Davis Institute of Health Economics. A review of the economic benefits of selected health education and promotion activities. 1982 May. (Interim report submitted to Johnson and Johnson Live for Life Program) Linkoping University, Center for Medical Technology Assessment. Economic aspects of prevention as a health care technology. Planned. Hearing aids Frost BL, Mason JL. "National Health Research and Development Program - Canada] The development and evaluation of a portable vibrotactile auditory prosthetic device for the profoundly deaf. 1986. (Grant No. 6606- 1959-51). {amieson DG. "National Health Research and Develop- ment Program - Canada; Optimizing procedures for prescribing and fitting hearing aids.1986. (Grant No. 6609- 1343-45). 428 Nucleus LTD. [Food and Drug Administration, Center for Devices and Radiological Health] Nucleus multi- channel implantable hearing prosthesis: summary of safety and effectiveness. 1985 Dec 9. (PMA no. P840024-0001. Hearing aids Use McGrath P. Durieux Smith A, Goodman IT. "National Health Research and Development Program - Cana- da] Compliance to hearing aid use in the classroom. 1985. (Grant No. 6606-2297-51~. Heart valve implantation Veterans Administration, Cooperative Studies Pro- gram. Prognosis and outcome following heart valve replacement (non-biological vs. tissue). Ongoing. Clinical trials] Heart valve prosthesis American Edwards Division of American Supply Cor- poration. tFood and Drug Administration, Center for Devices and Radiological Health] Duromedics bilea- flet heart valve: summary of safety and effectiveness. 1986 Sep 26. (PMA no. P850006-000). Medical Inc. Good and Drug Administration, Center for Devices and Radiological Health] Omniscience prosthetic cardiac valve: summary of safety and effec- tiveness. 1985 Sep 11. (PMA no. P830039-000~. Food and Drug Administration, Center for Devices and Radiological Health. Prosthetic heart valves: a study of in vitro performance, phase II final report part II. 1984. (NTIS order No. PB84-162387~. Food and Drug Administration, Center for Devices and Radiological Health. Prosthetic heart valves: a study of in vitro performance, phase II final report part III. 1984. (NTIS order No. PB84-162395~. Food and Drug Administration, Center for Devices and Radiological Health. Prosthetic heart valves: a study of in vitro performance, phase II final report part 1. 1984. (NTIS order No. PB84-1623791. St. Jude Medical Inc. Good and Drug Administration, Center for Devices and Radiological Health] Bileaflet- -center opening cardiac valve: summary of safety and effectiveness. 1983 Mar 1. (PMA no. P810002-000~. Medtronic, Inc. fFood and Drug Administration, Cen- ter for Devices and Radiological Health] Medtronic (r) Hall prosthetic heart valve: summary of safety and effectiveness. 1982 Jan 29. (PMA no. P790018-000~.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Heimlich maneuver American Medical Association, Council on Scientific Af- fairs. The Heimlich maneuver- interim report (Reso- lution 52, I-851. 1986. tGroup judgment] American Medical Association, Council on Scientific Af- fairs. Choking: the Heimlich maneuver (abdominal thrust) vs. back blows. 1983. Group judgment] Hemodialysis Tousignant P. Hollomby D, Guttman RD. tMcGill Uni- versity, Department of Epidemiology and Biostatis- tics] Transplantation and home hemodialysis: their cost-effectiveness in the treatment of end stage renal disease. ~ Chronic Dis 1985;38. Evans RW. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Quality of self-care (home) and facility hemodialysis. 1981. (NTIS order no. PB81- 140477) American College of Physicians, Clinical Efficacy As- sessment Project. Hemodialysis for the treatment of schizophrenia. 1980. "Information syntheses] Veterans Administration, Cooperative Studies Pro- gram. Renal failure self-care dialysis (hemo vs. perito- neal dialysis). t1980J. "Clinical trials] Hemofiltration Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Continuous arte- riovenous hemofiltration. 1986. [Information synthe- ses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hemofiltration as a substitute for hemodialysis. 1986. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Continuous arterio- venous hemofiltration (CAVH) for fluid removal. TAMA 1985 Mar 1. tExpert opinion, Information syntheses] Hemoglobin A1C measurements American College of Physicians, Clinical Efficacy As- sessment Project. Clinical usefulness of hemoglobin A1C measurements. Ann Intern Med 1984; 101 :710-3. "Information syntheses] Hemoglobinopathies screening National Institutes of Health, Consensus Development Program. Newborn screening for sickle cell disease and other hemoglobinopathies. (Consensus Develop- ment Conference Statement, Apr 6-8 1987~. tGroup judgment] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of sickle cell haemoglobin (HBS) screening methods. 1985 Sep. (Report no. STB3A/85/41) fEpi- demiological and other observational methods, Bench testing] Hemophilus influenza type B vaccine American Academy of Pediatrics, Committee on Infec- tious Diseases. Hemophilus type B polysaccharide vaccine. Pediatrics 1985 Aug. Health Council of the Netherlands. Vaccination against haemophilus influenzae B. Ongoing. Hemostatic mater~als Datoscope Corporation. fFood and Drug Administra- tion, Center for Devices and Radiological Health] No- vacol (TM) textured collagen hemostatic agent: sum- mary of safety and effectiveness. l 986 Tul 7. (PMA no. P850023-0001. Hilitrex, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Helistat (TM) absorbable collagen hemostatic sponge: summary of safety and effectiveness. 1986 Jan 2. (PMA no. P850010-000~. Johnson & Johnson. tFood and Drug Administration, Center for Devices and Radiological Health] 3-Coil (TM) collagen absorbable hemostat: summary of safe- ty and effectiveness. 1985 Nov 15. (PMA no. 830079-000). Avicon, Inc. tFood and Drug Administration, Center for Devices and Radiological Health1 Microfibrillar collagen hemostat non-woven web: summary of safe- ty and effectiveness. 1983 Feb 15. (PMA no. P800002-0001. Upjohn. fFood and Drug Administration, Center for Devices and Radiological Health] Gelfoam: summary of safety and effectiveness. 1983 Aug 29. (PMA no. N 18286-0001. American Medical Products Corporation. tFood and Drug Administration, Center for Devices and Radio- logical Health] Collastat: summary of safety and ef- fectiveness. 1982 Jan 5. (PMA no. P810006-000). 429

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Interface Biomedical Labs., Inc. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Superstat: summary of safety and effective- ness. 1982 fun 25. (PMA no. P810040-000~. Heparin Hull R. Delmore T. Carter C, et al. tMcMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Adjusted subcutaneous heparin versus warfa- rin sodium in the long-term treatment of venous thrombosis. New Eng T Med 1982; 306: 189- 194. Hepatitis B tests Organon Teknika Corp. tFood and Drug Administra- tion, Center for Devices and Radiological Health] He- panostika (TM) HBEAG/anti HBE microelisa (TM) system: summary of safety and effectiveness.1986 [ul 1. (PMA no. P840070-000). Sorin Biomedica, Fiat, USA Inc. fFood and Drug Ad- ministration, Center for Devices and Radiological Health] AB-Core K hepatitis B core antigen 1251: summary of safety and effectiveness. 1986 Apr 10. (PMA no. P850044-000). Abbott Labs. fFood and Drug Administration, Center for Devices and Radiological Health] Corzyme (TM)-M diagnostic kit: summary of safety and effec- tiveness. 1984 tan 26. (PMA no. P830014-000). Herpes simplex infection screening, Neonatal Sacks S. "National Health Research and Development Program - Canada] Prevention of neonatal herpes simplex virus infection: a cost-effectiveness compari- son of low risk versus high risk screening. 1986. (Grant No. 6610- 1421 -54~. Hexachlorophene Food and Drug Administration, Center for Drugs and Biologics. Hexachlorophene. 1981. (NTIS order no. PB 81 -915904). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Hexachlorophene. 1981. (NTIS order no. PB81-9159091. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 43O Hip joint replacement Bunker {P. (National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Outcomes of total hip replacement using northern California claims data: a pilot study. 1985 Aug. (NTIS order no. PB86- 129574/as, inventory only) Nevitt MD, Epstein WV, Masem M, Murray WR. tUni- versity of California, San Francisco, Institute for Health Policy Studies] Work disability before and af- ter total hip arthroplasty: assessment of effectiveness in reducing disability. Arthritis Rheum 1984;27:410-421. National Institutes of Health, Consensus Development Program. Total hip joint replacement. (Consensus Development Conference Statement, Mar 1-3 19821. ~Group judgment] Hip prosthesis CBO (Centraal Begeleidingsorgaan voor de Intercolle- giale Toetsing) Consensus Development Program. Total hip protheses. 1987. tDutch language only] tGroup judgment, Expert opinion] ECRI Technology Assessment Program. Cementless hip prosthesis. Issues Health Care Technol 1984;sec.5.H.3. fInformation syntheses] Depuy (R). fFood and Drug Administration, Center for Devices and Radiological Health] Prosthesis, hip, he- mi-femoral, metal: summary of safety and effective- ness. 1983 Sep 16. (PMA no. P820024-000~. Richards Medical Co. fFood and Drug Administration, Center for Devices and Radiological Health] Osteo ceramic hip: summary of safety and effectiveness. 1982 Dec 10. (PMA no. P810048-0001. Swedish Planning and Rationalization Institute of the Health Services and the Swedish Medical Research Council. The artificial hip. 1982. fCost analyses, Epi- demiological and other observational methods] Histamine therapy American Academy of Neurology, Practice Committee. Histamine desensitization for cluster headache. 1983 Jun. tExpert opinion, Group judgment! American Academy of Neurology, Practice Committee. Histamine therapy for Meniere's Disease. 1981 Tul. [Expert opinion, Group judgment1 American College of Physicians, Clinical Efficacy As- sessment Project. Intravenous histamine therapy. 1981. [Information syntheses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY HISTLINE Kopp }I. [National Library of Medicine] Research and writing in the history of health sciences, 1970-1982: a quantitative analysis of NLM's HISTLINE database. Bull Med Libr Assoc 1985;73:146-152. fEpidemio- logical and other observational methods] HIV detection assays National Institutes of Health, Consensus Development Program. Impact of routine HTLV-III antibody test- ing of blood and plasma donors on the health of the public. (Consensus Development Conference State- ment, Jul 7-9 1986~. [Group judgment] Wainberg MA. "National Health Research and Develop- ment Program - Canada] Development of an antigen detection assay and a neutralization assay for HTLV-III. Studies on transmission and infectivity. 1986. (Grant No. 6605-2450-X). United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. PHLS & DHSS evaluation of five anti-HTLV3/LAV assay kits. 1985 Sep. (Report no. STB3A/85/40) tEpi- demiological and other observational methods, Bench testing] Holter monitoring U.S. Administrators, Professional Policy Committee. Holter monitoring. t7/86] Group judgment] Home care Steering Committee on Future Health Scenarios, Com- mission on Future Health Care Technology (Nether- lands). Prospective assessment of future health care technology: home care technology.1987. Comparison of the cost and quality of home health and nursing home care. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Develop the technology of aide sharing into a transfer- able form for use by home health agencies to reduce home health costs. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No.03219~. Home services for functionally disabled adults. In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Larson C. "National Health Research and Development Program - Canada1 Perinatal intervention project: the effectiveness of prenatal and postpartum home visit- ing. 1986. (Grant No. 6605-1878-44~. Studies evaluating Medicaid home- and community- -based services: a report to Congress. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Jan 1986. (HCFA Pub. No. 03219~. The impact of Medicaid home and community-based waiver services for the mentally retarded in Maine. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financ- ing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Veterans Administration, Cooperative Studies Pro- gram. A comparison of hospital and home treatment programs for aphasic patients. f1980] (Clinical trials] Project HOPE, Center for Health Affairs. A review of the cost-effectiveness of home health care services. Ongoing, expected 1987. "Information syntheses, Cost analyses] Georgetown University Medical Center, Institute for Health Policy Analysis. Home health technologies. Planned. Health Council of the Netherlands. Home care. Planned. Hormone therapy Trachtenberg J. "Department Surgery, University To- ronto] "Medical Research Council - Canada] Hor- monal control of human prostatic cancer. (Grant peri- od 1980-1985~. Hospice Hospice patient outcomes and quality of care. In: Office of Research and Demonstrations, Health Care Fi- nancing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986.(HCFA Pub. No. 03219~. 431

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Implications of the National Hospice Study for hospice prospective reimbursement. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. fan 1986. (HCFA Pub. No.03219). National Hospice Study. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Noncertified hospice cost analysis. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Tan 1986. (HCFA Pub. No. 03219). Population-based study of hospice. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No.03219). The nature, process, and modes of hospice care deliv- ery. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. [an 1986. (HCFA Pub. No. 03219). Title XVIII Hospice Benefit Program evaluation (Medi- care). In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. [an 1986. (HCFA Pub. No. 03219). U.S. Administrators, Professional Policy Committee. Hospice care/Alzheimer's. Ongoing. tGroup judg- ment] Hostel Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Patient hostel unit guidelines. 1978. tInforma- tion syntheses, Expert opinion, group judgment] Hubbard method California Medical Association, Medical Practice Opin- ion Program. Hubbard method of detoxification. 1987 Apr. (Medical Practice Opinion #347) tGroup judgment] 432 Human growth hormone U.S. Administrators, Professional Policy Committee. Growth hormone - human. [7/86] tGroup judgment] American Academy of Pediatrics, Committee on Drugs. Growth hormone in treatment of children with short stature. 1983. Health Council of the Netherlands. Synthetic growth hormone. Planned. Human milk banking American Academy of Pediatrics, Committee on Nutri- tion. Human milk banking. Pediatrics 1980 Apr. Humidifiers ECRI Health Devices Program. Heat and moisture ex- change humidifiers. Health Devices 1983; 12: 155-67. Hyaluronidase Muller JE (ed), Braunwald E, Mock MB, et al. (assoc. eds). "National Heart, Lung, and Blood Institute] Na- tional Heart, Lung, and Blood Institute Multicenter Investigation of the Limitation of Infarct Size (MI- LIS). Design and methods of the clinical trial. An investigation of beta-blockade and myaluronidase for treatment of acute myocardial infarction. Am Heart Assoc Monograph 1984; 100: 1 - 134. Hybridomas Roder JC. Department Microbiology and Immunolo- gy, Queens University] [Medical Research Council- Canada] The application of human hybridoma tech- nology to cancer and autoimmune disease. (Grant period 1983-1985~. Hydralazine Veterans Administration, Cooperative Studies Pro- gram. Prazosin vs. hydralazine in hypertension. ~ 1980] Clinical trials] Hydrochlorothiazide Food and Drug Administration, Center for Drugs and Biologics. Propranolol SlR/hydrochlorothiazide.1987. (Summary basis of approval, NDA # 19-059~. fInfor- mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Food and Drug Administration, Center for Drugs and Biologics. Amiloride HCl/hydrochlorothiazide. 1982. (NTIS order no. PB82-915901). "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Timolol maleate & hydrochlorothiazide. 1982. (NTIS order no. PB82-915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clincial trials, Bench testing] Veterans Administration, Cooperative Studies Pro- gram. Comparison of propranolol with hydrochloro- thiazide for the "step 1" treatment of hypertension. ~ 1980] "Clinical trials] Hydrocortisone Food and Drug Administration, Center for Drugs and Biologics. Hydrocortisone butyrate. 1983. (NTIS or- der no. PB83-915901). "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Hydrocortisone butyrate. 1982. (NTIS or- der no. PB82-915902J. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Hydromorphone Food and Drug Administration, Center for Drugs and Biologics. Hydromorphone HC1. 1987. (Summary basis of approval, NDA # 19-0341. "Information syn- theses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Hydrotherapy National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hydrotherapy (whirlpool) baths for treatment of decubitus ulcers. 1981. Hydroxycholecalciferol level American College of Physicians, Clinical Efficacy As- sessment Project. 25 hydroxyvitamin D level. 1981. "Information syntheses] Hyperbaric oxygen therapy American Academy of Neurology, Practice Committee. Hyperbaric oxygen therapy for treatment of senility, multiple sclerosis, and cerebral edema.1986 Feb. tEx- pert opinion, Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen for treatment of chronic peripheral vascular insuffi- ciency. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen in treatment of severed limbs. 1984. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for acute cerebral edema. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: acute, traumatic peripheral ischemia. 1983. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: chron- ic vascular insufficiency. 1983. "Information synthe- ses] American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: decu- bitus ulcers. 1983. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: senil- ity. fInformation syntheses! California Medical Association, Medical Practice Opin- ion Program. Hyperbaric oxygen therapy. 1983 Sep. (Medical Practice Opinion #243) tGroup judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen for treatment of actinomycosis. 1983. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of crush injury and acute trau- matic peripheral ischemia. 1983. ECRI Technology Assessment Program. Hyperbaric oxygen (HBO) therapy. Issues Health Care Technol 1982;sec.5.H.1. fInformation syntheses] 433

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of arthritic diseases. 1982. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of chronic refractory osteomy- elitis. 1982. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of multiple sclerosis. 1982. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of organic brain syndrome (se- nility). National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Hyperbaric oxygen therapy for treatment of soft tissue radionecrosis and osteoradionecrosis. 1982. American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: actino- mycosis. 1981. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: arthri- tis. 1981. [Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Hyperbaric oxygen therapy: osteo- myelitis. 1981. "Information syntheses] U.S. Administrators, Professional Policy Committee. Hyperbaric oxygen therapy. Ongoing. [Group judg- mentJ Hyperthermia systems Clin-Therm Corporation. fFood and Drug Administra- tion, Center for Devices and Radiological Health] Clini-Therm Mark I/IV: summary of safety and effec- tiveness. 1985 Sep 11. (PMA no. P840015-0004. BSD Medical Corp. j rood and Drug Administration, Center for Devices and Radiological Health] BSD 1000 Hyperthermia system: summary of safety and effectiveness. 1984 Aug 27. (PMA no. P820088-002~. BSD Medical Corporation. [Food and Drug Adminis- tration, Center for Devices and Radiological Health] BSD 1000 Hyperthermia system: summary of safety and effectiveness. 1984Jan 25. (PMA no. P820088-000~. 434 Hyperthermia therapy Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Hyperthermia, local. 1986. [Information syntheses] U.S. Administrators, Professional Policy Committee. Hyperthermia. i7/86] (Group judgment] ECRI Technology Assessment Program. Hyperthermia treatment of tumors. Issues Health Care Technol 1985;sec.5.H.2. "Information syntheses] Podgorsak EB. "Department Radiation Oncology, McGill University] "Medical Research Council - Cana- da] Noninvasive thermometry and Hyperthermia in cancer treatment. (Grant period 1982-1985~. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Hyperthermia treat- ment for cancer - Update. Sep 17,1984. tExpert opin- ion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Local Hyperthermia for treatment of superficial and subcutaneous malig- nancies. 1984. California Medical Association, Medical Practice Opin- ion Program. Hyperthermia treatment for cancer. 1983 Oct. (Medical Practice Opinion #296) tGroup judgment] American College of Physicians, Clinical Efficacy As- sessment Project. Whole body Hyperthermia for can- cer patients. 1980. "Information syntheses] Hypnosis American Medical Association, Council on Scientific Af- fairs. Scientific status of refreshing recollection by the use of hypnosis. [AMA 1985 Apr 5;253: 1918-1923. [Group judgment] California Medical Association, Medical Practice Opin- ion Program. Anesthesia by hypnosis. 1981 Aug. (Medical Practice Opinion #250) [Group judgment] Hypnotic drugs American Medical Association, Council on Scientific Af- fairs. Hypnotic drugs and treatment of insomnia. MAMA 1981 Feb 20;245:749. tGroup judgments

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Hypothyroidism screening, Neonatal American Academy of Pediatrics, Committee on Screening Genetics. New issues in newborn screening for phenylketonuria and congenital hypothyroidism. Pediatrics 1982 Jan. Hysterectomy Sandberg SI, Barnes BA, Weinstein MC, Braun P. tHar- vard School of Public Health, Institute for Health Research] Elective hysterectomy: benefits, risks and costs. Med Care 1985;23: 1067-1085. "Information syntheses] Braun P. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Elective hysterectomy: bene- fits, risks, and costs. 1984. (NTIS order no. PB84-240126) Office of Technology Assessment, U.S. Congress. Elec- tive hysterectomy: costs, risks and benefits. Washing- ton, D.C.: U.S. Government Printing Office, October 1981. (Health technology case study series #15) Hysteroscopy American College of Obstetricians and Gynecologists, Committee Opinion. Hysteroscopy. Revised 1986 Tan. [Information syntheses] Ibuprofen Food and Drug Administration, Center for Drugs and Biologics Ibuprofen. 1987. (Summary basis of ap- proval, NDA # 19-012~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Ibuprofen. 1987. (Summary basis of ap- proval, NDA #18-989~. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Ibuprofen. 1982. (NTIS order no. PB82-915902~. [Information syntheses, expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Ibuprofen. 1981. (NTIS order no. PB81-915908~. [Information syntheses, expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Ileal bypass Buchwald H. Fitch L, Varco RL. "National Heart, Lung, and Blood Institute] Ileal bypass for hyperlipidemia. World ~ Surg 1985:9;850-859. Buchwald H. Fitch L, Varco RL. "National Heart, Lung, and Blood Institute] Ileal bypass for hyperlipidemia. World J Surg 1985:9;850-859. Buchwald H. Fitch L, Varco RL. "National Heart, Lung, and Blood Institute] Partial ileal bypass; hypercholes- terolemia; atherosclerosis. In: Nyhus LM, Nelson RL, feds): Blackwell Scientific Publ Inc. Boston, MA, 1985 (in press). Buchwald H. Fitch L, Varco RL. iNational Heart, Lung, and Blood Institute] Surgical intervention in athero- sclerosis: partial ileal bypass and the Program of Sur- gical Control of the Hyperlipidemias (POSCH). Int Encyclo Pharm Therapy, 1985 (in press). Buchwald H. Moore RB, Rucker RD, et al. "National Heart, Lung, and Blood Institute] Clinical angio- graphic regression of atherosclerosis after partial ileal bypass. Artherosclerosis 1983 ;46: 117. Buchwald H. Moore RB, Rucker Rd. et al. "National Heart, Lung, and Blood Institute] Clinical angio- graphic regression of atheroscerosis after partial ileal bypass. Artherosclerosis 1983;46: 117. Buchwald H. Moore RB, Varco RL. "National Heart, Lung, and Blood Institute] Surgery in the therapy of atherosclerosis: partial ileal bypass. In: Arteriosclero- sis: clinical evaluation and therapy. MTP Press Limit- ed, International Medical Publication, 1982. Buchwald H. Rucker RD Jr, Moore RB, et al. "National Heart, Lung, and Blood Institute] Regression of ath- erosclerosis by surgical cholesterol reduction. In: No- seda CI, et al. eds. Lipoproteins and coronary athero- sclerosis. Elsevier Biomedical Press, 1982:417. Moore RB, Buchwald H. Varco RL, and the Participants in the Program on the Surgical Control of the Hyper- lipidemias. "National Heart, Lung, and Blood Insti- tute] The effect of partial ileal bypass on plasma lipo- proteins. Circulation 1980;62:469-476. Ileal bypass and diet therapy Long, JM. [National Heart, Lung, and Blood Institute] The POSCH secondary intervention trial. Proc Int Cong Prev Cardiology, Moscow, 1985. 435

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Imaging centers ECRI Technology Assessment Program. Freestanding imaging centers. J Health Care Technol 1985; 1 :257-278. "Information syntheses] Immunoassay systems, Fluorescence United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of the Syra Advance (summary report). 1985 May. (Report no. STB3A/85/22) [Epidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of the Syva advance automated fluorescence immuno-assay system. Final report. 1985 Dec. (Re- port no. STB3A185/47) [Epidemiological and other observational methods, Bench testing] Immunologic diagnostic tests Urbach GI. [National Health Research and Develop- ment Program - Canada] Immunodiagnosis of hu- man ovarian cancer.1986. (Grant No.6606-2908-541. Rippey tH, Nakamura RM, eds. Diagnostic immunolo- gy: technology assessment and quality assurance. CAP Conference/1983. Skokie, IL: College of Ameri- can Pathologists, 1984. [Expert opinion, Bench test- ing] Immunoradiometric assay with monoclonal anti- bodies Rock GA. [National Health Research and Development Program - Canada] Development of immunoradio- metric assay for the measurement of factor VIII pro- coagulant antigen using monoclonal antibodies to procoagulant factor VIII. 1986. (Grant No. 6613-1178-52). Immunoradiometric assays Abbott Laboratories. fFood and Drug Administration, Center for Devices and Radiological Health] Abbott anti-delta diagnostic kit (RIA): summary of safety and effectiveness. 1986 Aug 7. (PMA no. P850062-000). Hybritech Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Tandem-it PSA immunoradiometric assay: summary of safety and ef- fectiveness. 1986 Apr 9. (PMA no. P850048-000~. 436 tones ED, Chouinarad G. "National Health Research and Development Program - Canada] Clinical appli- cation of the neuroleptic radio receptor assay in the management of schizophrenia. 1986. (Grant No. 6605-1867-44~. Immunosuppressants American Medical Association, Council on Scientific Af- fairs. Use of immunosuppressants in organ transplan- tation. 1986. [Group judgment] Office of Technology Assessment, U.S. Congress. The use of immunosuppressive drugs in kidney transplan- tation. Washington, D.C.: Office of Technology As- sessment, March 1984. Immunotherapy Office of Technology Assessment, U.S. Congress. Im- muno-augmentative therapy. Washington, D.C.: U.S. Government Printing Office (to be completed in Win- ter 1987/19881. American Medical Association, Council on Scientific Af- fairs. Use of immunosuppressants in organ transplan- tation. 1986. (Group judgment] U.S. Administrators, Professional Policy Committee. Immunoaugmentative therapy. (7/86; (Group judg- ment] Office of Technology Assessment, U.S. Congress. The use of immunosuppressive drugs in kidney transplan- tation. Washington, D.C.: Office of Technology As- sessment, March 1984. Immunotherapy Cancer California Medical Association, Medical Practice Opin- ion Program. Immunotherapy for melanoma. 1984 Feb. (Medical Practice Opinion #305) iGroup judg- ment] California Medical Association, Medical Practice Opin- ion Program. Immunotherapy for treatment of can- cer. 1984 Jul. (Medical Practice Opinion #204) iGroup judgments American College of Physicians, Clinical Efficacy As- sessment Project. Immunotherapy of cancer. 1982. fInformation syntheses] Impotence diagnosis Morales A. "Department Urology, Queens University1 (Medical Research Council - Canada] The validation of nocturnal and sexual erections in the etiological diagnosis of impotence. (Grant period 1984- 1985~.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Diagnostic tests for impotency: devices (Snap-gauge, Rigi-scan). Ongo ing. Impotence treatment National Center for Health Services Research and Health Care Technology Assessment, Office of Incontment pads Health Technology Assessment. Treatments for im potency: drug injections. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Treatments for im potency: other significant therapeutic modalities. On go~ng. In vitro chemosensitivity testing Veterans Administration, Cooperative Studies Pro gram. Treatment of multiple myeloma directed by in vitro chemosensitivity testing. Ongoing. FClinical tri als] In vitro fertilization Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. In vitro fertiliza tion. 1986. "Information syntheses] Caplan A. tThe Hastings Center] Ethics of in vitro fertil ization. Primary Care 1986 Jun. U.S. Administrators, Professional Policy Committee. Fertilization, in vitro. t7/86] iGroup judgment] California Medical Association, Medical Practice Opin ion Program. In vitro fertilization.1985 Jun. (Medical Practice Opinion #278) iGroup judgment] American College of Obstetricians and Gynecologists, Committee Opinion. Human in vitro fertilization and embryo placement. 1984 Apr. fInformation synthe ses] Health Council of the Netherlands. In vitro fertilization. Ongoing assessment. Incentive payment Encouraging appropriate care for the chronically ill el derly: a controlled experiment to evaluate the impacts of incentive payments on nursing home admissions, discharges, case mix, care, outcomes,and costs. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing sta tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Incentive spirometry U.S. Administrators, Professional Policy Committee. In- centive spirometry. f7/86] tGroup judgment] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Respiratory therapy: incentive spirome- try. 1982. fInformation syntheses] ECRI Health Devices Program. Incontinent pads. Health Devices 1983; 12: 108-18. Incubator therapy Thomas KA}. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] The influence of in- cubator air temperature on the respiratory responses of preterm infants. 1986 Mar. (NTIS order no. Pb86-218096/AS) Incubators ECRI Health Devices Program. Infant incubators. Health Devices 1982; 11: 191-9. ECRI Health Devices Program. Infant transport incu- bators. Health Devices 1982; 11: 179-91. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Intensive care convection incubators. 1981. Indomethacin Food and Drug Administration, Center for Drugs and Biologics. Indomethacin. 1982. (NTIS order no. PB82-915901). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth oafs, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Indomethacin. 1982. (NTIS order no. PB82-915902). [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Induction of labor American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Induction of la- bor. 1978 May. (Technical bulletin no. 49~. tExpert opinion] 437

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Infant foods Friel ~K. "National Health Research and Development Program - Canada] Trace element supplementation of pre-term infants. 1986. (Grant No.6602- 1087-56~. American Academy of Pediatrics, Committee on Nutri- tion. Imitation and substitute milks. Pediatrics 1984 Jun. American Academy of Pediatrics, Committee on Nutri- tion. The use of whole cow's milk in infancy. Pediat- rics 1983 Aug. American Academy of Pediatrics, Committee on Nutri- tion. Soy-protein formulas: recommendations for use in infant feeding. t1983] American Medical Association, Council on Scientific Af- fairs. Infant formula marketing (Resolution 155, A-81). 1982. (Group judgment] American Academy of Pediatrics, Committee on Nutri- tion. On the feeding of supplemental foods to infants. Pediatrics 1980 Jun. American Medical Association, Council on Scientific Af- fairs. Infant nutrition (Resolution III, I-78.) 1980. tGroup judgment] American Academy of Pediatrics, Committee on Nutri- tion. Juice in ready-to-use bottles and nursing bottle caries. 1978. American Academy of Pediatrics, Committee on Nutri- tion. Commentary on breast-feeding and infant for- mulas, including proposed standards for formulas. Pediatrics 1976 Feb. Influenza vaccine American Medical Association, Council on Scientific Af- fairs. Pneumococcal, influenza and hepatitis-B vac- cine (Resolution 75, A-82. 1982. tGroup judgment] Office of Technology Assessment, U.S. Congress. Cos- t-effectiveness of influenza vaccination. Washington, D.C.: U.S. Government Printing Office, December 1981. Health Council of the Netherlands. Vaccination against influenza. Ongoing assessment. Information systems [National Library of Medicine] Evaluation of medical information science in medical education. Adopted by the Executive Council of the Asociation of Ameri- can Medical Colleges, Washington, DC, January 23, 1986. ~ Med Educ 1986;61 :487-543. 438 Anderson JG. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Use of an HIS by physicians and nurses. 1985 Aug. (NTIS order no. PB86-121126/AS) American Hospital Association, Hospital Technology Series Program. A medical device recall and report- ing system. 1984. (Guideline report) I Information syntheses, Expert opinion, Cost analyses] American Hospital Association, Hospital Technology Series Program. Materials management information systems. 1983. (Guideline report) "Information syn- theses, Expert opinion, Cost analyses] American Hospital Association, Hospital Technology Series Program. Clinical laboratory information sys- tems. 1982. (Guideline report) tInformaton synthe- ses, Expert opinion, Cost analyses] Cohen, SN, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Development, im- plementation and evaluation of drug interactions by a pharmacy oriented reporting system.1982 (NTIS or- der no. PB82-140757) Pittman IT. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Health information system transferability evaluation. 1981. (NTIS order no. PB81-206500) Long JM, Brashear JR, Matts JP, et al. "National Heart, Lung, and Blood Institute] The POSCH Information Management System: experience with alternative ap- proaches. J Med Systems 1980;4:355-366. Office of Technology Assessment, U.S. Congress. Policy implications of medical information systems. Wash- ington, D.C.: U.S. Government Printing Office, No- vember 1977. Linkoping University, Center for Medical Technology Assessment. Health care information systems and cost-effectiveness: a review of methodological issues and assessment methods. Ongoing. Infusion pumps Swedish Planning and Rationalization Institute of the Health Services. Spri technology report 8: treatment with insulin infusion pump: cost and effects. 1987. tCost analyses, Epidemiological and other observa- tional methods1 Perlman K. "National Health Research and Develop- ment Program - Canada1 Dietary studies with new insulin delivery systems for the treatment of diabetes mellitus. 1986. (Grant No. 6606-2451-521.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Diabetes Association. Continuous subcutane- ous insulin infusion. Diabetes 1985;34:946. tExpert opinion, Group judgment] ECRI Health Devices Program. Infusion controllers. Health Devices 1985; 14:219-256. American College of Physicians, Clinical Efficacy As- sessment Project. Heparin infusion pumps. Ann In- tern Med 1984;100:305-6. "Information syntheses] ECRI Health Devices Program. Infusion pumps. Health Devices 1983-84; 13:31-62. Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Drip-rate controlled and volumetric infusion pumps. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. Management of diabetes mellitus: computerized insulin infusion pumps. Ann Intern Med 1983;99::272-4. "Information syntheses] American Hospital Association, Hospital Technology Series Program. Automated infusion devices. 1982. (Guideline report) "Information syntheses, Expert opinion, Cost analyses] ECRI Health Devices Program. Infusion controllers. Health Devices 1982; 11:75-96. ECRI Technology Assessment Program. Insulin deliv- ery devices. Issues Health Care Technol 1981;sec.5.I.2. "Information syntheses] ECRI Technology Assessment Program. Insulin infu- sion systems (controlled). Issues Health Care Technol 1981 ;sec.5.I.1. "Information syntheses] Netherlands Organization for Applied Scientific Re- search, Medical Technology Unit (TNO). Ambula- tory insulin pumps. Ongoing. tExpert opinion, Group judgment, Bench testing] Infusion pumps-External National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. External open-loop pump for the subcutaneous infusion of insulin in diabetics. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. Management of diabetes mellitus: external infusion pumps. Ann Intern Med 1983;99:272-4. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. External infusion pump for heparin. 1983. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: external infusion pumps for IV antibody thera- py. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: external infusion pumps for rehydration thera- py. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: external pump for chemotherapy for other than liver cancer. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: external pumps for morphine for pain of non- malignant origin. Ongoing. Infusion pumps Implantable Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Implantable infu- sion pump. 1986. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Implantable pump for chronic heparin therapy. 1984. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Implantable infusion pump for continuous drug therapy. JAMA 1983 Oct 14. tExpert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Implantable chemo- therapy infusion pump for the treatment of liver can- cer. 1983. ECRI Technology Assessment Program. Implantable drug infusion pumps. Issues Health Care Technol 1982;sec.5.I.4. "Information syntheses] Intermedics Infusaid, Inc. iFood and Drug Administra- tion, Center for Devices and Radiological Health] In- fusaid Implantable infusion pump model 100,200, 4: summary of safety and effectiveness. 1982 Mar 26. (PMA no. P800036-0001. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: Implantable pumps for chemotherapy for other than liver cancer. Ongoing. 439

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: implantable pumps for infusion of drugs for congestive heart failure. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys- tems: implantable pumps for morphine (analgesia) intractable cancer nain. ()n~oin~ Food and Drug Administration, Center for Drugs and Biologics. Prompt purified beef insulin zinc suspen- sion. 1981. (NTIS order no. PB81-9159091. tInfor- mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Purified beef insulin zinc suspension.1981. (NTIS order no. PB81-915909~. "Information synthe --- rid c ~ses, Expert opinion, Epidemiological and other obser National Center for Health Services Research and vational methods, Clinical trials, Bench testing] Health Care Technology Assessment, Office of Health Technology Assessment. Drug delivery sys tems: implanted pumps for morphine for pain of nonmalignant origin. Ongoing. Injury severity scales Mackenzie E}. "National Center for Health Services Re search and Health Care Technology Assessment, Di vision of Extramural Research] Injury severity scales: overview and directions for future research. Am Emerg Med 1984 Nov;2~6~:537-549. Insulin Food and Drug Administration, Center for Drugs and Biologics. Human insulin (recombinant DNA origin) isophane suspension. 1983. (NTIS order no. PB83 915901). fInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Regular human insulin (recombinant DNA origin) injection. 1983. (NTIS order no. PB83 915901). "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Extended purified beef insulin zinc suspen sion. 1981. (NTIS order no. PB81-915909~. tInfor mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Isophane purified beef insulin suspension. 1981. (NTIS order no. PB81-915909~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Isophane purified pork insulin suspension. 1981. (NTIS order no. PB81 -915910~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] 44o Food and Drug Administration, Center for Drugs and Biologics. Purified pork insulin injection. 1981. (NTIS order no. PB81-915909~. fInformation synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Insulin injection California Medical Association, Medical Practice Opin- ion Program. Needleless insulin injection. 1982 Dec. (Medical Practice Opinion #274) tGroup judgment] Intensive care Cohen C. (The Hastings CenterJ Autonomy and equity in the ICU. Hastings Cent Rep 1986. American Academy of Pediatrics, Committee on Hospi- tal Care. Guidelines for pediatric intensive care units. Pediatrics 1983 Sep. Office of Technology Assessment, U.S. Congress. In- tensive care units: costs, outcome, and decisionmak- ing. Washington, D.C.: U.S. Government Printing Office, October 1984. (Health technology case study series #28) American Hospital Association, Hospital Technology Series Program. Evaluation methods for intensive care units.1982. (Guideline report) "Information syn- theses, Expert opinion, Cost analyses! Knaus WA, et al. (National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Researchl A comparison of intensive care in the USA and France. Lancet 1982 Sep:642-646. Knaus WA, et al. [National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Evaluating out- come from intensive care: a preliminary multihospital comparison. Crit Care Med 1 982; 1 0~8) :49 1 -496.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Scheffler RM, et al. ENational Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Severity of illness and the relationship between intensive care and sur- vival. Am ~ Public Health 1982 May;72~51:449-454 Draper EA, Wagner DP, Knaws WA. [National Center for Health Services Research and Health Care Tech- nology Assessment, Division of Extramural Research] The use of intensive care: a comparison of a universi- ty and community hospital. Health Care Financ Rev 1981 Dec;3~2~:49-64. Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Intensive care unit guidelines. 1979. tInforma- tion syntheses, Expert opinion, Group judgment] Intensive care systems, Mobile New Jersey mobile intensive care system. In: Office of Research and Demonstrations, Health Care Financ- ing Administration. Health care financing status re- port: research and demonstrations in health care fi- nancing. Jan 1986. (HCFA Pub. No. 032191. Wagner GS. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] The effectiveness of mobile intensive care. 1985. (NTIS order no. PB85- 191211/AS) Keller MD, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The impact of mo- bile coronary care units. 1981. (NTIS order no. PB81-13381) Interferons Paty DW. "Department Medicine, University British Co- lumbia] [Medical Research Council - Canada] A ther- apeutic trial of interferon in multiple sclerosis (MS). (Grant period 1983-1985). Paty DW. (Department Medicine, University British Co- lumbia] "Medical Research Council - Canada] Inter- feron therapeutic trial in MS - supplemental applica- tion. (Grant Period 1984- 1985) California Medical Association, Medical Practice Opin- ion Program. Interferon for the treatment of cancer. 1983 Sep. (Medical Practice Opinion #299) tGroup judgment] California Medical Association, Medical Practice Opin- ion Program. Interferon for the treatment of infec- tious diseases. 1983 Sep. (Medical Practice Opinion #300) tGroup judgment] Intermittent positive pressure breathing U.S. Administrators, Professional Policy Committee. In- termittent positive pressure breathing. t7/86] tGroup judgment] Intermittent Positive Pressure Breathing Trial Group. [National Heart, Lung, and Blood Institute] Intermit- tent positive pressure breathing therapy of chronic obstructive pulmonary disease - a clinical trial. Ann Intern Med 1983;99:612-620. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Respiratory therapy: intermittent posi- tive pressure breathing. 1982. fInformation synthe- ses] California Medical Association, Medical Practice Opin- ion Program. Intermittent positive pressure breath- ing. 1981 Aug. (Medical Practice Opinion #259) tGroup judgment] Hodgkin BE and Zorn KG. "National Heart, Lung, and Blood Institute] Intermittent positive pressure breathing (IPPB) in the outpatient management of chronic obstructive pulmonary disease (COPD): de- scription of the NIH clinical trial. Respir Care 1981 ;26: 1095-1104. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Intermittent positive pressure breathing (IPPB therapy). Ongoing. Intra-aortic balloon pumps ECRI Technology Assessment Program. Intra-aortic balloon pumps. Issues Health Care Technol 1982;sec.5.I.3. fInformation syntheses] Intracranial pressure monitoring National Center for Health Services Research and Health Care Technology Assessment, Off~ce of Health Technology Assessment. Intracranial pres- sure measurement. 1981. Intracranial pressure monitors Radionics, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Cosman ICP tale-sensor (R): summary of safety and effectiveness. 1984 Nov 21. (PMA no. P820012-000~. Radionics, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Cosman ICP Tele-sensor (R): summary of safety and effectiveness. 1982 Oct 1. (PMA no. P820012-0001 441

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY American Academy of Neurology, Practice Committee. Intracranial pressure monitors. 1980 Oct. j expert opinion, Group judgment] Intracutaneous titration California Medical Association, Medical Practice Opin- ion Program. Rinkel serial intracutaneous titration- /diagnosis. 1984 Feb. (Medical Practice Opinion #295) iGroup judgment] American College of Physicians, Clinical Efficacy As- sessment Project. Intracutaneous titration. 1981. LIn- formation syntheses] Intraocular lens implantation Intraocular lens implants. In: Prospective Payment As- sessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Human Services, April 1, 1985. Washington, DC: Government Printing Office, 1985: 101-105. [Information syntheses, Cost analyses] National Institutes of Health, Consensus Development Program. Intraocular lens implantation. (Consensus Development Conference Statement, Sep 10- 11 1979~. (Group judgment] Swedish Planning and Rationalization Institute of the Health Services. Artificial lens implantation: a cost-ef- fectiveness analysis. Ongoing. tCost analyses, Epide- miological and other observational methods] Intraocular lenses Precision-Cosmet., Inc. fFood and Drug Administra- tion, Center for Devices and Radiological Health] Kel- man (TM) omnific II model 2100: summary of safety and effectiveness. 1987 Feb 2. (PMA no. P850059-000). Coburn Optical Industries. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Intraocular lens: summary of safety and effective- ness. 1986 Dec 16. (PMA no. P860002-000~. Coburn Optical. iFood and Drug Administration, Cen- ter for Devices and Radiological HealthJ J loop poste- rior chamber type II 0 & I0: summary of safety and effectiveness. 1986 foul 1. (PMA no. P840039-000~. Coopervision Cilco. Good and Drug Administration, Center for Devices and Radiological Health] Optiflex anterior chamber lenses (L1-L5~: summary of safety and effectiveness. 1986 Jun 18. (PMA no. P8200035-000~. 442 Coopervision Cilco. [Food and Drug Administration, Center for Devices and Radiological Health] SM-1, CR- 1, & GR- 1 IOLS: summary of safety and effective- ness. 1986 fun 11. (PMA no. P840060-000~. Iolab Corp. [Food and Drug Administration, Center for Devices and Radiological Health] Model 91-50 IOL: summary of safety and effectiveness. 1986 Feb 14. (PMA no. P820044-000~. Optical Radiation Corporation. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Styles 31-34 posterior IOLS: summary of safety and effectiveness. 1986 Jun 18. (PMA no. P830056-0004. McGhan/3M. iFood and Drug Administration, Center for Devices and Radiological Health] Styles 30 & 31 posterior chamber IOLS: summary of safety and ef- fectiveness. 1985 Oct 17. (PMA no. P830040-000~. Surgidev Corp. (Food and Drug Administration, Center for Devices and Radiological HealthJ Style 17 & 17A posterior chamber IOLS: summary of safety and ef- fectiveness. 1985 Oct 17. (PMA no. P830033-000~. Allergan Medical Optics. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Model AC10 & AC20 IOLS: summary of safety and effectiveness. 1983 Aug 16. (PMA no. P810056-000~. Allergan Medical Optics. fFood and Drug Administra- tion, Center for Devices and Radiological Health] Models PC10 & PC21: summary of safety and effec- tiveness. 1983 Jun 17. (PMA no. P820049-000~. Cilco, Inc. (Food and Drug Administration, Center for Devices and Radiological Health] Models IS & IP: summary of safety and effectiveness. 1983 Apr 26. (PMA no. P800049-000~. Cilco, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Posterior chamber intraocular lenses: summary of safety and effective- ness. 1983 Apr 1. (PMA no. P810018-001). Coopervision Cilco. fFood and Drug Administration, Center for Devices and Radiological Health] Model AC (ACI-AC5~: summary of safety and effectiveness. 1983 Apr 12. (PMA no. P810001 -000~. Intermedics Intraocular Inc. [Food and Drug Adminis- tration, Center for Devices and Radiological HealthJ Models 011 & 011B iridocapsular IOLS: summary of safety and effectiveness. 1983 Jan 25. (PMA no. P810042-000~. Intermedics Intraocular Inc. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Models 019B, 019C, 019E, 019F, 019J, 019K: sum- mary of safety and effectiveness. 1983 Feb 25. (PMA no. P810055-000~.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Precision-Cosmet Co., Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Cir- cular open loop posterior IOLS & Kratz elliptic: sum- mary of safety and effectiveness. 1983 Aug 9 (PMA no. P820072-~)00). Coburn Optical Industries, Inc. [Food and Drug Ad- ministration, Center for Devices and Radiological Health] Binkhorst & Fedorov I iris clip IOLS: sum- mary of safety and effectiveness. l 982 Aug 31. (PMA no. P800027-000~. Coopervision Cilco. [Food and Drug Administration, Center for Devices and Radiological Health] Posterior chamber intraocular lenses: summary of safety and effectiveness. 1982 Aug 31. (PMA no. P810018-000~. Coopervision, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Models B-13F (P-10) & B-1H (P-l l): summary of safety and effectiveness. 1982 May 25. (PMA no. P810032-000~. Pharmacia, Inc. tFood and Drug Administration, Cen- ter for Devices and Radiological Health] Medallion (R): summary of safety and effectiveness.1982 Tan 1. (PMA no. P810060-000~. Precision-Cosmet. tFood and Drug Administration, Center for Devices and Radiological Health] Tennant (TM) & Kelman (TM) type II: summary of safety and effectiveness. 1982 Apr 20. (PMA no. PB00016-000~. Intraosseous pressure measurement California Medical Association, Medical Practice Opin- ion Program. Intraosseous pressure measurement. 1985 Oct. (Medical Practice Opinion #334) [Group judgment] In~avenous fat emulsions Food and Drug Administration, Center for Drugs and Biologics. Intravenous fat emulsion. 1982. (NTIS or- der no. PB82-915901~. [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Intravenous fat emulsion. 1981. (NTIS or- der no. 81-915904~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Iodide therapy American Academy of Pediatrics, Committee on Drugs. Adverse reactions to iodide therapy of asthma and other pulmonary diseases. Pediatrics 1976 Feb. Iodoxamate meglumine Food and Drug Administration, Center for Drugs and Biologics. Iodoxamate meglumine. 1981. (NTIS or- der no. PB81-915911). [Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing. Iontophoresis Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Iontophoresis. 1986. "Information syntheses] Iridology American Medical Association, Council on Scientific Af- fairs. Evalution of iridology. l 981. tGroup judgment] Iron-dextran complex Food and Drug Administration, Center for Drugs and Biologics. Iron dextran Inj. USP. 1981. (NTIS order no. PB81-9159061. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Isosulfan blue Food and Drug Administration, Center for Drugs and Biologics. Isosulfan blue. 1981. (NTIS order no. PB81-9159104. "Information syntheses, Expert opin- ion, Ep~demiological and other observational meth- ods, Clinical trials, Bench testing; Isotretinoin Food and Drug Administration, Center for Drugs and Biologics. Isotretinoin. 1982. (NTIS order no. PB82-915903~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Joint prosthesis Sauter WF, Galway RH, Gillespie R. [National Health Research and Development Program - Canadal De- velopment of onionized (layered) upper extremity prosthetic sockets forjuvenile amputees. 1985. (Grant No. 6606-2115-55~. Office of Technology Assessment, U.S. Congress. Cost- -benefit/cost-effectiveness of medical technologies: a case study of orthopedic joint implants. Washington, D.C.: U.S. Government Printing Office, September 1981. (Health technology case study series #14) 443

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Keratom~leusis American Academy of Ophthalmology. Keratophakia and keratomileusis: safety and effectiveness. San Francisco, CA: American Academy of Ophthalmolo- gy, 1986. [Information syntheses, Expert opinion] Keratophakia American Academy of Ophthalmology. Keratophakia and keratomileusis: safety and effectiveness. San Francisco, CA: American Academy of Ophthalmolo- gy, 1986. [Information syntheses, Expert opinion! Ketoconazole Food and Drug Administration, Center for Drugs and Biologics. Ketoconazole. 1981. (NTIS order no. PB81-915909~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Keyes technique Office of Technology Assessment, U.S. Congress. Peri- odontal disease: assessing the effectiveness and costs of the Keyes technique. Washington, D.C.: U.S. Gov- ernment Printing Office, May 1981. (Health technol- ogy case study series #5~. Kinetic therapy California Medical Association, Medical Practice Opin- ion Program. Kinetic therapy for lumbago. l 984 Nov. (Medical Practice Opinion #312) tGroup judgments Knee prosthesis Christian CL. "National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] Total knee replace- ment study. 1985 Apr. (NTIS order no. PB85-236909/AS) Depuy, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] New Jersey inte- grated knee replacement system: summary of safety and effectiveness. 1985 May 20. (PMA no. P830055-0001. Depuy, Inc. Good and Drug Administration, Center for Devices and Radiological Health] New Jersey inte- grated knee replacement system: summary of safety and effectiveness. 1985 May 20. (PMA no. P830055-0021. 414 Kunkel test American College of Physicians, Clinical Efficacy As- sessment Project. Kunkel test (total serum gammaglo- bulin). 1982. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. The Kunkel test for estimating total serum gamma globulin levels in pa- tients with rheumatoid arthritis. 1981. Labetalol Oster G. Huse DM, Delea TE, Savage DD, Colditz GA. tPolicy Analysis, Inc.] Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks. 1987 Mar. Lactates Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Lacate infusion for panic disorder. 1986. fInformation syntheses] Laparotomy U.S. Administrators, Professional Policy Committee. Hodgkin's disease, routine staging laparotomy. t7/86] tGroup judgment] Laser angioplasty ECRI Technology Assessment Program. Laser angio- plasty for atherosclerosis. Issues Health Care Technol 1985;sec.5.L.3. fInformation syntheses] Laser iridotomy California Medical Association, Medical Practice Opin- ion Program. Assistant surgeon for laser iridotomy. 1982 Jul. (Medical Practice Opinion #272) 1!Group judgment] Laser photocoagulation Overholt BE. Ulcer hemorrhage - laser treatment. In: American Society for Gastrointestinal Endoscopy, Committee on Technology Assessment. Therapeutic gastrointestinal endoscopy: an information resource manual. 1987. fInformation syntheses, Expert opin- ion, Group judgment, Cost analyses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Nd:YAG laser gastrointestinal bleeding. 1986. fInformation synthe- ses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Endoscopic laser photocoagulation for gastrointestinal hemorrhage. JAMA 1985 May 11. tExpert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Endoscopic photo- coagulation for upper gastrointestinal hemorrhage. Ongoing. Laser radiation therapy California Medical Association, Medical Practice Opin- ion Program. Laser irradiation for pain of Charcot- -Marie-Tooth disease. 1985 May. (Medical Practice Opinion #321) tGroup judgment] ECRI Technology Assessment Program. Photoradia- tion therapy (PRT) of tumors. Issues Health Care Technol 1984;sec.5.P.6. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Laser photoradiation therapy for carci- noma. 1983 Feb. (Medical Practice Opinion #279) tGroup judgment] Laser surgery Fleischer DE. Esophageal cancer: laser treatment. In: American Society for Gastrointestinal Endoscopy, Committee on Technology Assessment. Therapeutic gastrointestinal endoscopy: an information resource manual. 1987. "Information syntheses, Expert opin- ion, Group judgment, Cost analyses] Steering Committee on Future Health Care Scenarios, Commission on Future Health Care Technology (Netherlands). Prospective assessment of future health care technology: lasers in cardiovascular sur- gery. 1987. California Medical Association, Medical Practice Opin- ion Program. Laser therapy for planter warts. 1985 May. (Medical Practice Opinion #320) [Group judg- ment] Laser surgery Carbon dioxide Committee on Ophthalmic Procedures Assessment. "American Academy of Ophthalmology] Carbon di- oxide laser surgery in head and neck surgery. San Francisco, CA: American Academy of Ophthalmolo- gy, 1984. "Information syntheses, Expert opinion] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Carbon dioxide la- sers in head and neck surgery. 1984. American Medical Association, Diagnostic and Thera- peutic Technology Assessment. C02 laser for the treatment of gynecologic malignancies. TAMA 1983 Aug 5. tExpert opinion, Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Carbon dioxide laser surgery for selected conditions. 1982. Laser surgery Nd:YAG Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Nd:YAG laser- posterior capsulotomy. 1986. [Information synthe- ses] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Nd:YAG laser- tracheo-bronchial obstruction. 1986. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. YAG laser for posterior lens capsules. 1985 Apr. (Medical Practice Opinion #319) [Group judgment] Coburn Optical Industries, Inc. iFood and Drug Ad- ministration, Center for Devices and Radiological Health] Neodymium-Yag op laser OPL-3: summary of safety and effectiveness. 1984Sep 7. (PMA no. P830064-000~. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Nd:YAG laser for posterior capsulotomies. 1984. Laser trabeculoplasty National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Laser trabeculo- plasty (LTP) for open angle glaucoma. 1984. American Academy of Ophthalmology. Laser trabecu- lar surgery for open-angle glaucoma. San Francisco, CA: American Academy of Ophthalmology, 1983. [Information syntheses, Expert opinion Lasers American Hospital Association, Hospital Technology Series Program. Implementing laser technology in the community hospital.1986. (Guideline report) tIn- formation syntheses, Expert opinion, Cost analysesJ 445

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY American Medical Association, Council on Scientific Af- fairs. Lasers in medicine and surgery. JAMA 1986 Aug 15;256~71:900-907. tGroup judgment] Sharplan Lasers Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Model 702: summary of safety and effectiveness. 1986 May 8. (PMA no. P850060-000). U.S. Administrators, Professional Policy Committee. Laser therapy. f7/86] tGroup judgment] Lasers for Medicine, Inc. Good and Drug Administra- tion, Center for Devices and Radiological Health; Phototome (TM) system 2700: summary of safety and effectiveness. 1985 Sep 18. (PMA no. P850019-000~. Health Council of the Netherlands. Lasers. Ongoing assessment. Health Council of the Netherlands. Lasers. Planned. Lasers Carbon dioxide American College of Obstetricians and Gynecologists, Committee Opinion. Carbon dioxide laser. Revised 1984 Apr. "Information syntheses] Lasers Nd:YAG Carl Zeiss, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Visulas Nd:Yag laser: summary of safety and effectiveness. 1986 Aug 7.(PMA no. P850083-000). Coherent Medical Division. (Food and Drug Adminis- tration, Center for Devices and Radiological Health] Neodymium:Yag ophthalmic laser system 9900: sum- mary of safety and effectiveness. 1986 Dec 31. (PMA no. P830054-000~. Elscint, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Gyrex, models S3500 & S5000: summary of safety and effectiveness. 1986 Sep 9. (PMA no. P840007-000~. Gish Biomedical, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Micro Yag Nd:Yag laser system: summary of safety and effectiveness. 1986 May 30. (PMA no. P850063-000~. Iolab. tFood and Drug Administration, Center for De- vices and Radiological Health] Microruptor MR-2 Nd:Yag laser system: summary of safety and effec- tiveness. 1986 Mar 28 (PMA no. P840012-000~. Cilco. fFood and Drug Administration, Center for De- vices and Radiological Health] Cilco Nd:Yag laser: summary of safety and effectiveness. 1985 Sep 11. (PMA no. P840047-0001. 446 Coopervision Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Horizon (TM) Yag laser model 2000: summary of safety and effectiveness. 1985 Aug 15. (PMA no. P850001-000~. Medical Lasers, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Meditec OPL3 Nd:Yag laser: summary of safety and effective- ness. 1985 Feb 21. (PMA no. P830025-000~. Allergan Pharmaceuticals, Inc. tFood and Drug Admin- istration, Center for Devices and Radiological Health] ND:Yag posterior capsulotomy model 100: summary of safety and effectiveness. 1984 Nov 26. (PMA no. P830062-0001. Coherent Medical Division. tFood and Drug Adminis- tration, Center for Devices and Radiological Health] Neodymium:Yag ophthalmic laser system 9900.: summary of safety and effectiveness. 1984 Jul 30. (PMA no. P830054-0001. Trokel S. fAmerican Academy of Ophthalmology] Academy recommendation: ophthalmic neodymium YAG lasers: safety and effectiveness. Ophthalmology 1984;91:539-42. fInformation syntheses, Expert . . op~n~on Lead screening Berwick DM, Komaroff AL. "Harvard School of Public Health, Institute for Health Research] Cost effective- ness of lead screening. N Eng ~ Med 1982;306:1392-1398. "Information syntheses] Leisure skills training Jongbloed L. "National Health Research and Develop- ment Program - Canada] Leisure skills training pro- gram with stroke survivors: a double blind study. 1986. (Grant No. 6610-1455-45~. Leukocyte differential counters ECRI Technology Assessment Program. Leukocyte dif- ferential counters, automated. J Health Care Technol 1985;2:51-72. fInformation syntheses] Levodopa Barbeau A. "Clinical Research Institute of Montreal fMedical Research Council - Canadal Etiology and treatment of Parkinson's disease iwith a study of effi- cacy and side effects of levodopa therapy). (Grant period 1973-19851.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Chouinard G. "Department Psychiatry, McGill Universi- ty] iMedical Research Council - Canada] A clinical trial of L-dopa in the prevention of tardive dyskinesia and in the long-term treatment of parkinsonian side effects indut ed by neuroleptics. (Grant period 1982-1985). Lidoca~ne Food and Drug Administration, Center for Drugs and Biologics. Lidocaine HC1 in 5% dextrose in plastic container (PL-146~. 1981. (NTIS order no. PB81-915907~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Lidocaine hydrochloride, USP sterile pow- der. 1981. (NTIS order no. PB81-915905. tInforma- tion syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Ligament prosthesis W.L. Gore & Associates, Inc. (Food and Drug Adminis- tration, Center for Devices and Radiological Health] Gore-tex expanded PTFE prosthetic ligament: sum- mary of safety and effectiveness. 1986 Nov 18. (PMA no. P850074-0001. Limb perfusion Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Isolated limb per- fusion. 1986. fInformation syntheses] Linear pumps U.S. Administrators, Professional Policy Committee. Linear Pump, Wright. t7/86] tGroup judgment] Lipoprotein evaluation Blue Cross and Blue Shield Association, Medical Neces- sity Program. Serum lipoprotein evaluation. 1985. "Information syntheses] Lithium Aierre YN, Waters BGH. "National Health Research and Development Program - Canada] Erythrocyte membrane enzyme and lithium in manic-depressive disorder. 1986. (Grant No. 6606-2149-52~. Chouinard G. "Department Psychiatry, McGill Universi- ty] [Medical Research Council - Canada] Controlled clinical trials of lithium and tryptophan in the treat- ment of patients with bipolar affective disorders. (Grant period 1982-1985). Veterans Administration, Cooperative Studies Pro- gram. Lithium treatment in alcohol dependence. [Clinical trials] Lithotripsy Health Services Research and Development Service. "Veterans Administration] The cost-effectiveness of lithotripsy: an information synthesis. Perry Point, MD: Special Projects Off~ce, Health Services Research and Development, Veterans Administration, 1986. American College of Physicians, Clinical Efficacy As- sessment Project. Lithotripsy. Ann Intern Med 1985; 103:626-9. [Information syntheses] U.S. Administrators, Professional Policy Committee. Lithotripsy - reconsideration re expanded indica- tions. Ongoing. tGroup judgment] Lithotripsy-Extracorporeal shock wave Medical Technology and Practice Patterns Institute. Ex- tracorporeal shockwave lithotripsy (inpatient). 1987. Medical Technology and Practice Patterns Institute. Ex- tracorporeal shockwave lithotripsy (outpatient).1987. Carlsson P. Tiselius HG. fLinkoping University, Center for Medical Technology Assessment] Evaluation of extracorporeal shock-wave lithotripsy treatment for upper urinary tract calculi the first year experi- ences. 1986. (Discussion series paper #10) iSwedish language only] tCost analyses, Clinical trials, Epidemi- ological methods] Extracorporeal shockwave lithotripsy. In: Prospective Payment Assessment Commission. Technical appen- dixes to the report and recommendations to the Sec- retary, U.S. Department of Health and Human Serv- ices, April 1, 1986 Washington, DC: Government Printing Office, 1986:112-114. fInformation synthe- ses, Cost analyses] Health Services Research and Development Service. [Veterans Administration] Technology assessment of extracorporeal shock wave lithotripsy (ESWL). Perry Point, MD: Special Projects Office, Health Services Research and Development, Veterans Administra- tion, 1986. 447

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Office of Technology Assessment, U.S. Congress. Ex- tracorporeal shock-wave lithotripsy. Washington, D.C.: U.S. Government Printing Office, May 1986. (Health technology case study series #36) U.S. Administrators, Professional Policy Committee. E.S.W.L. t7/86] [Group judgments American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Non-invasive extra- corporeal lithotripsy for disruption of kidney stones Update. Feb 15, 1985. tExpert opinion, In- formation syntheses] California Medical Association, Medical Practice Opin- ion Program. Extracorporeal shock-wave lithotripsy. 1985 Sep. (Medical Practice Opinion #32) tGroup judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Extracorporeal shock wave lithotripsy (ESWL) procedures for the treatment of kidney stones. 1985. ECRI Technology Assessment Program. Extracorpore- al shock-wave lithotripsy (ESWL). Issues Health Care Technol 1984;sec.5.L.2. "Information syntheses] Lithotripsy-Percutaneous Medical Technology and Practice Patterns Institute. Percutaneous lithotripsy. 1987. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous ultra- sound procedures for the treatment of kidney stones. 1985. ECRI Technology Assessment Program. Percutaneous lithotripsy of kidney stones. Issues Health Care Tech- nol 1983;sec.5.L.1. [Information syntheses] Lithotripsy Transurethral National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Transurethral ure- teroscopic lithotripsy procedures for the treatment of kidney stones. 1985. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Treatment of kidney stones transurethral ureteroscopic lithotripsy. On- going. 448 Lithotripters, Extracorporeal shock wave American Hospital Association, Hospital Technology Series Program. Lithotripters. 1985. (Guideline re- port) "Information syntheses, Expert opinion, Cost analyses] Dornier System GMBH. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Dornier lithotripter, model HM3: summary of safety and effectiveness. 1985 Ian 16. (PMA no. P840008-000). Health Council of the Netherlands. Lithotryptor. Ongo- ing assessment. L· - lXlSCOpe National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Portable hand-held x-ray instrument (lixiscope). 1985. United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Lixiscop hand held imager with radioac- tive source. 1985 Sep. (Report no. STB6E/85/33) tEpidemiological and other observational methods, Bench testing] Long term care A longitudinal study of case-mix outcomes and resource use in nursing homes. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). An evaluation of "Life-Continuum of Care" residential centers in the United States. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Can geriatric nurse practitioners improve nursing home care? In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub No. 03219~. Chamberg LW, Mohide AK, Tugwell P. Bayne R. Pill ML, Nightingale H. "National Health Research and Development Program - Canada] Randomized trial of resident care quality assurance by criteria mapping in nursing homes. 1986. (Grant No. 6606-2450-44~.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Comparison by state of SNF/ICF types: beds, staffing, utilization, and ownership. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Comparison of the cost and quality of home health and nursing home care. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Evaluation of coordinated community-oriented, long- -term care demonstration. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Long-term care of aged individuals with hip fractures: public versus private costs. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Long-term care residential services for developmentally disabled people. In: Office of Research and Demon- strations, Health Care Financing Administration. Health care financing status report: research and demonstrations health care financing. Jan 1986. (HCFA Pub. No. 03219). National and cross-national study of long-term care populations. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219). Planning study: phase I of a major study of national long-term care policies. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). Quality of life among life-care facility and community residents: A comparison. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219). State Medicaid nursing home policies, utilization, and expenditures. In: Office of Research and Demonstra- tions, Health Care Financing Administration. Health care financing status report: research and demonstra- tions in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Study of long-term care quality and reimbursement in teaching and nonteaching nursing homes. In: Office of Research and Demonstrations, Health Care Fi- nancing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Adult long-term institutional care. 1984. tInfor- mation syntheses, Expert opinion, Group judgment] Veterans Administration, Cooperative Studies Pro- gram. Community vs. VA nursing home care vs. hos- pitalization in psychiatric patients. t1980] "Clinical tri- als] Lymphangiography U.S. Administrators, Professional Policy Committee. Hodgkin's disease, routine lymphangiography. t7/86] tGroup judgment] Magnesium chloride Food and Drug Administration, Center for Drugs and Biologics. CaCl2, MgCl, Kcl, & NaCl. 1982. (NTIS order no. PB82-915902~. fInformation syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testingJ Magnesium sulfate Food and Drug Administration, Center for Drugs and Biologics. NaCl, KC1, MgSO4, NaPO4, & KPO4. 1982. (NTIS order no. PB82-915901). [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testingJ Magnetic resonance imaging Medical Technology and Practice Patterns Institute. Magnetic resonance imaging (inpatient). 1987. Medical Technology and Practice Patterns Institute. Magnetic resonance imaging (outpatient). 1987. National Institutes of Health, Consensus Development Program. Magnetic resonance imaging. (Consensus Development Conference Statement, Oct 26-28, 19871. l Group judgmentJ Health Services Research and Development Service. "Veterans Administration] Nuclear magnetic reso . . . ~ nance Imaging: Information synthesis on clinical ap- plications and cost considerations. Perry Point, MD: Special Projects Office, Health Services Research and Development, Veterans Administration, April 1986. 449

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY University of Pennsylvania, Leonard Davis Institute of Health Economics. Magnetic resonance imaging. 1986 Dec. (Pilot study for University of Pennsylvania) Magnetic resonance imaging In: Prospective Payment Assessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Human Services, April 1, 1986. Washington, DC: Government Print- ing Office, 1986: 107-111. Nicholson RL. [National Health Research and Develop- ment Program - Canada] Nuclear magnetic reso- nance imaging: clinical evaluation and future impact on health care. 1986. (Grant No. 6606-2240-03~. Prato FS. "National Health Research and Development Program - Canadal Effects on human and rat learn- ing and behavior of radio frequency waves and mag- netic fields associated with NMR imaging. 1986. (Grant No. 6606-2300-031. U.S. Administrators, Professional Policy Committee. Nuclear magnetic resonance imaging. t7/86] tGroup judgment] Allen PS. "Department Medicine, University Alberta] "Medical Research Council - Canada] In-vivo medical applications of nuclear magnetic resonance. (Grant period 1984-1985~. American Hospital Association, Hospital Technology Series Program. NMR - issues for 1985 and beyond. 1985. (Guideline report) "Information syntheses, Ex- pert opinion, Cost analyses] Bronskill M I. "Princess Margaret Hospital, Toronto] "Medical Research Council - Canada] Physical studies of NMR imaging. (Grant period 1983-1985~. California Medical Association, Medical Practice Opin- ion Program. Magnetic resonance imaging.1985 Sep. (Medical Practice Opinion #277) tGroup judgment] ECRI Technology Assessment Program. Magnetic reso- nance imaging (MRI). J Health Care Technol 1985;2:23-50. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Magnetic resonance imaging (MRI'. 1985. 45O Stason WE, Localio AR. "Harvard School of Public Health, Institute for Health Research] Magnetic reso- nance imaging: clinical efficacy, costs and policy con- siderations. Blue Cross and Blue Shield Association, 1985. [Information syntheses] American Academy of Neurology, Practice Committee. Nuclear magnetic resonance. l 984 Feb. tExpert opin- ion, Group judgment] Office of Technology Assessment, U.S. Congress. Nu- clear magnetic resonance imaging technology: a clini- cal, industrial, and policy analysis. Washington, D.C.: U.S. Government Printing Office, September 1984. (Health technology case study series #27) American Hospital Association, Hospital Technology Series Program. Nuclear magnetic resonance (NMR). 1983. (Guideline report) "Information syntheses, Ex- pert opinion, Cost analyses1 Health Council of the Netherlands. NMR/MRI. Ongo Swedish Planning and Rationalization Institute of the ing. Health Services. Spri technology report 7: MRT magnetic resonance tomography: experience in Swe den. 1986. tCost analyses, Epidemiological and other observational methods] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Coverage of gating devices and the use of surface radio frequency coils in conjunction with magnetic resonance imaging (MRI) procedures. Ongoing. University of Pennsylvania, Leonard Davis Institute of Health Economics. Adoption and diffusion of mag- netic resonance imaging under DRGs. Ongoing. (Study for the National Center for Health Services Research, DHHS) University of Pennsylvania, Leonard Davis Institute of Health Economics. Evaluation of magnetic resonance imaging. Planned. (Submitted to Riverside Methodist Hospital, Columbus, OH). Magnetic resonance imaging-Brain and spine American College of Physicians, Clinical Efficacy As- sessment Project. Magnetic resonance imaging of the brain and spine, 1987. "Information syntheses] Magnetic resonance imaging- Lung injury Inch WR. [Department Radiation Oncology, University Western Ontario1 EMedical Research Council - Cana- da] Nuclear magnetic resonance to monitor lung inju- ry. (Grant period 1983-19851.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Magnetic resonance imaging Multiple sclero s~s Paty DW. "Department Medicine, University British Co- lumbia] "Medical Research Council - Canada] NMR imaging in MS, I: The nature of the lesion. (Grant period 1984-1985~. Paty DW. [Department Medicine, University British Co- lumbia] "Medical Research Council - Canada] NMR imaging in MS, II, diagnosis of the disease and quanti- tation. (Grant period 1984-19851. Magnetic resonance imaging Neoplasms Sharp AR. [National Health Research and Develop- ment Program - Canada] Resolution enhanced pulsed NMR investigation of normal, preneoplastic and neo- plastic systems. 1986. (Grant No. 6604-1042-03. Magnetic resonance imaging systems Phillips Medical Systems, Inc. fFood and Drug Adminis- tration, Center for Devices and Radiological Health] Gyroscan (TM): summary of safety and effectiveness. 1986 Sep 16. (PMA no. P840063-000). Thompson CGR Medical Corp. fFood and Drug Ad- ministration, Center for Devices and Radiological Health] Magniscan 5000 MRI System: summary of safety and effectiveness. 1986 Oct 6. (PMA no. 850043-000). General Electric, Co. [Food and Drug Administration, Center for Devices and Radiological Health] GE signa . magnetic resonance diagnostic imaging system: sum- mary of safety and effectiveness. 1985 fun 5. (PMA no. P830074-000) Siemans Medical Systems, Inc. fFood and Drug Admin- istration, Center for Devices and Radiological Health] Magnetom: summary of safety and effectiveness. 1985 Jan 2. (PMA no. P830081-000). Diasonics, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Diasonics NMR . . Imaging system: summary of safety and effectiveness. 1984 Apr 25. (PMA no. P830053-000). Fonar Corp. tFood and Drug Administration, Center for Devices and Radiological Health] Fonar NMR whole body scanner beta 3000: summary of safety and effectiveness. 1984 Nov 13. (PMA no. P830076). Picker International. tFood and Drug Administration, Center for Devices and Radiological Health] Nuclear magnetic resonance scanner models NMR 1000: summary of safety and effectiveness. 1984 Jun 8. (PMA no. P830052-000). Technicare Corporation. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Teslacon (TM) NMR imaging system: summary of safety and effectiveness. 1984 Apr 25. (PMA no. P830051-000). Magnetic resonance spectroscopy Health Council of the Netherlands. Magnetic resonance spectroscopy. 1986. "English summary only]. Magnetoencephalography Health Systems Research and Development Division. "Veterans AdministrationJ Technology assessment of magnetoencephalography (MEG). Perry Point, MD: Special Projects Office, Health Systems Research and Development Division, Veterans Administration, in preparation, expected August 1987. Malathion Food and Drug Administration, Center for Drugs and Biologics. Malathion. 1982. (NTIS order no. PB82-9159041. [Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Mammographic devices American College of Radiology, Task Force on Breast Cancer. Policy statement on oscillating grids for mam- mography equipment. Expected 1987. [Group judg- ment] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Elscint Mam LS3 mammographic unit. 1986 Jan. (Report no. STB6E/86/3) tEpidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Wolverson X-ray (Acoma) MXR 102 mammography unit. 1986 Tan. (Report no. STB6E/86/1) tEpidemiological and other observa- tional methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of medical X-ray supplies (Soredex) Mam- mex DC mammographic unit. 1986 Jan. (Report no. STB6E/86/2) tEpidemiological and other observa- tional methods, Bench testing] 451

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Mammography Eddy DM, Hasselblad V, McGivney W. Hendee W. [Duke University, Center for Health Policy Research and Education] The value of mammography screen ing for women age 40-49. (Submitted for publication) "Information syntheses] Eddy DM. [Duke University, Center for Health Policy Research and Education] Screening by mammogra- Mass spectroscopy phy for women over age 65, reassessment. (Expected publication 1988) "Information syntheses] Office of Technology Assessment, U.S. Congress. Mam mography screening for the Medicare population. Washington, D.C.: Office of Technology Assessment (to be completed in Summer 19871. American College of Radiology, Task Force on Breast Cancer. Resolution no. 1: supplementary mammog raphy statement. 1986 Sep. tGroup judgment] American College of Radiology, Task Force on Breast Cancer. Resolution no. 2: mammography perform ance guidelines. 1986 Sep. (Group judgment] American Medical Association, Diagnostic and Thera peutic Technology Assessment. Mammographic screening for breast cancer. Oct 19, 1986. tExpert opinion, Information syntheses] Eddy DM. (Duke University, Center for Health Policy Research and Education] The effectiveness, cost, & cost-effectiveness of breast cancer screening with an nual mammography & breast physical exam. for women over 65. Report prepared for Committee on Ways & Means, Subcommittee on Health, U.S. House of Representatives. 1986 Ian 7. fInformation synthe ses] CBO (Centraal Begeleidingsorgaan voor de Intercolle giale Toetsing) Consensus Development Program. Mammography policy. 1983. iDutch language only] tGroup judgment, Expert opinion] American College of Radiology, Task Force on Breast Cancer. Policy statement: guidelines for mammogra phy. 1982 Sep 22. tGroup judgment] American College of Obstetricians and Gynecologists, Committee Opinion. ACOG statement on mammog raphy. 1979 Sep. fInformation syntheses] Swedish Planning and Rationalization Institute of the Health Services. Mammography screening for breast cancer: a randomized controlled cost-effectiveness analysis. Ongoing. tCost analyses, Epidemiological and other observational methods] 452 Maple syrup urine disease screening Hasselblad V. (Duke University, Center for Health Poli- cy Research and Education] Analysis of the preven- tion of mental retardation by screening for maple syrup urine disease. (Expected publication 1988) tIn- formation syntheses] ECRI Technology Assessment Program. Clinical use of mass spectrometers. Issues Health Care Technol 1986;sec.5.M.2. "Information syntheses] Mastectomy U.S. Administrators, Professional Policy Committee. Subcutaneous (subareolar) mastectomy (bilateral). t7/86] [Group judgment] Zemore R. Shepel LF. "National Health Research and Development Program - Canada] Coping with breast cancer and mastectomy. 1986. (Grant No. 6608-1170-421. Mate~nal serum alpha fetoprotein monitoring Burton BK, Dillard RG, Clark EN. "National Center for Health Services Research and Health Care Technol- ogy Assessment, Division of Extramural Research] MSAFP screening: the effect of participation on anxi- ety and attitudes toward pregnancy in women with normal results. Am J Obset Gynecol 1985; 152:540-543. Gutzwiller F. Grob PJ, Boppart I, Marguerat PH, eds. [University of Lausanne, Institute of Social and Pre- ventive Medicine] Swiss alpha-foetoprotein screening working group: results of the collaborative study of early detection of neural tube defects. 1985. tEpide- miological and other observational methods] ECRI Technology Assessment Program. Prenatal al- pha-fetoprotein (AFP) testing. Issues Health Care Technol 1984;sec.5.A.2. fInformation syntheses] American Medical Association, Council on Scientif~c Af- fairs. Maternal serum a-fetoprotein monitoring. JAMA 1982 Mar 12;247:1478. [Group judgment] Measles-mumps-rubella vaccine Stewart M. (National Health Research and Develop- ment Program - Canada] Illness after measles- -mumps-rubella (MMR) vaccination - a study using the health diary method. 1986. (Grant No. 6606-3028-431.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Medical record systems Woogh CM. "National Health Research and Develop ment Program - Canada] Kingston psychiatric record linkage system. 1986. (Grant No. 6606-2880-43~. Long TM. "National Heart, Lung, and Blood Institute] Discovery and confirmation of causal relationships in a large medical record database: a POSCH expert- Med 0 yprogesterone meet. Society for Clinical Trials, Annual Conference, 1985. Whiting-O'Keefe QE, et al. "National Center for Health Services Research and Health Care Technology As sessment, Division of Extramural Research] A com puterized summary medical record system can pro vide more information than the standard medical re cord. JAMA 1 985 Sep 6;254~91: 1 1 85- 1 1 92. Barnett GO. "National Center for Health Services Re search and Health Care Technology Assessment, Di vision of Extramural Research] The application of computer-based medical record systems in ambula tory practice. N Engl J Med 1984 tun;310~25): 1643-1650. Simborg DW. "National Center for Health Services Re search and Health Care Technology Assessment, Di vision of Extramural Research] Evaluation of a sum mary medical record system. 1984 (NTIS order no. PB84- 100247) Widerhold G. "National Center for Health Services Re search and Health Care Technology Assessment, Di vision of Extramural Research] Automated ambula tory medical records systems in the U.S. 1984. (NTIS order no. PB84- 118884) "National Center for Health Services Research and Health Care Technology Assessment, Division of Ex tramural Research] The effect of immediate access to a computerized medical record on physician test or dering: a controlled clinical trial in the emergency room. Amy Public Health 1982 tu1;72~71:698-702. MEDLARS Office of Technology Assessment, U.S. Congress. MED LARS and health information policy. Washington, D.C.: U.S. Government Printing Office, September 1982. MEDLINE "National Library of Medicine] Health professionals use of MEDLINE. Bethesda, MD: National Library of Medicine, 1987. tEpidemiological and other observa tional methods] MEDLINE- Optical disk (National Library of Medicine] Field test and evaluation of MEDLINE on optical disk. Bethesda, MD: Nation- al Library of Medicine. Ongoing. tEpidemiological and other observational methods] American Academy of Pediatrics, Committee on Drugs. Medroxyprogesterone acetate (Depo-Provera). Pedi- atrics 1980 Mar. Melodic intonation therapy American Academy of Neurology, Practice Committee. Melodic intonation therapy for aphasia. tExpert opin- ion, Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Melodic intonation therapy. 1982. Methaqualone American Medical Association, Council on Scientific Af- fairs. Methaqualone, abuse limits its usefulness. JAMA 1983 Dec 9;250:3052. tGroup judgment] Methotrexate American College of Physicians, Clinical Efficacy As- sessment Project. Methotrexate for rheumatoid ar- thritis, 1987. "Information syntheses] U.S. Administrators, Professional Policy Committee. Arthritis, low-dose methotrexate therapy. [7/86] tGroup judgment] Methoxsalen Food and Drug Administration, Center for Drugs and Biologics. Methoxsalen. 1982. (NTIS order no. PB82-915903). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Methyldopa Food and Drug Administration, Center for Drugs and Biologics. Methyldopa. 1981. (NTIS order no. PB 81 -91591). "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 453

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Methylethylketone California Medical Association, Medical Practice Opin- ion Program. Methylethylketone damage of the im- mune system. 1982 Nov. (Medical Practice Opinion #261 ~ tGroup judgment] Methylphenidate Simeon iG. "National Health Research and Develop- ment Program - Canada] Biological and behavioural factors associated with methylphenidate therapy of attention deficit and conduct disorders in children. 1986. (Grant No. 6606-2407-52~. Metoc l op rami de Food and Drug Administration, Center for Drugs and Biologics. Metoclopramide HC1. 1982. (NTIS order no. PB82-915903~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Metolazone Food and Drug Administration, Center for Drugs and Biologics. Metolazone. 1981. (NTIS order no. PB81-915905~. "Information syntheses, Expert op~n- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Metoprolol Levin, LA. ~Linkoping University, Center for Medical Technology Assessment] Economic consequences of postinfarction prophylaxis with beta-blockers: a cost effect study of metoprolol treatment. 1982. (Discus- sion series paper #2) [Swedish language onlyJ tCost analyses, Epidemiological methods] Metronidazole California Medical Association, Medical Practice Opin- ion Program. Treatment of rheumatoid arthritis with flagyl. 1985 Oct. (Medical Practice Opinion #330) tGroup judgment] Food and Drug Administration, Center for Drugs and Biologics. Metronidazole injection, 0.5%. 1982. (NTIS order no. PB82-915904~. [Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] 454 Mezloc it l in Food and Drug Administration, Center for Drugs and Biologics. Mezlocillin sodium. 1981. (NTIS order no. PB81 -915912~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Miconazole Food and Drug Administration, Center for Drugs and Biologics. Miconazole nitrate. 1982. (NTIS order no. PB82-9159024. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Miconazole nitrate. 1982. (NTIS order no. PB82-915904~. "Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Microbiolog~cal testing systems Analytab Products, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Un- iscept (TM): summary of safety and effectiveness. 1984 Apr 25. (PMA no. P830028-0004. Boehringer Mannheim Diagnostics Inc. tFood and Drug Administration, Center for Devices and Radio- logical Health] Micur-mic systems: summary of safety and effectiveness. 1983 Jul 19. (PMA no. P820073-000~. Warner Lambert. [Food and Drug Administration, Center for Devices and Radiological Health] Autobac MTS plus test system: summary of safety and effec- tiveness. 1982 Mar 26. (PMA no. P810024-00001. Microbiology equipment United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of Don Whitley Mark II anaerobic cabinet- /work station. 1986 Mar. (Report no. STB/86/11) [Epidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. An evaluation of the Hamilton Microlab 2100.1985 Apr. (Report no. STB3A/85/18) [Epidemiological and oth- er observational methods, Bench testing]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of the Autobac IDX. 1985 Dec. (Report no. STB3A/85/46) tEpidemiological and other observa- tional methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Eval- uation of the Matascan. 1985 May. (Report no. STB3A/85/23) tEpidemiological and other observa- tional methods, Bench testing] Micronucleus test Stich HF. "National Health Research and Development Program - Canada] Application of the micronucleus test to exfoliated human urinary cells for quantitating exposures to lifestyle factors and industrial carcino- gens. 1986. (Grant No. 6610-1329-52~. Microsurgery American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Microsurgical recon- struction for brachial plexus injury. Jul l 6,1986. tEx- pert opinion, Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Microsurgery in the treatment of infer- tility. 1985 Aug. (Medical Practice Opinion #308) [Group judgment] Daniel RK. [Department Plastic Surgery, McGill Uni- versity] Medical Research Council - Canada] Surgical reconstruction utilizing microsurgical tissue trans- plants. (Grant period 1984-1985~. American College of Obstetricians and Gynecologists, Committee Opinion. Microsurgery.1984 Apr. tInfor- mation syntheses] California Medical Association, Medical Practice Opin- ion Program. Microsurgical lumbar discectomy.1980 Feb. (Medical Practice Opinion #238J tGroup judg- ment] Migration inhibition test Warrington RJ. "National Health Research and Devel- opment Program - Canada] Assessment of the migra- tion inhibition test in the diagnosis of hypersensitivity to food additives and salicylates in chronic urticaria. 1986. (Grant No. 6607-12878-08~. Minerals American Academy of Pediatrics, Committee on Nutri- tion. Vitamins and mineral supplement needs. 1980. Minnesota Q-Qs codes Karnegis IN, Malts JP, Tuna N. et al and the POSCH Group. (National Heart, Lung, and Blood Institute] Quantitative assessment of left ventricular function after myocardial infarction using the Minnesota Q-Qs codes for resting electrocardiograms. Cathet Cardio- vasc Diagn 1985; 11:393-400. Karnegis IN, Matts UP, Tuna N and the POSCH Group. "National Heart, Lung, and Blood Institute] Develop- ment and evolution of electrocardiographic Minneso- ta Q-Qs codes in patients with acute myocardial in- farction. Am Heart I 1985; 110:452-459. Mobility aids Lotto WN, Milner M. "National Health Research and Development Program - Canada] Evaluations and de- velopment of powered mobility aids for two-to-f~ve year olds with neuromusculoskeletaal disorders. 1985. (Grant No. 6606-2114-51~. Moire topography Tredwell S], Saunders CG. "National Health Research and Development Program - Canada] A clinical study of shadow moire contourography as a useful assess- ment of the effects of orthotic treatment of curvature of the spine. 1986. (Grant No. 6610-1366-51~. Scott RN. [National Health Research and Development Program - Canada1 Evaluation of moire topography in sclerosis monitoring. 1985. (Grant No. 6604-1055-51~. Scott RN. [National Health Research and Development Program - Canada] Moire topography in scoliosis monitoring. 1985. (Contract No. 6604- 1049-51). Monoclonal antibodies Steering Committee on Future Health Scenarios, Com- mission on Future Health Care Technology (Nether- lands). Prospective assessment of future health care technology: monoclonal antibodies and diagnostic kits.1987. Health Council of the Netherlands. Monoclonal anti- bodies. 1986. Health Council of the Netherlands. Monoclonal anti- bodies. 1986. "English summary only]. Walker MC. [National Health Research and Develop- ment Program - Canada] The development of human monoclonal antibodies against HLA antigens. 1986. (Grant No. 6605-2035-52~. 455 ~1

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Health Council of the Netherlands. Monoclonal anti- bodies, advice on regulatory issues. Ongoing. Mouth protectors American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Mouth protectors and sports team dentists. ~ Am Dent Assoc 1984; 109:84-87. Moxalactam Food and Drug Administration, Center for Drugs and Biologics. Moxalactam disodium. 1982. (NTIS order no. PB82-915901~. [Information syntheses, Expert opinion, Epidemiological and other observational methods, clinical trials, Bench testing] Mycoplasma complement fixation test National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. The use of the myco- plasma complement fixation test in the diagnosis of rheumatoid arthritis. 1981. Myoelectric prostheses Scott RN, Dunfield VA. "National Health Research and Development Program - Canada] Design and evalua- tion of myoelectric controls. 1986. (Grant No. 6604- 1029-51). Scott RN. [National Health Research and Development Program - Canada] Infants and myoelectric prosthe- ses. 1986. (Grant No. 6604- 1056-51). Shwedyk E, Quanbury AO, Marinic J. "National Health Research and Development Program - Canada] Se- quential myoelectric processor evaluation. 1986. (Grant No. 6607-1332-51~. Nadolol Food and Drug Administration, Center for Drugs and Biologics. Nadolol-bendroflumethiazide. 1983. (NTIS order no. PB 83-915903~. "Information syn- theses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Veterans Administration, Cooperative Studies Pro- gram. Evaluation of nadolol in treatment of hyper- tension. [19801. fClinical trials] 456 Nafcillin Veterans Administration, Cooperative Studies Pro- gram. Nafcillin therapy of staphylococcal bacteremia. [19803. fClinical trials] Naloxone Chernick V. "Department Pediatrics, University Manito- ba] "Medical Research Council - Canada] Clinical trial of naloxone in birth asphyxia. (Grant period 1983-19851. Food and Drug Administration, Center for Drugs and Biologics. Pentazocine HC1 and naloxone HC1. 1983. (NTIS order no. PB83-915901). [Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] American Academy of Pediatrics, Committee on Drugs. Naloxone use in newborns. Pediatrics 1980 Mar. Nebulizers Food and Drug Administration, Center for Drugs and Biologics. Bronalide inhaler system. 1987. (Summary basis of approval, NDA #18-3401. "Information syn- theses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Needle aspiration cytology American College of Obstetricians and Gynecologists, Committee Opinion. Needle aspiration cytology in the evaluation of breast lesions. 1984 Jun. tInforma- tion syntheses] Negative pressure respirators National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Negative pressure respirators. 1983. American Academy of Neurology, Practice Committee. Negative pressure respirators for home use in chronic neuromuscular disease. 1982 Oct. tExpert opinion, Group judgment] Neonatal intensive care Budetti P. McManus P. ~University of California, San Francisco, Institute for Health Policy Studies] Assess- ing the effectiveness of neonatal intensive care. Med Care 1982;20:1027-1039. Health Council of the Netherlands. Neonatal intensive care. 1982.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Kaufman SL, Shepard DS. Harvard School of Public Health, Institute for Health Research] Costs of neo- natal intensive care by day of stay. Inquiry 1982; 19: 167-178. Office of Technology Assessment, U.S. Congress. The costs and effectiveness of neonatal intensive care. Washington, D.C.: U.S. Government Printing Office, August 1981. (Health technology case study series #10) Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Perinatal intensive care unit guidelines. 1979. [Information syntheses, Expert opinion, Group judg- ment] Neonatal monitors Corometrics Medical Systems, Inc. iFood and Drug Ad- ministration, Center for Devices and Radiological Health] Model 515 neonatal monitor: summary of safety and effectiveness. 1986 Ian 31. (PMA no. P840037-000). Nephrolithotomy American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Endoscopic transur- ethral nephrolithotomy for disruption of kidney stones. MAMA 1984 Dec 21. tExpert opinion, Infor- mation syntheses] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Percutaneous neph- rolithotomy for kidney stone removal. JAMA 1984 Dec 2. tExpert opinion, Information syntheses] Nephrostomy ECRI Technology Assessment Program. Percutaneous nephrostomy. Issues Health Care Technol 1984;sec.5.N.1. fInformation syntheses] Neurotox~ns American Academy of Neurology, Practice Committee. Amyotrophic lateral sclerosis - injected modified neu- rotoxin for treatment. 1983 Feb. tExpert opinion, Group judgment] American Academy of Neurology, Practice Committee. Modified neurotoxin in the treatment of ALS. 1983 fun. [Expert opinion, Group judgment] Neutralization therapy- Food allergies National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Intracutaneous (in- tradermal) and subcutaneous provocative and neu- tralization testing and neutralization therapy for food allergies. 1981. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Sublingual provoca- tive testing and neutralization therapy for food aller- gies. 1981 Niclosamide Food and Drug Administration, Center for Drugs and Biologics. Niclosamide.1982. (NTIS order no. PB82- 915903~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Nicotine gum Oster G. Huse DM, Delea TE, Colditz GA. tPolicy Anal- ysis, Inc.] Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smok- ing. JAMA 1986;256: 1315-1318. American Medical Association, Council on Scientific Af- fairs. Nicotine chewing gum for cessation of smoking. 1984. tGroup judgment] Nifedipine Food and Drug Administration, Center for Drugs and Biologics. Nifedipine. 1982. (NTIS order no. PB82- 915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Nissen fundoplication California Medical Association, Medical Practice Opin- ion Program. Nissen's fundoplication - gastric reser- voir reduction for morbid obesity. 1983 May. (Medi- cal Practice Opinion #290) tGroup judgments Ni~oprusside Food and Drug Administration, Center for Drugs and Biologics. Sodium nitroprusside. 1981. (NTIS order no. PB81-915912) "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] 457

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Noncardiac pain diagnosis American Gastroenterological Association, Patient Care Committee. Diagnostic procedures in noncardiac chest pain. Ongoing. Nonion~zing radiation measurement devices Food and Drug Administration, Center for Devices and Radiological Health. Instrumentation for nonioniz- ing radiation measurement. 1984. (NTIS Order No. 84-180603). Norethindrone with ethinyl estradiol Food and Drug Administration, Center for Drugs and Biologics. Norethindrone & ethinyl estradiol. 1982. (NTIS order no. PB82-915902~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Normaline kit Apothecary Products, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] The normaline kit: summary of safety and effective- ness. 1983 {un 17. (PMA no. P800055-0021. Apothecary Products, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] The normaline kit: summary of safety and effective- ness. 1982 Jan 12. (PMA no. P800055-000~. Nutritional counseling Chandra RK. "National Health Research and Develop- ment Program - Canada] Influence of nutritional counselling and support on immunocompetence, nu- tritional status and illness in the elderly. 1986. (Grant No. 6601- 1063-56~. Apothecary Products, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] The normaline kit: summary of safety and effective- ness. 1983 Jun 17. (PMA no. P800055-002~. Apothecary Products, Inc. tFood and Drug Administra- tion, Center for Devices and Radiological Health] The normaline kit: summary of safety and effective- ness. 1982 Jan 12. (PMA no. P800055-000~. 458 Oral contraceptives American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Oral contracep- tion 1976 Jul. (Technical bulletin no. 41~. tExpert . . opinion National Institute of Child Health and Human Devel- opment. Safety and efficacy of oral contraceptives. Planned. [Group judgment, Expert opinion] Oral rehydradon therapy American Academy of Pediatrics, Committee on Nutri- tion. Use of oral fluid therapy and posttreatment feeding following enteritis in children in a developed country. Pediatrics 1985 Feb. Organ preservation Bitter-Suermann H. "Department Surgery, Dalhousie University] "Medical Research Council- Canada; Liv- er preservation. (Grant Period 1984-19851. Guttman FM. "Montreal Children's Hospital] [Medical Research Council - Canada] Long term organ preser- vation. (Grant period 1979-19851. Organ procurement Caplan A. tThe Hastings Center] Should fetuses or in- fants be used as organ donors? Bioethics (forthcom- ing) Developing incentive systems to increase the supply of cadaveric kidneys for transplants. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Organ Donor Education Project. In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Tan 1986. (HCFA Pub. No. 03219). Prottas JM, Batten HL. [Brandeis University, Health Policy Center, Organ Procurement Project] Attitudes . . . . anct incentives In organ procurement: report to the Health Care Financing Administration. 1986 Apr. tEpidemiological and other observational methods1 Prottas JM. [Brandeis University, Health Policy Center, Organ Procurement Project] Organ procurement in Europe and the United States. Millbank Mem Fund Q 1985;63~11:94-126. fEpidemiological and other ob- servational methods]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Prottas JM. (Brandeis University, Health Policy Center, Oximeters Organ Procurement Project] The structure and effec tiveness of the U.S. procurement system. Inquiry 1985;22~4~365-376. tEpidemiological and other ob servational methods] The Hastings Center. Ethical, legal and policy issues pertaining to solid organ procurement: a report of the Project on Organ Transplantation. 1985 Oct. Prottas TM. tBrandeis University, Health Policy Center, Organ Procurement Project] Encouraging altruisms: public attitudes and the marketing of organ donation. Milbank Mem Fund Q 1983;61:278-306. [Epidemio logical and other observational methods] Prottas ~M. [Brandeis University, Health Policy Center, Organ Procurment Project] Obtaining replacements: the organizational framework of organ procurement. J Health Polit Policy Law 1983;8~2~:235-250. tEpide miological and other observational methods] American Medical Association, Council on Scientific Af fairs. Organ donor recruitment. TAMA 1981 Nov 13;246:2157. [Group judgment] Orphan devices Georgetown University Medical Center, Institute for Health Policy Analysis. Orphan devices in health care. (Planned). Orthodontic appliances Mclachlan KR. "Department Dentistry, University Manitoba] "Medical Research Council - Canada] The effectiveness of loops and auxiliary appliances in con tinuous arch orthodontic therapy. American Dental Association, Council on Dental Mate rials, Instruments and Equipment. Status report on beta titanium orthodontic wire. ~ Am Dent Assoc 1982; 105:684-685. Orthotic devices Foort J. (National Health Research and Development Program - Canada] Tabular orthoses for stabilizing body joints. 1986. (Grant No. 6610- 1290-51). Osteoporosis screening Critchfield GC, Eddy DM. iDuke University, Center for Health Policy Research and Education] Screening for osteoporosis. (Expected publication 1988) tInforma tion syntheses] U.S. Administrators, Professional Policy Committee. Screening tests for osteoporosis. Ongoing. tGroup judgment] ECRI Technology Assessment Program. Pulse oxi- meters. Issues Health Care Technol 1986;sec.5.0.1. fInformation syntheses] Oximetry Medical Technology and Practice Patterns Institute. Pulse oximetry. 1987. Oxprenolol Veterans Administration, Cooperative Studies Pro- gram. Oxprenolol vs. propranolol in hypertension. ~ 1980~. fClinical trials] Oxybutynin chloride with metoclopramide Jewett M. "National Health Research and Development Program - Canada] Evaluation of oxybutynin chlo- ride and metoclopramide in the treatment of detru- sor instability in the elderly. 1986. (Grant No. 6606- 2677-531. Oxygen-air proportioners ECRI Health Devices Program. Oxygen-air propor- tioners. Health Devices 1985;14:263-76. Oxygen analyzers ECRI Health Devices Program. Oxygen analyzers. Health Devices 1983; 12: 183-97. Oxygen therapy Blue Cross and Blue Shield Association, Medical Neces- sity Program. Oxygen therapy. 1982. fInformation synthesesJ Nocturnal Oxygen Therapy Trial Group. "National Heart, Lung, and Blood Institute] Continuous or noc- turnal oxygen therapy in hypoxemic chronic obstruc- tive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398. Oxygen therapy Inhalation Heaton RK, Grant I, McSweeny J. et al. [National Heart, Lung, and Blood Institute] Psychologic effects of con- tinuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med 1983; 143: 1941-1947. 459

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Nocturnal Oxygen Therapy Trial Group. [National Heart, Lung, and Blood Institute] Continuous or noc- turnal oxygen therapy in hypoxemic chronic obstruc- tive lung disease: a clinical trial. Ann Intern Med 1980;93:391-398. Nocturnal Oxygen Therapy Trial Study Group. [Na- tional Heart, Lung, and Blood Institute] Is 12-hour oxygen as effective as 24-hour oxygen in advanced chronic obstructive pulmonary disease with hypox- emia? (The Nocturnal Oxygen Therapy Trial - NOTT). Chest 1980;78:419-420. Oxygen therapy- Topical National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Topical oxygen ther- apy in the treatment of decubitus ulcers and persis- tent skin lesions. 1983. Pain assessment McGrath PA. [National Health Research and Develop- ment Program - Canada] Pacdiatric pain and beha- vioural medicine: pain assessment and the role of an endogenous opiate system in pain relief by psycholog- ical intervention. 1986. (Grant No. 6606-2244-04~. Pain rehabilitation U.S. Administrators, Professional Policy Committee. Pain rehabilitation programs. t7/86] (Group judg- ment] Pain therapy Health Council of the Netherlands. Pain treatment. 1986. "English summary only]. National Institutes of Health, Consensus Development Program. Integrated approach to the management of pain. (Consensus Development Conference State- ment, May 19-21 19861. [Group judgment] ECRI Technology Assessment Program. Patient-con- trolled analgesia. Issues Health Care Technol 1985;sec.5.P.8. "Information syntheses American Academy of Neurology, Practice Committee. Functional integration in the alleviation of chronic muscular pain and spasticity. l 984 Feb. tExpert opin- ion, Group judgment] National Institutes of Health, Consensus Development Program. Pain, discomfort, and humanitarian care. (Consensus Development Conference Statement, Feb 16 1979). (Group judgment] 460 Health Council of the Netherlands. Pain treatment and clinics. Ongoing. U.S. Administrators, Professional Policy Committee. Pain clinics. Ongoing. (Group judgment] Palatopharyngoplast~r California Medical Association, Medical Practice Opin- ion Program. Palatopharyngoplasty for the treatment of snoring. 1983 Dec. (Medical Practice Opinion #301) tGroup judgment] Pap smear National Institutes of Health, Consensus Development Program. Cervical cancer screening: the pap smear. (Consensus Development Conference Statement, Saul 23-25 19801. (Group judgment] Papaverine National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Diagnostic tests for impotency: papaverine injections. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Treatments for im- potency: papaverine. Ongoing. Parenteral nutrition Veterans Administration, Cooperative Studies Pro- gram. A randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Pending. Clinical trials] American College of Physicians, Clinical Efficacy As- sessment Project. Parenteral nutrition, 1987. fInfor- mation syntheses] Medical Technology and Practice Patterns Institute. To- tal parenteral nutrition (inpatient). 1987. Medical Technology and Practice Patterns Institute. To- tal parenteral nutrition (outpatient). 1987. Sitzmann JV, Pitt HA. "American Gastroenterological Association, Patient Care Committee] Guidelines for total parenteral nutrition. Gastroenterology 1987 (in press). Callahan D. The Hastings Center] Public policy and the cessation of nutrition. In: Lynn J. ed. By no extraordi- nary means: the choice to forgo life-sustaining food and water. University of Indiana Press, 1986.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Academy of Pediatrics, Committee on Nutri- tion. Commentary on parenteral nutrition. Pediatrics 1983 Apr. Veterans Administration, Cooperative Studies Pro- gram. Randomized clinical trial of total parenteral nutrition in malnourished surgical patients. Ongoing. fClinical trials] Partial thromboplastin time Blue Cross and Blue Shield Association, Medical Neces- sity Program. Activated partial thromboplastin time and prothrombin time.1987. "Information syntheses] Patch tests American Dental Association, Council on Dental Mate- rials, Instruments and Equipment, Council on Dental Therapeutics. Patch tests for sensitivity to mercury or nickel. I Am Dent Assoc 1984;108:381. PEEP valves ECRI Health Devices Program. Positive end expiratory pressure (PEEP) valves. Health Devices 1985; 14:379- 99. Peer group counseling Buchanan WW, Kragg G. Tugwell R. "National Health Research and Development Program - Canada] A trial to assess the efficacy of peer group rehabilitative counselling in patients with rheumatoid arthritis. 1986. (Grant No. 6606- 1941 -43~. Penile artery bypass National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Treatments for im- potency: penile artery bypass. Ongoing. Penile prosthesis Penile prostheses. In: Prospective Payment Assessment Commission. Technical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Human Services, April 1, 1986. Wash- ington, DC: Government Printing Office, 1986: 104- 106. "Information syntheses, Cost analyses] ECRI Technology Assessment Program. Penile pros- theses. Issues Health Care Technol 1983 ;sec.5.P.5. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Treatments for im- potency: Erect-aid system. Ongoing. U.S. Administrators, Professional Policy Committee. Pe- nile implants. Ongoing. tGroup judgment] Pentazocine Food and Drug Administration, Center for Drugs and Biologics. Pentazocine HC1 and naloxone HC1. 1983. (NTIS order no. PB83-915901). "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Pentazocine hydrochloride and acetamino- phen. 1982. (NTIS order no. PB82-915904~. tInfor- mation syntheses, Expert opinion, epidemiological and other observational methods, Clinical trials, Bench testing] Pentetate indium disodium Food and Drug Administration, Center for Drugs and Biologics. Pentetate indium disodium In 111. 1982. (NTIS order no. PB82-915902~. "Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Percutaneous balloon valvuloplasty ECRI Technology Assessment Program. Percutaneous balloon valvuloplasty. Issues Health Care Technol 1986;sec.5.P.9. [Information syntheses] Percutaneous transluminal angioplasty Adar R. Critchfield GC, Eddy DM. [Duke University, Center for Health Policy and Education] A confi- dence profile analysis of the results of percutaneous transluminal angioplasty in the treatment of ischemic femoropopliteal artery disease. (Expected publication 1988) "Information syntheses] American Academy of Neurology, Practice Committee. Percutaneous transluminal angioplasty (PTA). 1985 Feb. tExpert opinion, Group judgment1 American Medical Association, Council on Scientific Af- fairs. Percutaneous transluminal angioplasty. JAMA 1984 Feb 10;251 :764-768. [Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous trans- luminal angioplasty for obstructive lesions of arterio- venous dialysis fistulas. 1984. 46]

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous transit luminal angioplasty for obstructive lesions of the aor- tic arch vessels. 1984. American College of Physicians, Clinical Efficacy As- sessment Project. Percutaneous transluminal angio- plasty: carotid, vertebral, and subclavian arteries. Ann Intern Med 1983;99:864-9. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Percutaneous transluminal angio- plasty: iliac, femoral, and popliteal arteries. Ann In- tern Med 1983;99:864-9. "Information syntheses] American College of Physicians, Clinical Efficacy As- sessment Project. Percutaneous transluminal angio- plasty: renal arteries. Ann Intern Med 1983;99:864- 9. "Information syntheses] ECRI Technology Assessment Program. Percutaneous transluminal angioplasty (PTA) of peripheral arter- ies. Issues Health Care Technol 1983;sec.5.P.4. tIn- formation syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous trans- luminal angioplasty in treatment of stenotic lesions of the renal arteries. 1982. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous trans- luminal angioplasty in treatment of the lower extrem- ities. 1981. Veterans Administration, Cooperative Studies Pro- gram. Percutaneous transluminal angioplasty in the lower extremity. Ongoing. [Clinical trials] Percutaneous transluminal coronary angioplasty American College of Physicians, Clinical Efficacy As- sessment Project. A comparative assessment of coro- nary artery bypass surgery and percutaneous translu- minal coronary angioplasty, expected completion 1988. [Information systheses] Medical Technology and Practice Patterns Institute. Percutaneous transluminal coronary angioplasty. 1987. American Edwards Laboratories. tFood and Drug Ad- ministration, Center for Devices and Radiological Health] Amer. Ed. Labs. PTCA: summary of safety and effectiveness. 1986 Soul 9. (PMA no. P850021- 0001. 462 ECRI Technology Assessment Program. Percutaneous transluminal coronary angioplasty (PTCA). Issues Health Care Technol 1986;sec.5.P.2. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Reconsideration of percutaneous and transluminal coronary angioplasty.1985 Feb. [Group judgment] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Patient selection cri- teria for percutaneous coronary angioplasty of a ste- notic lesion in a single coronary artery. 1985. Percutaneous transluminal coronary angioplasty. In: Prospective Payment Assessment Commission. Tech- nical appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Hu- man Services, April 1, 1985. Washington, DC: Gov- ernment Printing Office, 1985: 105-111. tInforma- tion syntheses, Cost analyses! American College of Physicians, Clinical Efficacy As- sessment Project. Percutaneous transluminal angio- plasty: coronary arteries. Ann Intern Med 1983;99:864-9. "Information syntheses] Holmes DR, Vliestra RE, Fisher LD, et al. [National Heart, Lung, and Blood Institute] Follow-up of pa- tients from the Coronary Artery Surgery Study (CASS) potentially suitable for percutaneous translu- minal coronary angioplasty. Am Heart 1983; 106:981-988. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous trans- luminal angioplasty for treatment of stenotic lesions of a single coronary artery. 1982. Gosselin AJ, Fisher L, Judkins MP, et al. [National Heart, Lung, and Blood InstituteJ An estimate of the number of possible candidates from the CASS regis- try. Proceedings of the workshop on percutaneous transluminal coronary angioplasty June 15-16, 1979, March 1980:89-100. (U.S. Department of Health, Ed- ucation and Welfare, NIH Publication No. 80-2030~. American College of Cardiology/American Heart Asso- elation Task Force on Assessment of Cardiovascular Procedures. Guidelines for percutaneous translu- minal coronary angioplasty (PTCA). Ongoing. [Group judgment]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Johns Hopkins Program for Medical Technology and Practice Assessment. Analysis of the comparative cost- effectiveness of alternative strategies for managing acute heart attacks, including use of thrombolytic drugs, such as tissue plasminogen activator and step- tokinase, and emergency coronary angioplasty. Ongoing. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Percutaneous trans- luminal coronary angioplasty when multi-vessel dis- ease is involved (reassessment). Ongoing. Veterans Administration, Cooperative Studies Pro- gram. Percutaneous transluminal coronary angio- plasty (PTCA3. Ongoing. "Clinical trials] Pyrometry Keltner JL. [American Academy of Ophthalmology] Academy recommendation: automated perimetry. Ophthalmology 1984;91:51-56. "Information synthe- ses, Expert opinion] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Computer enhanced perimetry. 1983. Periodontal ligament injection American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Status report: the periodontal ligament injection. ~ Am Dent Assoc 1983; 106:222-224. Peritoneal dialysis Veterans Administration, Cooperative Studies Pro- gram. Renal failure self-care dialysis (hemo vs. perito- neal dialysis). t19803. "Clinical trials] Peritoneal dialysis cyclers ECRI Health Devices Program. Peritoneal dialysis cy- clers. Health Devices 1986; 15:31-61. Peritoneal dialysis solutions Food and Drug Administration, Center for Drugs and Biologics. Peritoneal dialysis solutions in plastic con- tainers.1982. (NTIS order no. PB82-915901~. [Infor- mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Permanent eyeliner California Medical Association, Medical Practice Opin- ion Program. Permanent eyeliner. 1985 Nov. (Medi- cal Practice Opinion #332) tGroup judgment] Pertussis vaccine American Academy of Pediatrics, Committee on Infec- tious Diseases. Pertussis vaccine. Pediatrics 1984 Aug. Koplan UP, Schoenbaum SC, Weinstein MC, Fraser DW. "Harvard School of Public Health, Institute for Health Research] Pertussis vaccine - an analysis of benefits, risks and costs. N Eng ~ Med 1979;301:906- 911. "Information syntheses] Phenobarbital Veterans Administration, Cooperative Studies Pro- gram. Evaluation of anti-epileptic drugs (phenobarb vs. phenytoin vs. primidone vs. carbamazopine). ~ 1980] "Clinical trials] Phenylketonuria screening American Academy of Pediatrics, Committee on Screening Genetics. Maternal phenylketonuria. Pedi- atrics 1985 Aug. American Academy of Pediatrics, Committee on Screening Genetics. New issues in newborn screening for phenylketonuria and congenital hypothyroidism. Pediatrics 1982 Jan. Phenylpropanolamine American Medical Association, Council on Scientific Af- fairs. OTC diet preparations containing phenylpro- panolamine (Resolution 100, I-851. 1986. tGroup judgment] Food and Drug Administration, Center for Drugs and Biologics. Phenylpropanolamine hydrochloride chlorpheniramine maleate. 1981. (NTIS order no. PB81-915910). fInformation syntheses, expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] 463

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Phenytoin Veterans Administration, Cooperative Studies Pro- gram. Evaluation of anti-epileptic drugs (phenobarb vs. phenytoin vs. primidone vs. carbamazopine). t1980] Clinical trials] Phlebography Hull R. Hirsch l, Sackett DL, et al. [McMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Replacement of venography in suspected ve- nous thrombosis by impedance plethysmography and I-f~brinogen leg scanning. Ann Intern Med 1981;94: 12-15. Hull R. Hirsh I, Sackett DL, et al. [McMaster University, Department of Clinical Epidemiology and Biostatis- tics] Clinical validity of a negative venogram in pa- tients with clinically suspected venous thrombosis. Circulation 1981 ;64:622. Phonocardiography . . . . Physician education American College of Physicians, Clinical Efficacy As- sessment Project. Phonocardiography. 1982. tInfor- mation syntheses] Photokymography National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Photokymography. 1983. Phototherapy Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Home photother- apy for neonataljaundice.1986. "Information synthe- ses] American Academy of Pediatrics, Committee on Fetus and Newborn. Home phototherapy. Pediatrics 1985 Jul. Physical therapy Kragg GR, Stokes B. "National Health Research and Development Program - Canada] The effects of com- prehensive home physiotherapy and supervision on patients with ankylosing spondylitis - A randomized controlled trial. 1986. (Grant No. 6606-2385-43). 464 Levison H. "National Health Research and Develop- ment Program - Canada] The effects of home care chest physiotherapy on the pulmonary function of patients with cystic fibrosis - a three year study to evaluate the effects of postural drainage with me- chanical percussion. l 986. (Grant No.6606-2355-44~. U.S. Administrators, Professional Policy Committee. Physical therapy. t7/86] tGroup judgment] Piper MC. [National Health Research and Development Program - Canada] Erect of early physical therapy on the neuromotor status of the high risk infant. 1985. (Grant No. 6605-1754-51~. Physical therapy with home exercise Wall TC. "National Health Research and Development Program - Canada] An evaluation of out-patent physiotherapy and a home exercise program in the restoration and improvement of locomotor function in residual hem~plegia. 1986. (Grant No. 6603-1161- 011. Laxdal OK. "National Health Research and Develop- ment Program - Canada] A study of the effectiveness of continuing medical education in improving physi- cian performance. 1986. (Grant No. 6608- 1144-07~. Schroeder SA, Myers LP, McPhee SJ, et al. [University of California, San Francisco, Institute for Health Poli- cy Studies] The failure of physician education as a cost containment strategy: report of a prospective con- trolled trial at a university hospital. JAMA 1984;252:225-230. Avorn JL, Soumerai SB. "National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Improv- ing drug-therapy decisions through educational out- reach: a randomized controlled trial of academically based "detailing." N Engl J Med 1983 Jun; 308~241: 1457-1463. Physiologic monitoring systems ECRI Health Devices Program. Physiologic monitoring systems. Health Devices 1985; 14: 143-182. ECRI Health Devices Program. Physiologic monitoring systems. Health Devices 1982; 11 :211 -47. Picture archiving and communication systems ECRI Technology Assessment Program. Image trans- mission and data compression. J Health Care Technol 1986;3:83-93. fInformation syntheses]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY American Hospital Association, Hospital Technology Series Program. Picture archiving and communica- tion systems. 1985. (Guideline report) Information syntheses, Expert opinion, Cost analyses] ECRI Technology Assessment Program. Digital imag- ing storage and retrieval. ~ Health Care Technol 1984; 1: 13-38. "Information syntheses] American College of Radiology, Task Force on Breast Cancer. Statement of the preservation of mammo- grams. 1983. tGroup judgment] Pindolol Food and Drug Administration, Center for Drugs and Biologics. Pindolol, 1982. (NTIS order no. PB82- 915904~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] P iperac ill l in Food and Drug Administration, Center for Drugs and Biologics. Sterile piperacillin sodium. 1982. (NTIS order no. PB82-9159011. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Piroxicam Food and Drug Administration, Center for Drugs and Biologics, Piroxicam. 1982. (NTIS order no. PB82- 9159031. fInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Plasma exchange Rock GA. National Health Research and Development Program - Canada] A clinical research project to study the role of plasma exchange and plasma infusion in the treatment of thrombotic thrombocytopenic pur- pura. 1986. (Grant No. 6613- 1158-46~. Rock GA. "National Health Research and Development Program - Canada] The role of plasma exchange in the management of immune thrombocytopenia. 1986. (Grant No. 6613- 1164-52). Rock GA. "National Health Research and Development Program - Canada] A clinical research project to study the role of plasma exchange in the treatment of Rh disease. 1985. (Grant No. 6613- 1156-52~. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Plasmapheresis and plasma exchange for thrombotic thrombocytopenic purpura. 1982. Plasma exchange devices Sarn, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Therapore (TM) system: summary of safety and effectiveness. 1986 Dec 24. (PMA no. 850092-000~. Parker Hannifin Corporation. tFood and Drug Admin- istration, Center for Devices and Radiological Health] Cryomax (TM): summary of safety and effectiveness. 1983 Feb 18. (PMA no. P820002-000). Cobe Laboratories, Inc. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Cobe century (R) TPE system: summary of safety and effectiveness. 1982 Mar 9. (PMA no. P810023-000~. Plasma filters Gambro, Inc. tFood and Drug Administration, Center for Devices and Radiological Health] Gambro fiber plasmafilter: summary of safety and effectiveness. 1986 Jul 7. (PMA no. P83006-000~. Plasma, Frozen National Institutes of Health, Consensus Development Program. Fresh frozen plasma: indications and risks. (Consensus Development Conference Statement, Sep 24-26 1984~. iGroup judgment] Plasma infusion Rock GA. iNational Health Research and Development Program - Canada] A clinical research project to study the role of plasma exchange and plasma infusion in the treatment of thrombotic thrombocytopenic pur- pura. 1986. (Grant No. 6613- 1158-46~. Plasma perfusion National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Plasma perfusion of charcoal filters for treatment of pruritis of cholestatic liver disease. 1983. 465

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Plasma separation systems Organon Teknika Corp. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Curesis plasma separator: summary of safety and ef- fectiveness. 1984 Nov 9. (PMA no. P830010-000~. Asahi Chemical Industry America, Inc. fFood and Drug Administration, Center for Devices and Radiological Health] Plasmaflo AP-05H Asahi plasma separator: summary of safety and effectiveness. 1983 Aug 12. (PMA no. P820033-0001. Travenol Laboratories. tFood and Drug Administra- tion, Center for Devices and Radiological Health] Plasma separation system: summary of safety and ef- fectiveness. 1983 Nov 3. (PMA no. P820032-000~. Plasmapheresis Cole EH, Cattran DC. "National Health Research and Development Program - Canada] A controlled trial of Plasmapheresis in idiopathic rapidly progressive glo- merulonephritis. 1986. (Grant No. 6606-2372-52~. National Institutes of Health, Consensus Development Program. The utility of therapeutic Plasmapheresis for neurological disorders. (Consensus Development Conference Statement, fun 2-4 1986J. [Group judg- ment] American Medical Association, Council on Scientific Af- fairs. Current status of therapeutic Plasmapheresis and related techniques. JAMA 1985 Feb 8;253:819- 825. [Group judgment] American College of Obstetricians and Gynecologists, Committee on Technical Bulletins. Blood component therapy. 1984 Jul. (Technical bulletin no.78~. [Expert . . Oplnlon American Academy of Neurology, Practice Committee. Plasmapheresis in treatment of multiple sclerosis. 1983 Feb. [Expert opinion, Group judgment] American Academy of Neurology, Practice Committee. Plasmapheresis in treatment of myasthenia gravis. 1983 Feb. fExpert opinion, Group judgment] California Medical Association, Medical Practice Opin- ion Program. Plasmapheresis for rheumatoid arthri- tis. 1982 Aug. (Medical Practice Opinion #263) tGroup judgments California Medical Association, Medical Practice Opin- ion Program. Plasmapheresis for six conditions. 1982 Sep. (Medical Practice Opinion #249) tGroup judg- ment] 466 California Medical Association, Medical Practice Opin- ion Program. Plasmapheresis treatment of multiple sclerosis. 1981 Dec. (Medical Practice Opinion #212) tGroup judgment] ECRI Technology Assessment Program. Therapeutic plasmapheresis. Issues Health Care Technol 1981 ;sec.5.P.1. [Information syntheses] Plasticizers Rock GA. [National Health Research and Development Program - Canada] An evaluation of the effects of various plasticizers and/or leachables contained in plastic medical devices on blood components, blood donors, and patients. 1986. (Grant No. 6613-1239- 52~. Rock GA. "National Health Research and Development Program - Canada] Toxicological evaluation of plasti- cizers and their metabolites leaching from plastic medical devices into human plasma. l 986. (Grant No. 6613-1177-52). Platelet transfusion National Institutes of Health, Consensus Development Program. Platelet transfusion therapy. (Consensus Development Conference Statement, Oct 6-8 1986~. [Group judgment] CBO (Centraal Begeleidingsorgaan voor de Intercolle- giale Toetsing) Consensus Development Program. Thrombocytes transfusion policy. 1984. tDutch lan- guage only] [Group judgment, Expert opinion] Plethysmography ECRI Technology Assessment Program. Plethysmogra- phy for diagnosing deep vein thrombosis. Issues Health Care Technol 1984;sec.5.P.7. "Information syntheses] National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Photoplethysmo- graphy. 1982. Hull R. Hirsch I, Sackett DL, et al. fMcMaster Universi- ty, Department of Clinical Epidemiology and Biosta- tistics] Replacement of venography in suspected ve- nous thrombosis by impedance plethysmography and I-fibrinogen leg scanning. Ann Intern Med 1981;94: 12-15. National Center for Health Services Research and Health Care Technology Assessment, Office of Health Technology Assessment. Diagnostic tests for impotency: plethysmography. Ongoing.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Pneumococcal vaccine American College of Physicians, Clinical Efficacy As- sessment Project. Pneumococcal vaccine. Ann Intern Med 1986; 104:118-120 American Academy of Pediatrics, Committee on Infec- tious Diseases. Recommendations for using pneumo- coccal vaccine in children. Pediatrics 1985 fun. American Academy of Pediatrics, Committee on Infec- tious Diseases. Recommendations for using pneumo- coccal vaccine in children. Pediatrics 1985 Jun. Office of Technology Assessment, U.S. Congress. Up- date of Federal activities regarding the use of pneu- mococcal vaccine. Washington, D.C.: U.S. Govern- ment Printing Office, May 1984. American Medical Association, Council on Scientific Af- fairs. Pneumococcal, influenza and hepatitis-B vac- cine (Resolution 75, A-82. 1982. tGroup judgment] Veterans Administration, Cooperative Studies Pro- gram. Pneumococcal capsular vaccine immunity in high risk patients. t19803. [Clinical trials] Polydextrose American Diabetes Association. Position statment on polydextrose. 1986. tExpert opinion, Group judg- ment1 Polypectomy Wayne ~D. Colonoscopic polypectomy. In: American Society for Gastrointestinal Endoscopy, Committee on Technology Assessment. Therapeutic gastrointes- tinal endoscopy: an information resource manual. 1987. "Information syntheses, Expert opinion, Group judgment, Cost analyses] Polyurethane tubing Food and Drug Administration, Center for Devices and Radiological Health. Surface cracking of polyure- thane tubing resulting from subcutaneous implanta- tion in dogs. 1985. (NTIS Order No. PB85-171619/ AS). Positron emission tomography American Hospital Association, Hospital Technology Series Program. Positron emission tomography. 1987. (Guideline report) fInformation syntheses, Ex- pert opinion, Cost analyses] Health Council of the Netherlands. Positron emission tomography. 1986. "English summary only]. Health Council of the Netherlands. PET-scan. Ongoing assessment. Postmarketing surveillance Strom BL, Melmon KL, Miettinen OS. FMcGill Universi- ty, Department of Epidemiology and Biostatistics] Post marketing studies of drug efficacy: why? Am Med 1985;78:475-480. Office of Technology Assessment, U.S. Congress. Post- marketing surveillance of prescription drugs. Wash- ington, D.C.: U.S. Government Printing Office, No- vember 1982. Health Council of the Netherlands. Post marketing sur- veillance of drugs. Planned. Postural drainage Levison H. "National Health Research and Develop- ment Program - Canada] The effects of home care chest physiotherapy on the pulmonary function of patients with cystic fibrosis - a three year study to evaluate the effects of postural drainage with me- chanical percussion.1986. (Grant No.6606-2355-44~. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Respiratory therapy: postural drainage. 1982. fInformation syntheses; Posture control devices Foort J. "National Health Research and Development Program - Canada] A modular exoskeletal system for supporting heavy disabled people in the sitting posi- tion. 1986. (Grant No. 6610-1291-51). Tredwell S}. "National Health Research and Develop- ment Program - Canada] Pelvic stabilizer for postural control. 1986. (Grant No. 6610- 1422-51). Potassium chloride Food and Drug Administration, Center for Drugs and Biologics. Potassium chloride. 1987. (Summary basis of approval substitute, NDA # 19- 123~. fInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testings Food and Drug Administration, Center for Drugs and Biologics. Potassium chloride. 1987. (Summary basis of approval, NDA # 19-439~. fInformation syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] 467

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Food and Drug Administration, Center for Drugs and Biologics. Potassium chloride. 1987. (Summary basis of approval, NDA# 19- 123). f Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. CaC12, MgCl, Kcl, & NaCl. 1982. (NTIS order no. PB82-9159021. "Information syntheses, Ex- pert opinion, Epidemiological and other observation- al methods, Clinical trials, Bench testing] Prenatal care Prenatal care and its relationship to Medicaid costs. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Tan 1986. (HCFA Pub. No. 03219). National Institute of Child Health and Human Devel- opment, Division of Maternal and Child Health. Con- tent of prenatal care. Ongoing. tGroup judgment, Expert opinion] Food and Drug Administration, Center for Drugs and Biologics. NaCl, KC1, MgSO4, NaPO4, & KPO4. 1982. (NTIS order no. PB82-9159011. [Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Robitaille Y. Kramaer MS. tMcGill University, Depart ment of Epidemiology and Biostatistics] Does partici pation in prenatal courses lead to heavier babies? Am I Public Health 1985;75: 1186-1189. Food and Drug Administration, Center for Drugs and Biologics. Potassium chloride 1981. (NTIS order no. PB81 -915901). f Information syntheses, Expert opin- ion, Epidemiological and other observational meth- ods, Clinical trials, Bench testing] Potassium citrate Food and Drug Administration, Center for Drugs and Biologics. Potassium citrate. 1987. (Summary basis of approval, NDA #19-071). "Information syntheses, Expert opinion, Epidemiological and other observa- tional methods, Clinical trials, Bench testing] Potassium phosphate Food and Drug Administration, Center for Drugs and Biologics. NaCl, KC1, MgSO4, NaPO4, & KPO4. 1982. (NTIS order no. PB82-915901~. LInformation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Praziqu an tell Food and Drug Administration, Center for Drugs and Biologics. Praziquantel, 1983. (NTIS order No. PB83- 915901~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Prazosin Veterans Administration, Cooperative Studies Pro- gram. Prazosin vs. hydralazine in hypertension. [1980] fClinical trials] 468 Prenatal education Pressure transducers ECRI Health Devices Program. Disposable pressure transducers. Health Devices 1984; 13:268-90. P"madone Veterans Administration, Cooperative Studies Pro- gram. Evaluation of anti-epileptic drugs (phenobarb vs. phenytoin vs. primidone vs. carbamazepine). t1980] "Clinical trials] Progesdn receptor assays New England Nuclear. [Food and Drug Administra- tion, Center for Devices and Radiological Health] Rianen (TM) (3H) progestin receptor assay- kit: sum- mary of safety and effectiveness. 1983 Oct 12. (PMA no. P820052-000). Prolotherapy American Academy of Neurology, Practice Committee. Prolotherapy.1981 Jul. tExpert opinion, Groupjudg- ment] Propranolol Food and Drug Administration, Center for Drugs and Biologics. Propranolol HC1 liquid. 1987. (Summary basis of approval substitute, NDA# 19-536). [Infor- mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing]

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Food and Drug Administration, Center for Drugs and Biologics. Propranolol SR/hydrochlorothiazide.1987. (Summary basis of approval, NDA ~ 19-059~. fInfor- mation syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Food and Drug Administration, Center for Drugs and Biologics. Propranolol hydrochloride.1987. (Summa- ry basis of approval, NDA #18-553~. "Information syntheses, Expert opinion, Epidemiological and other observational methods, Clinical trials, Bench testing] Oster G. Huse DM, Delea TE, Savage DD, Colditz GA. tPolicy Analysis, Inc.] Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks. 1987 Mar. Friedman LM, Byington RP, Capone R}, et aL for the Beta-Blocker Heart Attack Trial Research Group. "National Heart, Lung, and Blood Institute] Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia. ~ Am Coll Cardiol 1986;7: 1-8. Morganroth }, Lichstein E, Byington R. "National Heart, Lung, and Blood Institute] Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias. Prev Med 1985; 14:346-357. Furberg CD, Hawkins CM, Lichstein E for the Beta- Blocker Heart Attack Study Group. "National Heart, Lung, and Blood Institute] Effect of propranolol in postinfarction patients with mechanical or electrical complications. Circulation 1984;69: 761 -765. Roberts R. Croft C, Gold HK, et al and the MILIS Study Group. "National Heart, Lung, and Blood Institute] Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. N Eng ~ Med 1984;311 :218-225. Beta-Blocker Heart Attack Trial Research Group. tNa- tional Heart, Lung, and Blood Institute] A random- ized trial of propranolol in patients with acute myo- cardial infarction. II. Morbidity results. JAMA 1983;250:2814-2819. Goldstein, S. "National Heart, Lung, and Blood Insti- tute] Propranolol therapy in patients with acute myo- cardial infarction: the Beta-Blocker Heart Attack Tri- al. Circulation 1983;67(Suppl 1~:53-57. Lichstein E, Morganroth {, Harrest R. et al. "National Heart, Lung, and Blood Institute] Effect of propran- olol on ventricular arrhythmia: the Beta-Blocker Heart Attack Trial Experience. Circulation 1983;67(Suppl b:5-10. Beta-Blocker Heart Attack Trial Research Group. tNa- tional Heart, Lung, and Blood Institute] A random- ized trial of propranolol in patients with acute myo- cardial infarction. 1. Mortality results. JAMA 1982;247: 1707-1713. Veterans Administration, Cooperative Studies Pro- gram. Comparison of propranolol with hydrochloro- thiazide for the "step 1" treatment of hypertension. t1980] [Clinical trials] Veterans Administration, Cooperative Studies Pro- gram. Oxprenolol vs. propranolol in hypertension. ~ 19803. "Clinical trials] Prospective payment systems Annual reports to Congress on the impact of the Medi- care Hospital prospective payment system. In: Office of Research and Demonstrations, Health Care Fi- nancing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Evaluability assessment of the Medicare prospective payment system on long-term care. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Home health agency prospective payment demonstra- tion. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Impact of DRG-based prospective payment system on quality of care for hospitalized Medicare patients. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Impact of Medicare's prospective payment system and private sector initiatives: the Blue Cross and Blue Shield Organization's experiences. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Impact of the prospective payment system on the quali- ty of inpatient care. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). 469

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Incentive prospective payment system for hospitals through fiscal intermediaries (Massachusetts). In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Longitudinal study of the impact of prospective reim- bursement under Medicaid on nursing home care in Maine. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. New York State case-mix, prospective reimbursement system for long-term care. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Office of Technology Assessment, U.S. Congress. OTA's second report on the Prospective Payment As- sessment Commission (special report). Washington, D.C.: Office of Technology Assessment, March 1986. Payment options for nonphysician anesthetists under the prospective payment system. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. fan 1986. (HCFA Pub. No. 03219~. Project HOPE, Center for Health Affairs. PPS pay- ments for expensive devices: issues and evidence. (for Prospective Payment Assessment Commission). 1986 Aug. tCost analyses] Prospective Payment Assessment Commission. Medi- care prospective payment and the American health care system: report to the Congress. February 1986. Washington, D.C.: Government Printing Office, 1986. "Information syntheses, Cost analyses] Prospective Payment Assessment Commission. Report and recommendataions to the Secretary, U.S. Depart- ment of Health and Human Services, April 1, 1986. Washington, DC: Government Printing Of rice, 1986. [Information syntheses, Cost analyses] Prospective Payment Assessment Commission. Techni- cal appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Hu- man Services, April 1, 1986. Washington, DC: Gov- ernment Printing Office, 1986. "Information synthe- ses, Cost analyses] 47O Prospective payment beneficiary impact study. In: Of- fice of Research and Demonstrations, Health Care Financing Administration. Health care financing sta- tus report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219~. Prospective payment in rehabilitation hospitals and pro- grams. In: Office of Research and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Tan 1986. (HCFA Pub. No. 03219). Prospective payment of physicians. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. tan 1986. (HCFA Pub. No. 03219). Prospective payment system and post-hospital care: use, cost, and market changes. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. {an 1986. (HCFA Pub. No. 03219). Prospective payment system for acute and chronic care hospitals in Maryland. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Prospective reimbursement system based on patient case mix for New Jersey hospitals. In: Office of Re- search and Demonstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Selected analyses of the prospective payment system's impact on hospital's behavior In: Office of Research and Demonstrations, Health Care Financing Admin- istration. Health care financing status report: re- search and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 03219). Office of Technology Assessment, U.S. Congress. Medi- care's prospective payment system: strategies for eval- uating cost, quality, and medical technology. Wash- ington, D.C.: U.S. Government Printing Office, Octo- ber 1985. Office of Technology Assessment, U.S. Congress. OTA's first report on the Prospective Payment As- sessment Commission (special report). Washington, D.C.: Off~ceof Technology Assessment, March 1985.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Prospective Payment Assessment Commission. Report and recommendations to the Secretary, U.S. Depart- ment of Health and Human Services, April 1, 1985. Washington, DC: Government Printing Office, 1985. fInformation syntheses, Cost analyses] Prospective Payment Assessment Commission. Techni- cal appendixes to the report and recommendations to the Secretary, U.S. Department of Health and Hu- man Services, April 1, 1985. Washington, DC: Gov- ernment Printing Office, 1985. "Information synthe- ses, Cost analyses] American Hospital Association, Hospital Technology Series Program. Equipment acquisition under pro- spective payment.1984. (Guideline report) fInforma- tion syntheses, Expert opinion, Cost analysesJ Project HOPE, Center for Health Affairs. The effect of PPS on the diffusion and use of medical technologies. (for Prospective Payment Assessment Commission). Ongoing, expected 1987. [Information syntheses] Prostatic acid phosphatase kits United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Com- parative evaluation of prostatic acid phosphatase kits. 1985 May. (Report no. STB3A/85/21) tEpidemiologi- cal and other observational methods, Bench testing] Prostheses Foort }. "National Health Research and Development Program- Canada] Amputee fitting standard shape processing. 1986. (Grant No. 6610- 1289-51). Saunders CG, Morrison {B. Foort I. "National Health Research and Development Program - Canada] Am- putee fitting standard shape processing (sealing) Part II. 1986. (Grant No. 6610- 1369-51). Protein-calorie therapy with anabolic steroids Veterans Administration, Cooperative Studies Pro- gram. Protein-calorie therapy in combination with anabolic steroids in alcoholic hepatitis. Ongoing. (Clinical trials] Prothrombin time Blue Cross and Blue Shield Association, Medical Neces- sity Program. Activated partial thromboplastin time and prothrombin time.1987. [Information syntheses] Prothrombin-complex concentrate Lusher ~M, Shapiro SS, Palascak ~E, et al. "National Heart, Lung, and Blood Institute] Efficiency of pro- thrombin-complex concentrates in hemophiliacs with antibodies to Factor VIII. N Eng ~ Med 1980;303:421. Psychoactive drugs American Academy of Pediatrics, Committee on Drugs. Psychotropic drugs in pregnancy and lactation. Pedi- atrics 1982 Feb. Psychosurgery Health Council of the Netherlands. Psychosurgery. On- go~ng. Psychotherapy Piper WE. "National Health Research and Development Program - Canada] A controlled study of patient suit- ability and outcome in short term, individual psycho- therapy. 1986. (Grant No. 6609- 1367-46~. Office of Technology Assessment, U.S. Congress. The efficacy and cost effectiveness of psychotherapy. Washington, D.C.: U.S. Government Printing Office, Oct 1980. (FIealth technology case study series #18) Pulmonary function tests American College of Physicians, Clinical Efficacy As- sessment Project. Preoperative pulmonary function tests, expected completion 1988. "Information syn- theses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Diagnostic studies for respiratory pa- tients: pulmonary function tests. 1982. "Information syntheses] Subcommittee on Special Services in Hospitals. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Divi- sion] Pulmonary function laboratories guidelines. 1982. "Information syntheses, Expert opinion, Group judgments Punctal occlusion American Academy of Ophthalmology. Punctal occlu- sion for the dry eye. San Francisco, CA: American Academy of Ophthalmology, 1987. fInformation syn- theses, Expert opinion] 471

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY PUVA therapy Stern RS and members of the 16-center PUVA Follow- up Study. "Harvard School of Public Health, Institute for Health Research] Long-term utilization of PUVA therapy for psoriasis - evidence for efficacy and cost savings. ~ Am Acad Dermatol, in press. "Clinical trials] Blue Cross and Blue Shield Association, Technology Evaluation and Coverage Program. Psoralens and ul- traviolet A (PUVA). 1986. "Information syntheses] American Academy of Pediatrics, Committee on Drugs. PUVA: a caution. Pediatrics 1978 Aug. Pyelography American College of Physicians, Clinical Efficacy As- sessment Project. Intravenous pyelography, expected completion 1988. "Information syntheses] Pyrimethamine Food and Drug Administration, Center for Drugs and Biologics. Sulfadoxine and pyrimethamine. 1982. (NTIS order no. PB82-915901). [Information synthe- ses, Expert opinion, Epidemiological and other obser- vational methods, Clinical trials, Bench testing] Quality assurance programs Howanitz Pi, ed. Quality assurance in physician office, bedside, and home testing. Skokie, IL: College of American Pathologists. (expected 1987) tExpert opin- ion, Bench testing] Evaluation of three-state demonstration in nursing home quality assurance. In: Office of Research and Demonstrations, Health Care Financing Administra- tion. Health care financing status report: research and demonstrations in health care financing. Jan 1986. (HCFA Pub. No. 032191. Improving New York State's Nursing Home Quality Assurance Program. In: Office of Research and Dem- onstrations, Health Care Financing Administration. Health care financing status report: research and demonstrations in health care financing. Ian 1986. (HCFA Pub. No. 03219~. Scherer K, Farrell P. [National Health Research and Development Program - Canada] A project for mea- suring the quality of nursing care in Manitoba. 1986. (Grant No. 6607- 1238-461. 472 Food and Drug Administration, Center for Devices and Radiological Health. Recommendations for quality assurance programs in nuclear medicine facilities. (GPO Stock No. 017-015-00225-0, NTIS Order No. 85- 145720/AS). Penner DW. [National Health Research and Develop- ment Program - Canada] Quality control (quality eval- uation) for diagnostic surgical pathology and cyto- pathology. l 985. (Grant No.6607- 1279-55~. Food and Drug Administration, Center for Devices and Radiological Health. A basic quality assurance pro- gram for small diagnostic radiology facilities. 1984. (NTIS Order No. PB84- 119098~. Poddercord M, Taylor RN. National Center for Health Services Research and Health Care Technology As- sessment, Division of Extramural Research] Evalua- tion of laboratory quality assurance activities. 1984. (NTIS order no. PB84-205913) Food and Drug Administration, Center for Devices and Radiological Health. Quality assurance in nuclear medicine - proceedings of an international sympo- sium and workshop, held in Washington, D.C., April 27-29.1981.1982. (GPO Stock No.017-015-00221-7, NTIS Order No. PB84- 199306~. McDonald C}. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] A controlled trial of a quality assurance mechanism. 1982. (NTIS order no. PB82-265539) Radial keratotomy American Academy of Ophthalmology. Radial kerato- tomy for myopia. San Francisco, CA: American Acad- emy of Ophthalmology, expected completion Octo- ber, 1987. j Information syntheses, Expert opinion] California Medical Association, Medical Practice Opin- ion Program. Radial keratotomy for myopia. 1985 Apr. (Medical Practice Opinion #244) [Group judg- ment] American Medical Association, Diagnostic and Thera- peutic Technology Assessment. Radial keratotomy for the treatment of myopia. JAMA 1983 Jul 15. [Expert opinon, Information syntheses] ECRI Technology Assessment Program. Radial kerato- tomy. Issues Health Care Technol 1982;sec.5.R.1. fInformation syntheses] Radiant warmers ECRI Health Devices Program. Infant radiant warmers. Health Devices 1984; 13: 119-45.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Radiation measurement Food and Drug Administration, Center for Devices and Radiological Health. Computer program for ab- sorbed dose to the breast in mammography. 1986. (GPO Stock No. 017-015-00228-4, NTIS Order No. PB86-114774/AS). Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of radiation expo- sure from diagnostic radiology examinations - tech- nique/exposure guides for the craniocaudal projec- tion in mammography. 1986. (NTIS Order No. PB86- 126075/AS). Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of radiation expo- sure from diagnostic radiology examinations: general recommendations. 1986. (NTIS Order No. PB86- 125903/AS). Food and Drug Administration, Center for Devices and Radiological Health. Recommendations for evalua- tion of radiation exposure from diagnostic radiology examinations.1986. (NTIS Order No. PB86-125846/ AS). Stuchly SS. "National Health Research and Develop- ment Program - Canada] Radiowave and microwave dosimetry in human models. 1986. (Grant No. 6606- 2455-52). Food and Drug Administration, Center for Devices and Radiological Health. Evaluation of radiation expo- sure from diagnostic radiology examinations (techni- que/exposure guides for the dental bitewing projec- tion). 1985. (FDA Pub No. 85-8245). Radiation protection Food and Drug Administration, Center for Devices and Radiological Health. Embryo, fetus, infant . . . recom- mendations to minimize diagnostic nuclear medicine exposure. 1986. (FDA Pub. No. FDA86-8254). Food and Drug Administration, Center for Devices and Radiological Health. Patient exposure reduction dur- ing scoliosis radiography. 1985. (GPO Stock No.017- 015-00227-6). Food and Drug Administration, Center for Devices and Radiological Health. Reducing patient exposure dur- ing scoliosis radiography. 1985. (FDA Pub No. FDA 85-8252). Radiation therapy American Hospital Association, Hospital Technology Series Program. Radiation therapy planning. 1987. (Guideline report) "Information syntheses, Expert opinion, Cost analyses California Medical Association, Medical Practice Opin- ion Program. Stereotactic heavy-ion irradiation for arteriovenous malformations. 1985 Sep. (Medical Practice Opinion #316) tGroup judgment] U.S. Administrators, Professional Policy Committee. Radiation therapy for lung carcinoma. Ongoing. tGroup judgments Radioallergosorbent test California Medical Association, Medical Practice Opin- ion Program. Radioallergosorbent test (RAST) 1984 Dec. (Medical Practice Opinion #255) tGroup judg- ment] American College of Physicians, Clinical Efficacy As- sessment Project. Radio allergosorbent technique (RAST). 1981. "Information syntheses] California Medical Association, Medical Practice Opin- ion Program. Paper radioallergosorbent test (PRAST). 1981 Aug. (Medical Practice Opinion #256) tGroup judgment] Radiographic contrast dyes ECRI Technology Assessment Program. Low-osmolali- ty radiographic contrast agents. Issues Health Care Technol 1986;sec.5.L.4. fInformation syntheses] American Academy of Pediatrics, Committee on Radiol- ogy. Water-soluble contrast material. Pediatrics 1978 Jul. Johns Hopkins Program for Medical Technology and Practice Assessment. A synthesis of the published lit- erature regarding the comparative toxicity of high osmolar and low osmolar radiographic contrast dyes. Ongoing. Johns Hopkins Program for Medical Technology and Practice Assessment. An analysis of economic and policy issues related to the introduction of low osmo- lar radiographic contrast dyes. Ongoing. Johns Hopkins Program for Medical Technology and Practice Assessment. A clinical trial at determining the comparative nephrotoxicity and comparative cost-effectiveness of low osmolar versus high osmolar radiographic contrast dyes. Planned. 473

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Radiographic darkrooms American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. Recommenda- tions for radiographic darkrooms and darkroom practices. ~ Am Dent Assoc 1982;104:636-637. Radiographic equipment United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Siemens Optilux 57 intensifier associated with the Sircam 100mm camera and Polyphos 300E generator. 1986 Jan. (Report no. STB6E/86/4) [Epi- demiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. An evaluation of eight non-invasive electronic KV mea- suring instruments which are commercially available in the UK. 1985 {un. (Report no. STB6E/85/19) tEpi- demiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Picker Clinix C servo chest unit.1985 Jun. (Report no. STB6E/85/14) tEpidemiological and oth- er observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Siemens basic radiological system (BRS) to WHO modified specification. 1985 Sep. (Report no. STB6E/85/34) LEpidemiological and other obser- vational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Sine Mobil 3N and 3H mobile imaging intensifiers. 1985 Sep. (Report no. STB6E/85/30) tEpidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Todd Research BRS to WHO modified specification. 1985 Sep. (Report no. STB6A/85/36) tEpidemiological and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Wolverson Mylo X radiographic unit, Royal Preston Hospital, North Manchester. 1985 Apr. (Report no. STB6E/85/8) iEpidemiological and other observational methods, Bench testing] 474 United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of a Siemens Polydoros 80 X-ray generator. 1985 Aug. (Report no. STB6E/85/27) tEpidemiologi- cal and other observational methods, Bench testing] United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. In- troduction to imaging cameras with assessment of Matric HPC 1010/4. 1985 Nov. (Report no. STB6E/ 85/42) tEpidemiological and other observational methods, Bench testing] Radiographic film United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. Phys- ical evaluation of the imaging performance of the Agfa Gevaert range of screen film systems.1985 Aug. (Report no. STB6E/85/26) tEpidemiological and oth- er observational methods, Bench testing] Radiographic film processors United Kingdom Department of Health and Social Se- curity, Medical Devices Evaluation Programme. As- sessment of Kodak M8 radiographic film processor. 1985 Tun. (Report no. STB6E/85/24) [Epidemiologi- cal and other observational methods, Bench testing] ECRI Health Devices Program. X-ray film processors. Health Devices 1982; 11 :99-115. Radiography Blue Cross and Blue Shield Association, Medical Neces- sity Program. Routine preoperative and general hos- pital admission chest x-rays. 1987. "Information syn- theses] Schwarz RD. "National Health Research and Develop- ment Program - Canada] An assessment of the need for radiological evaluation of all girls with recurrent urinary infection. 1986. (Grant No. 6603-1201-42~. U.S. Administrators, Professional Policy Committee. Multiple views - diagnostic radiology. t7/86] (Group judgment] Food and Drug Administration, Center for Devices and Radiological Health. Assessment and modification of clinical utility in diagnostic radiology: the oral chole- cystogram and the upper gastrointestinal examina- tions. 1985. (NTIS Order No. PB-85-246916/AS). Food and Drug Administration, Center for Devices and Radiological Health. Extremity radiography follow- ing trauma: an overview. 1985. (GPO Stock No. 017- 015-00224-1, NTIS Order No. PB85-1150531.

ASSESSMENT REPORT CITATIONS BY TECHNOLOGY Podgorsak FB. "Department Radiation Oncology, McGill University] "Medical Research Council - Cana- da] Radiographic imaging by solid state electrostatic techniques. (Grant period 1981 - 1985~. Blue Cross and Blue Shield Association, Medical Neces- sity Program. Chest x-ray examinations. 1984. tInfor- mation syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Radionuclide bone scan and x-ray of bones in the evaluation of bone metastases. 1984. "Information syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Ultrasound and x-ray pelvimetry in ma- ternity care. 1984. "Information syntheses] Brand DA. [National Center for Health Services Re- search and Health Care Technology Assessment, Di- vision of Extramural Research] An x-ray screening protocol for extremity injuries. 1984. (NTIS order no. PB84-111384) American Academy of Pediatrics, Committee on Hospi- tal Care. Preoperative chest radiographs. Pediatrics 1983 May. Liang M, Komaroff A. "Harvard School of Public Health, Institute for Health Research] Roentgeno- grams in primary care patients with acute low back pain. Arch Intern Med 1982; 142: 1108- 1112. [Epide- miological methods] Office of Technology Assessment, U.S. Congress. As- sessment of four common X-ray procedures. Wash- ington, D.C.: U.S. Government Printing Office, April 1982. (Health technology case study series #19) American Academy of Pediatrics, Committee on Radiol- ogy. Comparison radiographs of extremities in child- hood: recommended usage. Pediatrics 1980 Mar. American Academy of Pediatrics, Committee on Radiol- ogy. Radiation of pregnant women. Pediatrics 1978 Jan. Neuhauser D. "Harvard School of Public Health, Insti- tute for Health Research] Cost effective clinical deci- sion making: are routine pediatric preoperative chest X-rays worth it? Ann Radiol (Paris) 1978;21:80-83. "Information syntheses] U.S. Administrators, Professional Policy Committee. Protocol for use of multiple EKG's and chest X-rays in CCUs and ICUs. Ongoing. tGroup judgment] Radionuclide angiography Pryor DB, et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] Prognostic indica- tors from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984 [an;53:18-22. Gibbons R], et al. "National Center for Health Services Research and Health Care Technology Assessment, Division of Extramural Research] The use of radio- nuclide angiography in the diagnosis of coronary ar- tery disease; a logistic regression analysis. Circulation 1983 Oct;68~4~:740-746. Radionuclide imaging O'Rourke RA, Chatterjee K, Dodge HT, et al. fAmeri- can College of Cardiology/American Heart Associa- tion Task Force on Assessment of Cardiovascular Procedures] Guidelines for clinical use of cardiac ra- dionuclide imaging. J Am Coll Cardiology 1986 Dec;8: 1471-83. tGroup judgment] U.S. Administrators, Professional Policy Committee. Radionuclide scans (post-operative). t7/86] (Group judgment1 U.S. Administrators, Professional Policy Committee. Radionuclide scans (pre-operative). t7/861 [Group judgment] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Outmoded radionuclide imaging pro- cedures. 1984. "Information syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Radionuclide bone scan and x-ray of bones in the evaluation of bone metastases. 1984. [Information syntheses] Blue Cross and Blue Shield Association, Medical Neces- sity Program. Radionuclide brain scan in the evalua- tion of adult intracranial disease. 1984. "Information syntheses] Office of Technology Assessment, U.S. Congress. Car- diac radionuclide imaging and cost-effectiveness. Washington, D.C.: U.S. Government Printing Office, May 1982. (Health technology case study series #13) Stason WB, Fortess E. "Harvard School of Public Health, Institute for Health Research] Case study #13: Cardiac radionuclide imaging and cost effective- ness. In: Implications of cost-effectiveness analysis of medical technology. Office of Technology Assess- ment, U.S. Congress, 1982. fInformation syntheses] 475

MEDICAL TECHNOLOGY ASSESSMENT DIRECTORY Radionuclide laboratories Health Council of the Netherlands. Classification of and standards for radionuclide laboratories. 1985. (Eng- lish summary only). Subcommittee on Institutional Program Guidelines. tHealth and Welfare Canada, Health Services and Promotion Branch, Institutional and Professional Services Division] Nuclear medicine units in hospitals. 1985. "Information syntheses, Expert opinion, Group judgments Radiopaque plastics American Dental Association, Council on Dental Mate- rials, Instruments and Equipment. The desirability of using radiopaque plastics in dentistry: a status report. T Am Dent Assoc 1981;102:347-349. Radiopharmaceutical